
<html lang="en"     class="pb-page"  data-request-id="5cf98c80-1d19-4f02-b50c-acd14b177116"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-14;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.8b00372;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Design and Synthesis of Novel and Selective Glycine Transporter-1 (GlyT1) Inhibitors with Memory Enhancing Properties" /></meta><meta name="dc.Creator" content="Vincent J.  Santora" /></meta><meta name="dc.Creator" content="Theresa A.  Almos" /></meta><meta name="dc.Creator" content="Richard  Barido" /></meta><meta name="dc.Creator" content="Jillian  Basinger" /></meta><meta name="dc.Creator" content="Chris L.  Bellows" /></meta><meta name="dc.Creator" content="Brett C.  Bookser" /></meta><meta name="dc.Creator" content="J. Guy  Breitenbucher" /></meta><meta name="dc.Creator" content="Nicola J.  Broadbent" /></meta><meta name="dc.Creator" content="Clifford  Cabebe" /></meta><meta name="dc.Creator" content="Chih-Kun  Chai" /></meta><meta name="dc.Creator" content="Mi  Chen" /></meta><meta name="dc.Creator" content="Stephine  Chow" /></meta><meta name="dc.Creator" content="De Michael  Chung" /></meta><meta name="dc.Creator" content="Lindsay  Crickard" /></meta><meta name="dc.Creator" content="Anne M.  Danks" /></meta><meta name="dc.Creator" content="Graeme C.  Freestone" /></meta><meta name="dc.Creator" content="Dany  Gitnick" /></meta><meta name="dc.Creator" content="Varsha  Gupta" /></meta><meta name="dc.Creator" content="Christine  Hoffmaster" /></meta><meta name="dc.Creator" content="Andrew R.  Hudson" /></meta><meta name="dc.Creator" content="Alan P.  Kaplan" /></meta><meta name="dc.Creator" content="Michael R.  Kennedy" /></meta><meta name="dc.Creator" content="Dong  Lee" /></meta><meta name="dc.Creator" content="James  Limberis" /></meta><meta name="dc.Creator" content="Kiev  Ly" /></meta><meta name="dc.Creator" content="Chi Ching  Mak" /></meta><meta name="dc.Creator" content="Brittany  Masatsugu" /></meta><meta name="dc.Creator" content="Andrew C.  Morse" /></meta><meta name="dc.Creator" content="Jim  Na" /></meta><meta name="dc.Creator" content="David  Neul" /></meta><meta name="dc.Creator" content="John  Nikpur" /></meta><meta name="dc.Creator" content="Marco  Peters" /></meta><meta name="dc.Creator" content="Robert E.  Petroski" /></meta><meta name="dc.Creator" content="Joel  Renick" /></meta><meta name="dc.Creator" content="Kristen  Sebring" /></meta><meta name="dc.Creator" content="Samantha  Sevidal" /></meta><meta name="dc.Creator" content="Ali  Tabatabaei" /></meta><meta name="dc.Creator" content="Jenny  Wen" /></meta><meta name="dc.Creator" content="Yingzhuo  Yan" /></meta><meta name="dc.Creator" content="Zachary W.  Yoder" /></meta><meta name="dc.Creator" content="Douglas  Zook" /></meta><meta name="dc.Description" content="We report here the identification and optimization of a novel series of potent GlyT1 inhibitors. A ligand design campaign that utilized known GlyT1 inhibitors as starting points led to the identifi..." /></meta><meta name="Description" content="We report here the identification and optimization of a novel series of potent GlyT1 inhibitors. A ligand design campaign that utilized known GlyT1 inhibitors as starting points led to the identifi..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 11, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00372" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00372" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00372" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00372" /></link>
        
    
    

<title>Design and Synthesis of Novel and Selective Glycine Transporter-1 (GlyT1) Inhibitors with Memory Enhancing Properties | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00372" /></meta><meta property="og:title" content="Design and Synthesis of Novel and Selective Glycine Transporter-1 (GlyT1) Inhibitors with Memory Enhancing Properties" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0012.jpeg" /></meta><meta property="og:description" content="We report here the identification and optimization of a novel series of potent GlyT1 inhibitors. A ligand design campaign that utilized known GlyT1 inhibitors as starting points led to the identification of a novel series of pyrrolo[3,4-c]pyrazoles amides (21–50) with good in vitro potency. Subsequent optimization of physicochemical and in vitro ADME properties produced several compounds with promising pharmacokinetic profiles. In vivo inhibition of GlyT1 was demonstrated for select compounds within this series by measuring the elevation of glycine in the cerebrospinal fluid (CSF) of rats after a single oral dose of 10 mg/kg. Ultimately, an optimized lead, compound 46, demonstrated in vivo efficacy in a rat novel object recognition (NOR) assay after oral dosing at 0.1, 1, and 3 mg/kg." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00372"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00372">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00372&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00372&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00372&amp;href=/doi/10.1021/acs.jmedchem.8b00372" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 6018-6033</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00360" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00373" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design and Synthesis of Novel and Selective Glycine Transporter-1 (GlyT1) Inhibitors with Memory Enhancing Properties</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Vincent J. Santora</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vincent J. Santora</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: 760-580-3455. E-mail: <a href="/cdn-cgi/l/email-protection#a2d4d1c3ccd6cdd0c393e2c5cfc3cbce8cc1cdcf"><span class="__cf_email__" data-cfemail="f58386949b819a8794c4b59298949c99db969a98">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vincent+J.++Santora">Vincent J. Santora</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0406-133X" title="Orcid link">http://orcid.org/0000-0003-0406-133X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Theresa A. Almos</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Theresa A. Almos</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Theresa+A.++Almos">Theresa A. Almos</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Richard Barido</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard Barido</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Barido">Richard Barido</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jillian Basinger</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jillian Basinger</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jillian++Basinger">Jillian Basinger</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chris L. Bellows</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chris L. Bellows</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chris+L.++Bellows">Chris L. Bellows</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Brett C. Bookser</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brett C. Bookser</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brett+C.++Bookser">Brett C. Bookser</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0822-7029" title="Orcid link">http://orcid.org/0000-0002-0822-7029</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">J. Guy Breitenbucher</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">J. Guy Breitenbucher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=J.+Guy++Breitenbucher">J. Guy Breitenbucher</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nicola J. Broadbent</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nicola J. Broadbent</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nicola+J.++Broadbent">Nicola J. Broadbent</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Clifford Cabebe</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Clifford Cabebe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Clifford++Cabebe">Clifford Cabebe</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chih-Kun Chai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chih-Kun Chai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chih-Kun++Chai">Chih-Kun Chai</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mi Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mi Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mi++Chen">Mi Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stephine Chow</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephine Chow</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephine++Chow">Stephine Chow</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">De Michael Chung</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">De Michael Chung</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=De+Michael++Chung">De Michael Chung</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lindsay Crickard</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lindsay Crickard</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lindsay++Crickard">Lindsay Crickard</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anne M. Danks</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anne M. Danks</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anne+M.++Danks">Anne M. Danks</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Graeme C. Freestone</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Graeme C. Freestone</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Graeme+C.++Freestone">Graeme C. Freestone</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dany Gitnick</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dany Gitnick</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dany++Gitnick">Dany Gitnick</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Varsha Gupta</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Varsha Gupta</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Varsha++Gupta">Varsha Gupta</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christine Hoffmaster</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christine Hoffmaster</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christine++Hoffmaster">Christine Hoffmaster</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andrew R. Hudson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrew R. Hudson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+R.++Hudson">Andrew R. Hudson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alan P. Kaplan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alan P. Kaplan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alan+P.++Kaplan">Alan P. Kaplan</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8780-2361" title="Orcid link">http://orcid.org/0000-0001-8780-2361</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael R. Kennedy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael R. Kennedy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+R.++Kennedy">Michael R. Kennedy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dong Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dong Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dong++Lee">Dong Lee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">James Limberis</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">James Limberis</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=James++Limberis">James Limberis</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kiev Ly</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kiev Ly</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kiev++Ly">Kiev Ly</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chi Ching Mak</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chi Ching Mak</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chi+Ching++Mak">Chi Ching Mak</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Brittany Masatsugu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brittany Masatsugu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brittany++Masatsugu">Brittany Masatsugu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andrew C. Morse</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrew C. Morse</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+C.++Morse">Andrew C. Morse</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jim Na</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jim Na</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jim++Na">Jim Na</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David Neul</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David Neul</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David++Neul">David Neul</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John Nikpur</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John Nikpur</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John++Nikpur">John Nikpur</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marco Peters</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marco Peters</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marco++Peters">Marco Peters</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Robert E. Petroski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert E. Petroski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert+E.++Petroski">Robert E. Petroski</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joel Renick</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joel Renick</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joel++Renick">Joel Renick</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kristen Sebring</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kristen Sebring</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kristen++Sebring">Kristen Sebring</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Samantha Sevidal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Samantha Sevidal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Samantha++Sevidal">Samantha Sevidal</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ali Tabatabaei</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ali Tabatabaei</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ali++Tabatabaei">Ali Tabatabaei</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jenny Wen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jenny Wen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jenny++Wen">Jenny Wen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yingzhuo Yan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yingzhuo Yan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yingzhuo++Yan">Yingzhuo Yan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zachary W. Yoder</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zachary W. Yoder</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zachary+W.++Yoder">Zachary W. Yoder</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Douglas Zook</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Douglas Zook</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Douglas++Zook">Douglas Zook</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00372&amp;href=/doi/10.1021%2Facs.jmedchem.8b00372" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 6018–6033</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 11, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 March 2018</li><li><span class="item_label"><b>Published</b> online</span>11 June 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 July 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00372" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00372</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6018%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DVincent%2BJ.%2BSantora%252C%2BTheresa%2BA.%2BAlmos%252C%2BRichard%2BBarido%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D14%26contentID%3Dacs.jmedchem.8b00372%26title%3DDesign%2Band%2BSynthesis%2Bof%2BNovel%2Band%2BSelective%2BGlycine%2BTransporter-1%2B%2528GlyT1%2529%2BInhibitors%2Bwith%2BMemory%2BEnhancing%2BProperties%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6033%26publicationDate%3DJuly%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00372"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1348</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">8</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00372" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design and Synthesis of Novel and Selective Glycine Transporter-1 (GlyT1) Inhibitors with Memory Enhancing Properties&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Vincent&quot;,&quot;last_name&quot;:&quot;J. Santora&quot;},{&quot;first_name&quot;:&quot;Theresa&quot;,&quot;last_name&quot;:&quot;A. Almos&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Barido&quot;},{&quot;first_name&quot;:&quot;Jillian&quot;,&quot;last_name&quot;:&quot;Basinger&quot;},{&quot;first_name&quot;:&quot;Chris&quot;,&quot;last_name&quot;:&quot;L. Bellows&quot;},{&quot;first_name&quot;:&quot;Brett&quot;,&quot;last_name&quot;:&quot;C. Bookser&quot;},{&quot;first_name&quot;:&quot;J.&quot;,&quot;last_name&quot;:&quot;Guy Breitenbucher&quot;},{&quot;first_name&quot;:&quot;Nicola&quot;,&quot;last_name&quot;:&quot;J. Broadbent&quot;},{&quot;first_name&quot;:&quot;Clifford&quot;,&quot;last_name&quot;:&quot;Cabebe&quot;},{&quot;first_name&quot;:&quot;Chih-Kun&quot;,&quot;last_name&quot;:&quot;Chai&quot;},{&quot;first_name&quot;:&quot;Mi&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Stephine&quot;,&quot;last_name&quot;:&quot;Chow&quot;},{&quot;first_name&quot;:&quot;De&quot;,&quot;last_name&quot;:&quot;Michael Chung&quot;},{&quot;first_name&quot;:&quot;Lindsay&quot;,&quot;last_name&quot;:&quot;Crickard&quot;},{&quot;first_name&quot;:&quot;Anne&quot;,&quot;last_name&quot;:&quot;M. Danks&quot;},{&quot;first_name&quot;:&quot;Graeme&quot;,&quot;last_name&quot;:&quot;C. Freestone&quot;},{&quot;first_name&quot;:&quot;Dany&quot;,&quot;last_name&quot;:&quot;Gitnick&quot;},{&quot;first_name&quot;:&quot;Varsha&quot;,&quot;last_name&quot;:&quot;Gupta&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Hoffmaster&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;R. Hudson&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;P. Kaplan&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;R. Kennedy&quot;},{&quot;first_name&quot;:&quot;Dong&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Limberis&quot;},{&quot;first_name&quot;:&quot;Kiev&quot;,&quot;last_name&quot;:&quot;Ly&quot;},{&quot;first_name&quot;:&quot;Chi&quot;,&quot;last_name&quot;:&quot;Ching Mak&quot;},{&quot;first_name&quot;:&quot;Brittany&quot;,&quot;last_name&quot;:&quot;Masatsugu&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;C. Morse&quot;},{&quot;first_name&quot;:&quot;Jim&quot;,&quot;last_name&quot;:&quot;Na&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Neul&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Nikpur&quot;},{&quot;first_name&quot;:&quot;Marco&quot;,&quot;last_name&quot;:&quot;Peters&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;E. Petroski&quot;},{&quot;first_name&quot;:&quot;Joel&quot;,&quot;last_name&quot;:&quot;Renick&quot;},{&quot;first_name&quot;:&quot;Kristen&quot;,&quot;last_name&quot;:&quot;Sebring&quot;},{&quot;first_name&quot;:&quot;Samantha&quot;,&quot;last_name&quot;:&quot;Sevidal&quot;},{&quot;first_name&quot;:&quot;Ali&quot;,&quot;last_name&quot;:&quot;Tabatabaei&quot;},{&quot;first_name&quot;:&quot;Jenny&quot;,&quot;last_name&quot;:&quot;Wen&quot;},{&quot;first_name&quot;:&quot;Yingzhuo&quot;,&quot;last_name&quot;:&quot;Yan&quot;},{&quot;first_name&quot;:&quot;Zachary&quot;,&quot;last_name&quot;:&quot;W. Yoder&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;Zook&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;11&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;6018-6033&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00372&quot;},&quot;abstract&quot;:&quot;We report here the identification and optimization of a novel series of potent GlyT1 inhibitors. A ligand design campaign that utilized known GlyT1 inhibitors as starting points led to the identification of a novel series of pyrrolo[3,4-c]pyrazoles amides (21–50) with good in vitro potency. Subsequent optimization of physicochemical and in vitro ADME properties produced several compounds with promising pharmacokinetic profiles. In vivo inhibition of GlyT1 was demonstrated for select compounds within this series by measuring the elevation of glycine in the cerebrospinal fluid (CSF) of rats after a single oral dose of 10 mg/kg. Ultimately, an optimized lead, compound 46, demonstrated in vivo efficacy in a rat novel object recognition (NOR) assay after oral dosing at 0.1, 1, and 3 mg/kg.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00372&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00372" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00372&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00372" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00372&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00372" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00372&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00372&amp;href=/doi/10.1021/acs.jmedchem.8b00372" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00372" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00372" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00372%26sid%3Dliteratum%253Aachs%26pmid%3D29886732%26genre%3Darticle%26aulast%3DSantora%26date%3D2018%26atitle%3DDesign%2Band%2BSynthesis%2Bof%2BNovel%2Band%2BSelective%2BGlycine%2BTransporter-1%2B%2528GlyT1%2529%2BInhibitors%2Bwith%2BMemory%2BEnhancing%2BProperties%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D14%26spage%3D6018%26epage%3D6033%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=290792" title="Circuits">Circuits</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291774" title="Nuclear magnetic resonance spectroscopy">Nuclear magnetic resonance spectroscopy</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/jmcmar.2018.61.issue-14/20180726/jmcmar.2018.61.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/medium/jm-2018-00372r_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00372&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We report here the identification and optimization of a novel series of potent GlyT1 inhibitors. A ligand design campaign that utilized known GlyT1 inhibitors as starting points led to the identification of a novel series of pyrrolo[3,4-<i>c</i>]pyrazoles amides (<b>21</b>–<b>50</b>) with good in vitro potency. Subsequent optimization of physicochemical and in vitro ADME properties produced several compounds with promising pharmacokinetic profiles. In vivo inhibition of GlyT1 was demonstrated for select compounds within this series by measuring the elevation of glycine in the cerebrospinal fluid (CSF) of rats after a single oral dose of 10 mg/kg. Ultimately, an optimized lead, compound <b>46</b>, demonstrated in vivo efficacy in a rat novel object recognition (NOR) assay after oral dosing at 0.1, 1, and 3 mg/kg.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88505" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88505" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The amino acid glycine is both an inhibitory and excitatory neurotransmitter in the mammalian central nervous system (CNS). Glycine acts as an inhibitory neurotransmitter at strychnine sensitive glycine receptor ion channels which are predominantly found in the cerebellum, brainstem, and spinal cord (glycine A binding sites).<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Conversely, in areas such as cortex, hippocampus, and thalamus, glycine modulates excitatory neurotransmission as an obligatory coagonist, along with glutamate, of the <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate (NMDA) receptor (glycine B binding sites). Synaptic concentrations of glycine are regulated by two sodium-dependent glycine transporters, GlyT1 and GlyT2, which maintain low extracellular glycine concentrations by removing it from synapses via transport into glial cells and neurons. GlyT1 is highly expressed in glial and neuronal cells in forebrain regions of the CNS including the cortex and hippocampus where it acts as an indirect modulator of NMDA function.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In addition, GlyT1 is expressed in the retina,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> as well as outside the CNS in the dorsal root ganglia<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and in red blood cells.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> By contrast, GlyT2 is found in the spinal cord, brainstem, and cerebellum where it is expressed on presynaptic glycinergic terminals and thought to regulate the function of glycine receptors.</div><div class="NLM_p">Considerable evidence exists to implicate NMDA receptor-mediated signaling in learning and memory. For example, NMDA receptor activation regulates new synapse formation and long-term memories.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5−8)</a> Synaptic plasticity is dependent on NMDA receptor activation. Specifically, pharmacological block or genetic disruption of NMDA receptor function can inhibit memory formation and long-term potentiation (LTP), a form of synaptic plasticity.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12">(9−12)</a> In addition, experimental manipulations that enhance NMDA receptor function enhance both memory formation and LTP.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16">(13−16)</a></div><div class="NLM_p">Given the obligatory role glycine plays in NMDA activation, it is not surprising that pharmacological manipulation of synaptic glycine levels via GlyT1 inhibition has been an active area of pharmaceutical research. Several GlyT1 antagonists have been described in the literature.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21">(17−21)</a> The first generation of GlyT1 inhibitors were predominantly sarcosine analogs (e.g., <b>1</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and <b>2</b><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a>) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) with initial in vitro profiles that appeared promising. However, further investigation showed that many of these sarcosine derivatives produced a range of deleterious side effects including ataxia, lateral recumbency, and respiratory depression.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> These side effects are likely the result of sustained elevation of glycine in caudal regions of the CNS, where GlyT1 and the glycine receptor (Gly A sites) are colocalized and play an important role in control of motor function and respiration.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> More recent efforts to develop GlyT1 inhibitors have focused on non-sarcosine chemotypes. A significant number of these second-generation compounds, exemplified by compounds <b>3</b>–<b>7</b>,<a onclick="showRef(event, 'ref28 ref29 ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30 ref31 ref32 ref33">(28−33)</a> have appeared in the literature recently, and some of these have demonstrated efficacy in preclinical animal models of cognition, pain, addiction, and anxiety.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a> In addition, several compounds have advanced into clinical development (including compounds <b>5</b>–<b>7</b>), as potential treatments for the negative and cognitive symptoms associated with schizophrenia and as treatments for obsessive compulsive disorder (OCD), depression, addiction, and Parkinson’s disease.<a onclick="showRef(event, 'ref34 ref36 ref37 ref38 ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref34 ref36 ref37 ref38 ref39 ref40 ref41">(34,36−41)</a> To date, no GlyT1 inhibitors have received FDA approval.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/medium/jm-2018-00372r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative GlyT1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00372&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We initiated a program to identify a new series of GlyT1 inhibitors as potential treatments for memory disorders using a ligand design approach based on known chemical matter. In their SAR disclosures Hoffman La Roche identified several potent and selective GlyT1 inhibitors based on a benzoylpiperazine scaffold.<a onclick="showRef(event, 'ref31 ref42'); return false;" href="javascript:void(0);" class="ref ref31 ref42">(31,42)</a> We speculated that replacing the aryl-piperazine moiety embedded within this chemotype with an aryl-pyrrolopyrazole group could provide additional opportunities for optimization. In particular, based on rapid overlay of chemical structures (ROCS)<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> overlays of these chemical structures, the aryl ring of the pyrrolopyrazole scaffold extends further, overlaying with the pyridyl CF<sub>3</sub> group in compound <b>7</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). We felt that this could allow us to investigate alternative aryl groups in combination with the pyrrolopyrazole linker.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/medium/jm-2018-00372r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. ROCS comparison of Roche compound <b>7</b> (blue) and aryl-pyrrolopyrazole <b>21</b> (gray).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00372&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Herein we describe the synthesis and optimization of this pyrrolopyrazole-containing series (<b>21</b>–<b>50</b>) that led to the identification of several analogs with promising in vitro profiles. In addition, we discuss the in vivo profiling of select examples from this new series in CNS penetration and CSF glycine elevation studies, leading to the identification of an optimized lead, compound <b>46</b>, which had a favorable pharmacokinetic profile and showed in vivo efficacy in a rat novel object recognition (NOR) assay.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27284" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27284" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The new pyrrolopyrazole amides were synthesized using the methods outlined in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch3" aria-label="3">3</a>.<named-content content-type="anchor" rid="sch2" type="simple"></named-content><named-content content-type="anchor" rid="sch3" type="simple"></named-content> Carboxylic acid precursors <b>10</b>–<b>17</b> were prepared from commercially available acids <b>8</b> and <b>9</b> using methods similar to those described in the literature (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref31 ref42'); return false;" href="javascript:void(0);" class="ref ref31 ref42">(31,42)</a> Specifically, 2-fluoro-5-sulfonyl or 2-fluoro-5-nitrile benzoic acids (<b>8a</b> or <b>9a</b>) were reacted with various alcohols or 4,4-difluoropiperidine under basic conditions to afford the 2-alkoxy substituted derivatives <b>10</b>–<b>13</b> and the difluoropiperidine analogs <b>14</b> and <b>15</b>. Alternatively, biphenyl carboxylic acids <b>16</b> and <b>17</b> were prepared from bromides <b>8b</b> or <b>9b</b>, respectively, by Suzuki coupling with 3-fluorophenylboronic acid.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/medium/jm-2018-00372r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Routes to Intermediates <b>10</b>–<b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00372&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>8a</b> or <b>9a</b>, <i><sup>i</sup></i>PrOH, NaH, 70 °C; (b) <b>8a</b> or <b>9a</b>, R<sub>2</sub>OH, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 110 °C; (c) <b>8a</b> or <b>9a</b>, 4,4-difluoropiperidine, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 120 °C; (d) <b>8b</b> or <b>9b</b>, 3-F-phenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub> or Pd(dppf)Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, 80 °C.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/medium/jm-2018-00372r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes to Intermediates <b>20a</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00372&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) ArI or ArBr, K<sub>3</sub>PO<sub>4</sub>, CuI, (1<i>S</i>,2<i>S</i>)-(+)-1,2-diaminocyclohexane, THF or dioxane, 120 °C; (b) alkyl halide, NaH, DMF; (c) HCl, dioxane.</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/medium/jm-2018-00372r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Routes to Compounds <b>21</b>–<b>50</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00372&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) <b>10</b>–<b>17</b>, SOCl<sub>2</sub>; (ii) <b>20a</b>–<b>f</b>, Et<sub>3</sub>N, DCM; (b) HATU, Et<sub>3</sub>N, DMF.</p></p></figure><div class="NLM_p last">The requisite pyrrolopyrazole intermediates <b>20a</b>–<b>f</b> for this study were prepared in two steps. The previously reported <i>N</i>-Boc-protected 4,6-dihydropyrrolo[3,4-<i>c</i>]pyrazole (<b>18</b>)<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> was first coupled with appropriate aryl halides using Buchwald–Ullmann conditions<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> or by treating with an alkyl halide under basic conditions. The desired linear regiochemistry was confirmed by NOESY-NMR, which showed the expected interaction between the ortho proton of the aryl group (or CH<sub>2</sub> of the cyclopentyl group) and the C–H proton of the pyrazole ring. The intermediate 2-substituted pyrrolopyrazoles (<b>19a</b>–<b>f</b>) were then deprotected under acidic conditions to provide pyrrolopyrazoles <b>20a</b>–<b>f</b>. The final pyrrolopyrazole amides of this study (<b>21</b>–<b>50</b>) were then prepared by amide coupling, either by conversion of acids <b>10</b>–<b>17</b> to acid chlorides followed by addition of amines <b>20a</b>–<b>f</b> or by utilizing HATU as the coupling reagent in a standard, one-step process.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Structure–Activity Relationships</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08077" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08077" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Peripheral functionality (R<sup>1</sup>-R<sup>3</sup>) for the new series was selected on the basis of knowledge gained from SAR studies with an earlier, in-house series and literature precedent.<a onclick="showRef(event, 'ref31 ref42 ref46'); return false;" href="javascript:void(0);" class="ref ref31 ref42 ref46">(31,42,46)</a> In vitro profiling of the pyrrolopyrazole amides consisted of extensive testing across a diverse panel of assays. These included in vitro GlyT1 and GlyT2 functional potency in HEK cells, as well as rat GlyT1 functional activity in rat cortical cultures. In vitro ADMET properties for the new compounds were also assessed for intrinsic clearance in rat and human liver microsomes (RLM and HLM, respectively), inhibition of CYP450 (1A2, 2C9, 2C19, 2D6, and 3A4 isozymes) and hERG channel inhibition as well as MDCK efflux and PAMPA-BBB permeability.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><div class="NLM_p">The initial compound <b>21</b>, incorporating an unsubstituted ring at the R<sup>3</sup>-aryl group, exhibited high in vitro potency against both rat and human GlyT1 (IC<sub>50</sub> = 4 and 15 nM, respectively). The compound was also stable in rat and human LMs and showed no hERG channel inhibition at concentrations of <10 μM. On the basis of these data, the SAR was expanded to include several alkyl sulfones exemplified by compounds <b>22</b>–<b>39</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Initial data were promising, with similar IC<sub>50</sub>’s observed for all compounds against both rat and human forms of GlyT1 and significant in vitro potency (hGlyT1 IC<sub>50</sub> values of < 38 nM) observed for all but one compound in the sulfone series (<b>39</b>, hGlyT1 IC<sub>50</sub> = 406 nM). In addition, the new compounds exhibited high selectivity for GlyT1 over GlyT2 (all GlyT2 IC<sub>50</sub>’s > 10 μM) and minimal inhibition of all CYP isozymes tested (all IC<sub>50</sub>’s of >10 μM). Finally, high in vitro permeability was observed for most compounds in this series (17 of 19 compounds had PAMPA-BBB permeability values of > 5 × 10<sup>–6</sup> cm/s).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Properties of Sulfone Analogs <b>21</b>–<b>39</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/medium/jm-2018-00372r_0008.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/medium/jm-2018-00372r_0009.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">In vitro GlyT1 inhibition determined using a scintillation proximity assay (SPA). Potency was assessed in inhibiting the uptake of radiolabeled glycine (11-concentration dose response, 2 points per concentration, single determination) in primary rat cortical neurons (rat IC<sub>50</sub>) or HEK cells expressing the human GlyT1c (human IC<sub>50</sub>).</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> determined in duplicate or higher (<i>n</i> ≥ 2). Standard deviation (SD) values were typically less than 40%.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Intrinsic in vitro clearance determined in rat and human liver microsomes (LMs) in the presence of NADPH.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">hERG channel inhibition was measured in an electrophysiology assay (QPatch) using Chinese hamster ovary (CHO) cells stably expressing the hERG potassium channel.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">Bidirectional transport determined across MDCK-MDR1 cell monolayers.</p></div></div><div></div></div><div class="NLM_p">Methyl sulfone analogs with <i>S</i>-trifluoromethylisopropoxy substituents at R<sup>2</sup> served as starting points for scanning the effects of various pyrazole N-substituents (R<sup>3</sup>) on in vitro profiles. Several compounds within this group exhibited unacceptably high efflux ratios in the MDCK assay, which can be indicative of being a substrate of P-glycoprotein (P-gp) or other CNS efflux transport, an undesirable characteristic for CNS drugs.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> This was particularly true for <i>N</i>-phenyl and <i>N</i>-cyclopentyl analogs <b>21</b> and <b>26</b> and pyridyl analogs <b>24</b> and <b>25</b>. Interestingly, the high efflux observed for <i>N</i>-phenyl substituted analogs such as <b>21</b> (efflux ratio = 5.9) was significantly improved by installing an <i>o</i>-fluorine substituent on the phenyl ring (e.g., compound <b>22</b>, efflux ratio = 2.1). Similar in vitro profiles were observed for methyl sulfones with other functionality in the R<sup>2</sup> position including alternative alkoxy groups (<b>27</b>–<b>29</b>), as well as difluoropiperidines (<b>30</b>–<b>32</b>) and 3-fluorophenyl substituents (<b>33</b>–<b>35</b>). Here again, high efflux ratios were observed for compounds with <i>N</i>-pyridyl substituents at R<sup>3</sup>. The efflux issue notwithstanding, the methyl sulfone analogs generally exhibited minimal hERG channel inhibition and modest intrinsic clearance in rat liver microsomes, regardless of the structure of R<sup>2</sup> and R<sup>3</sup> groups. The only exceptions were the neopentyloxy analog <b>28</b> and the <i>m</i>-fluorophenyl derivatives <b>33</b> and <b>35</b>.</div><div class="NLM_p">Attempts to reduce the MDCK efflux observed for certain methyl sulfones, by increasing the size and lipophilicity of sulfone alkyl groups, were only marginally successful. Ethyl sulfones <b>36</b>–<b>38</b> (hGlyT1 IC<sub>50</sub> = 12–29 nM) largely retained the potency observed with methyl sulfone analogs, and their efflux ratios were approximately equal to (<b>36</b> cf. <b>22</b>) or significantly lower than their corresponding methyl sulfone analogs (<b>37</b> cf. <b>24</b> and <b>38</b> cf. <b>25</b>). However, despite these improvements, none of these compounds demonstrated efflux ratios low enough to warrant further testing (vide infra). Increasing the steric bulk of the sulfone alkyl group by incorporating an isopropyl sulfone group (compound <b>39</b>) considerably lowered the efflux (efflux ratio = 2.2 cf. 5.9 for compound <b>21</b>), but unfortunately, this decrease in efflux was accompanied by substantially reduced potency (hGlyT1 IC<sub>50</sub> = 406 nM).</div><div class="NLM_p">We next examined the in vitro profiles of several nitrile analogs (<b>40</b>–<b>50</b>) with continued interest in lowering the efflux ratios in this series. As observed for the sulfone analogs, compounds in the nitrile series consistently displayed low activity against GlyT2 (all GlyT2 IC<sub>50</sub>’s of >10 μM), minimal inhibition of various CYP enzymes (all IC<sub>50</sub>’s of >10 μM) and high permeability (PAMPA-BBB of >10 × 10<sup>–6</sup> cm/s for all compounds). However, GlyT1 potency across the nitrile series was generally lower compared to the sulfones, particularly for <i>N</i>-2-fluorophenyl and <i>N</i>-cycloalkyl analogs (e.g., <b>40</b> and <b>43</b>), which showed approximately 10-fold lower potency compared to similarly substituted methyl sulfone analogs (<b>22</b> and <b>26</b>). In addition, a wider range of potencies was observed within subsets of the nitrile series compared to those of the sulfone series. For example, 3-fluoro-5-pyridyl analogs (<b>41</b>, <b>45</b>, and <b>49</b>) had hGlyT1 IC<sub>50</sub> values that ranged from 69 to 383 nM and 3-methyl-4-pyridyl analogs (<b>42</b>, <b>46</b>–<b>48</b>, and <b>50</b>) had hGlyT1 IC<sub>50</sub> values that ranged from 18 to 441 nM, whereas the analogous sulfones had IC<sub>50</sub> values that were consistently below 12 nM. The loss of potency for some nitrile analogs notwithstanding, several analogs from this class had IC<sub>50</sub> values in the sub-100 nM range.</div><div class="NLM_p">Analogs in the nitrile series generally exhibited modest intrinsic clearance in rat liver microsomes, with the exception of compounds with nonpolar pyrazole substituents, such as <b>40</b>, <b>43</b>, and <b>44</b>, which were substantially less stable than their corresponding sulfone analogs (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). These observations, coupled with the significant improvement in MDCK efflux ratios and the lack of any significant hERG channel inhibition observed within the nitrile series, resulted in a number of analogs with promising in vitro profiles (e.g., <b>41</b>, <b>42</b>, <b>46</b>, <b>48</b>, and <b>50</b>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Properties of Nitrile Analogs <b>40</b>–<b>50</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/medium/jm-2018-00372r_0010.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/medium/jm-2018-00372r_0011.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">In vitro GlyT1 inhibition determined using a scintillation proximity assay (SPA). Potency was assessed in inhibiting the uptake of radiolabeled glycine (11-concentration dose response, 2 points per concentration, single determination) in primary rat cortical neurons (rat IC<sub>50</sub>) or HEK cells expressing the human GlyT1c (human IC<sub>50</sub>).</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> determined in duplicate or higher (<i>n</i> ≥ 2). Standard deviation (SD) values were typically less than 40%.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Intrinsic in vitro clearance determined in rat and human liver microsomes (LMs) in the presence of NADPH.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">hERG channel inhibition was measured in an electrophysiology assay (QPatch) using Chinese hamster ovary (CHO) cells stably expressing the hERG potassium channel.</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">Bidirectional transport determined across MDCK-MDR1 cell monolayers.</p></div></div><div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">DMPK Profiling and Glycine Elevation Studies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27148" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27148" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In order to identify promising compounds for in vivo behavioral studies, the CNS penetration properties of four representative compounds (two from the sulfone series and two from the nitrile series) were measured in Sprague-Dawley rats 90 min after administration of a single 10 mg/kg oral dose of each compound (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Sulfone analogs <b>22</b> and <b>29</b> had similar exposure profiles in terms of plasma concentrations (<i>C</i><sub>plasma</sub> = 3093 and 2138 nM, respectively), total brain concentrations (<i>C</i><sub>brain</sub> = 687 and 605 nM, respectively), and CSF levels (<i>C</i><sub>CSF</sub> = 44 and 26 nM, respectively). In contrast, plasma exposure for nitrile analogs <b>41</b> and <b>46</b> was higher (<i>C</i><sub>plasma</sub> = 4684 and 3237 nM, respectively) and CNS penetration was considerably higher (<i>C</i><sub>brain</sub> = 2862 and 1700 nM, and <i>C</i><sub>CSF</sub> = 319 and 304 nM, respectively). These results were somewhat unexpected considering the calculated properties and in vitro profiles of the test compounds (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Specifically, sulfones <b>22</b> and <b>29</b> showed higher permeability (PAMPA-BBB = 43.1 and 77.9 × 10<sup>–6</sup> cm/s, respectively) compared to nitriles <b>41</b> and <b>46</b> (PAMPA-BBB = 25.5 and 16.3 × 10<sup>–6</sup> cm/s, respectively) and the calculated topological polar surface area (tPSA) values for sulfones <b>22</b> and <b>29</b> (tPSA = 81.5 for both compounds) were slightly lower than the nitriles <b>41</b> and <b>46</b> (tPSA = 84.0 and 85.3, respectively).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Summary of CNS Penetration, Glycine Elevation, in Vitro ADME, and Calculated Properties for Compounds <b>22</b>, <b>29</b>, <b>41</b>, and <b>46</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">rat IC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>Plasma</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>brain</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>CSF</sub></th><th class="colsep0 rowsep0" align="center" char=".">CSF glycine</th><th class="colsep0 rowsep0" align="center">glycine elevation</th><th class="colsep0 rowsep0" align="center" char=".">tPSA<a class="ref internalNav" href="#t3fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center" char=".">cLogP<a class="ref internalNav" href="#t3fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center" char=".">PAMPA-BBB</th><th class="colsep0 rowsep0" align="center" char=".">plasma <i>F</i><sub>u</sub></th><th class="colsep0 rowsep0" align="center" char=".">brain <i>F</i><sub>u</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>u,brain</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>u,brain</sub>/rat IC<sub>50</sub></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">nM</th><th class="colsep0 rowsep0" align="center" char=".">nM<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">nM<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">nM<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">μM<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">% control<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char=".">10<sup>–6</sup> cm/s</th><th class="colsep0 rowsep0" align="center" char=".">% unbound<a class="ref internalNav" href="#t3fn7" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center" char=".">% unbound<a class="ref internalNav" href="#t3fn7" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center" char=".">nM<a class="ref internalNav" href="#t3fn8" aria-label="h">h</a></th><th class="colsep0 rowsep0" align="center" char="."> </th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">3093</td><td class="colsep0 rowsep0" align="char" char=".">687</td><td class="colsep0 rowsep0" align="char" char=".">44</td><td class="colsep0 rowsep0" align="char" char=".">9.5</td><td class="colsep0 rowsep0" align="left">169 ± 29<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char=".">81.5</td><td class="colsep0 rowsep0" align="char" char=".">2.98</td><td class="colsep0 rowsep0" align="char" char=".">43.1</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">8.9</td><td class="colsep0 rowsep0" align="char" char=".">2.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">28</td><td class="colsep0 rowsep0" align="char" char=".">2138</td><td class="colsep0 rowsep0" align="char" char=".">605</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">7.6</td><td class="colsep0 rowsep0" align="left">110 ± 26</td><td class="colsep0 rowsep0" align="char" char=".">81.5</td><td class="colsep0 rowsep0" align="char" char=".">2.85</td><td class="colsep0 rowsep0" align="char" char=".">77.9</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">10.3</td><td class="colsep0 rowsep0" align="char" char=".">0.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="char" char=".">82</td><td class="colsep0 rowsep0" align="char" char=".">4684</td><td class="colsep0 rowsep0" align="char" char=".">2862</td><td class="colsep0 rowsep0" align="char" char=".">319</td><td class="colsep0 rowsep0" align="char" char=".">7.2</td><td class="colsep0 rowsep0" align="left">109 ± 20</td><td class="colsep0 rowsep0" align="char" char=".">84</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">25.5</td><td class="colsep0 rowsep0" align="char" char=".">10.4</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">91.6</td><td class="colsep0 rowsep0" align="char" char=".">1.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="char" char=".">3237</td><td class="colsep0 rowsep0" align="char" char=".">1700</td><td class="colsep0 rowsep0" align="char" char=".">304</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="left">167 ± 18<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char=".">85.3</td><td class="colsep0 rowsep0" align="char" char=".">2.87</td><td class="colsep0 rowsep0" align="char" char=".">16.3</td><td class="colsep0 rowsep0" align="char" char=".">11.3</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td><td class="colsep0 rowsep0" align="char" char=".">107.1</td><td class="colsep0 rowsep0" align="char" char=".">2.98</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Male SD rats (<i>n</i> = 5) 90 min after administration of a single 10 mg/kg dose formulated in a mixture of NMP/PEG400/water (10:50:40).</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Standard deviation typically <35%.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Standard deviation typically <15%.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">CSF glycine mean % of treatment group vs vehicle control ± propagated absolute uncertainty of the ratio (test compound glycine concn/vehicle glycine concn).</p></div><div class="footnote" id="t3fn5"><sup><sup>e</sup></sup><p class="last">Statistical significance, <i>p</i> < 0.05 vs vehicle control.</p></div><div class="footnote" id="t3fn6"><sup><sup>f</sup></sup><p class="last">Calculated using Chemdraw 12.</p></div><div class="footnote" id="t3fn7"><sup><sup>g</sup></sup><p class="last">Unbound fraction of compound in rat plasma or brain homogenate determined by rapid equilibrium dialysis.</p></div><div class="footnote" id="t3fn8"><sup><sup>h</sup></sup><p class="last">Calculated according to the formula <i>C</i><sub>u,brain</sub> = <i>C</i><sub>brain</sub> × brain <i>F</i><sub>u</sub>.</p></div></div></div><div class="NLM_p">In additional experiments, in vivo GlyT1 target engagement for these compounds was assessed by measuring changes in glycine concentrations in the CSF of rats in an acute, single dose–response study (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Specifically, CSF samples from rats were collected 90 min after oral administration of 10 mg/kg of test compound, a time point close to <i>T</i><sub>max</sub> (data not shown). The CSF glycine concentrations were determined by derivation of glycine with Marfey’s reagent<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> and subsequent LC–MS/MS analysis. Interestingly, statistically significant increases in CSF levels of glycine were only observed for one compound in each series (sulfone <b>22</b> and nitrile <b>46</b>) when compared to vehicle treated animals. These discrepancies are not easily explained given the in vitro potency, high structural similarity, and similar in vitro and CNS penetration profiles shared by each pair of compounds. However, examination of the relationship between free brain concentrations (<i>C</i><sub>u,brain</sub>) and rat GlyT1 potency for each compound suggests that significant glycine elevation occurs only when the ratio of <i>C</i><sub>u,brain</sub>/rat IC<sub>50</sub> is greater than 2 (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). In addition, it is possible that these compounds have different binding kinetics profiles (i.e., <i>k</i><sub>on</sub> and <i>k</i><sub>off</sub>) with GlyT1, which could result in different in vivo target engagement profiles.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> To date, the binding kinetics of these analogs have not been explored to confirm if such differences correlate with the levels of glycine elevation observed experimentally.</div><div class="NLM_p">Of the two compounds that showed in vivo elevation of CSF glycine, nitrile <b>46</b> emerged as the preferred lead compound by virtue of its superior CNS penetration profile. Subsequent evaluation of its pharmacokinetic profile in rat after a single 1 mg/kg iv or po dose (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) revealed that <b>46</b> had low systemic clearance (CL = 14.6 min mL<sup>–1</sup> kg<sup>–1</sup>; 23% of liver blood flow) with an elimination half-life of 2.4 h. Compound <b>46</b> was rapidly absorbed after oral administration (<i>T</i><sub>max</sub> = 0.67 h) with good oral bioavailability (<i>F</i> = 81%). In addition, compound <b>46</b> was profiled in a general off-target selectivity panel consisting of 95 targets, including enzymes and receptors, and was found to be highly selective for GlyT1 with <50% activity when screened at 10 μM against all targets.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/medium/jm-2018-00372r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Rat plasma concentrations of <b>46</b> following either a single 1 mg/kg po or 1 mg/kg iv administration in 10:50:40 NMP/PEG400/H<sub>2</sub>O.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00372&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Rat Pharmacokinetic Parameters of <b>46</b> after 1 mg/kg Administration</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">route of administration<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">pharmacokinetic parameter</th><th class="colsep0 rowsep0" align="center">iv (1 mg/kg)</th><th class="colsep0 rowsep0" align="center">po (1 mg/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> (h)</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a> (ng/mL)</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">290</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>inf</sub><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a> (ng·h/mL)</td><td class="colsep0 rowsep0" align="left">1176</td><td class="colsep0 rowsep0" align="left">958</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub><a class="ref internalNav" href="#t4fn5" aria-label="e">e</a> (h)</td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left">2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub><a class="ref internalNav" href="#t4fn6" aria-label="f">f</a> (L/kg)</td><td class="colsep0 rowsep0" align="left">1.83</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<a class="ref internalNav" href="#t4fn7" aria-label="g">g</a> (mL min<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">14.6</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i><a class="ref internalNav" href="#t4fn8" aria-label="h">h</a> (%)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">81</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Male SD rats (<i>n</i> = 3) following administration of a single dose formulated in a mixture of NMP/PEG400/water (10:50:40).</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Time of maximum observed concentration of compound in plasma.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Maximum observed concentration of compound in plasma.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">Area under the plasma concentration versus time curve from 0 to the last time point compound was quantifiable in plasma.</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">Apparent half-life of the terminal phase of elimination of compound from plasma.</p></div><div class="footnote" id="t4fn6"><sup><sup>f</sup></sup><p class="last">Volume of distribution at steady state.</p></div><div class="footnote" id="t4fn7"><sup><sup>g</sup></sup><p class="last">Clearance.</p></div><div class="footnote" id="t4fn8"><sup><sup>h</sup></sup><p class="last">Bioavailability.</p></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Memory Study</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05653" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05653" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Given its promising profile, nitrile <b>46</b> was evaluated for long-term memory enhancement in a NOR test in rat (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The NOR task is a widely used behavioral task to assess visual recognition memory and is based on an animal’s innate preference for novelty.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> This task consists of a training phase, where rats are presented with two identical objects to explore. Following a delay interval, memory is assessed by presenting rats with a trained object and a novel object. Rats with memory of the previously presented object will preferentially explore the novel object. Rats that receive a memory enhancing drug in conjunction with submaximal training are expected to exhibit improved memory performance similar to that of untreated animals that have received stronger training (i.e., more exposure to objects during the training phase).</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/medium/jm-2018-00372r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of <b>46</b> in a rat model of recognition memory. (A) Study design, <i>n</i> = 18–24 male, Long–Evans rats/treatment group. (B) Effect on 24 h memory retention. Rats treated with 0.1, 1, and 3 mg/kg <b>46</b> exhibited significantly higher memory scores than rats treated with vehicle and trained for 3 min. Asterisk = <i>p</i> < 0.05 vs 3 min training + vehicle. (C) Exploration of the novel and familiar object during 24 h memory testing. (D) Compound <b>46</b> did not affect object exploration during training. (E) Compound <b>46</b> did not affect locomotion during training. The mean ± SEM values are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00372&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Rats were dosed orally with compound <b>46</b> or vehicle 90 min prior to training and then given 3 min (submaximal memory training) or 20 min (strong memory training) to explore the arena and objects (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Rats treated with compound <b>46</b> (0.1, 1, or 3 mg/kg) exhibited enhanced long-term object recognition memory compared to submaximally trained vehicle-treated rats at the 24 h retention test (<i>p</i> < 0.05, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). Further, the memory scores for the <b>46</b>-treated rats were no different from that of vehicle-treated rats that had received strong 20 min training (<i>p</i> > 0.07), and these groups also exhibited a significant preference for the object at test (one sample <i>t</i> test, <i>p</i> < 0.05, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B, C). By contrast, submaximally trained vehicle-treated rats did not exhibit a preference for the novel object at test (<i>p</i> = 0.91). Importantly, analog <b>46</b> did not affect object exploration time or the distance traveled during training, indicating that the drug did not alter locomotor activity or motivation to explore the objects (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D, E).</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84112" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84112" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Activation of NMDA receptor-mediated signaling plays an important role in learning and memory. Because glycine acts as an obligatory coagonist of the NMDA receptor, pharmacological enhancement of synaptic glycine concentrations via inhibition of GlyT1 may provide the means to enhance NMDA signaling. We identified and optimized a novel series of GlyT1 inhibitors using a ligand design/scaffold modification strategy starting from known GlyT1 inhibitors. Several compounds from this new series showed promising in vitro profiles, and selected examples demonstrated good CNS penetration. Further evaluation of these advanced compounds revealed a disparity in their ability to elevate CSF glycine concentrations in rats following oral dosing at 10 mg/kg.</div><div class="NLM_p last">Analog <b>46</b>, which possessed a promising in vitro and in vivo profile, showed efficacy in a rat NOR test of long-term recognition memory after oral dosing at 0.1, 1, and 3 mg/kg. Unfortunately, subsequent testing of this compound at higher doses revealed a side effect profile that was similar to those of previously reported GlyT1 inhibitors<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> and a safety margin we considered insufficient for further development. Taken together, these results suggest that compounds such as <b>46</b> can serve as tools to examine GlyT1 inhibitors as potential treatments of cognitive disorders where NMDA receptor hypofunction may play a role. The difficulty in identifying GlyT1 inhibitors with sufficiently wide therapeutic indexes is also highlighted. Further details on compounds from this and related series will be reported in future publications from our laboratories.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14541" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14541" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General Methods</h3><div class="NLM_p last">Solvents and reagents were purchased and used without further purification unless otherwise noted. Flash column chromatography (FCC) was performed on Teledyne Isco CombiFlash instruments equipped with silica gel columns. Preparative HPLC purification was performed on a Waters preparative LCMS system equipped with a Waters XBridge Prep C18 5 μm OBD 19 mm × 50 mm column. Elution was achieved with increasing concentration of CH<sub>3</sub>CN in water and 0.05% TFA added as a modifier. Analytical HPLC was performed on an Acquity UPLC system equipped with a BEH C18 1.7 μm, 2.1 mm × 50 mm column. Elution was achieved with increasing concentrations of CH<sub>3</sub>CN in water and 0.1% formic acid added as modifier. NMR was performed on a Bruker Ultrashield 400 Plus spectrometer. The purity of all compounds tested was determined by LCMS to be >95%.</div></div><div id="sec6_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (<i>S</i>)-5-(Methylsulfonyl)-2-((1,1,1-trifluoropropan-2-yl)oxy)benzoic Acid (<b>10a</b>). General Method A</h3><div class="NLM_p last">To a 100 mL pressure vessel was added 2-fluoro-5-(methylsulfonyl)benzoic acid (4.00 g; 18.33 mmol; 1.00 equiv), (<i>S</i>)-1,1,1-trifluoropropan-2-ol (3.27 mL; 36.66 mmol; 2.00 equiv), and cesium carbonate (11.95 g; 36.66 mmol; 2.00 equiv) in 65 mL of dioxane. The vessel was flushed with N<sub>2</sub>, sealed, and the mixture was heated and stirred at 115 <sup>◦</sup>C for 23 h and then cooled to room temperature. The mixture was diluted with 100 mL of H<sub>2</sub>O, acidified with conc HCl to pH 1, and extracted with EtOAc (2 × 75 mL). The combined organics were dried with Na<sub>2</sub>SO<sub>4</sub> and concentrated under vacuum to give the title compound as a white solid (5.50 g, 96%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.26 (br s, 1H), 8.13 (d, <i>J</i> = 2.3 Hz, 1H), 8.03 (dd, <i>J</i> = 2.5, 8.8 Hz, 1H), 7.57 (d, <i>J</i> = 9.0 Hz, 1H), 5.49 (td, <i>J</i> = 6.4, 12.6 Hz, 1H), 3.55 (s, 3H), 3.22 (s, 3H), 1.44 (d, <i>J</i> = 6.3 Hz, 3H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 313.1.</div></div><div id="sec6_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 2-Isopropoxy-5-(methylsulfonyl)benzoic Acid (<b>10b</b>). General Method B</h3><div class="NLM_p last">To a 500 mL round-bottomed flask was added sodium hydride (60% dispersion in mineral oil, 2.75 g, 68.7 mmol) and isopropanol (100 mL). The mixture was heated to 110 <sup>◦</sup>C and stirred for 10 min. Then, the mixture was cooled to 70 °C, and 2-fluoro-5-(methylsulfonyl)benzoic acid (3.0 g, 13.75 mmol) was added in one portion. Heating and stirring were continued for 7 h. Solvents were removed under reduced pressure, and the resulting solids were taken up in water (150 mL). The resulting aqueous mixture was acidified to pH 1 using conc HCl and extracted with EtOAc (2 × 100 mL). The combined organic layers were dried over sodium sulfate, filtered, and evaporated to afford the title compound (2.9 g, 82%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.00 (br s, 1H), 8.06 (d, <i>J</i> = 2.7 Hz, 1H), 7.95 (dd, <i>J</i> = 2.3, 9.0 Hz, 1H), 7.36 (d, <i>J</i> = 9.0 Hz, 1H), 4.81 (td, <i>J</i> = 6.1, 12.1 Hz, 1H), 3.18 (s, 3H), 1.29 (d, <i>J</i> = 6.3 Hz, 6H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 259.0.</div></div><div id="sec6_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 5-(Methylsulfonyl)-2-(neopentyloxy)benzoic Acid (<b>10c</b>)</h3><div class="NLM_p last">The title compound was prepared using general method A (0.53 g, 20%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.17–12.98 (m, 1H), 8.11 (d, <i>J</i> = 2.7 Hz, 1H), 7.98 (dd, <i>J</i> = 2.3, 8.6 Hz, 1H), 7.31 (d, <i>J</i> = 9.0 Hz, 1H), 3.79 (s, 2H), 1.00 (s, 9H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 287.3.</div></div><div id="sec6_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 2-(Cyclopropylmethoxy)-5-(methylsulfonyl)benzoic Acid (<b>10d</b>)</h3><div class="NLM_p last">The title compound was prepared using general method A (1.7 g, 68%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ13.07 (br s, 1H), 8.10 (d, <i>J</i> = 2.6 Hz, 1H), 7.99 (dd, <i>J</i> = 2.6, 8.8 Hz, 1H), 7.34 (d, <i>J</i> =8.9 Hz, 1H), 4.05 (d, <i>J</i> = 6.7 Hz, 2H), 3.20 (s, 3H), 1.32–1.19 (m, 1H), 0.61–0.55 (m, 2H), 0.42–0.35 (m, 2H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 271.0.</div></div><div id="sec6_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (<i>S</i>)-5-(Ethylsulfonyl)-2-((1,1,1-trifluoropropan-2-yl)oxy)benzoic Acid (<b>11a</b>)</h3><div class="NLM_p last">The title compound was prepared using general method A (1.4 g 83%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.29 (br s, 1H), 8.11 (d, <i>J</i> = 2.4 Hz, 1H), 8.01 (dd, <i>J</i> = 2.5, 8.9 Hz, 1H), 7.60 (d, <i>J</i> =8.9 Hz, 1H), 5.52 (quin, <i>J</i> = 6.4 Hz, 1H), 3.36–3.32 (m, 2H), 1.47 (d, <i>J</i> = 6.2 Hz, 3H), 1.11 (t, <i>J</i> = 7.3 Hz, 3H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 327.0.</div></div><div id="sec6_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (<i>S</i>)-5-(Isopropylsulfonyl)-2-((1,1,1-trifluoropropan-2-yl)oxy)benzoic Acid (<b>12a</b>)</h3><div class="NLM_p last">The title compound was prepared using general method A (0.4 g, 61%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 13.30 (br s, 1H), 8.07 (d, <i>J</i> = 2.4 Hz, 1H), 7.98 (dd, <i>J</i> = 2.4, 8.8 Hz, 1H), 7.60 (d, <i>J</i> = 9.0 Hz, 1H), 5.52 (spt, <i>J</i> = 6.4 Hz, 1H), 3.46 (spt, <i>J</i> = 6.8 Hz, 1H), 1.48 (d, <i>J</i> = 6.4 Hz, 3H), 1.17 (d, <i>J</i> = 6.7 Hz, 6H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 341.0.</div></div><div id="sec6_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (<i>S</i>)-5-Cyano-2-((1,1,1-trifluoropropan-2-yl)oxy)benzoic Acid (<b>13a</b>)</h3><div class="NLM_p last">The title compound was prepared using general method A (8.0 g, 84%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.35 (d, <i>J</i> = 2.2 Hz, 1H), 7.84 (dd, <i>J</i> = 8.7, 2.2 Hz, 1H), 7.14 (d, <i>J</i> = 8.8 Hz, 1H), 4.93–4.83 (m, 1H), 1.63 (d, <i>J</i> = 6.5 Hz, 3H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 260.2.</div></div><div id="sec6_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 5-Cyano-2-isopropoxybenzoic Acid (<b>13b</b>)</h3><div class="NLM_p last">The title compound was prepared using general method B (14.2 g, 76%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.00 (br s, 1H), 7.96 (d, <i>J</i> = 2.3 Hz, 1H), 7.89 (dd, <i>J</i> = 2.3, 8.6 Hz, 1H), 7.30 (d, <i>J</i> = 9.0 Hz, 1H), 4.80 (td, <i>J</i> = 5.9, 12.0 Hz, 1H), 1.40–1.14 (m, 6H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 206.2.</div></div><div id="sec6_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 5-Cyano-2-(cyclopropylmethoxy)benzoic Acid (<b>13d</b>)</h3><div class="NLM_p last">The title compound was prepared using general method A, using DMF as solvent and heating at 120 °C for 30 min in a sealed vial (20 mg, 15%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.09 (d, <i>J</i> = 2.2 Hz, 1H), 7.84 (dd, <i>J</i> = 2.2, 8.8 Hz, 1H), 7.27 (d, <i>J</i> =8.8 Hz, 1H), 4.07 (d, <i>J</i> = 6.7 Hz, 2H), 1.34 (tt, <i>J</i> = 1.5, 6.6 Hz, 1H), 0.77–0.57 (m, 2H), 0.50–0.34 (m, 2H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 218.1.</div></div><div id="sec6_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2-(4,4-Difluoropiperidin-1-yl)-5-(methylsulfonyl)benzoic Acid (<b>14</b>)</h3><div class="NLM_p last">The title compound was prepared using general method A using 4,4-difluoropiperidine (1.7 g, 62%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.40 (br s, 1H), 8.11 (d, <i>J</i> = 2.3 Hz, 1H), 7.90 (dd, <i>J</i> = 2.4, 8.8 Hz, 1H), 7.32 (d, <i>J = 8</i>.7 Hz, 1H), 3.32–3.28 (m, 4H), 3.19 (s, 3H), 2.19–2.06 (m, 4H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 320.1</div></div><div id="sec6_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 5-Cyano-2-(4,4-difluoropiperidin-1-yl)benzoic Acid (<b>15</b>)</h3><div class="NLM_p last">The title compound was prepared using general method A using 4,4-difluoropiperidine (0.1 g, 43%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.98 (d, <i>J</i> = 2.1 Hz, 1H), 7.81 (dd, <i>J</i> = 2.2, 8.7 Hz, 1H), 7.24 (d, <i>J = 8</i>.8 Hz, 1H), 3.29 (d, <i>J</i> = 5.3 Hz, 4H), 2.19–2.03 (m, 4H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 267.1.</div></div><div id="sec6_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 3′-Fluoro-4-(methylsulfonyl)-[1,1′-biphenyl]-2-carboxylic Acid (<b>16</b>). General Method C</h3><div class="NLM_p last">A 100 mL round-bottomed flask, equipped with an argon inlet adaptor, was charged with 2.8 g (10 mmol) of <b>8b</b>, 3-fluorophenylboronic acid (1.5 g, 10.4 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.54 g, 0.5 mmol), and Na<sub>2</sub>CO<sub>3</sub> (2.1 g, 19.8 mmol) followed by 40 mL of dioxane and 20 mL of water. The reaction mixture was flushed with argon and stirred at 80 °C for 2 days. The mixture was filtered, and the filtrate was washed with EtOAc. To the water phase, was added 1 N HCl until the solution reached pH 3. Then the mixture was stirred at room temperature for 2 days. The desired compound was filtered as a white solid (0.9 g, 31%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.41 (br s, 1H), 8.31–8.23 (m, 1H), 8.13 (dd, <i>J</i> = 2.0, 8.1 Hz, 1H), 7.71 (d, <i>J</i> = 8.1 Hz, 1H), 7.59–7.44 (m, 1H), 7.35–7.12 (m, 3H), 3.33 (s, 3H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 295.0.</div></div><div id="sec6_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 4-Cyano-3′-fluoro-[1,1′-biphenyl]-2-carboxylic Acid (<b>17</b>)</h3><div class="NLM_p last">The title compound was prepared using general method C using Pd(dppf)Cl<sub>2</sub> as catalyst (120 mg, 7%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.18 (s, 1H), 8.04 (d, <i>J</i> = 8.2 Hz, 1H), 7.62 (d, <i>J</i> = 7.8 Hz, 1H), 7.51–7.44 (m, 2H), 7.27–7.15 (m, 3H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 242.0.</div></div><div id="sec6_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>tert</i>-Butyl 2-Phenyl-4,6-dihydropyrrolo[3,4-<i>c</i>]pyrazole-5(2<i>H</i>)-carboxylate (<b>19a</b>. General Method D</h3><div class="NLM_p last">To a 50 mL pressure vessel were added <i>tert</i>-butyl 4,6-dihydropyrrolo[3,4-<i>c</i>]pyrazole-5(2<i>H</i>)-carboxylate (2.0 g, 9.56 mmol) and iodobenzene (2.4 g, 11.95 mmol) in dioxane (20 mL). Nitrogen gas was bubbled through the mixture for 5 min. K<sub>3</sub>PO<sub>4</sub> (4.0 g, 19.1 mmol), CuI (364 mg, 1.9 mmol), and (1<i>S</i>,2<i>S</i>)-(+)-1,2-diaminocyclohexane (218 mg, 1.9 mmol) was then added. The reaction vessel was sealed and the mixture stirred at 120 <sup>◦</sup>C for 5 days. The reaction mixture was removed from heating and filtered while still hot. The filtrate was allowed to cool, diluted with EtOAc (250 mL), and washed with concentrated ammonium hydroxide (2 × 100 mL) and brine. The organic layer was dried (MgSO<sub>4</sub>), filtered, and evaporated, and the resulting residue was purified by FCC (15% EtOAc/hexanes) to afford <b>19a</b> (2.7 g, 35%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.71–7.59 (m, 3H), 7.44 (dd, <i>J</i> = 7.6, 8.4 Hz, 2H), 7.34–7.27 (m, 1H), 4.64–4.42 (m, 4H), 1.52 (s, 9H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 286.1.</div></div><div id="sec6_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>tert</i>-Butyl 2-(2-Fluorophenyl)-4,6-dihydropyrrolo[3,4-<i>c</i>]pyrazole-5(2<i>H</i>)-carboxylate (<b>19b</b>)</h3><div class="NLM_p last">The title compound was prepared using general method D (150 mg, 52%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.46 (s, 9 H) 4.43 (t, <i>J</i> = 9.85 Hz, 4 H) 7.28–7.52 (m, 3 H) 7.69–7.82 (m, 1 H) 8.00 (dd, <i>J</i> = 10.42, 2.26 Hz, 1H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 304.3.</div></div><div id="sec6_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>tert</i>-Butyl 2-(<i>m</i>-Tolyl)-4,6-dihydropyrrolo[3,4-<i>c</i>]pyrazole-5(2<i>H</i>)-carboxylate (<b>19c</b>)</h3><div class="NLM_p last">The title compound was prepared using general method D (530 mg, 19%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.24 (d, <i>J</i> = 11.0 Hz, 1H), 7.64–7.52 (m, 2H), 7.33 (t, <i>J</i> = 7.8 Hz, 1H), 7.08 (d, <i>J</i> = 7.4 Hz, 1H), 4.43–4.36 (m, 4H), 2.36–2.33 (m, 3H), 1.44 (s, 9H) ppm. LCMS (ESI) [M – COO<sup><i>t</i></sup>Bu]<sup>+</sup> 200.4 (molecular ion was not observed).</div></div><div id="sec6_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>tert</i>-Butyl 2-(5-Fluoropyridin-3-yl)-4,6-dihydropyrrolo[3,4-<i>c</i>]pyrazole-5(2<i>H</i>)-carboxylate (<b>19d</b>)</h3><div class="NLM_p last">The title compound was prepared using general method D (320 mg, 31%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.98 (br s, 1H), 8.51 (d, <i>J</i> = 2.7 Hz, 1H), 8.44 (d, <i>J</i> = 7.4 Hz, 1H), 8.23–8.13 (m, 1H), 4.49–4.35 (m, 4H), 1.51–1.37 (bs, 9H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 305.3.</div></div><div id="sec6_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>tert</i>-Butyl 2-(2-Methylpyridin-4-yl)-4,6-dihydropyrrolo[3,4-<i>c</i>]pyrazole-5(2<i>H</i>)-carboxylate (<b>19e</b>)</h3><div class="NLM_p last">The title compound was prepared using general method D (150 mg, 21%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.51 (d, <i>J</i> = 5.9 Hz, 1H), 7.75 (d, <i>J</i> = 15.3 Hz, 1H), 7.49 (dd, <i>J</i> = 1.8, 5.3 Hz, 1H), 7.36 (dd, <i>J</i> = 2.2, 5.7 Hz, 1H), 4.63–4.38 (m, 4H), 2.62 (s, 3H), 1.52 (d, <i>J</i> =0.8 Hz, 9H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 301.3.</div></div><div id="sec6_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>tert</i>-Butyl 2-Cyclopentyl-4,6-dihydropyrrolo[3,4-<i>c</i>]pyrazole-5(2<i>H</i>)-carboxylate (<b>19f</b>)</h3><div class="NLM_p last">To a 25 mL round-bottom flask was added 60% sodium hydride in mineral oil (0.11 g, 2.87 mmol), anhydrous DMF (5.0 mL), and <i>tert</i>-butyl 4,6-dihydropyrrolo[3,4-<i>c</i>]pyrazole-5(2<i>H</i>)-carboxylate (0.5 g, 2.39 mmol). The mixture stirred at room temperature for 1 h. A solution of bromocyclopentane (0.53 g, 3.58 mmol) and DMF (7.5 mL) was then added dropwise to the mixture and the mixture was stirred overnight at room temperature. The crude reaction mixture was quenched with water and then diluted with EtOAc (20 mL), washed with H<sub>2</sub>O (3 × 50 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated under reduced pressure. The crude was purified by FCC (20–30% EtOAc/hexanes) to afford the title compound (0.33 g, 50%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.16 (d, <i>J</i> = 17.6 Hz, 1H), 4.62 (qd, <i>J</i> = 7.0, 13.9 Hz, 1H), 4.52–4.34 (m, 4H), 2.23–2.10 (m, 2H), 2.07–1.93 (m, 2H), 1.93–1.79 (m, 2H), 1.77–1.59 (m, 2H), 1.52–1.43 (m, 9H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 278.3.</div></div><div id="sec6_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2-Phenyl-2,4,5,6-tetrahydropyrrolo[3,4-<i>c</i>]pyrazole (<b>20a</b>). General Method E</h3><div class="NLM_p last">A solution of <i>tert</i>-butyl 2-(4-fluorophenyl)-4,6-dihydropyrrolo[3,4-<i>c</i>]pyrazole-5(2<i>H</i>)-carboxylate (7.4 g, 24.4 mmol) in dioxane (60 mL) was treated with 4 N HCl/dioxane solution (61 mL, 244 mmol) and stirred at ambient temperature for 16 h. Solvents were removed under vacuum and the resulting solids treated with a minimum amount of methanol followed by excess diethyl ether. The title compound was filtered off and dried under reduced pressure to give the title compound white solid. The compound was isolated as the free base by dissolving the crude salt in CHCl<sub>3</sub> and washing with 1 N NaOH followed by drying under vacuum (250 mg, 96%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.60–7.71 (m, 3H), 7.41–7.51 (m, 2H), 7.24–7.33 (m, 2H), 4.00–4.25 (m, 4H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 186.1.</div></div><div id="sec6_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2-(2-Fluorophenyl)-2,4,5,6-tetrahydropyrrolo[3,4-<i>c</i>]pyrazole Hydrochloride (<b>20b</b>)</h3><div class="NLM_p last">The title compound was prepared using general method E (1 g, 94%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.01 (d, <i>J</i> = 2.2 Hz, 1H), 7.80 (td, <i>J</i> = 7.8, 1.5 Hz, 1H), 7.50–7.32 (m, 3H), 4.56–4.52 (m, <i>J</i> = 3.5 Hz, 4H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 204.3.</div></div><div id="sec6_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-(<i>m</i>-Tolyl)-2,4,5,6-tetrahydropyrrolo[3,4-<i>c</i>]pyrazole Hydrochloride (<b>20c</b>)</h3><div class="NLM_p last">The title compound was prepared using general method E (6.1 g, 84%). <sup>1</sup>H NMR (400 MHz, DMSO) δ 10.14 (s, 2H), 8.36 (s, 1H), 7.64 (s, 1H), 7.58 (dd, <i>J</i> = 8.0, 1.8 Hz, 1H), 7.38 (t, <i>J</i> = 7.8 Hz, 1H), 7.15 (d, <i>J</i> = 7.5 Hz, 1H), 4.37 (s, 4H), 2.38 (s, 3H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 200.4.</div></div><div id="sec6_1_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-(5-Fluoropyridin-3-yl)-2,4,5,6-tetrahydropyrrolo[3,4-<i>c</i>]pyrazole (<b>20d</b>)</h3><div class="NLM_p last">The title compound was prepared using general method E. The compound was isolated as the free base by dissolving the crude salt in CHCl<sub>3</sub>, washing with 1 N NaOH followed by drying under vacuum (400 mg, 97%). <sup>1</sup>H NMR (400 MHz CD<sub>3</sub>OD) δ 8.91 (s, 1H), 8.44 (s, 1H), 8.295 (s, 1H), 8.08–8.11 (m, 2H), 4.49 (s, 2H), 4.51 (s, 2H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 205.1.</div></div><div id="sec6_1_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-(2-Methylpyridin-4-yl)-2,4,5,6-tetrahydropyrrolo[3,4-<i>c</i>]pyrazole Dihydrochloride (<b>20e</b>)</h3><div class="NLM_p last">The title compound was prepared using general method E (12.8 g, 98%). <sup>1</sup>H NMR (400 MHz, deuterium oxide) δ 8.58–8.52 (m, 1H), 8.35–8.29 (m, 1H), 8.09–8.06 (m, 1H), 8.05–8.01 (m, 1H), 4.62–4.50 (m, 4H), 2.81–2.66 (m, 3H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 201.4.</div></div><div id="sec6_1_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 2-Cyclopentyl-2,4,5,6-tetrahydropyrrolo[3,4-<i>c</i>]pyrazole Hydrochloride (<b>20f</b>)</h3><div class="NLM_p last">The title compound was prepared using general method E (200 mg, 95%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.60 (s, 1H), 4.73 (quin, <i>J</i> = 7.1 Hz, 1H), 4.43 (s, 2H), 4.40 (s, 2H), 2.25–2.12 (m, 2H), 2.05–1.95 (m, 2H), 1.94–1.83 (m, 2H), 1.80–1.68 (m, 2H) ppm. LCMS (ESI) [M + H]<sup>+</sup><i>m</i>/<i>z</i> 178.2.</div></div><div id="sec6_1_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 5-(5-Methanesulfonyl-2-{[(2<i>S</i>)-1,1,1-trifluoropropan-2-yl]oxy}benzoyl)-2-phenyl-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazole (<b>21</b>). General Method F</h3><div class="NLM_p last">To a 10 mL glass vial was added <b>10a</b> (40 mg, 0.13 mmol), HATU (58.4 mg, 0.15 mmol), triethylamine (90 μL, 0.06 g, 0.64 mmol), and 34.1 mg (0.15 mmol) of <b>20a</b> in 1 mL of DMF. The mixture was stirred at room temperature for 5 h, then diluted with 1 mL of MeOH and purified by preparative HPLC using 5–95% CH<sub>3</sub>CN–H<sub>2</sub>O. Pure fractions were combined, diluted with DCM, and washed with aqueous NaHCO<sub>3</sub>. The organic phase was separated and evaporated to give the title compound as an off white solid (27 mg, 44%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.04–7.97 (m, 2H), 7.76 (s, 1H), 7.67–7.60 (m, 2H), 7.50–7.42 (m, 2H), 7.33–7.27 (m, 1H), 7.19 (dd, <i>J</i> = 1.6, 8.6 Hz, 1H), 4.90–4.78 (m, 3H), 4.53–4.36 (m, 2H), 3.07 (d, <i>J</i> = 1.2 Hz, 3H), 1.54 (d, <i>J</i> = 6.3 Hz, 3H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 480.1200. Found: 480.1194.</div></div><div id="sec6_1_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 2-(2-Fluorophenyl)-5-(5-methanesulfonyl-2-{[(2<i>S</i>)-1,1,1-trifluoropropan-2-yl]oxy}benzoyl)-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazole (<b>22</b>). General Method G</h3><div class="NLM_p last">A mixture of acid <b>10a</b> (125 mg, 0.40 mmol) in thionyl chloride (500 μL) was heated in a sealed 10 mL glass vial at 70 <sup>◦</sup>C for 45 min. After cooling to room temperature, the mixture was evaporated to dryness. The resulting residue was dissolved in EtOAc and evaporated to dryness, then dissolved in 2 mL of CH<sub>2</sub>Cl<sub>2</sub>. In a second glass vial a solution of pyrazole <b>20b</b>·HCl (96 mg, 0.4 mmol) in 2 mL of CH<sub>2</sub>Cl<sub>2</sub> was treated with TEA (226 μL, 1.61 mmol). After stirring at room temperature for 10 min, the two CH<sub>2</sub>Cl<sub>2</sub> mixtures were combined and the resulting mixture was stirred at room temperature for 3 h. The reaction mixture was washed with water and the organic phase evaporated to dryness. Purification (HPLC, 30–95% gradient ACN–H<sub>2</sub>O) afforded the title compound as an off white solid (144 mg, 72%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.10–7.88 (m, 3H), 7.81–7.68 (m, 1H), 7.60 (dd, <i>J</i> = 2.0, 9.0 Hz, 1H), 7.50–7.28 (m, 3H), 5.60–5.50 (m, 1H), 4.67 (d, <i>J</i> = 10.2 Hz, 2H), 4.45–4.27 (m, 2H), 3.24 (s, 3H), 1.45–1.40 (m, 3H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 498.1105. Found: 498.1096.</div></div><div id="sec6_1_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 5-(5-Methanesulfonyl-2-{[(2<i>S</i>)-1,1,1-trifluoropropan-2-yl]oxy}benzoyl)-2-(3-methylphenyl)-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazole (<b>23</b>)</h3><div class="NLM_p last">The title compound was prepared using general method G (66 mg, 80%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.36–8.20 (m, 2H), 8.00 (dd, <i>J</i> = 2.3, 8.6 Hz, 1H), 7.90 (dd, <i>J</i> = 2.3, 4.3 Hz, 1H), 7.65–7.49 (m, 4H), 7.34 (dt, <i>J</i> = 2.0, 7.8 Hz, 1H), 7.09 (d, <i>J</i> = 7.8 Hz, 1H), 5.54 (dq, <i>J</i> = 3.9, 6.4 Hz, 1H), 4.66 (d, <i>J</i> = 5.5 Hz, 2H), 4.39–4.30 (m, 2H), 3.24 (s, 3H), 2.35 (d, <i>J</i> = 2.7 Hz, 3H), 1.42 (dd, <i>J</i> = 2.0, 6.3 Hz, 3H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 494.1356. Found: 494.1352.</div></div><div id="sec6_1_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 3-Fluoro-5-[5-(5-methanesulfonyl-2-{[(2<i>S</i>)-1,1,1-trifluoropropan-2-yl]oxy}-benzoyl)-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazol-2-yl]pyridine (<b>24</b>)</h3><div class="NLM_p last">The title compound was prepared using general method F (26 mg, 41%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.77 (d, <i>J</i> = 1.6 Hz, 1H), 8.44–8.40 (m, 1H), 8.06–7.96 (m, 2H), 7.90–7.78 (m, 2H), 7.69 (s, 1H), 7.19 (d, <i>J</i> = 9.0 Hz, 1H), 4.93–4.78 (m, 3H), 4.54–4.38 (m, 2H), 3.08 (s, 3H), 1.55 (d, <i>J</i> = 6.7 Hz, 3H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 499.1058. Found: 499.1050.</div></div><div id="sec6_1_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 4-[5-(5-Methanesulfonyl-2-{[(2<i>S</i>)-1,1,1-trifluoropropan-2-yl]oxy}benzoyl)-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazol-2-yl]-2-methylpyridine (<b>25</b>)</h3><div class="NLM_p last">The title compound was prepared using general method F (30 mg, 47%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.53 (dd, <i>J</i> = 2.7, 5.9 Hz, 1H), 8.05–7.96 (m, 2H), 7.93–7.76 (m, 1H), 7.57 (dd, <i>J</i> = 2.0, 18.0 Hz, 1H), 7.48 (ddd, <i>J</i> = 2.3, 6.0, 8.1 Hz, 1H), 7.19 (d, <i>J</i> = 8.6 Hz, 1H), 4.91–4.77 (m, 3H), 4.54–4.36 (m, 2H), 3.07 (s, 3H), 2.68 (d, <i>J</i> = 3.1 Hz, 3H), 1.54 (d, <i>J</i> = 6.3 Hz, 3H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 495.1309. Found: 495.1300.</div></div><div id="sec6_1_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 2-Cyclopentyl-5-(5-methanesulfonyl-2-{[(2<i>S</i>)-1,1,1-trifluoropropan-2-yl]oxy}benzoyl)-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazole (<b>26</b>)</h3><div class="NLM_p last">The title compound was prepared using general method F (9 mg, 30%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.03–7.92 (m, 1H), 7.86 (dd, <i>J</i> = 2.5, 4.9 Hz, 1H), 7.65–7.49 (m, 2H), 5.52 (td, <i>J</i> = 6.6, 12.7 Hz, 1H), 4.65 (quin, <i>J</i> = 7.1 Hz, 2H), 4.54 (s, 2H), 4.35–4.08 (m, 3H), 3.22 (s, 3H), 2.14–1.94 (m, 3H), 1.86 (br s, 2H), 1.81–1.67 (m, 2H), 1.66–1.50 (m, 2H), 1.41 (dd, <i>J</i> = 2.2, 6.5 Hz, 3H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 472.1513. Found: 472.1508.</div></div><div id="sec6_1_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2-(2-Fluorophenyl)-5-[5-methanesulfonyl-2-(propan-2-yloxy)benzoyl]-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazole (<b>27</b>)</h3><div class="NLM_p last">The title compound was prepared using general method G (164 mg, 77%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.09–7.89 (m, 2H), 7.82–7.68 (m, 2H), 7.50–7.29 (m, 4H), 4.88–4.79 (m, 1H), 4.68 (d, <i>J</i> = 10.2 Hz, 2H), 4.43–4.33 (m, 2H), 3.20 (s, 3H), 1.27 (d, <i>J</i> = 5.9 Hz, 6H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 444.1388. Found: 444.1383.</div></div><div id="sec6_1_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 5-[2-(2,2-Dimethylpropoxy)-5-methanesulfonylbenzoyl]-2-(2-fluorophenyl)-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazole (<b>28</b>)</h3><div class="NLM_p last">The title compound was prepared using general method G (57 mg, 74%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.09–7.91 (m, 2H), 7.85–7.66 (m, 2H), 7.49–7.37 (m, 2H), 7.37–7.28 (m, 2H), 4.68 (d, <i>J</i> = 9.8 Hz, 2H), 4.43–4.33 (m, 2H), 3.81 (d, <i>J</i> = 4.7 Hz, 2H), 3.20 (s, 3H), 0.88 (d, <i>J</i> = 3.1 Hz, 9H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 472.1701. Found: 472.1695.</div></div><div id="sec6_1_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 5-[2-(Cyclopropylmethoxy)-5-methanesulfonylbenzoyl]-2-(2-fluorophenyl)-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazole (<b>29</b>)</h3><div class="NLM_p last">The title compound was prepared using general method G (21 mg, 31%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.08–7.91 (m, 2H), 7.83–7.68 (m, 2H), 7.49–7.29 (m, 4H), 4.69 (d, <i>J</i> = 9.8 Hz, 2H), 4.49–4.36 (m, 2H), 4.06 (dd, <i>J</i> = 3.7, 6.8 Hz, 2H), 3.20 (s, 3H), 1.25–1.14 (m, 1H), 0.53–0.45 (m, 2H), 0.31–0.25 (m, 2H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 456.1388. Found: 456.1382.</div></div><div id="sec6_1_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 4,4-Difluoro-1-{2-[2-(2-fluorophenyl)-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazole-5-carbonyl]-4-methanesulfonylphenyl}piperidine (<b>30</b>)</h3><div class="NLM_p last">The title compound was prepared using general method G (59 mg, 79%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.10–7.91 (m, 1H), 7.87 (ddd, <i>J</i> = 1.2, 2.3, 8.6 Hz, 1H), 7.80–7.66 (m, 2H), 7.50–7.29 (m, 4H), 4.72 (d, <i>J</i> = 11.3 Hz, 2H), 4.61–4.31 (m, 2H), 3.39–3.32 (m, 2H), 3.27 (br s, 2H), 3.19 (d, <i>J</i> = 1.2 Hz, 3H), 2.07–1.94 (m, 4H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 505.1516. Found: 505.1510.</div></div><div id="sec6_1_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 3-{5-[2-(4,4-Difluoropiperidin-1-yl)-5-methanesulfonylbenzoyl]-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazol-2-yl}-5-fluoropyridine (<b>31</b>)</h3><div class="NLM_p last">The title compound was prepared using general method G (42 mg, 56%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.98 (dd, <i>J</i> = 1.4, 11.9 Hz, 1H), 8.56–8.49 (m, 1H), 8.36 (s, 1H), 8.25–8.12 (m, 1H), 7.88 (dd, <i>J</i> = 2.5, 8.8 Hz, 1H), 7.75 (dd, <i>J</i> = 1.2, 2.3 Hz, 1H), 7.32 (dd, <i>J</i> = 1.8, 8.8 Hz, 1H), 4.73 (d, <i>J</i> = 11.3 Hz, 2H), 4.46 (br s, 2H), 3.38–3.30 (m, 4H), 3.22–3.15 (m, 3H), 2.08–1.92 (m, 4H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 506.1468. Found: 506.1464.</div></div><div id="sec6_1_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 4-{5-[2-(4,4-Difluoropiperidin-1-yl)-5-methanesulfonylbenzoyl]-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazol-2-yl}-2-methylpyridine (<b>32</b>)</h3><div class="NLM_p last">The title compound was prepared using general method G (15 mg, 20%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.55 (s, 0.5H), 8.46 (dd, <i>J</i> = 1.6, 5.9 Hz, 1H), 8.37 (s, 0.5H), 7.92–7.85 (m, 1H), 7.75 (dd, <i>J</i> = 1.6, 2.3 Hz, 1H), 7.69 (dd, <i>J</i> = 2.2, 15.8 Hz, 1H), 7.60 (ddd, <i>J</i> = 2.0, 5.5, 12.9 Hz, 1H), 7.32 (dd, <i>J</i> = 1.0, 8.8 Hz, 1H), 4.72 (d, <i>J</i> = 9.8 Hz, 2H), 4.61–4.34 (m, 2H), 3.44–3.32 (m, 3H), 3.19 (d, <i>J</i> = 0.8 Hz, 3H), 2.49 (d, <i>J</i> = 1.6 Hz, 3H), 1.99 (t, <i>J</i> = 13.3 Hz, 4H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 502.1719. Found: 502.1711.</div></div><div id="sec6_1_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 2-(2-Fluorophenyl)-5-[2-(3-fluorophenyl)-5-methanesulfonylbenzoyl]-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazole (<b>33</b>)</h3><div class="NLM_p last">The title compound was prepared using general method G (23 mg, 59%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.11–7.99 (m, 2H), 7.87–7.81 (m, 1H), 7.69 (dtd, <i>J</i> = 1.8, 7.9, 19.5 Hz, 1H), 7.55–7.20 (m, 8H), 4.53 (d, <i>J</i> = 11.7 Hz, 2H), 4.27–4.09 (m, 2H), 3.33 (d, <i>J</i> = 1.2 Hz, 3H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 480.1188. Found: 480.1184.</div></div><div id="sec6_1_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 3-Fluoro-5-{5-[2-(3-fluorophenyl)-5-methanesulfonylbenzoyl]-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazol-2-yl}pyridine (<b>34</b>)</h3><div class="NLM_p last">The title compound was prepared using general method G (96 mg, 59%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.93 (d, <i>J</i> = 9.4 Hz, 1H), 8.53–8.48 (m, 1H), 8.46–8.28 (m, 1H), 8.19–8.12 (m, 1H), 8.12–8.05 (m, 2H), 7.83 (dd, <i>J</i> = 4.7, 8.2 Hz, 1H), 7.53–7.45 (m, 1H), 7.41–7.32 (m, 2H), 7.28–7.21 (m, 1H), 4.54 (d, <i>J</i> = 10.2 Hz, 2H), 4.19 (d, <i>J</i> = 18.8 Hz, 2H), 3.33 (s, 3H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 481.1141. Found: 481.1138.</div></div><div id="sec6_1_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 4-{5-[2-(3-Fluorophenyl)-5-methanesulfonylbenzoyl]-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazol-2-yl}-2-methylpyridine (<b>35</b>)</h3><div class="NLM_p last">The title compound was prepared using general method G (75 mg, 46%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.49–8.40 (m, 1H), 8.35–8.09 (m, 1H), 8.09–8.04 (m, 1H), 7.85–7.78 (m, 1H), 7.65 (d, <i>J</i> = 13.3 Hz, 1H), 7.59–7.53 (m, 1H), 7.52–7.44 (m, 1H), 7.42–7.28 (m, 1H), 7.24 (t, <i>J</i> = 8.6 Hz, 1H), 4.61–4.41 (m, 2H), 4.18 (d, <i>J</i> = 17.6 Hz, 2H), 3.32 (d, <i>J</i> = 1.6 Hz, 3H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 477.1391. Found: 477.1385.</div></div><div id="sec6_1_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 5-[5-(Ethanesulfonyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzoyl]-2-(2-fluorophenyl)-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazole (<b>36</b>)</h3><div class="NLM_p last">The title compound was prepared using general method G (213 mg, 65%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.09–7.96 (m, 1H), 7.95 (dd, <i>J</i> = 0.8, 2.3 Hz, 1H), 7.86 (dd, <i>J</i> = 2.5, 3.3 Hz, 1H), 7.81–7.68 (m, 1H), 7.60 (dd, <i>J</i> = 2.0, 9.0 Hz, 1H), 7.50–7.29 (m, 3H), 5.54 (td, <i>J</i> = 6.4, 12.6 Hz, 1H), 4.67 (d, <i>J</i> = 9.8 Hz, 2H), 4.44–4.26 (m, 2H), 3.37–3.31 (m, 2H), 1.47–1.40 (m, 3H), 1.14–1.07 (m, 3H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 512.1262. Found: 512.1255.</div></div><div id="sec6_1_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 3-{5-[5-(Ethanesulfonyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzoyl]-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazol-2-yl}-5-fluoropyridine (<b>37</b>)</h3><div class="NLM_p last">The title compound was prepared using general method G (24 mg, 40%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.02–8.93 (m, 1H), 8.54–8.37 (m, 2H), 8.24–8.14 (m, 1H), 7.96 (ddd, <i>J</i> = 1.4, 2.4, 8.7 Hz, 1H), 7.86 (dd, <i>J</i> = 2.3, 3.1 Hz, 1H), 7.60 (dd, <i>J</i> = 2.0, 9.0 Hz, 1H), 5.60–5.48 (m, 1H), 4.68 (d, <i>J</i> = 9.0 Hz, 2H), 4.46–4.28 (m, 2H), 3.38–3.31 (m, 2H), 1.43 (dd, <i>J</i> = 1.6, 6.3 Hz, 3H), 1.11 (t, <i>J</i> = 7.4 Hz, 3H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 513.1214. Found: 513.1206.</div></div><div id="sec6_1_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 4-{5-[5-(Ethanesulfonyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzoyl]-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazol-2-yl}-2-methylpyridine (<b>38</b>)</h3><div class="NLM_p last">The title compound was prepared using general method G (26 mg, 44%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.77–8.58 (m, 2H), 8.25–8.05 (m, 2H), 8.02–7.94 (m, 1H), 7.90–7.83 (m, 1H), 7.62 (dd, <i>J</i> = 2.3, 9.0 Hz, 1H), 5.55 (td, <i>J</i> = 6.3, 12.5 Hz, 1H), 4.71 (d, <i>J</i> = 12.9 Hz, 2H), 4.50–4.31 (m, 2H), 3.32 (q, <i>J</i> = 7.3 Hz, 3H), 2.68 (d, <i>J</i> = 2.0 Hz, 3H), 1.42 (d, <i>J</i> = 6.3 Hz, 3H), 1.11 (dt, <i>J</i> = 1.0, 7.3 Hz, 3H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 509.1465. Found: 509.1458.</div></div><div id="sec6_1_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 2-Phenyl-5-[5-(propane-2-sulfonyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzoyl]-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazole (<b>39</b>)</h3><div class="NLM_p last">The title compound was prepared using general method F (8 mg, 24%).<sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.39–8.22 (m, 1H), 7.93 (ddd, <i>J</i> = 1.0, 2.3, 8.8 Hz, 1H), 7.83 (t, <i>J</i> = 2.3 Hz, 1H), 7.80–7.73 (m, 2H), 7.60 (dd, <i>J</i> = 1.6, 9.0 Hz, 1H), 7.51–7.43 (m, 2H), 7.32–7.24 (m, 1H), 5.60–5.48 (m, 1H), 4.66 (d, <i>J</i> = 6.7 Hz, 2H), 4.42–4.25 (m, 2H), 3.45 (quind, <i>J</i> = 6.8, 13.5 Hz, 1H), 1.43 (dd, <i>J</i> = 1.6, 6.3 Hz, 3H), 1.16 (d, <i>J</i> = 7.0 Hz, 6H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 508.1513. Found: 508.1507.</div></div><div id="sec6_1_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 3-[2-(2-Fluorophenyl)-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazole-5-carbonyl]-4-{[(2<i>S</i>)-1,1,1-trifluoropropan-2-yl]oxy}benzonitrile (<b>40</b>)</h3><div class="NLM_p last">The title compound was prepared using general method F (5 mg, 15%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.10–7.93 (m, 2H), 7.89 (dd, <i>J</i> = 2.2, 7.6 Hz, 1H), 7.82–7.64 (m, 1H), 7.54 (dd, <i>J</i> = 2.5, 8.8 Hz, 1H), 7.51–7.23 (m, 3H), 5.53 (td, <i>J</i> = 6.4, 12.6 Hz, 1H), 4.65 (d, <i>J</i> = 10.6 Hz, 2H), 4.48–4.19 (m, 2H), 1.41 (d, <i>J</i> = 6.3 Hz, 3H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 445.1282. Found: 445.1276.</div></div><div id="sec6_1_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 3-[2-(5-Fluoropyridin-3-yl)-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazole-5-carbonyl]-4-{[(2<i>S</i>)-1,1,1-trifluoropropan-2-yl]oxy}benzonitrile (<b>41</b>)</h3><div class="NLM_p last">The title compound was prepared using general method F (19 mg, 44%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.97 (dd, <i>J</i> = 1.6, 10.6 Hz, 1H), 8.55–8.32 (m, 2H), 8.19 (tdd, <i>J</i> = 2.3, 10.2, 16.4 Hz, 1H), 7.98 (dd, <i>J</i> = 2.0, 9.0 Hz, 1H), 7.88 (dd, <i>J</i> = 2.0, 7.0 Hz, 1H), 7.54 (dd, <i>J</i> = 2.3, 9.0 Hz, 1H), 5.52 (td, <i>J</i> = 6.4, 12.6 Hz, 1H), 4.66 (d, <i>J</i> = 9.0 Hz, 2H), 4.49–4.25 (m, 2H), 1.40 (d, <i>J</i> = 6.7 Hz, 3H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 446.1235. Found: 446.1231.</div></div><div id="sec6_1_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 3-[2-(2-Methylpyridin-4-yl)-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazole-5-carbonyl]-4-{[(2<i>S</i>)-1,1,1-trifluoropropan-2-yl]oxy}benzonitrile (<b>42</b>)</h3><div class="NLM_p last">The title compound was prepared using general method F (13 mg, 9%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.73–8.48 (m, 2H), 8.14–7.83 (m, 4H), 7.55 (dd, <i>J</i> = 2.3, 9.0 Hz, 1H), 5.53 (td, <i>J</i> = 6.0, 12.3 Hz, 1H), 4.79–4.60 (m, 2H), 4.48–4.28 (m, 2H), 2.62 (d, <i>J</i> = 2.3 Hz, 3H), 1.40 (d, <i>J</i> = 6.3 Hz, 3H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 442.1486. Found: 442.1476.</div></div><div id="sec6_1_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 3-{2-Cyclopentyl-F-pyrrolo[3,4-<i>c</i>]pyrazole-5-carbonyl}-4-{[(2<i>S</i>)-1,1,1-trifluoropropan-2-yl]oxy}benzonitrile (<b>43</b>)</h3><div class="NLM_p last">The title compound was prepared using general method F (20 mg, 62%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.71 (ddd, <i>J</i> = 2.3, 4.1, 8.8 Hz, 1H), 7.65 (d, <i>J</i> = 2.0 Hz, 1H), 7.17–7.04 (m, 2H), 4.87–4.67 (m, 3H), 4.62 (dt, <i>J</i> = 2.7, 7.2 Hz, 1H), 4.47–4.19 (m, 2H), 2.27–2.09 (m, 2H), 2.07–1.94 (m, 2H), 1.94–1.81 (m, 2H), 1.78–1.61 (m, 2H), 1.51 (d, <i>J</i> = 6.3 Hz, 3H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 419.1690. Found: 419.1685.</div></div><div id="sec6_1_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 3-{2-Phenyl-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazole-5-carbonyl}-4-(propan-2-yloxy)-benzonitrile (<b>44</b>)</h3><div class="NLM_p last">The title compound was prepared using general method F (24 mg, 66%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.80–7.28 (m, 8H), 7.03 (d, <i>J</i> = 8.6 Hz, 1H), 4.85 (d, <i>J</i> = 19.6 Hz, 2H), 4.75–4.60 (m, 1H), 4.45 (d, <i>J</i> = 12.9 Hz, 2H), 1.36 (d, <i>J</i> = 5.9 Hz, 6H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 373.1659. Found: 373.1653.</div></div><div id="sec6_1_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 3-[2-(5-Fluoropyridin-3-yl)-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazole-5-carbonyl]-4-(propan-2-yloxy)benzonitrile (<b>45</b>)</h3><div class="NLM_p last">The title compound was prepared using general method F (13 mg, 34%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.75 (d, <i>J</i> = 5.5 Hz, 1H), 8.41 (br s, 1H), 7.90–7.73 (m, 2H), 7.74–7.57 (m, 2H), 7.03 (d, <i>J</i> = 8.6 Hz, 1H), 4.85 (d, <i>J</i> = 14.9 Hz, 2H), 4.70 (qd, <i>J</i> = 5.8, 11.5 Hz, 1H), 4.47 (d, <i>J</i> = 11.3 Hz, 2H), 1.44–1.29 (m, 6H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 392.1518. Found: 392.1511.</div></div><div id="sec6_1_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 3-[2-(2-Methylpyridin-4-yl)-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazole-5-carbonyl]-4-(propan-2-yloxy)benzonitrile (<b>46</b>)</h3><div class="NLM_p last">The title compound was prepared using general method F (125 mg, 44%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.54 (d, <i>J</i> = 5.9 Hz, 1H), 7.96–7.76 (m, 1H), 7.74–7.58 (m, 2H), 7.59–7.41 (m, 2H), 7.04 (dd, <i>J</i> = 1.2, 8.6 Hz, 1H), 4.85 (d, <i>J</i> = 15.3 Hz, 2H), 4.76–4.62 (m, 1H), 4.47 (d, <i>J</i> = 11.0 Hz, 2H), 2.68 (d, <i>J</i> = 7.0 Hz, 3H), 1.36 (dd, <i>J</i> = 2.0, 6.3 Hz, 6H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 388.1768. Found: 388.1762.</div></div><div id="sec6_1_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 4-(Cyclopropylmethoxy)-3-[2-(2-methylpyridin-4-yl)-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazole-5-carbonyl]benzonitrile (<b>47</b>)</h3><div class="NLM_p last">The title compound was prepared using general method F (6 mg, 26%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.54 (dd, <i>J</i> = 2.2, 5.7 Hz, 1H), 7.89–7.72 (m, 1H), 7.71–7.63 (m, 2H), 7.58–7.46 (m, 1H), 7.40 (d, <i>J</i> = 5.5 Hz, 1H), 7.06–6.99 (m, 1H), 4.87 (d, <i>J</i> = 16.0 Hz, 2H), 4.51 (d, <i>J</i> = 12.1 Hz, 2H), 3.98 (dd, <i>J</i> = 2.0, 7.0 Hz, 2H), 2.66 (s, 3H), 1.32–1.12 (m, 1H), 0.70–0.45 (m, 2H), 0.41–0.19 (m, 2H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 400.1768. Found: 400.1762.</div></div><div id="sec6_1_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 4-(4,4-Difluoropiperidin-1-yl)-3-[2-(2-methylpyridin-4-yl)-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazole-5-carbonyl]benzonitrile (<b>48</b>)</h3><div class="NLM_p last">The title compound was prepared using general method F (12 mg, 6%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.55 (dd, <i>J</i> = 1.6, 5.9 Hz, 1H), 7.92–7.71 (m, 1H), 7.70–7.59 (m, 2H), 7.55–7.37 (m, 2H), 7.10 (dd, <i>J</i> = 3.9, 8.6 Hz, 1H), 5.04–4.20 (m, 4H), 3.35 (br s, 4H), 2.67 (br s, 3H), 2.14–1.91 (m, 4H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 449.1896. Found: 449.1892.</div></div><div id="sec6_1_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 4-(3-Fluorophenyl)-3-[2-(5-fluoropyridin-3-yl)-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazole-5-carbonyl]benzonitrile (<b>49</b>)</h3><div class="NLM_p last">The title compound was prepared using general method G (15 mg, 33%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.98–8.85 (m, 1H), 8.50 (d, <i>J</i> = 2.3 Hz, 1H), 8.47–8.29 (m, 1H), 8.14 (tdd, <i>J</i> = 2.4, 10.4, 16.8 Hz, 1H), 8.08–7.99 (m, 2H), 7.80–7.68 (m, 1H), 7.54–7.42 (m, 1H), 7.39–7.28 (m, 2H), 7.28–7.19 (m, 1H), 4.52 (d, <i>J</i> = 11.7 Hz, 2H), 4.23 (d, <i>J</i> = 13.7 Hz, 2H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 428.1318. Found: 428.1312.</div></div><div id="sec6_1_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 4-(3-Fluorophenyl)-3-[2-(2-methylpyridin-4-yl)-2<i>H</i>,4<i>H</i>,5<i>H</i>,6<i>H</i>-pyrrolo[3,4-<i>c</i>]pyrazole-5-carbonyl]benzonitrile (<b>50</b>)</h3><div class="NLM_p last">The title compound was prepared using general method F (15 mg, 65%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.47–8.32 (m, 2H), 8.07–8.01 (m, 2H), 7.77–7.72 (m, 1H), 7.65 (dd, <i>J</i> = 2.2, 15.5 Hz, 1H), 7.56 (ddd, <i>J</i> = 2.0, 5.6, 12.0 Hz, 1H), 7.51–7.44 (m, 1H), 7.37–7.29 (m, 2H), 7.27–7.18 (m, 1H), 4.51 (d, <i>J</i> = 11.3 Hz, 2H), 4.22 (d, <i>J</i> = 14.1 Hz, 2H), 2.48 (s, 3H) ppm. HRMS (ESI): [M + H]<sup>+</sup><i>m</i>/<i>z</i> calculated, 424.1568. Found: 424.1560.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> GlyT1 Inhibition Uptake Assay</h3><div class="NLM_p last">A scintillation proximity assay (SPA) was used to measure the uptake of [<sup>14</sup>C]-glycine in HEK293 cells stably expressing human GlyT1c and in cultured primary rat cortical neurons.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Human GlyT1c Assay</h3><div class="NLM_p last">HEK293 cells stably expressing hGlyT1c were plated onto 96-well Cytostar plates at a density of 4.5 × 10<sup>4</sup> cells per well in 100 μL of growth media (DMEM containing 1× penicillin/streptomycin and 10% fetal bovine serum) and incubated overnight in a 37 °C, 10% CO<sub>2</sub> incubator. The following day stock compounds, 10 mM solution in DMSO, were serially diluted in DMSO, and 2× compound solutions were prepared by diluting compound again (1:100) in HBSS. Growth medium was removed from the plate, and 30 μL of 2× compound solution was added. Immediately after, 30 μL of 15 μM [<sup>14</sup>C] glycine in HBSS was added and plates were sealed and allowed to incubate at room temperature for 2 h. Plates were then read on a MicroBeta plate counter (PerkinElmer). Dose–response data (11-concentration dose response, 2 data points per concentration) for tested compounds were analyzed and curves were fit using a four-parameter logistic fit to determine IC<sub>50</sub> values.</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Human GlyT2 Assay</h3><div class="NLM_p last">GlyT2 inhibition was measured in HEK293 cells stably expressing GlyT2 for each compound at a single concentration of 10 μM using the methods analogous to those described above for in the GlyT1 assay.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Rat Primary Cortical Neuron Assay</h3><div class="NLM_p last">Primary rat cortical neurons were harvested from rat E18 pups and plated onto poly-<span class="smallcaps smallerCapital">d</span>-lysine-coated 96-well Cytostar plates at a density of 3.5 × 10<sup>4</sup> cells per well in 100 μL of astrocyte media (MEM medium with 20 mM glucose, 1× penicillin/streptomycin, and 10% fetal bovine serum) and incubated at 37 °C in a 5% CO<sub>2</sub> environment. Twenty-four hours, medium was replaced with 200 μL of neuronal media (BME medium with 20 mM glucose, 1 mM sodium pyruvate, 2 mM GlutaMAX, 1× penicillin/streptomycin, 1% horse serum, and B27 supplement) and the cells were cultured for an additional 5 days in a 37 °C, 5% CO<sub>2</sub> incubator. The following day, stock compounds in 10 mM DMSO were serially diluted in DMSO and 2× compound solutions were prepared by diluting compound again (1:100) in HBSS. Growth medium was removed from the plate, and 30 μL of 2× compound solution was added. Immediately after, 30 μL of 25 μM [<sup>14</sup>C]glycine in HBSS supplemented with 5 mM <span class="smallcaps smallerCapital">l</span>-alanine and 5 mM HEPES was added and plates were sealed and allowed to incubate at room temperature for 2 h. Plates were then read on a MicroBeta plate counter (PerkinElmer). Dose–response data (11-point dose response, 2 data points per concentration) for tested compounds were analyzed, and curves were fit using a four-parameter logistic fit to determine IC<sub>50</sub> values.</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Metabolic Stability in the Presence of Rat or Human Liver Microsomes</h3><div class="NLM_p last">Test compound was incubated at a final concentration of 1 μM in a reaction mixture containing rat liver microsomes of 0.5 mg of protein/mL in Tris buffer at 37 °C. The reaction was started by addition of NADPH (2 mM). Aliquots of the incubation mixture were removed and quenched with three volumes of cold ACN containing internal standard, indomethacin (0.5 μM) at 0, 5, 15, and 30 min for RLM and at 0, 15, 30, and 60 min for HLM. The samples were vortex mixed and centrifuged at 4000 rpm for 10 min at 4 °C, and the supernatant was transferred to a 384-well plate followed by dilution with same volume of distilled water. An amount of 5 μL of the samples was analyzed using a Shimadzu HPLC system (Kyoto, Japan) equipped with a reverse-phase column (Thermo Hypersil GOLD 3 μm Drop-In guard cartridges, 10 mm × 2.1 mm). Mobile phase consisted of 0.1% formic acid in water and of 0.1% formic acid in ACN with a flow rate of 0.7 mL/min. Eluent was directed to an API4000 triple quadruple mass spectrometer (AB Sciex, Framingham, MA) equipped with a turbo electrospray interface. Multiple reaction monitoring (MRM) transition in positive ion mode was used. Integration of the sample peaks was performed using AB Sciex Analyst and DiscoveryQuant software; peak area ratio of the analyte to the internal standard was determined accordingly. In vitro intrinsic clearance (Cl<sub>int</sub>) was calculated by dividing the first-order degradation rate constant (<i>K</i><sub>deg</sub>) by the concentration of microsomal protein used in the incubation. <i>K</i><sub>deg</sub> was the slope using least-squares fit to the curve of percent test compound remaining vs time (0 to 30 min for RLM and 0 to 60 min for HLM).</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> hERG Potassium Channel Inhibition</h3><div class="NLM_p last">The hERG potassium current was recorded from a CHO cell line stably expressing the hERG channel (Kv11.1) cell line. hERG tail currents were recorded using a QPatch automated patch clamp instrument in standard extracellular and intracellular recording solutions. The voltage protocol was (1) Vstep from −80 mV to −50 mV for 0.5 s to determine holding current, (2) Vstep from −50 mV to +10 mV for 2 s to activate HERG current, (3) Vstep to −50 mV for 2 s to remove voltage-dependent inactivation and elicit the HERG tail current, and (4) return to the holding potential of −80 mV. The voltage waveform was repeated every 12 s. The baseline HERG tail current was recorded for at least 5–10 min in drug-free external recording. After a stable baseline HERG tail current was established, four concentrations of test compound(s) were cumulatively applied (10 nM, 100 nM, 1 μM, 10 μM), and the hERG current was measured at the end of a 5 min application of each drug concentration. The hERG current at each test concentration was normalized to the predrug baseline, and concentration–response curves were generated.</div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> MDCK-MDR1 Cell Permeability and Efflux Transport</h3><div class="NLM_p last">Efflux was determined across monolayers of Madin–Darby canine kidney (MDCK) cells transfected with the human multidrug resistance 1 gene (MDR1 or P-gp) (Netherlands Cancer Institute, Amsterdam, The Netherlands). Cell monolayers were grown for 3 days on trans well cell culture devices (Millipore, Billerica, MA) at a density equal to 1.1 × 10<sup>6</sup> cells/mL. Bidirectional transport of each test compound was assessed using a final concentration equal to 5 μM dissolved in Hanks’ balanced salt solution (HBSS) (Gibco, Grand Island, NY). Permeability experiments were conducted at 37 °C, 5% CO<sub>2</sub> with compounds dosed either on the apical (for A to B determinations) or the basolateral (for B to A) compartment with donor samples collected at time zero and donor and receiver samples collected at 60 min incubation. Samples were collected from the MDCK-MDR1 cell monolayers and appropriately diluted with blank HBSS. The final step of sample preparation was the addition of 0.1% formic acid in CH<sub>3</sub>CN containing buspirone as the internal standard (IS). Sample plates were analyzed by high pressure liquid chromatography tandem mass spectrometry (LC–MS/MS) to determine the amount of parent compound in each chamber. Each well was monitored for the presence of the test compound, buspirone, and atenolol (negative control). Time 0 samples were collected in order to obtain initial concentration measurements, and peak area ratios were used to calculate the permeability of the test compounds. All the high performance liquid chromatography–tandem quadrupole mass spectrometry (LC–MS/MS) experiments for quantitative analysis were performed using a triple quadrupole mass spectrometer (API4000, AB Sciex, Framingham, MA) coupled with a Shimadzu HPLC system (Shimadzu Scientific Instruments, Columbia, MD). The Shimadzu LC system consisted of a pump, column and column heater (40 °C), autosampler, and a vacuum degasser/mobile phase tray. Mobile phase A was water containing 0.1% formic acid, and mobile phase B was CH<sub>3</sub>CN containing 0.1% formic acid. All samples were analyzed in multiple reaction monitoring (MRM) positive ion mode. A turbo spray ion source was used on the API4000 mass spectrometer. The reverse-phase column was a Phenomenex Luna C18 100A column 50 mm × 2 mm, 5 μm (Phenomenex, Torrance, CA). Integration of the sample peaks was performed using AB Sciex Analyst software; peak area ratio of the analyte to the internal standard was determined accordingly. Apparent permeability coefficients (<i>P</i><sub>app</sub>) were determined for each compound in both the A to B and B to A directions. Efflux ratios were calculated using the ratio of <i>P</i><sub>app</sub>(B→A) to <i>P</i><sub>app</sub>(A→B).</div></div><div id="sec6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> BBB PAMPA Permeability Assay</h3><div class="NLM_p last">The determination of permeability was performed using an Evolution instrument (Pion Inc., Billerica, MA) combined with a Tecan Freedom Evo Workstation (Tecan Group Ltd., Mannedorf, Switzerland) robotic liquid handling system. The liquid handling draws 8 μL of 10 mM DMSO stock of new chemical entities and mixes it into 800 μL of an aqueous universal PRIZMA buffer solution at pH 7.4 (Pion Inc., Billerica, MA) so that the final sample concentration is 100 μM in buffer solutions. The DMSO concentration was kept at 1.0% (v/v) in the final buffer solutions. 200 μL of the 100 μM NCE was dispensed to a 96-well microtiter plate “sandwich” (pION, PN 110212, preloaded with magnetic stirrers) of the donor side and 200 μL of brain sink buffer (Pion Inc., Billerica, MA) to the receiver solutions contained a surfactant mixture (“lipophilic sink”) to mimic tissue binding. Vigorous stirring was employed in the assay, with stirring speed set to produce an ABL thickness of about 60 μm, to minimize the ABL contribution to the measured permeability. The PAMPA sandwich was assembled and allowed to incubate for 60 min in a controlled-environment chamber (pION Gut-Box, PN 110205) with a built-in magnetic stirring mechanism. Both the donor and receiver wells were assayed for the amount of material present, by comparison with the UV spectrum (210–500 nm) obtained from a reference standard. Permeability values were corrected for membrane retention.</div></div><div id="sec6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> CYP Inhibition Assay</h3><div class="NLM_p last">In vitro incubation to determine CYP inhibition of five CYPs (1A2, 2C9, 2C19, 2D6, and 3A4) was performed by using a semiautomated procedure on a Hamilton Microlab Nimbus Personal Pipetting Workstation (Hamilton Robotics HQ, Reno, NV). Incubations from frozen pooled human liver microsomes from 200 donors (Xenotech, Lenexa, KS), and 50 μL was added to each well containing 0.1 mg/mL final in 50 mM potasium phosphate buffer (pH 7.4) and spiked with test compound solution (100 μL), 10 μM final, known specific CYP inhibitors (10 μM furafylline 1A2, 10 μM sulphenazole 2C9, 20 μM tranylcypromine 2C19, 1 μM quinidine 2D6, 1 μM ketoconazole), or vehicle control. 50 μL of NADPH-generating system (all final concentration; 0.6 mM MgCl<sub>2</sub>, 0.2 mM EDTA, 1 mM glucose 6-phosphate, 0.2 mM NADP<sup>+</sup>, and 0.2 units/ml glucose 6-phosphate dehydrogenase). To start the reaction, 50 μL of known CYP specific substrate solution was added to each plate (50 μM phenacetin 1A2, 4 μM diclofenac 2C9, 35 μM <i>S</i>-mephenytoin 2C19, 5 μM dextromethorphan 2D6, and 3 μM midazolam 3A4/5). Samples were incubated in a shaking water bath at 37 °C for 10 min for all CYPs except 3A4 (7 min). The reaction was stopped by adding 300 μL of stop solution containing an internal standard of 40 nM diazepam in acetonitrile. Samples were vortexed and centrifuged at 3500 rpm for 10 min. 150 μL of supernatant was transferred into a 96-deep well containing 150 μL of 0.3% formic acid in Milli-Q water and analyzed using LC–MS/MS. An amount of 5 μL of the samples was analyzed using a Shimadzu HPLC system (Kyoto, Japan) equipped with a reversed-phase column (Thermo Hypersil GOLD 3 μm Drop-In guard cartridges, 10 mm × 2.1 mm). Mobile phase consisted of 0.1% formic acid in water and of 0.1% formic acid in ACN with a flow rate of 0.7 mL/min. Eluent was directed to an API5500 triple quadruple mass spectrometer (AB Sciex, Framingham, MA) equipped with a turbo electrospray interface. Multiple reaction monitoring (MRM) transition in positive ion mode was used for formation of metabolites (acetaminophin 1A2, 4-hydroxydiclofenac 2C9, 4-hydroxymephnetoin 2C19, dextrorphan 2D6, 1-hydroxymidazolam 3A4/5). Integration of the sample peaks was performed using AB Sciex Analyst software; peak area ratio of the analyte to the internal standard was determined accordingly. For each test compound or positive control sample, % inhibition = ((<i>S</i><sub>vehicle</sub> – <i>S</i><sub>compound</sub>)/<i>S</i><sub>Vehicle</sub>) × 100, where <i>S</i><sub>vehicle</sub> is the average area ratio from the vehicle samples and <i>S</i><sub>compound</sub> is the area ratio from the test compounds or positive controls.</div></div><div id="sec6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> Plasma Protein Binding and Brain Tissue Binding Assay</h3><div class="NLM_p">The free fraction of compounds in the rat plasma and brain homogenate was determined using a 96-well rapid equilibrium dialysis (RED) device with MWCO 8000 RED inserts (Thermo Fisher Scientific, Waltham, MA). Rat plasma and brain were purchased from Bioreclamation IVT (Baltimore, MD) and thawed on the day of experiment. Rat brain was homogenized with BupH phosphate buffered saline, 0.1 M, pH 7.2 (Thermo Scientific), to a final 1:6 brain/buffer using a FastPrep-24. Plasma and brain homogenate were spiked with each tested compound (final concentration of 1.0 μM) and triplicate 300 μL was loaded to designated RED device donor chambers followed by addition of 500 μL of PBS buffer to the corresponding receiver chambers. Dialysis against the PBS buffer was started by shaking the sealed RED device at 125 rpm using an orbital microplate shaker in an incubation oven (Panasonic, Newark, NJ) at 37 °C for 6 h. Postdialysis donor (plasma or brain homogenate) and receiver (dialysate) samples along with the standard curve samples (0.005–1 μM in plasma or brain homogenate) were prepared in a similar method to become mixed matrix samples. In brief, an amount of 20 μL of plasma/brain homogenate standards or plasma/brain homogenate donor samples was added into 100 μL of phosphate buffered saline, and an amount 100 μL of dialysate receiver samples was added into 20 μL of control matrix fluid so that the ratio of the final volume of the buffer to the plasma or brain homogenate was the same. The mixed matrix samples were then mixed with 300 μL of protein precipitation solution containing diazepam as internal standard in CH<sub>3</sub>CN (250 nM) followed by vortex mixing for approximately 2 min and centrifugation for 10 min at 2830 G-force. After mixing the supernatant (150 μL) with the same volume of water containing 0.1% formic acid, the final samples were injected and analyzed by LC–MS/MS system using a Sciex QTrap 5500 mass spectrometer (AB Sciex, Framingham, MA) coupled with Shimadzu LC-20 UPLC system (Shimadzu Scientific Instruments, Columbia, MD). The samples were eluted using a Luna C18 100A 50 mm × 2 mm, 5 μm column (Phenomenex, Torrance, CA) at a flow rate of 0.6 mL/min (mobile phase A was water containing 0.1% formic acid and mobile phase B was CH<sub>3</sub>CN containing 0.1% formic acid). Quantification for the analyte was calculated based on the analyte to internal standard peak area ratios plotted against its concentration using a linear regression with 1/<i>x</i><sup>2</sup> weighting.</div><div class="NLM_p last">The unbound fraction in plasma and in diluted brain homogenate is calculated based on the following equation: <i>f</i><sub>u,</sub>= <i>C</i><sub>r</sub>/ <i>C</i><sub>d</sub>, where <i>C</i><sub>r</sub> and <i>C</i><sub>d</sub> are the RED postdialysis receiver and donor concentrations with mixed-matrix dilution factor corrected, respectively. The unbound fraction in undiluted brain homogenate was corrected for dilution factor according to the following equation (Kalvass and Maurer, 2002): undiluted <i>f</i><sub>u</sub> = (1/<i>D</i>)/(((1/<i>f</i><sub>u,apparent</sub>) – 1) + 1/<i>D</i>), where <i>D</i> = dilution factor in brain homogenate and <i>f</i><sub>u,apparent</sub> is the measured free fraction of diluted brain homogenate.</div></div><div id="sec6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> Rat Pharmacokinetics Determination</h3><div class="NLM_p last">Pharmacokinetics properties in male SD rats (200–250 g) were determined following intravenous (iv) and oral (po) administration. For iv dosing (<i>N</i> = 3, 1 mg/kg), rats were catheterized in the jugular and femoral vein. For po dosing (<i>N</i> = 3, 10 mg/kg) rats were catheterized in the femoral vein. Test article was formulated in NMP/PEG400/water (10:50:40). Rats were not fasted during this study. Blood was sampled at 0.033, 0.083, 0.25, 0.5, 1, 2, 4, 6, 8, and 24 h following iv dosing and at 0.25, 0.5, 1, 2, 4, 6, 8, and 24 h following po dosing. Plasma was isolated by centrifugation, and all samples were frozen at −80 °C. Calibration standards were prepared by the addition of known concentrations of test article to blank rat plasma to provide a calibration range of 0.5 ng/mL to 2000 ng/mL. Fifty microliter plasma samples or calibration standard was added to 250 μL of internal standard solution in CH<sub>3</sub>CN. Samples were vortex mixed and centrifuged at 12 000 rpm for 5 min at 4 °C. Supernatant (100 μL) was transferred to labeled autosampler vials containing 300 μL of mobile phase (CH<sub>3</sub>CN/water 10:90 with 0.1% formic acid), vortex mixed, and analyzed by LC–MS/MS. A bioanalytical method was developed for the quantification of test article in rat plasma. Method development and sample analysis were conducted using a Waters Quattro Premier LC–MS/MS system equipped with a Waters Acquity UPLC system. An amount of 5 μL of the samples was analyzed using a Waters Acquity UPLC system equipped with a C 18 reverse-phase column (Phenomenex Kinetex C18, 1.7 μm, 2.1 mm × 50.0 mm). Mobile phase consisted of 0.1% formic acid in water and 0.1% formic acid in CH<sub>3</sub>CN with a flow rate of 0.6 mL/min. Eluent was directed to a Waters Quattro Premier mass spectrometer equipped with a turbo electrospray interface. Multiple reaction monitoring (MRM) transition in positive ion mode was used.</div></div><div id="sec6_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> Rat CSF Glycine Determination</h3><div class="NLM_p last">Glycine levels in rat cerebrospinal fluid (CSF) were determined following oral administration of the test article at 10 mg/kg in male Sprague-Dawley (CD) rats (300–400 g, <i>n</i> = 5) obtained from Charles River (Hollister, CA). Food was provided ad libitum. Test articles were formulated in NMP/PEG400/water (10:50:40) and dosed at 10 mL/kg. A vehicle only control group (<i>n</i> = 5) was included in every study to establish a CSF glycine baseline level for comparison to the treatment groups. Samples were collected at 90 min; prior to collection, animals were anesthetized (confirmed with toe-pinch) and approximately 100 μL of CSF was collected with a butterfly catheter (Exel 27G<sup>3/4</sup> needle attached to the PVC catheter containing DEHP). A LoBind microcentrifuge tube (2 mL, Eppendorf) was used for CSF sample collection and storage. All samples were frozen at −80 °C until analysis. On the day of analysis fresh glycine calibration standards and QC samples were prepared in artificial CSF (Harvard Apparatus, Holliston, MA) by addition of known concentrations of glycine (>99%, Sigma) to provide a calibration range of 400–20 000 μmol/L. 50 μL of CSF, calibration standards, and quality control samples were aliquoted into conical glass tubes (2 mL, Flex-tier 96 well, Analytical Sales and Service) to which 10 μL of 10 μM <sup>13</sup>C<sub>2</sub>-<sup>15</sup>N-glycine (>98%, Aldrich) internal standard solution was added followed by dry-down under a stream of nitrogen at 45 °C. 50 μL of 2,4-dinitro-5-fluorphenyl (Marfey’s reagent) at 0.5% w/v acetone (99.8% extra dry, Acros Organics) was then added to the dry tubes followed by 100 μL of 0.125 M sodium tetraborate decahydrate (>99.5%, Sigma). After sealing, the samples were placed in a water bath at 45 °C and mixed gently for 30 min; the amine derivatization reaction was stopped by addition of 25 μL of 4 M HCl with mixing. The quenched derivatization mixture was then diluted using 1.2 mL of 4 mM ammonium formate, pH 4.6, and transferred into a 96 well polypropylene plate (2 mL, True taper, Analytical Sales and Service). Sample analysis was conducted using a Sciex QTRAP 5500 liquid chromatography mass spectrometer (LC–MS) system equipped with a Shimadzu autosampler and HPLC system. Mobile phase A consisted of 4 mM ammonium formate, pH 4.6, and mobile phase B was acetonitrile. 10 μL of processed sample was introduced to a Waters Atlantis dC18 reverse-phase column (3.0 μm, 3.9 mm × 150 mm) using 10–90% B gradient elution at a flow rate of 0.4 mL/min with a 16 min runtime. The eluent was directed to the mass spectrometer equipped with a turbo electrospray interface operated in negative ion mode. The analyte and internal standard were detected with selected ion monitoring. Analyst software (version 1.5.2) was used for LC–MS data processing using a linear regression and 1/<i>x</i><sup>2</sup> weighting. Statistical analysis of determined glycine concentrations included one-way ANOVA with multiple comparisons between treatment groups and vehicle control (GraphPad Prism).</div></div><div id="sec6_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> Novel Object Recognition Training and Testing</h3><div class="NLM_p last">Male Long–Evans rats (<i>n</i> = 24/group; 330–380 g) were obtained from Envigo (Livermore, CA). Rats were habituated to handling, and an empty test arena for 7 min on each of 3 consecutive days. On the training day, the drug was administered po in a vehicle of 10:50:40 NMP/PEG400/H<sub>2</sub>O at a volume of 1 mL/kg. Ninety minutes after dosing, each rat was placed in the test arena, which now contained two identical objects located centrally in the arena. Rats were given either 3 min (to induce a weak memory) or 20 min (to induce a strong memory) to explore the arena and objects. Memory retention was tested 24 h after training. Rats were placed back in the arena with one “familiar” (previously trained) and one “novel” object and given 5 min to explore. The spatial position of objects (left–right position) and which object was novel (ball or cube) were counterbalanced across subjects. Objects and arenas were cleaned with diluted quaternary ammonium disinfectant (5 mL of Coverage Plus NPD: 1 L of H<sub>2</sub>O; Steris Corporation, OH) between trials to remove rat feces and urine. To determine memory performance, an object-discrimination index (DI) was calculated as [novel exploration – familiar exploration]/[total exploration]. Rats were excluded from the analysis if total exploration during training or test was less than 5 s. Locomotor activity and object exploration during training was also recorded. Data were analyzed by ANOVA with least-squares means planned comparisons (Student’s <i>t</i> test). All data are presented as the mean ± SEM.</div></div><div id="sec6_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Statement on Animal Research</h3><div class="NLM_p last">All studies involving animals were conducted in compliance with protocols approved by the Dart NeuroScience LLC., Institutional Animal Care and Use Committee, and followed the guidance of the National Research Council Guide for the Care and Use of Laboratory Animals Studies (2011).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i86"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00372" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45137" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45137" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00372" class="ext-link">10.1021/acs.jmedchem.8b00372</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Off-target selectivity panel for compound <b>46</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00372/suppl_file/jm8b00372_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (SMILES data) and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00372/suppl_file/jm8b00372_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00372/suppl_file/jm8b00372_si_001.pdf">jm8b00372_si_001.pdf (240.98 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00372/suppl_file/jm8b00372_si_002.csv">jm8b00372_si_002.csv (4.09 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00372" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26716" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26716" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincent J. Santora</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0406-133X" title="Orcid link">http://orcid.org/0000-0003-0406-133X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#493f3a28273d263b2878092e24282025672a2624"><span class="__cf_email__" data-cfemail="dcaaafbdb2a8b3aebded9cbbb1bdb5b0f2bfb3b1">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Theresa A. Almos</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Barido</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jillian Basinger</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chris L. Bellows</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brett C. Bookser</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0822-7029" title="Orcid link">http://orcid.org/0000-0002-0822-7029</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">J. Guy Breitenbucher</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicola J. Broadbent</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Clifford Cabebe</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chih-Kun Chai</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mi Chen</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephine Chow</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">De Michael Chung</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lindsay Crickard</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne M. Danks</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Graeme C. Freestone</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dany Gitnick</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Varsha Gupta</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Hoffmaster</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew R. Hudson</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan P. Kaplan</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8780-2361" title="Orcid link">http://orcid.org/0000-0001-8780-2361</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael R. Kennedy</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dong Lee</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Limberis</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kiev Ly</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chi Ching Mak</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brittany Masatsugu</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew C. Morse</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jim Na</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Neul</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Nikpur</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marco Peters</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert E. Petroski</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joel Renick</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristen Sebring</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Samantha Sevidal</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ali Tabatabaei</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jenny Wen</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yingzhuo Yan</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zachary W. Yoder</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas Zook</span> - <span class="hlFld-Affiliation affiliation">Dart NeuroScience LLC, 12278 Scripps Summit Drive, San Diego, California 92121, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ADMET</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, elimination, and toxicology</p></td></tr><tr><td class="NLM_term">br s</td><td class="NLM_def"><p class="first last">broad signal</p></td></tr><tr><td class="NLM_term">CYP450</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">LTP</td><td class="NLM_def"><p class="first last">long-term potentiation</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney</p></td></tr><tr><td class="NLM_term">NOR</td><td class="NLM_def"><p class="first last">novel object recognition</p></td></tr><tr><td class="NLM_term">PAMPA-BBB</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeability assay, blood–brain barrier</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsome</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i88">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71310" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71310" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 52 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomeza, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armsen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholze, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eulenburg, V.</span></span> <span> </span><span class="NLM_article-title">Glycine transporters: essential regulators of synaptic transmission</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1042/BST0340055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1042%2FBST0340055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=16417482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtlOquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=55-58&author=H.+Betzauthor=J.+Gomezaauthor=W.+Armsenauthor=P.+Scholzeauthor=V.+Eulenburg&title=Glycine+transporters%3A+essential+regulators+of+synaptic+transmission&doi=10.1042%2FBST0340055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Glycine transporters: essential regulators of synaptic transmission</span></div><div class="casAuthors">Betz, H.; Gomeza, J.; Armsen, W.; Scholze, P.; Eulenburg, V.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-58</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Glycine is a major inhibitory neurotransmitter in the mammalian CNS (central nervous system).  Glycinergic neurotransmission is terminated by the uptake of glycine into glycinergic nerve terminals and neighboring glial cells.  This uptake process is mediated by specific Na+/Cl--dependent GlyTs (glycine transporters), GlyT1 and GlyT2.  GlyT1, in addn., is thought to regulate the concn. of glycine at excitatory synapses contg. NMDARs (N-methyl-D-aspartate receptors), which require glycine as a co-agonist.  We have analyzed the physiol. roles and regulation of GlyT1 and GlyT2 by generating transporter-deficient mice and searching for interacting proteins.  Our genetic results indicate that at glycinergic synapses, the glial transporter GlyT1 catalyzes the removal of glycine from the synaptic cleft, whereas GlyT2 is required for the re-uptake of glycine into nerve terminals, thereby allowing for neurotransmitter reloading of synaptic vesicles.  Both GlyT1 and GlyT2 are essential for CNS function, as revealed by the lethal phenotypes of the resp. knockout mice.  Mice expressing only a single GlyT1 allele are phenotypically normal but may have enhanced NMDAR function.  GlyT2 is highly enriched at glycinergic nerve terminals, and Ca2+-triggered exocytosis and internalization are thought to regulate GlyT2 nos. in the pre-synaptic plasma membrane.  We have identified different interacting proteins that may play a role in GlyT2 trafficking and/or pre-synaptic localization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt4U0hOmczH7Vg90H21EOLACvtfcHk0lgUyqSufw4kaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtlOquw%253D%253D&md5=9d9f8d182fd88bef8fed7b79d13fcf70</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1042%2FBST0340055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0340055%26sid%3Dliteratum%253Aachs%26aulast%3DBetz%26aufirst%3DH.%26aulast%3DGomeza%26aufirst%3DJ.%26aulast%3DArmsen%26aufirst%3DW.%26aulast%3DScholze%26aufirst%3DP.%26aulast%3DEulenburg%26aufirst%3DV.%26atitle%3DGlycine%2520transporters%253A%2520essential%2520regulators%2520of%2520synaptic%2520transmission%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2006%26volume%3D34%26spage%3D55%26epage%3D58%26doi%3D10.1042%2FBST0340055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zafra, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giménez, C.</span></span> <span> </span><span class="NLM_article-title">Glycine transporters and synaptic function</span>. <i>IUBMB Life</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">810</span>– <span class="NLM_lpage">817</span>, <span class="refDoi"> DOI: 10.1002/iub.128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1002%2Fiub.128" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=810-817&author=F.+Zafraauthor=C.+Gim%C3%A9nez&title=Glycine+transporters+and+synaptic+function&doi=10.1002%2Fiub.128"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1002%2Fiub.128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fiub.128%26sid%3Dliteratum%253Aachs%26aulast%3DZafra%26aufirst%3DF.%26aulast%3DGim%25C3%25A9nez%26aufirst%3DC.%26atitle%3DGlycine%2520transporters%2520and%2520synaptic%2520function%26jtitle%3DIUBMB%2520Life%26date%3D2008%26volume%3D60%26spage%3D810%26epage%3D817%26doi%3D10.1002%2Fiub.128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Eulenburg, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armsen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomeza, J.</span></span> <span> </span><span class="NLM_article-title">Glycine transporters: essential regulators of neurotransmission</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">325</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2005.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.tibs.2005.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=15950877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFCks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2005&pages=325-333&author=V.+Eulenburgauthor=W.+Armsenauthor=H.+Betzauthor=J.+Gomeza&title=Glycine+transporters%3A+essential+regulators+of+neurotransmission&doi=10.1016%2Fj.tibs.2005.04.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Glycine transporters: essential regulators of neurotransmission</span></div><div class="casAuthors">Eulenburg, Volker; Armsen, Wencke; Betz, Heinrich; Gomeza, Jesus</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">325-333</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Glycine has important neurotransmitter functions at inhibitory and excitatory synapses in the vertebrate central nervous system.  The effective synaptic concns. of glycine are regulated by glycine transporters (GlyTs), which mediate its reuptake into nerve terminals and adjacent glial cells.  GlyTs are members of the Na+/Cl--dependent transporter family, whose activities and subcellular distributions are regulated by phosphorylation and interactions with other proteins.  The anal. of GlyT knockout mice has revealed distinct functions of individual GlyT subtypes in synaptic transmission and provided animal models for two hereditary human diseases, glycine encephalopathy and hyperekplexia.  Selective GlyT inhibitors could be of therapeutic value in cognitive disorders, schizophrenia and pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqofHR4bEe5crVg90H21EOLACvtfcHk0lj1oPnOrPIcXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFCks7g%253D&md5=301b273b32ec8f6858285b101d1403a6</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2005.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2005.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DEulenburg%26aufirst%3DV.%26aulast%3DArmsen%26aufirst%3DW.%26aulast%3DBetz%26aufirst%3DH.%26aulast%3DGomeza%26aufirst%3DJ.%26atitle%3DGlycine%2520transporters%253A%2520essential%2520regulators%2520of%2520neurotransmission%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2005%26volume%3D30%26spage%3D325%26epage%3D333%26doi%3D10.1016%2Fj.tibs.2005.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Benarroch, E. E.</span></span> <span> </span><span class="NLM_article-title">Glycine and its synaptic interactions: functional and clinical implications</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">683</span>, <span class="refDoi"> DOI: 10.1212/WNL.0b013e31822a2791</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1212%2FWNL.0b013e31822a2791" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2011&pages=677-683&author=E.+E.+Benarroch&title=Glycine+and+its+synaptic+interactions%3A+functional+and+clinical+implications&doi=10.1212%2FWNL.0b013e31822a2791"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1212%2FWNL.0b013e31822a2791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.0b013e31822a2791%26sid%3Dliteratum%253Aachs%26aulast%3DBenarroch%26aufirst%3DE.%2BE.%26atitle%3DGlycine%2520and%2520its%2520synaptic%2520interactions%253A%2520functional%2520and%2520clinical%2520implications%26jtitle%3DNeurology%26date%3D2011%26volume%3D77%26spage%3D677%26epage%3D683%26doi%3D10.1212%2FWNL.0b013e31822a2791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pow, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrickson, A.</span></span> <span> </span><span class="NLM_article-title">Distribution of the glycine transporter in mammalian and non-mammalian retinae</span>. <i>Vis. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1017/S0952523899162047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1017%2FS0952523899162047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10367958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A280%3ADyaK1M3psVChtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1999&pages=231-239&author=D.+V.+Powauthor=A.+Hendrickson&title=Distribution+of+the+glycine+transporter+in+mammalian+and+non-mammalian+retinae&doi=10.1017%2FS0952523899162047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of the glycine transporter glyt-1 in mammalian and nonmammalian retinae</span></div><div class="casAuthors">Pow D V; Hendrickson A E</div><div class="citationInfo"><span class="NLM_cas:title">Visual neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">231-9</span>
        ISSN:<span class="NLM_cas:issn">0952-5238</span>.
    </div><div class="casAbstract">We have examined the distribution of the glycine transporter glyt-1 in retinae of macaques, cats, rabbits, rats, and chickens.  In all species, all glycine-containing amacrine cells expressed immunoreactivity for glyt-1, though the intensity of immunoreactivity for glyt-1 did not appear to directly correlate with the intensity of immunoreactivity for glycine in individual cells.  A small subpopulation of glycine-immunoreactive displaced amacrine cells or ganglion cells also expressed glyt-1 in retinae from macaques, cats, chickens, and rats but not in retinae from rabbits.  In addition, in all species examined, some displaced amacrine cells also contained glycine but did not express glyt-1.  In monkeys, cats, and rats, populations of cells which we interpret as being glycine-containing interplexiform cells expressed glyt-1: these cells lacked a content of glutamate, suggesting they are not bipolar cells.  The glycine-containing bipolar cells did not express glyt-1, suggesting that these cells probably acquired their content of glycine by other means such as via gap junctional connections with glycine-containing amacrine cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQMTWo3e6n07-WhZTslLrfffW6udTcc2eZ_RAgJxx6Atbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3psVChtg%253D%253D&md5=3ab08fedf5f32b1a76fd69c49747d5f2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1017%2FS0952523899162047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0952523899162047%26sid%3Dliteratum%253Aachs%26aulast%3DPow%26aufirst%3DD.%2BV.%26aulast%3DHendrickson%26aufirst%3DA.%26atitle%3DDistribution%2520of%2520the%2520glycine%2520transporter%2520in%2520mammalian%2520and%2520non-mammalian%2520retinae%26jtitle%3DVis.%2520Neurosci.%26date%3D1999%26volume%3D16%26spage%3D231%26epage%3D239%26doi%3D10.1017%2FS0952523899162047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlösser, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barthel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandenburger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eulenburg, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werdehausen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermanns, H.</span></span> <span> </span><span class="NLM_article-title">Glycine transporter GlyT1, but not GlyT2, is expressed in rat dorsal root ganglion--Possible implications for neuropathic pain</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>600</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">219</span>, <span class="refDoi"> DOI: 10.1016/j.neulet.2015.06.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.neulet.2015.06.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=600&publication_year=2015&pages=213-219&author=L.+Schl%C3%B6sserauthor=F.+Barthelauthor=T.+Brandenburgerauthor=E.+Neumannauthor=I.+Bauerauthor=V.+Eulenburgauthor=R.+Werdehausenauthor=H.+Hermanns&title=Glycine+transporter+GlyT1%2C+but+not+GlyT2%2C+is+expressed+in+rat+dorsal+root+ganglion%2D%2DPossible+implications+for+neuropathic+pain&doi=10.1016%2Fj.neulet.2015.06.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2015.06.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2015.06.026%26sid%3Dliteratum%253Aachs%26aulast%3DSchl%25C3%25B6sser%26aufirst%3DL.%26aulast%3DBarthel%26aufirst%3DF.%26aulast%3DBrandenburger%26aufirst%3DT.%26aulast%3DNeumann%26aufirst%3DE.%26aulast%3DBauer%26aufirst%3DI.%26aulast%3DEulenburg%26aufirst%3DV.%26aulast%3DWerdehausen%26aufirst%3DR.%26aulast%3DHermanns%26aufirst%3DH.%26atitle%3DGlycine%2520transporter%2520GlyT1%252C%2520but%2520not%2520GlyT2%252C%2520is%2520expressed%2520in%2520rat%2520dorsal%2520root%2520ganglion--Possible%2520implications%2520for%2520neuropathic%2520pain%26jtitle%3DNeurosci.%2520Lett.%26date%3D2015%26volume%3D600%26spage%3D213%26epage%3D219%26doi%3D10.1016%2Fj.neulet.2015.06.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Santos, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schranzhofer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheftel, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponka, P.</span></span> <span> </span><span class="NLM_article-title">Extracellular glycine is necessary for optimal hemoglobinization of erythroid cells</span>. <i>Haematologica</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">1314</span>– <span class="NLM_lpage">1323</span>, <span class="refDoi"> DOI: 10.3324/haematol.2016.155671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.3324%2Fhaematol.2016.155671" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2017&pages=1314-1323&author=D.+Garcia-Santosauthor=M.+Schranzhoferauthor=R.+Bergeronauthor=A.+D.+Sheftelauthor=P.+Ponka&title=Extracellular+glycine+is+necessary+for+optimal+hemoglobinization+of+erythroid+cells&doi=10.3324%2Fhaematol.2016.155671"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2016.155671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2016.155671%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Santos%26aufirst%3DD.%26aulast%3DSchranzhofer%26aufirst%3DM.%26aulast%3DBergeron%26aufirst%3DR.%26aulast%3DSheftel%26aufirst%3DA.%2BD.%26aulast%3DPonka%26aufirst%3DP.%26atitle%3DExtracellular%2520glycine%2520is%2520necessary%2520for%2520optimal%2520hemoglobinization%2520of%2520erythroid%2520cells%26jtitle%3DHaematologica%26date%3D2017%26volume%3D102%26spage%3D1314%26epage%3D1323%26doi%3D10.3324%2Fhaematol.2016.155671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. G. M.</span></span> <span> </span><span class="NLM_article-title">NMDA receptors and memory encoding</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2013.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.neuropharm.2013.04.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2013&pages=32-40&author=R.+G.+M.+Morris&title=NMDA+receptors+and+memory+encoding&doi=10.1016%2Fj.neuropharm.2013.04.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2013.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2013.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DR.%2BG.%2BM.%26atitle%3DNMDA%2520receptors%2520and%2520memory%2520encoding%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D74%26spage%3D32%26epage%3D40%26doi%3D10.1016%2Fj.neuropharm.2013.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huerta, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonegawa, S.</span></span> <span> </span><span class="NLM_article-title">Formation of temporal memory requires NMDA receptors within CA1 pyramidal neurons</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">473</span>– <span class="NLM_lpage">480</span>, <span class="refDoi"> DOI: 10.1016/S0896-6273(00)80909-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2FS0896-6273%2800%2980909-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2000&pages=473-480&author=P.+T.+Huertaauthor=L.+D.+Sunauthor=M.+A.+Wilsonauthor=S.+Tonegawa&title=Formation+of+temporal+memory+requires+NMDA+receptors+within+CA1+pyramidal+neurons&doi=10.1016%2FS0896-6273%2800%2980909-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2980909-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252980909-5%26sid%3Dliteratum%253Aachs%26aulast%3DHuerta%26aufirst%3DP.%2BT.%26aulast%3DSun%26aufirst%3DL.%2BD.%26aulast%3DWilson%26aufirst%3DM.%2BA.%26aulast%3DTonegawa%26aufirst%3DS.%26atitle%3DFormation%2520of%2520temporal%2520memory%2520requires%2520NMDA%2520receptors%2520within%2520CA1%2520pyramidal%2520neurons%26jtitle%3DNeuron%26date%3D2000%26volume%3D25%26spage%3D473%26epage%3D480%26doi%3D10.1016%2FS0896-6273%2800%2980909-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, A. J.</span></span> <span> </span><span class="NLM_article-title">The molecular and cellular biology of enhanced cognition</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1038/nrn2572</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1038%2Fnrn2572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=19153576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntFGksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=126-140&author=Y.+S.+Leeauthor=A.+J.+Silva&title=The+molecular+and+cellular+biology+of+enhanced+cognition&doi=10.1038%2Fnrn2572"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular and cellular biology of enhanced cognition</span></div><div class="casAuthors">Lee, Yong-Seok; Silva, Alcino J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">126-140</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Most mol. and cellular studies of cognitive function have focused on either normal or pathol. states, but recent research with transgenic mice has started to address the mechanisms of enhanced cognition.  These results point to key synaptic and nuclear signaling events that can be manipulated to facilitate the induction or increase the stability of synaptic plasticity, and therefore enhance the acquisition or retention of information.  Here, the authors review these surprising findings and explore their implications to both mechanisms of learning and memory and to ongoing efforts to develop treatments for cognitive disorders.  The extent and consistency of the findings reviewed suggest that the key conclusions, namely that long-term potentiation-like mechanisms play a role in learning and memory and that there are a core of rate-limiting mechanisms that can enhance learning and memory, may well stand the test of time.  These findings represent the beginning of a fundamental new approach in the study of enhanced cognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTAKBocZGitbVg90H21EOLACvtfcHk0lgfria9t9ZD9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntFGksw%253D%253D&md5=ff98bdd158f73453db577b7e8ba45b14</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrn2572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2572%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DSilva%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520molecular%2520and%2520cellular%2520biology%2520of%2520enhanced%2520cognition%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2009%26volume%3D10%26spage%3D126%26epage%3D140%26doi%3D10.1038%2Fnrn2572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collingridge, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volianskis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">France, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidball, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaghan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortolotto, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molnár, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodge, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jane, D. E.</span></span> <span> </span><span class="NLM_article-title">The NMDA receptor as a target for cognitive enhancement</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2012.06.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.neuropharm.2012.06.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=22796429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFahsL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=13-26&author=G.+L.+Collingridgeauthor=A.+Volianskisauthor=N.+Bannisterauthor=G.+Franceauthor=L.+Hannaauthor=M.+Mercierauthor=P.+Tidballauthor=G.+Fangauthor=M.+W.+Irvineauthor=B.+M.+Costaauthor=D.+T.+Monaghanauthor=Z.+A.+Bortolottoauthor=E.+Moln%C3%A1rauthor=D.+Lodgeauthor=D.+E.+Jane&title=The+NMDA+receptor+as+a+target+for+cognitive+enhancement&doi=10.1016%2Fj.neuropharm.2012.06.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The NMDA receptor as a target for cognitive enhancement</span></div><div class="casAuthors">Collingridge, Graham L.; Volianskis, Arturas; Bannister, Neil; France, Grace; Hanna, Lydia; Mercier, Marion; Tidball, Patrick; Fang, Guangyu; Irvine, Mark W.; Costa, Blaise M.; Monaghan, Daniel T.; Bortolotto, Zuner A.; Molnar, Elek; Lodge, David; Jane, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-26</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  NMDA receptors (NMDARs) play an important role in neural plasticity including long-term potentiation and long-term depression, which are likely to explain their importance for learning and memory.  Cognitive decline is a major problem facing an aging human population, so much so that its reversal has become an important goal for scientific research and pharmaceutical development.  Enhancement of NMDAR function is a core strategy toward this goal.  In this review we indicate some of the major ways of potentiating NMDAR function by both direct and indirect modulation.  There is good evidence that both pos. and neg. modulation can enhance function suggesting that a subtle approach correcting imbalances in particular clin. situations will be required.  Excessive activation and the resultant deleterious effects will need to be carefully avoided.  Finally we describe some novel pos. allosteric modulators of NMDARs, with some subunit selectivity, and show initial evidence of their ability to affect NMDAR mediated events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwosQmB8cQb7Vg90H21EOLACvtfcHk0lgfria9t9ZD9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFahsL3P&md5=4d63552250a5bb940a8d0a7a2d51fd75</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2012.06.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2012.06.051%26sid%3Dliteratum%253Aachs%26aulast%3DCollingridge%26aufirst%3DG.%2BL.%26aulast%3DVolianskis%26aufirst%3DA.%26aulast%3DBannister%26aufirst%3DN.%26aulast%3DFrance%26aufirst%3DG.%26aulast%3DHanna%26aufirst%3DL.%26aulast%3DMercier%26aufirst%3DM.%26aulast%3DTidball%26aufirst%3DP.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DIrvine%26aufirst%3DM.%2BW.%26aulast%3DCosta%26aufirst%3DB.%2BM.%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26aulast%3DBortolotto%26aufirst%3DZ.%2BA.%26aulast%3DMoln%25C3%25A1r%26aufirst%3DE.%26aulast%3DLodge%26aufirst%3DD.%26aulast%3DJane%26aufirst%3DD.%2BE.%26atitle%3DThe%2520NMDA%2520receptor%2520as%2520a%2520target%2520for%2520cognitive%2520enhancement%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D13%26epage%3D26%26doi%3D10.1016%2Fj.neuropharm.2012.06.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. G.</span></span> <span> </span><span class="NLM_article-title">The NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.12-01-00021.1992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1523%2FJNEUROSCI.12-01-00021.1992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1345945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADyaK38Xit1yks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1992&pages=21-34&author=S.+Davisauthor=S.+P.+Butcherauthor=R.+G.+Morris&title=The+NMDA+receptor+antagonist+D-2-amino-5-phosphonopentanoate+%28D-AP5%29+impairs+spatial+learning+and+LTP+in+vivo+at+intracerebral+concentrations+comparable+to+those+that+block+LTP+in+vitro&doi=10.1523%2FJNEUROSCI.12-01-00021.1992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro</span></div><div class="casAuthors">Davis, S.; Butcher, S. P.; Morris, R. G. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-34</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    </div><div class="casAbstract">This series of expts. investigated whether the NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) could induce impairments of spatial learning across a dose range comparable to its impairment of hippocampal long-term potentiation (LTP) in vivo.  Estns. of the extracellular concn. of D-AP5 in hippocampus using microdialysis were also made to compare whether these impairments occur at concns. similar to those required to impair LTP in the in vitro hippocampal slice.  Rats were chronically infused with D-AP5 into the lateral ventricle at a range of concns. (0-50 mM) via osmotic minipumps.  They were first trained to find and escape onto a hidden platform in an open-field water maze task.  After the behavioral learning, they were anesthetized with urethane and an attempt was made to evoke and monitor hippocampal LTP.  Extracellular samples of D-AP5 in hippocampus were then taken using microdialysis, and finally, the animals were killed and tissue samples dissected.  The microdialysis and tissue samples were analyzed for D-AP5 content using HPLC with fluorescence detection.  The results established, first, that D-AP5 impairs spatial learning in a linear dose-dependent manner, highly correlated with its corresponding impairment of hippocampal LTP in vivo.  No concn. of D-AP5 was obsd. to block LTP without affecting learning.  Second, the microdialysis ests. indicated that, subject to certain assumptions, D-AP5 causes these impairments at extracellular concns. comparable to those that impair LTP in vitro.  Third, comparison of the whole tissue and microdialysis samples revealed a concn. ratio of approx. 30:1, indicating that 97% of the intracerebral D-AP5 is inaccessible to the dialysis probes.  Infusion of 20 mM EGTA was found to cause a sevenfold increase in D-AP5 in the dialysis perfusates, suggesting that at least part of the inaccessible D-AP5 is trapped by calcium-dependent mechanism.  Two further behavioral control studies indicated that the D-AP5-induced impairment of spatial learning is unlikely to be secondary to a drug-induced motor disturbance, and that the performance of the D-AP5 group whose concn. was just sufficient to block hippocampal LTP completely was statistically indistinguishable from that of a group of rats with bilateral hippocampal lesions induced by ibotenic acid.  Taken together, these findings offer support for the hypothesis that activation of NMDA receptors is necessary for certain kinds of learning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpltcERCuXxWbVg90H21EOLACvtfcHk0lhRafZinGtTDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xit1yks7g%253D&md5=c57812e0952ff507321bd3ab759d97ca</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.12-01-00021.1992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.12-01-00021.1992%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DS.%26aulast%3DButcher%26aufirst%3DS.%2BP.%26aulast%3DMorris%26aufirst%3DR.%2BG.%26atitle%3DThe%2520NMDA%2520receptor%2520antagonist%2520D-2-amino-5-phosphonopentanoate%2520%2528D-AP5%2529%2520impairs%2520spatial%2520learning%2520and%2520LTP%2520in%2520vivo%2520at%2520intracerebral%2520concentrations%2520comparable%2520to%2520those%2520that%2520block%2520LTP%2520in%2520vitro%26jtitle%3DJ.%2520Neurosci.%26date%3D1992%26volume%3D12%26spage%3D21%26epage%3D34%26doi%3D10.1523%2FJNEUROSCI.12-01-00021.1992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steele, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. G. M.</span></span> <span> </span><span class="NLM_article-title">Delay-dependent impairment of a matching-to-place task with chronic and intrahippocampal infusion of the NMDA-antagonist D-AP5</span>. <i>Hippocampus</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1002%2F%28SICI%291098-1063%281999%299%3A2%3C118%3A%3AAID-HIPO4%3E3.0.CO%3B2-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=118-136&author=R.+J.+Steeleauthor=R.+G.+M.+Morris&title=Delay-dependent+impairment+of+a+matching-to-place+task+with+chronic+and+intrahippocampal+infusion+of+the+NMDA-antagonist+D-AP5&doi=10.1002%2F%28SICI%291098-1063%281999%299%3A2%3C118%3A%3AAID-HIPO4%3E3.0.CO%3B2-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1063%281999%299%3A2%3C118%3A%3AAID-HIPO4%3E3.0.CO%3B2-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1063%25281999%25299%253A2%253C118%253A%253AAID-HIPO4%253E3.0.CO%253B2-8%26sid%3Dliteratum%253Aachs%26aulast%3DSteele%26aufirst%3DR.%2BJ.%26aulast%3DMorris%26aufirst%3DR.%2BG.%2BM.%26atitle%3DDelay-dependent%2520impairment%2520of%2520a%2520matching-to-place%2520task%2520with%2520chronic%2520and%2520intrahippocampal%2520infusion%2520of%2520the%2520NMDA-antagonist%2520D-AP5%26jtitle%3DHippocampus%26date%3D1999%26volume%3D9%26spage%3D118%26epage%3D136%26doi%3D10.1002%2F%28SICI%291098-1063%281999%299%3A2%3C118%3A%3AAID-HIPO4%3E3.0.CO%3B2-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baudry, M.</span></span> <span> </span><span class="NLM_article-title">Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>319</i></span>,  <span class="NLM_fpage">774</span>– <span class="NLM_lpage">776</span>, <span class="refDoi"> DOI: 10.1038/319774a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1038%2F319774a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=2869411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADyaL28XhsVaktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=1986&pages=774-776&author=R.+G.+M.+Morrisauthor=E.+Andersonauthor=G.+S.+Lynchauthor=M.+Baudry&title=Selective+impairment+of+learning+and+blockade+of+long-term+potentiation+by+an+N-methyl-D-aspartate+receptor+antagonist%2C+AP5&doi=10.1038%2F319774a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5</span></div><div class="casAuthors">Morris, R. G. M.; Anderson, E.; Lynch, G. S.; Baudry, M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">6056</span>),
    <span class="NLM_cas:pages">774-6</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">In rats, chronic intraventricular administration of D,L-aminophosphonovaleric acid (D,L-AP5)  [76326-31-3], an N-methyl-D-aspartate  [6384-92-5] receptor antagonist, caused a selective impairment of spacial learning, which is highly sensitive to hippocampal damage, without affecting visual discrimination learning, which is not sensitive to hippocampal damage; the L-isomer of AP5 did not produce behavioral effects.  Treatment with D,L-AP5 also suppressed the induction of hippocampal long-term potentiation following brief high-frequency stimulation.  Thus, N-methyl-D-aspartate receptors are involved in spatial learning, and hippocampal long-term potentiation is involved in some, but not all, forms of learning.  The results are discussed in relation to the potential anticonvulsant activities of N-methyl-D-aspartate receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4kRpAEXklM7Vg90H21EOLACvtfcHk0lhRafZinGtTDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XhsVaktLc%253D&md5=cb6be2239121e185b19278fe77791125</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2F319774a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F319774a0%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DR.%2BG.%2BM.%26aulast%3DAnderson%26aufirst%3DE.%26aulast%3DLynch%26aufirst%3DG.%2BS.%26aulast%3DBaudry%26aufirst%3DM.%26atitle%3DSelective%2520impairment%2520of%2520learning%2520and%2520blockade%2520of%2520long-term%2520potentiation%2520by%2520an%2520N-methyl-D-aspartate%2520receptor%2520antagonist%252C%2520AP5%26jtitle%3DNature%26date%3D1986%26volume%3D319%26spage%3D774%26epage%3D776%26doi%3D10.1038%2F319774a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsien, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huerta, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonegawa, S.</span></span> <span> </span><span class="NLM_article-title">The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">1327</span>– <span class="NLM_lpage">1338</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)81827-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2FS0092-8674%2800%2981827-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=8980238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADyaK2sXitlSjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1996&pages=1327-1338&author=J.+Z.+Tsienauthor=P.+T.+Huertaauthor=S.+Tonegawa&title=The+essential+role+of+hippocampal+CA1+NMDA+receptor-dependent+synaptic+plasticity+in+spatial+memory&doi=10.1016%2FS0092-8674%2800%2981827-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory</span></div><div class="casAuthors">Tsien, Joe Z.; Huerta, Patricio T.; Tonegawa, Susumu</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1327-1338</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The authors have produced a mouse strain in which the deletion of the NMDAR1 gene is restricted to the CA1 pyramidal cells of the hippocampus by using a new and general method that allows CA1-restricted gene knockout.  The mutant mice grow into adulthood without obvious abnormalities.  Adult mice lack NMDA receptor-mediated synaptic currents and long-term potentiation in the CA1 synapses and exhibit impaired spatial memory but unimpaired nonspatial learning.  The authors' results strongly suggest that activity-dependent modifications of CA1 synapses, mediated by NMDA receptors, play an essential role in the acquisition of spatial memories.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBYS66CjljfbVg90H21EOLACvtfcHk0lhRafZinGtTDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitlSjuw%253D%253D&md5=c3b83ba8ebe367b3383c32d5fec652f0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981827-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981827-9%26sid%3Dliteratum%253Aachs%26aulast%3DTsien%26aufirst%3DJ.%2BZ.%26aulast%3DHuerta%26aufirst%3DP.%2BT.%26aulast%3DTonegawa%26aufirst%3DS.%26atitle%3DThe%2520essential%2520role%2520of%2520hippocampal%2520CA1%2520NMDA%2520receptor-dependent%2520synaptic%2520plasticity%2520in%2520spatial%2520memory%26jtitle%3DCell%26date%3D1996%26volume%3D87%26spage%3D1327%26epage%3D1338%26doi%3D10.1016%2FS0092-8674%2800%2981827-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dube, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerchner, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsien, J. Z.</span></span> <span> </span><span class="NLM_article-title">Genetic enhancement of learning and memory in mice</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>401</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1038/43432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1038%2F43432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10485705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADyaK1MXlvVGms70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=1999&pages=63-69&author=Y.+P.+Tangauthor=E.+Shimizuauthor=G.+R.+Dubeauthor=C.+Ramponauthor=G.+A.+Kerchnerauthor=M.+Zhuoauthor=G.+Liuauthor=J.+Z.+Tsien&title=Genetic+enhancement+of+learning+and+memory+in+mice&doi=10.1038%2F43432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic enhancement of learning and memory in mice</span></div><div class="casAuthors">Tang, Ya-Ping; Shimizu, Eiji; Dube, Gilles, R.; Rampon, Claire; Kerchner, Geoffrey; Zhuo, Min; Liu, Guosong; Tsien, Joe Z.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">6748</span>),
    <span class="NLM_cas:pages">63-69</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Hebb's rule (1949) states that learning and memory are based on modifications of synaptic strength among neurons that are simultaneously active.  This implies that enhanced synaptic coincidence detection would lead to better learning and memory.  If the NMDA (N-methyl-D-aspartate) receptor, a synaptic coincidence detection would lead to better learning and memory.  If the NMDA (N-methyl-D-aspartate) receptor, a synaptic coincidence detector, acts as a graded switch for memory formation, enhanced signal detection by NMDA receptors should enhance learning and memory.  Here we show that overexpression of NMDA receptor 2B (NR2B) in the forebrains of transgenic mice leads to enhanced activation of NMDA receptors, facilitating synaptic potentiation in response to stimulation at 10-100 Hz.  These mice exhibit superior ability in learning and memory in various behavioral tasks, showing that NR2B is crit. in gating the age-dependent threshold for plasticity and memory formation.  NMDA-receptor-dependent modifications of synaptic efficacy, therefore, represent a unifying mechanism for associative learning and memory.  Our results suggest that genetic enhancement of mental and cognitive attributes such as intelligence and memory in mammals is feasible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpztBLI9qsOIbVg90H21EOLACvtfcHk0lgWdExlXOjDbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvVGms70%253D&md5=b2ef8b0610c3c070063f869f82a838e6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2F43432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F43432%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DY.%2BP.%26aulast%3DShimizu%26aufirst%3DE.%26aulast%3DDube%26aufirst%3DG.%2BR.%26aulast%3DRampon%26aufirst%3DC.%26aulast%3DKerchner%26aufirst%3DG.%2BA.%26aulast%3DZhuo%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DTsien%26aufirst%3DJ.%2BZ.%26atitle%3DGenetic%2520enhancement%2520of%2520learning%2520and%2520memory%2520in%2520mice%26jtitle%3DNature%26date%3D1999%26volume%3D401%26spage%3D63%26epage%3D69%26doi%3D10.1038%2F43432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kistler, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawasli, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiederhold, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibb, J. A.</span></span> <span> </span><span class="NLM_article-title">Memory enhancement by targeting Cdk5 regulation of NR2B</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">1070</span>– <span class="NLM_lpage">1083</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2014.01.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.neuron.2014.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=24607229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjslKksr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2014&pages=1070-1083&author=F.+Plattnerauthor=A.+Hern%C3%A1ndezauthor=T.+M.+Kistlerauthor=K.+Pozoauthor=P.+Zhongauthor=E.+Y.+Yuenauthor=C.+Tanauthor=A.+H.+Hawasliauthor=S.+F.+Cookeauthor=A.+Nishiauthor=A.+Guoauthor=T.+Wiederholdauthor=Z.+Yanauthor=J.+A.+Bibb&title=Memory+enhancement+by+targeting+Cdk5+regulation+of+NR2B&doi=10.1016%2Fj.neuron.2014.01.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Memory Enhancement by Targeting Cdk5 Regulation of NR2B</span></div><div class="casAuthors">Plattner, Florian; Hernandez, Adan; Kistler, Tara M.; Pozo, Karine; Zhong, Ping; Yuen, Eunice Y.; Tan, Chunfeng; Hawasli, Ammar H.; Cooke, Sam F.; Nishi, Akinori; Guo, Ailan; Wiederhold, Thorsten; Yan, Zhen; Bibb, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1070-1083</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Many psychiatric and neurol. disorders are characterized by learning and memory deficits, for which cognitive enhancement is considered a valid treatment strategy.  The N-methyl-D-aspartate receptor (NMDAR) is a prime target for the development of cognitive enhancers because of its fundamental role in learning and memory.  In particular, the NMDAR subunit NR2B improves synaptic plasticity and memory when overexpressed in neurons.  However, NR2B regulation is not well understood and no therapies potentiating NMDAR function have been developed.  Here, we show that serine 1116 of NR2B is phosphorylated by cyclin-dependent kinase 5 (Cdk5).  Cdk5-dependent NR2B phosphorylation is regulated by neuronal activity and controls the receptor's cell surface expression.  Disrupting NR2B-Cdk5 interaction via a small interfering peptide (siP) increases NR2B surface levels, facilitates synaptic transmission, and improves memory formation in vivo.  Our results reveal a regulatory mechanism crit. to NR2B function that can be targeted for the development of cognitive enhancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEMKrScxILe7Vg90H21EOLACvtfcHk0lgWdExlXOjDbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjslKksr8%253D&md5=a309690cecd4c9a91da508dcea7c3bd0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2014.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2014.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DPlattner%26aufirst%3DF.%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DKistler%26aufirst%3DT.%2BM.%26aulast%3DPozo%26aufirst%3DK.%26aulast%3DZhong%26aufirst%3DP.%26aulast%3DYuen%26aufirst%3DE.%2BY.%26aulast%3DTan%26aufirst%3DC.%26aulast%3DHawasli%26aufirst%3DA.%2BH.%26aulast%3DCooke%26aufirst%3DS.%2BF.%26aulast%3DNishi%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DA.%26aulast%3DWiederhold%26aufirst%3DT.%26aulast%3DYan%26aufirst%3DZ.%26aulast%3DBibb%26aufirst%3DJ.%2BA.%26atitle%3DMemory%2520enhancement%2520by%2520targeting%2520Cdk5%2520regulation%2520of%2520NR2B%26jtitle%3DNeuron%26date%3D2014%26volume%3D81%26spage%3D1070%26epage%3D1083%26doi%3D10.1016%2Fj.neuron.2014.01.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zlomuzica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Souza Silva, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huston, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dere, E.</span></span> <span> </span><span class="NLM_article-title">NMDA receptor modulation by D-cycloserine promotes episodic-like memory in mice</span>. <i>Psychopharmacology (Berl.)</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>193</i></span>,  <span class="NLM_fpage">503</span>– <span class="NLM_lpage">509</span>, <span class="refDoi"> DOI: 10.1007/s00213-007-0816-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1007%2Fs00213-007-0816-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=17497136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotVWmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2007&pages=503-509&author=A.+Zlomuzicaauthor=M.+A.+De+Souza+Silvaauthor=J.+P.+Hustonauthor=E.+Dere&title=NMDA+receptor+modulation+by+D-cycloserine+promotes+episodic-like+memory+in+mice&doi=10.1007%2Fs00213-007-0816-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor modulation by D-cycloserine promotes episodic-like memory in mice</span></div><div class="casAuthors">Zlomuzica, Armin; Souza Silva, Maria A.; Huston, Joseph P.; Dere, Ekrem</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">503-509</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Rationale: NMDA-R (N-methyl-D-aspartate receptors) have been implicated in synaptic plasticity underlying one-trial learning of event-place assocns.  In rodents, episodic-like memory (ELM) of personally experienced events can be inferred from behavior that reflects the remembrance of the content (what kind of object was presented), place (where was this object placed), and temporal context (when was the object presented).  We have previously shown that D-cycloserine (DCS), an NMDA-R agonist, ameliorates stress-induced deficits in ELM.  Objectives: In this study, we used an exptl. protocol designed to detect promnestic drug effects and investigated whether DCS, which is known to enhance learning and memory, can induce ELM under conditions where mice normally do not show ELM.  Results: Mice that have been treated i.p. with DCS (20 mg/kg) both remembered the temporal order in which two different objects had been encountered during two consecutive sample trials, as well as their spatial position during the sample trials.  Most importantly, the test trial performance of these mice is compatible with ELM in terms of an integrated memory for unique experiences comprising "what", "where", and "when" information.  In contrast, mice that have received either a saline injection or lower doses of DCS (0.2 and 2.0 mg/kg) did not show such an integrated ELM.  Conclusions: To our knowledge, this is the first report showing that DCS can promote ELM in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqiw2pqDmS97Vg90H21EOLACvtfcHk0lgWdExlXOjDbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotVWmurk%253D&md5=a31c38d39adce451eec996cb9f5a123d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2Fs00213-007-0816-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-007-0816-x%26sid%3Dliteratum%253Aachs%26aulast%3DZlomuzica%26aufirst%3DA.%26aulast%3DDe%2BSouza%2BSilva%26aufirst%3DM.%2BA.%26aulast%3DHuston%26aufirst%3DJ.%2BP.%26aulast%3DDere%26aufirst%3DE.%26atitle%3DNMDA%2520receptor%2520modulation%2520by%2520D-cycloserine%2520promotes%2520episodic-like%2520memory%2520in%2520mice%26jtitle%3DPsychopharmacology%2520%2528Berl.%2529%26date%3D2007%26volume%3D193%26spage%3D503%26epage%3D509%26doi%3D10.1007%2Fs00213-007-0816-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peters, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz-Lopez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. G.</span></span> <span> </span><span class="NLM_article-title">Spatial memory and hippocampal enhancement</span>. <i>Curr. Opin. Behav. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1016/j.cobeha.2015.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.cobeha.2015.03.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=81-91&author=M.+Petersauthor=M.+Munoz-Lopezauthor=R.+G.+Morris&title=Spatial+memory+and+hippocampal+enhancement&doi=10.1016%2Fj.cobeha.2015.03.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.cobeha.2015.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cobeha.2015.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DM.%26aulast%3DMunoz-Lopez%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DR.%2BG.%26atitle%3DSpatial%2520memory%2520and%2520hippocampal%2520enhancement%26jtitle%3DCurr.%2520Opin.%2520Behav.%2520Sci.%26date%3D2015%26volume%3D4%26spage%3D81%26epage%3D91%26doi%3D10.1016%2Fj.cobeha.2015.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolkenberg, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinney, G. G.</span></span> <span> </span><span class="NLM_article-title">Progress in the preparation and testing of glycine transporter type-1 (GlyT1) inhibitors</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1883</span>– <span class="NLM_lpage">1896</span>, <span class="refDoi"> DOI: 10.2174/156802606778249784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.2174%2F156802606778249784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=17017963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVClurnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1883-1896&author=C.+W.+Lindsleyauthor=S.+E.+Wolkenbergauthor=G.+G.+Kinney&title=Progress+in+the+preparation+and+testing+of+glycine+transporter+type-1+%28GlyT1%29+inhibitors&doi=10.2174%2F156802606778249784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the preparation and testing of glycine transporter type-1 (GlyT1) inhibitors</span></div><div class="casAuthors">Lindsley, Craig W.; Wolkenberg, Scott E.; Kinney, Gene G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1883-1896</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Clin. utilized antipsychotic agents share as a common mechanism the ability to antagonize dopamine D2 receptors and it is widely assumed that this activity contributes to their efficacy against the pos. symptoms of schizophrenia.  The efficacy of currently marketed antipsychotic agents on the neg. and cognitive symptoms of this disease, however, is not optimal.  One alternate hypothesis to the "dopamine hypothesis" of schizophrenia derives from the observation that antagonists of NMDA receptor activity better mimic the symptomatol. of schizophrenia in its entirety than do dopamine agonists.  Findings from this line of research have led to the NMDA receptor hypofunction (or glutamate dysfunction) hypothesis of schizophrenia, which complements existing research implicating dopamine dysfunction in the disease.  According to the NMDA receptor hypofunction hypothesis, any treatment that enhances NMDA receptor activity may prove useful for the treatment of the complex symptoms that define schizophrenia.  This idea is now supported by numerous clin. studies that have reported an efficacious response following treatment with activators of the NMDA receptor co-agonist glycineB site.  One area of study, aimed at potentiating the NMDA receptor via activation of the glycineB site is small mol. blockade of the glycine reuptake transporter type 1 (GlyT1).  Broadly, these efforts have focused on derivs. of the substrate inhibitor, sarcosine, and non-sarcosine based GlyT1 inhibitors.  Accordingly, the following review discusses the development of both sarcosine and non-sarcosine based GlyT1 inhibitors and their current status as putative treatments for schizophrenia and other disorders assocd. with NMDA receptor hypoactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5Qzf3xnbWSbVg90H21EOLACvtfcHk0lidZQkYEKmyig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVClurnN&md5=a3d701faff26e057b2b36fd2a160ebb2</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F156802606778249784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606778249784%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DWolkenberg%26aufirst%3DS.%2BE.%26aulast%3DKinney%26aufirst%3DG.%2BG.%26atitle%3DProgress%2520in%2520the%2520preparation%2520and%2520testing%2520of%2520glycine%2520transporter%2520type-1%2520%2528GlyT1%2529%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1883%26epage%3D1896%26doi%3D10.2174%2F156802606778249784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bridges, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span> <span> </span><span class="NLM_article-title">Design of potent GlyT1 inhibitors: in vitro and in vivo profiles</span>. <i>Curr. Opin. Mol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">591</span>– <span class="NLM_lpage">601</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=19051137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvFKlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=591-601&author=T.+M.+Bridgesauthor=R.+Williamsauthor=C.+W.+Lindsley&title=Design+of+potent+GlyT1+inhibitors%3A+in+vitro+and+in+vivo+profiles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Design of potent GlyT1 inhibitors: in vitro and in vivo profiles</span></div><div class="casAuthors">Bridges, Thomas M.; Williams, Richard; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Molecular Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">591-601</span>CODEN:
                <span class="NLM_cas:coden">CUOTFO</span>;
        ISSN:<span class="NLM_cas:issn">1464-8431</span>.
    
            (<span class="NLM_cas:orgname">Thomson Reuters</span>)
        </div><div class="casAbstract">A review.  Inhibitors of Gly transporter type-1 (GlyT1) for the treatment of schizophrenia have been pursued on the basis of the NMDA receptor (R) hypofunction hypothesis, which stems largely from the observation that NMDAR antagonists induce symptoms that more closely mimic those characteristic of schizophrenia than do other classes of psychotic agents.  GlyT1 is responsible for uptake of synoptic Gly, an NMDAR co-agonist amino acid, in neuronal populations throughout the forebrain.  GlyT1 inhibition thereby potentiates NMDAR activity by increasing synoptic Gly levels.  Correspondingly, a large body of data suggests that GlyT1 inhibitors likely confer more comprehensive symptom alleviation than current antipsychotics.  To date, a no. of small-mol. GlyT1 inhibitors have been reported by the pharmaceutical industry.  Developments in the discovery and characterization of GlyT1 inhibitors are discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj_Xg_UVKWkrVg90H21EOLACvtfcHk0lidZQkYEKmyig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvFKlsw%253D%253D&md5=d2bcb77b26535a440edfdabe13f18433</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDesign%2520of%2520potent%2520GlyT1%2520inhibitors%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520profiles%26jtitle%3DCurr.%2520Opin.%2520Mol.%2520Ther.%26date%3D2008%26volume%3D10%26spage%3D591%26epage%3D601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wolkenberg, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sur, C.</span></span> <span> </span><span class="NLM_article-title">Recent progress in the discovery of non-sarcosine based GlyT1 inhibitors</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.2174/156802610790410974</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.2174%2F156802610790410974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=20166956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFajsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=170-186&author=S.+E.+Wolkenbergauthor=C.+Sur&title=Recent+progress+in+the+discovery+of+non-sarcosine+based+GlyT1+inhibitors&doi=10.2174%2F156802610790410974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the discovery of non-sarcosine based GlyT1 inhibitors</span></div><div class="casAuthors">Wolkenberg, Scott E.; Sur, Cyrille</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">170-186</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The simple amino acid glycine is implicated in both inhibitory and excitatory neurotransmission in mammalian central nervous system, and it modulates excitatory neurotransmission through its role as a necessary co-agonist for glutamatergic N-methyl-D-aspartate (NMDA) receptors.  Given the involvement of NMDA receptor-mediated neurotransmission in complex cerebral processes such as cognition, pharmacol. manipulation of extracellular synaptic glycine biol. is an active area of pharmaceutical research to develop novel treatments for neuropsychiatric disorders.  A key component of cerebral glycine metab. is the glycine transporter type 1 (GlyT1) and elevation of extracellular synaptic glycine concn. by blockade of GlyT1 has been hypothesized to potentiate NMDA receptor function in vivo and to represent a rational approach for the treatment of schizophrenia and cognitive disorders.  The present article will review the wealth of scientific evidence supporting that hypothesis and the medicinal chem. effort by many pharmaceutical companies and academic institutions to develop potent and selective GlyT1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmkOKDTB4jd7Vg90H21EOLACvtfcHk0lidZQkYEKmyig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFajsrs%253D&md5=5a06f909d25a62ca71ea8a915a46cda4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F156802610790410974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610790410974%26sid%3Dliteratum%253Aachs%26aulast%3DWolkenberg%26aufirst%3DS.%2BE.%26aulast%3DSur%26aufirst%3DC.%26atitle%3DRecent%2520progress%2520in%2520the%2520discovery%2520of%2520non-sarcosine%2520based%2520GlyT1%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D170%26epage%3D186%26doi%3D10.2174%2F156802610790410974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Porter, R.</span>; <span class="NLM_string-name">Dawson, L.</span></span> In  <i>Small Molecule Therapeutics for Schizophrenia</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celanire, S.</span>, <span class="NLM_string-name">Poli, S.</span></span>, Eds.; <span class="NLM_publisher-name">Springer International Publishing</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2015</span>; Vol.  <span class="NLM_volume">13</span>, pp  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">99</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=51-99&author=R.+Porter&author=L.+Dawsonauthor=S.+Celanire&author=S.+Poli&title=Small+Molecule+Therapeutics+for+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DR.%26btitle%3DSmall%2520Molecule%2520Therapeutics%2520for%2520Schizophrenia%26aulast%3DCelanire%26aufirst%3DS.%26pub%3DSpringer%2520International%2520Publishing%26date%3D2015%26volume%3D13%26spage%3D51%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albert, J. S.</span>; <span class="NLM_string-name">Wood, M. W.</span></span> In  <i>Targets and Emerging Therapies for Schizophrenia</i>; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2012</span>; pp  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">254</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1002%2F9781118309421.ch8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=233-254&author=J.+S.+Albert&author=M.+W.+Wood&title=Targets+and+Emerging+Therapies+for+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2F9781118309421.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118309421.ch8%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26btitle%3DTargets%2520and%2520Emerging%2520Therapies%2520for%2520Schizophrenia%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2012%26spage%3D233%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vivo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalski, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lechner, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ognyanov, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tham, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klitenick, M. A.</span></span> <span> </span><span class="NLM_article-title">ALX 5407: a potent, selective inhibitor of the hGlyT1 glycine transporter</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1414</span>– <span class="NLM_lpage">1420</span>, <span class="refDoi"> DOI: 10.1124/mol.60.6.1414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1124%2Fmol.60.6.1414" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=1414-1420&author=B.+N.+Atkinsonauthor=S.+C.+Bellauthor=M.+De+Vivoauthor=L.+R.+Kowalskiauthor=S.+M.+Lechnerauthor=V.+I.+Ognyanovauthor=C.+S.+Thamauthor=C.+Tsaiauthor=J.+Jiaauthor=D.+Ashtonauthor=M.+A.+Klitenick&title=ALX+5407%3A+a+potent%2C+selective+inhibitor+of+the+hGlyT1+glycine+transporter&doi=10.1124%2Fmol.60.6.1414"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fmol.60.6.1414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.60.6.1414%26sid%3Dliteratum%253Aachs%26aulast%3DAtkinson%26aufirst%3DB.%2BN.%26aulast%3DBell%26aufirst%3DS.%2BC.%26aulast%3DDe%2BVivo%26aufirst%3DM.%26aulast%3DKowalski%26aufirst%3DL.%2BR.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DOgnyanov%26aufirst%3DV.%2BI.%26aulast%3DTham%26aufirst%3DC.%2BS.%26aulast%3DTsai%26aufirst%3DC.%26aulast%3DJia%26aufirst%3DJ.%26aulast%3DAshton%26aufirst%3DD.%26aulast%3DKlitenick%26aufirst%3DM.%2BA.%26atitle%3DALX%25205407%253A%2520a%2520potent%252C%2520selective%2520inhibitor%2520of%2520the%2520hGlyT1%2520glycine%2520transporter%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D1414%26epage%3D1420%26doi%3D10.1124%2Fmol.60.6.1414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Man, T.</span>; <span class="NLM_string-name">Milot, G.</span>; <span class="NLM_string-name">Porter, W. J.</span>; <span class="NLM_string-name">Reel, J. K.</span>; <span class="NLM_string-name">Rudyk, H. C. E.</span>; <span class="NLM_string-name">Valli, M. J.</span>; <span class="NLM_string-name">Walter, M. W.</span></span> <span> </span><span class="NLM_article-title">Preparation of N-(2-aryloxyethyl)glycine Derivatives and Their Use as Glycine Transport Inhibitors</span>. <span class="NLM_patent">WO2005100301</span>, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=T.+Man&author=G.+Milot&author=W.+J.+Porter&author=J.+K.+Reel&author=H.+C.+E.+Rudyk&author=M.+J.+Valli&author=M.+W.+Walter&title=Preparation+of+N-%282-aryloxyethyl%29glycine+Derivatives+and+Their+Use+as+Glycine+Transport+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMan%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520N-%25282-aryloxyethyl%2529glycine%2520Derivatives%2520and%2520Their%2520Use%2520as%2520Glycine%2520Transport%2520Inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kopec, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flood, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasior, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuvich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvino, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durkin, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ator, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, M. J.</span></span> <span> </span><span class="NLM_article-title">Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 mice</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">1407</span>– <span class="NLM_lpage">1417</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2010.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.bcp.2010.07.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2010&pages=1407-1417&author=K.+Kopecauthor=D.+G.+Floodauthor=M.+Gasiorauthor=B.+A.+McKennaauthor=E.+Zuvichauthor=J.+Schreiberauthor=J.+M.+Salvinoauthor=J.+T.+Durkinauthor=M.+A.+Atorauthor=M.+J.+Marino&title=Glycine+transporter+%28GlyT1%29+inhibitors+with+reduced+residence+time+increase+prepulse+inhibition+without+inducing+hyperlocomotion+in+DBA%2F2+mice&doi=10.1016%2Fj.bcp.2010.07.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2010.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2010.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DKopec%26aufirst%3DK.%26aulast%3DFlood%26aufirst%3DD.%2BG.%26aulast%3DGasior%26aufirst%3DM.%26aulast%3DMcKenna%26aufirst%3DB.%2BA.%26aulast%3DZuvich%26aufirst%3DE.%26aulast%3DSchreiber%26aufirst%3DJ.%26aulast%3DSalvino%26aufirst%3DJ.%2BM.%26aulast%3DDurkin%26aufirst%3DJ.%2BT.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DMarino%26aufirst%3DM.%2BJ.%26atitle%3DGlycine%2520transporter%2520%2528GlyT1%2529%2520inhibitors%2520with%2520reduced%2520residence%2520time%2520increase%2520prepulse%2520inhibition%2520without%2520inducing%2520hyperlocomotion%2520in%2520DBA%252F2%2520mice%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D80%26spage%3D1407%26epage%3D1417%26doi%3D10.1016%2Fj.bcp.2010.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perry, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcone, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fell, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Love, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Man, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomikos, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phebus, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cauvin, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandusky, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, K. A.</span></span> <span> </span><span class="NLM_article-title">Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areas</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">743</span>– <span class="NLM_lpage">754</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2008.06.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.neuropharm.2008.06.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=743-754&author=K.+W.+Perryauthor=J.+F.+Falconeauthor=M.+J.+Fellauthor=J.+W.+Ryderauthor=H.+Yuauthor=P.+L.+Loveauthor=J.+Katnerauthor=K.+D.+Gordonauthor=M.+R.+Wadeauthor=T.+Manauthor=G.+G.+Nomikosauthor=L.+A.+Phebusauthor=A.+J.+Cauvinauthor=K.+W.+Johnsonauthor=C.+K.+Jonesauthor=B.+J.+Hoffmannauthor=G.+E.+Sanduskyauthor=M.+W.+Walterauthor=W.+J.+Porterauthor=L.+Yangauthor=K.+M.+Merchantauthor=H.+E.+Shannonauthor=K.+A.+Svensson&title=Neurochemical+and+behavioral+profiling+of+the+selective+GlyT1+inhibitors+ALX5407+and+LY2365109+indicate+a+preferential+action+in+caudal+vs.+cortical+brain+areas&doi=10.1016%2Fj.neuropharm.2008.06.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2008.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2008.06.016%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DK.%2BW.%26aulast%3DFalcone%26aufirst%3DJ.%2BF.%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DRyder%26aufirst%3DJ.%2BW.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DLove%26aufirst%3DP.%2BL.%26aulast%3DKatner%26aufirst%3DJ.%26aulast%3DGordon%26aufirst%3DK.%2BD.%26aulast%3DWade%26aufirst%3DM.%2BR.%26aulast%3DMan%26aufirst%3DT.%26aulast%3DNomikos%26aufirst%3DG.%2BG.%26aulast%3DPhebus%26aufirst%3DL.%2BA.%26aulast%3DCauvin%26aufirst%3DA.%2BJ.%26aulast%3DJohnson%26aufirst%3DK.%2BW.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DHoffmann%26aufirst%3DB.%2BJ.%26aulast%3DSandusky%26aufirst%3DG.%2BE.%26aulast%3DWalter%26aufirst%3DM.%2BW.%26aulast%3DPorter%26aufirst%3DW.%2BJ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DMerchant%26aufirst%3DK.%2BM.%26aulast%3DShannon%26aufirst%3DH.%2BE.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26atitle%3DNeurochemical%2520and%2520behavioral%2520profiling%2520of%2520the%2520selective%2520GlyT1%2520inhibitors%2520ALX5407%2520and%2520LY2365109%2520indicate%2520a%2520preferential%2520action%2520in%2520caudal%2520vs.%2520cortical%2520brain%2520areas%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D743%26epage%3D754%26doi%3D10.1016%2Fj.neuropharm.2008.06.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gomeza, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hülsmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohno, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eulenburg, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szöke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, H.</span></span> <span> </span><span class="NLM_article-title">Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic Inhibition</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">785</span>– <span class="NLM_lpage">796</span>, <span class="refDoi"> DOI: 10.1016/S0896-6273(03)00672-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2FS0896-6273%2803%2900672-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2003&pages=785-796&author=J.+Gomezaauthor=S.+H%C3%BClsmannauthor=K.+Ohnoauthor=V.+Eulenburgauthor=K.+Sz%C3%B6keauthor=D.+Richterauthor=H.+Betz&title=Inactivation+of+the+glycine+transporter+1+gene+discloses+vital+role+of+glial+glycine+uptake+in+glycinergic+Inhibition&doi=10.1016%2FS0896-6273%2803%2900672-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2803%2900672-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252803%252900672-X%26sid%3Dliteratum%253Aachs%26aulast%3DGomeza%26aufirst%3DJ.%26aulast%3DH%25C3%25BClsmann%26aufirst%3DS.%26aulast%3DOhno%26aufirst%3DK.%26aulast%3DEulenburg%26aufirst%3DV.%26aulast%3DSz%25C3%25B6ke%26aufirst%3DK.%26aulast%3DRichter%26aufirst%3DD.%26aulast%3DBetz%26aufirst%3DH.%26atitle%3DInactivation%2520of%2520the%2520glycine%2520transporter%25201%2520gene%2520discloses%2520vital%2520role%2520of%2520glial%2520glycine%2520uptake%2520in%2520glycinergic%2520Inhibition%26jtitle%3DNeuron%26date%3D2003%26volume%3D40%26spage%3D785%26epage%3D796%26doi%3D10.1016%2FS0896-6273%2803%2900672-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szoke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graß, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirrlinger, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirrlinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulsmann, S.</span></span> <span> </span><span class="NLM_article-title">Glycine transporter 1 expression in the ventral respiratory group is restricted to protoplasmic astrocytes</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1119</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2006.08.089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.brainres.2006.08.089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=17010320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKmtLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1119&publication_year=2006&pages=182-189&author=K.+Szokeauthor=K.+Hartelauthor=D.+Gra%C3%9Fauthor=P.+G.+Hirrlingerauthor=J.+Hirrlingerauthor=S.+Hulsmann&title=Glycine+transporter+1+expression+in+the+ventral+respiratory+group+is+restricted+to+protoplasmic+astrocytes&doi=10.1016%2Fj.brainres.2006.08.089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Glycine transporter 1 expression in the ventral respiratory group is restricted to protoplasmic astrocytes</span></div><div class="casAuthors">Szoke, Katalin; Haertel, Kai; Grass, Dennis; Hirrlinger, Petra G.; Hirrlinger, Johannes; Huelsmann, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1119</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">182-189</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The lack of the glycine transporter 1 (GlyT1) leads to early postnatal death due to failure of respiratory network activity.  Here we demonstrate a segregated expression of GlyT1 on different astroglial cell populations of the ventral respiratory group.  In TgN(hGFAP-EGFP) mice a combined immunohistochem. and electrophysiol. approach was used to define the cellular expression of GlyT1 in the respiratory network.  EGFP-labeled cells with outwardly rectifying current-voltage relationship did not express glycine transporter 1, while GlyT1 was abundantly expressed in mature protoplasmic astrocytes, which are electrophysiol. characterized by a large potassium conductance, a more neg. membrane potential and the expression of glutamate transporters.  Taken together, the vital capacity for the clearance of extracellular glycine is restricted to a subpopulation of astroglial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcvXQs5p573rVg90H21EOLACvtfcHk0lgy-xtEZ_QXJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKmtLbJ&md5=4d8531529ac41fec22e779ae54b75f0b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2006.08.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2006.08.089%26sid%3Dliteratum%253Aachs%26aulast%3DSzoke%26aufirst%3DK.%26aulast%3DHartel%26aufirst%3DK.%26aulast%3DGra%25C3%259F%26aufirst%3DD.%26aulast%3DHirrlinger%26aufirst%3DP.%2BG.%26aulast%3DHirrlinger%26aufirst%3DJ.%26aulast%3DHulsmann%26aufirst%3DS.%26atitle%3DGlycine%2520transporter%25201%2520expression%2520in%2520the%2520ventral%2520respiratory%2520group%2520is%2520restricted%2520to%2520protoplasmic%2520astrocytes%26jtitle%3DBrain%2520Res.%26date%3D2006%26volume%3D1119%26spage%3D182%26epage%3D189%26doi%3D10.1016%2Fj.brainres.2006.08.089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, J. A.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tingley, F. D.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHardy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deninno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tunucci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valentine, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronk, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, E.</span></span> <span> </span><span class="NLM_article-title">The discovery of a structurally novel class of inhibitors of the type 1 glycine transporter</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2974</span>– <span class="NLM_lpage">2976</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.04.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.bmcl.2009.04.035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2974-2976&author=J.+A.+Loweauthor=X.+Houauthor=C.+Schmidtauthor=F.+D.+Tingleyauthor=S.+McHardyauthor=M.+Kalmanauthor=S.+Deninnoauthor=M.+Sannerauthor=K.+Wardauthor=L.+Lebelauthor=D.+Tunucciauthor=J.+Valentineauthor=B.+S.+Bronkauthor=E.+Schaeffer&title=The+discovery+of+a+structurally+novel+class+of+inhibitors+of+the+type+1+glycine+transporter&doi=10.1016%2Fj.bmcl.2009.04.035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.04.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.04.035%26sid%3Dliteratum%253Aachs%26aulast%3DLowe%26aufirst%3DJ.%2BA.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DSchmidt%26aufirst%3DC.%26aulast%3DTingley%26aufirst%3DF.%2BD.%26aulast%3DMcHardy%26aufirst%3DS.%26aulast%3DKalman%26aufirst%3DM.%26aulast%3DDeninno%26aufirst%3DS.%26aulast%3DSanner%26aufirst%3DM.%26aulast%3DWard%26aufirst%3DK.%26aulast%3DLebel%26aufirst%3DL.%26aulast%3DTunucci%26aufirst%3DD.%26aulast%3DValentine%26aufirst%3DJ.%26aulast%3DBronk%26aufirst%3DB.%2BS.%26aulast%3DSchaeffer%26aufirst%3DE.%26atitle%3DThe%2520discovery%2520of%2520a%2520structurally%2520novel%2520class%2520of%2520inhibitors%2520of%2520the%2520type%25201%2520glycine%2520transporter%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2974%26epage%3D2976%26doi%3D10.1016%2Fj.bmcl.2009.04.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blackaby, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, A. S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodacre, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLeod, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almond, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guscott, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamill, T. G.</span></span> <span> </span><span class="NLM_article-title">Identification of an orally bioavailable, potent, and selective inhibitor of GlyT1</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">350</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1021/ml1001085</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml1001085" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=350-354&author=W.+P.+Blackabyauthor=R.+T.+Lewisauthor=J.+L.+Thomsonauthor=A.+S.+R.+Jenningsauthor=S.+C.+Goodacreauthor=L.+J.+Streetauthor=A.+M.+MacLeodauthor=A.+Pikeauthor=S.+Woodauthor=S.+Thomasauthor=T.+A.+Brownauthor=A.+Smithauthor=G.+Pillaiauthor=S.+Almondauthor=M.+R.+Guscottauthor=H.+D.+Burnsauthor=W.+Engauthor=C.+Ryanauthor=J.+Cookauthor=T.+G.+Hamill&title=Identification+of+an+orally+bioavailable%2C+potent%2C+and+selective+inhibitor+of+GlyT1&doi=10.1021%2Fml1001085"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fml1001085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1001085%26sid%3Dliteratum%253Aachs%26aulast%3DBlackaby%26aufirst%3DW.%2BP.%26aulast%3DLewis%26aufirst%3DR.%2BT.%26aulast%3DThomson%26aufirst%3DJ.%2BL.%26aulast%3DJennings%26aufirst%3DA.%2BS.%2BR.%26aulast%3DGoodacre%26aufirst%3DS.%2BC.%26aulast%3DStreet%26aufirst%3DL.%2BJ.%26aulast%3DMacLeod%26aufirst%3DA.%2BM.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DT.%2BA.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DPillai%26aufirst%3DG.%26aulast%3DAlmond%26aufirst%3DS.%26aulast%3DGuscott%26aufirst%3DM.%2BR.%26aulast%3DBurns%26aufirst%3DH.%2BD.%26aulast%3DEng%26aufirst%3DW.%26aulast%3DRyan%26aufirst%3DC.%26aulast%3DCook%26aufirst%3DJ.%26aulast%3DHamill%26aufirst%3DT.%2BG.%26atitle%3DIdentification%2520of%2520an%2520orally%2520bioavailable%252C%2520potent%252C%2520and%2520selective%2520inhibitor%2520of%2520GlyT1%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D350%26epage%3D354%26doi%3D10.1021%2Fml1001085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugane, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamaguchi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeno, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimizuka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, S.-i.</span></span> <span> </span><span class="NLM_article-title">Atropisomeric 4-Phenyl-4H-1,2,4-triazoles as selective glycine transporter 1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5744</span>– <span class="NLM_lpage">5756</span>, <span class="refDoi"> DOI: 10.1021/jm400383w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400383w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKqtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5744-5756&author=T.+Suganeauthor=T.+Tobeauthor=W.+Hamaguchiauthor=I.+Shimadaauthor=K.+Maenoauthor=J.+Miyataauthor=T.+Suzukiauthor=T.+Kimizukaauthor=S.+Sakamotoauthor=S.-i.+Tsukamoto&title=Atropisomeric+4-Phenyl-4H-1%2C2%2C4-triazoles+as+selective+glycine+transporter+1+inhibitors&doi=10.1021%2Fjm400383w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Atropisomeric 4-Phenyl-4H-1,2,4-triazoles as Selective Glycine Transporter 1 Inhibitors</span></div><div class="casAuthors">Sugane, Takashi; Tobe, Takahiko; Hamaguchi, Wataru; Shimada, Itsuro; Maeno, Kyoichi; Miyata, Junji; Suzuki, Takeshi; Kimizuka, Tetsuya; Sakamoto, Shuichi; Tsukamoto, Shin-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5744-5756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of trisubstituted 4H-1,2,4-triazoles was synthesized and evaluated aiming to increase their activity and selectivity as glycine transporter 1 (GlyT1) inhibitors.  Structure-activity relationship exploration resulted in the identification of 3-[3-ethyl-5-(6-phenylpyridin-3-yl)-4H-1,2,4-triazol-4-yl]-2-methylbenzonitrile (I) with markedly higher selectivity for GlyT1.  Physiochem. studies revealed that the compd. I exists as a stable pair of atropisomers under physiol. conditions.  These atropisomers were successfully sepd. to obtain active enantiomer (R)-I, which displayed favorable pharmacokinetic properties, as well as pos. results in the mice Y-maze test.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM-2SGK3g_mrVg90H21EOLACvtfcHk0lhiAKlh-yLWfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKqtLvN&md5=c3218bd9ccae1f172f6d995e089a1a74</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm400383w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400383w%26sid%3Dliteratum%253Aachs%26aulast%3DSugane%26aufirst%3DT.%26aulast%3DTobe%26aufirst%3DT.%26aulast%3DHamaguchi%26aufirst%3DW.%26aulast%3DShimada%26aufirst%3DI.%26aulast%3DMaeno%26aufirst%3DK.%26aulast%3DMiyata%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKimizuka%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DTsukamoto%26aufirst%3DS.-i.%26atitle%3DAtropisomeric%25204-Phenyl-4H-1%252C2%252C4-triazoles%2520as%2520selective%2520glycine%2520transporter%25201%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5744%26epage%3D5756%26doi%3D10.1021%2Fjm400383w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Alberati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lengyel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mory, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borroni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoflach, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlotterbeck, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hainzl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettstein, J. G.</span></span> <span> </span><span class="NLM_article-title">Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1152</span>– <span class="NLM_lpage">1161</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2011.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.neuropharm.2011.11.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=1152-1161&author=D.+Alberatiauthor=J.+L.+Moreauauthor=J.+Lengyelauthor=N.+Hauserauthor=R.+Moryauthor=E.+Borroniauthor=E.+Pinardauthor=F.+Knoflachauthor=G.+Schlotterbeckauthor=D.+Hainzlauthor=J.+G.+Wettstein&title=Glycine+reuptake+inhibitor+RG1678%3A+a+pharmacologic+characterization+of+an+investigational+agent+for+the+treatment+of+schizophrenia&doi=10.1016%2Fj.neuropharm.2011.11.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2011.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2011.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DAlberati%26aufirst%3DD.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DLengyel%26aufirst%3DJ.%26aulast%3DHauser%26aufirst%3DN.%26aulast%3DMory%26aufirst%3DR.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DKnoflach%26aufirst%3DF.%26aulast%3DSchlotterbeck%26aufirst%3DG.%26aulast%3DHainzl%26aufirst%3DD.%26aulast%3DWettstein%26aufirst%3DJ.%2BG.%26atitle%3DGlycine%2520reuptake%2520inhibitor%2520RG1678%253A%2520a%2520pharmacologic%2520characterization%2520of%2520an%2520investigational%2520agent%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DNeuropharmacology%26date%3D2012%26volume%3D62%26spage%3D1152%26epage%3D1161%26doi%3D10.1016%2Fj.neuropharm.2011.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit31b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alanine, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borroni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourdeaux, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brom, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hainzl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halm, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolidon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lengyel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marty, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mory, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narquizian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettekoven, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norcross, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puellmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stalder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermuth, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettstein, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerli, D.</span></span> <span> </span><span class="NLM_article-title">Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4603</span>– <span class="NLM_lpage">4614</span>, <span class="refDoi"> DOI: 10.1021/jm100210p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100210p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4603-4614&author=E.+Pinardauthor=A.+Alanineauthor=D.+Alberatiauthor=M.+Benderauthor=E.+Borroniauthor=P.+Bourdeauxauthor=V.+Bromauthor=S.+Burnerauthor=H.+Fischerauthor=D.+Hainzlauthor=R.+Halmauthor=N.+Hauserauthor=S.+Jolidonauthor=J.+Lengyelauthor=H.+P.+Martyauthor=T.+Meyerauthor=J.+L.+Moreauauthor=R.+Moryauthor=R.+Narquizianauthor=M.+Nettekovenauthor=R.+D.+Norcrossauthor=B.+Puellmannauthor=P.+Schmidauthor=S.+Schmittauthor=H.+Stalderauthor=R.+Wermuthauthor=J.+G.+Wettsteinauthor=D.+Zimmerli&title=Selective+GlyT1+inhibitors%3A+discovery+of+%5B4-%283-fluoro-5-trifluoromethylpyridin-2-yl%29piperazin-1-yl%5D%5B5-methanesulfonyl-2-%28%28S%29-2%2C2%2C2-trifluoro-1-methylethoxy%29phenyl%5Dmethanone+%28RG1678%29%2C+a+promising+novel+medicine+to+treat+schizophrenia&doi=10.1021%2Fjm100210p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=10.1021%2Fjm100210p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100210p%26sid%3Dliteratum%253Aachs%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DAlanine%26aufirst%3DA.%26aulast%3DAlberati%26aufirst%3DD.%26aulast%3DBender%26aufirst%3DM.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DBourdeaux%26aufirst%3DP.%26aulast%3DBrom%26aufirst%3DV.%26aulast%3DBurner%26aufirst%3DS.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DHainzl%26aufirst%3DD.%26aulast%3DHalm%26aufirst%3DR.%26aulast%3DHauser%26aufirst%3DN.%26aulast%3DJolidon%26aufirst%3DS.%26aulast%3DLengyel%26aufirst%3DJ.%26aulast%3DMarty%26aufirst%3DH.%2BP.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DMory%26aufirst%3DR.%26aulast%3DNarquizian%26aufirst%3DR.%26aulast%3DNettekoven%26aufirst%3DM.%26aulast%3DNorcross%26aufirst%3DR.%2BD.%26aulast%3DPuellmann%26aufirst%3DB.%26aulast%3DSchmid%26aufirst%3DP.%26aulast%3DSchmitt%26aufirst%3DS.%26aulast%3DStalder%26aufirst%3DH.%26aulast%3DWermuth%26aufirst%3DR.%26aulast%3DWettstein%26aufirst%3DJ.%2BG.%26aulast%3DZimmerli%26aufirst%3DD.%26atitle%3DSelective%2520GlyT1%2520inhibitors%253A%2520discovery%2520of%2520%255B4-%25283-fluoro-5-trifluoromethylpyridin-2-yl%2529piperazin-1-yl%255D%255B5-methanesulfonyl-2-%2528%2528S%2529-2%252C2%252C2-trifluoro-1-methylethoxy%2529phenyl%255Dmethanone%2520%2528RG1678%2529%252C%2520a%2520promising%2520novel%2520medicine%2520to%2520treat%2520schizophrenia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4603%26epage%3D4614%26doi%3D10.1021%2Fjm100210p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varnes, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forst, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmquist, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frietze, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dembofsky, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andisik, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinkley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steelman, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkins, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonak, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potts, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brugel, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alhambra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veale, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, J. S.</span></span> <span> </span><span class="NLM_article-title">Bicyclo((aryl)methyl)benzamides as inhibitors of GlyT1</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1043</span>– <span class="NLM_lpage">1049</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.02.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.bmcl.2018.02.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=1043-1049&author=J.+G.+Varnesauthor=H.+Xiongauthor=J.+M.+Forstauthor=C.+R.+Holmquistauthor=G.+E.+Ernstauthor=W.+Frietzeauthor=B.+Dembofskyauthor=D.+W.+Andisikauthor=W.+E.+Palmerauthor=L.+Hinkleyauthor=G.+B.+Steelmanauthor=D.+E.+Wilkinsauthor=G.+Tianauthor=G.+Jonakauthor=W.+M.+Pottsauthor=X.+Wangauthor=T.+A.+Brugelauthor=C.+Alhambraauthor=M.+W.+Woodauthor=C.+A.+Vealeauthor=J.+S.+Albert&title=Bicyclo%28%28aryl%29methyl%29benzamides+as+inhibitors+of+GlyT1&doi=10.1016%2Fj.bmcl.2018.02.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.02.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.02.029%26sid%3Dliteratum%253Aachs%26aulast%3DVarnes%26aufirst%3DJ.%2BG.%26aulast%3DXiong%26aufirst%3DH.%26aulast%3DForst%26aufirst%3DJ.%2BM.%26aulast%3DHolmquist%26aufirst%3DC.%2BR.%26aulast%3DErnst%26aufirst%3DG.%2BE.%26aulast%3DFrietze%26aufirst%3DW.%26aulast%3DDembofsky%26aufirst%3DB.%26aulast%3DAndisik%26aufirst%3DD.%2BW.%26aulast%3DPalmer%26aufirst%3DW.%2BE.%26aulast%3DHinkley%26aufirst%3DL.%26aulast%3DSteelman%26aufirst%3DG.%2BB.%26aulast%3DWilkins%26aufirst%3DD.%2BE.%26aulast%3DTian%26aufirst%3DG.%26aulast%3DJonak%26aufirst%3DG.%26aulast%3DPotts%26aufirst%3DW.%2BM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DBrugel%26aufirst%3DT.%2BA.%26aulast%3DAlhambra%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DM.%2BW.%26aulast%3DVeale%26aufirst%3DC.%2BA.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26atitle%3DBicyclo%2528%2528aryl%2529methyl%2529benzamides%2520as%2520inhibitors%2520of%2520GlyT1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D1043%26epage%3D1049%26doi%3D10.1016%2Fj.bmcl.2018.02.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cioffi, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzzo, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadalapure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parthasarathy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loong, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeng, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carulli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karunakaran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matta, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panduga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckle, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakwa, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sargent, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luche, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khmelnitsky, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismail, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leong, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sachdev, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mhyre, A. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of N-((1-(4-(Sulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide inhibitors of glycine transporter-1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8473</span>– <span class="NLM_lpage">8494</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00914</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00914" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWntr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8473-8494&author=C.+L.+Cioffiauthor=S.+Liuauthor=M.+A.+Wolfauthor=P.+R.+Guzzoauthor=K.+Sadalapureauthor=V.+Parthasarathyauthor=D.+T.+Loongauthor=J.+H.+Maengauthor=E.+Carulliauthor=X.+Fangauthor=K.+Karunakaranauthor=L.+Mattaauthor=S.+H.+Chooauthor=S.+Pandugaauthor=R.+N.+Buckleauthor=R.+N.+Davisauthor=S.+A.+Sakwaauthor=P.+Guptaauthor=B.+J.+Sargentauthor=N.+A.+Mooreauthor=M.+M.+Lucheauthor=G.+J.+Carrauthor=Y.+L.+Khmelnitskyauthor=J.+Ismailauthor=M.+Chungauthor=M.+Baiauthor=W.+Y.+Leongauthor=N.+Sachdevauthor=S.+Swaminathanauthor=A.+J.+Mhyre&title=Synthesis+and+biological+evaluation+of+N-%28%281-%284-%28Sulfonyl%29piperazin-1-yl%29cycloalkyl%29methyl%29benzamide+inhibitors+of+glycine+transporter-1&doi=10.1021%2Facs.jmedchem.6b00914"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of N-((1-(4-(Sulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide Inhibitors of Glycine Transporter-1</span></div><div class="casAuthors">Cioffi, Christopher L.; Liu, Shuang; Wolf, Mark A.; Guzzo, Peter R.; Sadalapure, Kashinath; Parthasarathy, Visweswaran; Loong, David T. J.; Maeng, Jun-Ho; Carulli, Edmund; Fang, Xiao; Karunakaran, Kalesh; Matta, Lakshman; Choo, Sok Hui; Panduga, Shailijia; Buckle, Ronald N.; Davis, Randall N.; Sakwa, Samuel A.; Gupta, Priya; Sargent, Bruce J.; Moore, Nicholas A.; Luche, Michele M.; Carr, Grant J.; Khmelnitsky, Yuri L.; Ismail, Jiffry; Chung, Mark; Bai, Mei; Leong, Wei Yee; Sachdev, Nidhi; Swaminathan, Srividya; Mhyre, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8473-8494</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors previously disclosed the discovery of rationally designed N-((1-(4-(propylsulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide inhibitors of glycine transporter-1 (GlyT-1), represented by analogs 10 and 11.  The authors describe herein further structure-activity relationship exploration of this series via an optimization strategy that primarily focused on the sulfonamide and benzamide appendages of the scaffold.  These efforts led to the identification of advanced leads possessing a desirable balance of excellent in vitro GlyT-1 potency and selectivity, favorable ADME and in vitro pharmacol. profiles, and suitable pharmacokinetic and safety characteristics.  Representative analog I exhibited robust in vivo activity in the cerebral spinal fluid glycine biomarker model in both rodents and nonhuman primates.  Furthermore, rodent microdialysis expts. also demonstrated that oral administration of I significantly elevated extracellular glycine levels within the medial prefrontal cortex (mPFC).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJGpndM6DMLLVg90H21EOLACvtfcHk0ljDy9LXYd3pcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWntr%252FO&md5=798d272412524f3c8af25cdccc595c63</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00914%26sid%3Dliteratum%253Aachs%26aulast%3DCioffi%26aufirst%3DC.%2BL.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DWolf%26aufirst%3DM.%2BA.%26aulast%3DGuzzo%26aufirst%3DP.%2BR.%26aulast%3DSadalapure%26aufirst%3DK.%26aulast%3DParthasarathy%26aufirst%3DV.%26aulast%3DLoong%26aufirst%3DD.%2BT.%26aulast%3DMaeng%26aufirst%3DJ.%2BH.%26aulast%3DCarulli%26aufirst%3DE.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DKarunakaran%26aufirst%3DK.%26aulast%3DMatta%26aufirst%3DL.%26aulast%3DChoo%26aufirst%3DS.%2BH.%26aulast%3DPanduga%26aufirst%3DS.%26aulast%3DBuckle%26aufirst%3DR.%2BN.%26aulast%3DDavis%26aufirst%3DR.%2BN.%26aulast%3DSakwa%26aufirst%3DS.%2BA.%26aulast%3DGupta%26aufirst%3DP.%26aulast%3DSargent%26aufirst%3DB.%2BJ.%26aulast%3DMoore%26aufirst%3DN.%2BA.%26aulast%3DLuche%26aufirst%3DM.%2BM.%26aulast%3DCarr%26aufirst%3DG.%2BJ.%26aulast%3DKhmelnitsky%26aufirst%3DY.%2BL.%26aulast%3DIsmail%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DM.%26aulast%3DBai%26aufirst%3DM.%26aulast%3DLeong%26aufirst%3DW.%2BY.%26aulast%3DSachdev%26aufirst%3DN.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DMhyre%26aufirst%3DA.%2BJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520N-%2528%25281-%25284-%2528Sulfonyl%2529piperazin-1-yl%2529cycloalkyl%2529methyl%2529benzamide%2520inhibitors%2520of%2520glycine%2520transporter-1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8473%26epage%3D8494%26doi%3D10.1021%2Facs.jmedchem.6b00914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yee, B. K.</span></span> <span> </span><span class="NLM_article-title">Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">866</span>– <span class="NLM_lpage">885</span>, <span class="refDoi"> DOI: 10.1038/nrd3893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1038%2Fnrd3893" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=866-885&author=R.+J.+Harveyauthor=B.+K.+Yee&title=Glycine+transporters+as+novel+therapeutic+targets+in+schizophrenia%2C+alcohol+dependence+and+pain&doi=10.1038%2Fnrd3893"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnrd3893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3893%26sid%3Dliteratum%253Aachs%26aulast%3DHarvey%26aufirst%3DR.%2BJ.%26aulast%3DYee%26aufirst%3DB.%2BK.%26atitle%3DGlycine%2520transporters%2520as%2520novel%2520therapeutic%2520targets%2520in%2520schizophrenia%252C%2520alcohol%2520dependence%2520and%2520pain%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D866%26epage%3D885%26doi%3D10.1038%2Fnrd3893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarimizu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aota, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doihara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, N.</span></span> <span> </span><span class="NLM_article-title">A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer’s disease</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>685</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2012.04.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.ejphar.2012.04.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=22542656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFCisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=685&publication_year=2012&pages=59-69&author=K.+Haradaauthor=K.+Nakatoauthor=J.+Yarimizuauthor=M.+Yamazakiauthor=M.+Moritaauthor=S.+Takahashiauthor=M.+Aotaauthor=K.+Saitaauthor=H.+Doiharaauthor=Y.+Satoauthor=T.+Yamajiauthor=K.+Niauthor=N.+Matsuoka&title=A+novel+glycine+transporter-1+%28GlyT1%29+inhibitor%2C+ASP2535+%284-%5B3-isopropyl-5-%286-phenyl-3-pyridyl%29-4H-1%2C2%2C4-triazol-4-yl%5D-2%2C1%2C3-benzoxadiazole%29%2C+improves+cognition+in+animal+models+of+cognitive+impairment+in+schizophrenia+and+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejphar.2012.04.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease</span></div><div class="casAuthors">Harada, Katsuya; Nakato, Kazuhiro; Yarimizu, Junko; Yamazaki, Mayako; Morita, Masahiko; Takahashi, Shinji; Aota, Masaki; Saita, Kyoko; Doihara, Hitoshi; Sato, Yuichiro; Yamaji, Takayuki; Ni, Keni; Matsuoka, Nobuya</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">685</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">59-69</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hypofunction of brain N-methyl-d-aspartate (NMDA) receptors has been implicated in psychiatric disorders such as schizophrenia and Alzheimer's disease.  Inhibition of glycine transporter-1 (GlyT1) is expected to increase glycine, a co-agonist of the NMDA receptor and, consequently, to facilitate NMDA receptor function.  We have identified ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole) as a novel GlyT1 inhibitor, and here describe our in vitro and in vivo characterization of this compd.  ASP2535 potently inhibited rat GlyT1 (IC50 = 92 nM) with 50-fold selectivity over rat glycine transporter-2 (GlyT2).  It showed minimal affinity for many other receptors except for μ-opioid receptors (IC50 = 1.83 μM).  Oral administration of ASP2535 dose-dependently inhibited ex vivo [3H]-glycine uptake in mouse cortical homogenate, suggesting good brain permeability.  This profile was confirmed by pharmacokinetic anal.  We then evaluated the effect of ASP2535 on animal models of cognitive impairment in schizophrenia and Alzheimer's disease.  Working memory deficit in MK-801-treated mice and visual learning deficit in neonatally phencyclidine (PCP)-treated mice were both attenuated by ASP2535 (0.3-3 mg/kg, p.o. and 0.3-1 mg/kg, p.o., resp.).  ASP2535 (1-3 mg/kg, p.o.) also improved the PCP-induced deficit in prepulse inhibition in rats.  Moreover, the working memory deficit in scopolamine-treated mice and the spatial learning deficit in aged rats were both attenuated by ASP2535 (0.1-3 mg/kg, p.o. and 0.1 mg/kg, p.o., resp.).  These studies provide compelling evidence that ASP2535 is a novel and centrally-active GlyT1 inhibitor that can improve cognitive impairment in animal models of schizophrenia and Alzheimer's disease, suggesting that ASP2535 may satisfy currently unmet medical needs for the treatment of these diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKCfrEvZzV97Vg90H21EOLACvtfcHk0ljDy9LXYd3pcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFCisr0%253D&md5=d98206f687016709ea9d6b2ddc29ab33</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2012.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2012.04.013%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DK.%26aulast%3DNakato%26aufirst%3DK.%26aulast%3DYarimizu%26aufirst%3DJ.%26aulast%3DYamazaki%26aufirst%3DM.%26aulast%3DMorita%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DAota%26aufirst%3DM.%26aulast%3DSaita%26aufirst%3DK.%26aulast%3DDoihara%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DYamaji%26aufirst%3DT.%26aulast%3DNi%26aufirst%3DK.%26aulast%3DMatsuoka%26aufirst%3DN.%26atitle%3DA%2520novel%2520glycine%2520transporter-1%2520%2528GlyT1%2529%2520inhibitor%252C%2520ASP2535%2520%25284-%255B3-isopropyl-5-%25286-phenyl-3-pyridyl%2529-4H-1%252C2%252C4-triazol-4-yl%255D-2%252C1%252C3-benzoxadiazole%2529%252C%2520improves%2520cognition%2520in%2520animal%2520models%2520of%2520cognitive%2520impairment%2520in%2520schizophrenia%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D685%26spage%3D59%26epage%3D69%26doi%3D10.1016%2Fj.ejphar.2012.04.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Singer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubroqua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yee, B. K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glycine transporter 1: The yellow brick road to new schizophrenia therapy?</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3771</span>– <span class="NLM_lpage">3787</span>, <span class="refDoi"> DOI: 10.2174/1381612821666150724100952</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.2174%2F1381612821666150724100952" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=3771-3787&author=P.+Singerauthor=S.+Dubroquaauthor=B.+K.+Yee&title=Inhibition+of+glycine+transporter+1%3A+The+yellow+brick+road+to+new+schizophrenia+therapy%3F&doi=10.2174%2F1381612821666150724100952"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.2174%2F1381612821666150724100952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612821666150724100952%26sid%3Dliteratum%253Aachs%26aulast%3DSinger%26aufirst%3DP.%26aulast%3DDubroqua%26aufirst%3DS.%26aulast%3DYee%26aufirst%3DB.%2BK.%26atitle%3DInhibition%2520of%2520glycine%2520transporter%25201%253A%2520The%2520yellow%2520brick%2520road%2520to%2520new%2520schizophrenia%2520therapy%253F%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2015%26volume%3D21%26spage%3D3771%26epage%3D3787%26doi%3D10.2174%2F1381612821666150724100952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit36b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Umbricht, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Facklam, M.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: A randomized, double-blind, proof-of-concept study</span>. <i>JAMA Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">646</span>, <span class="refDoi"> DOI: 10.1001/jamapsychiatry.2014.163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1001%2Fjamapsychiatry.2014.163" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=637-646&author=D.+Umbrichtauthor=D.+Alberatiauthor=M.+Martin-Facklam&title=Effect+of+bitopertin%2C+a+glycine+reuptake+inhibitor%2C+on+negative+symptoms+of+schizophrenia%3A+A+randomized%2C+double-blind%2C+proof-of-concept+study&doi=10.1001%2Fjamapsychiatry.2014.163"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=10.1001%2Fjamapsychiatry.2014.163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamapsychiatry.2014.163%26sid%3Dliteratum%253Aachs%26aulast%3DUmbricht%26aufirst%3DD.%26aulast%3DAlberati%26aufirst%3DD.%26aulast%3DMartin-Facklam%26aufirst%3DM.%26atitle%3DEffect%2520of%2520bitopertin%252C%2520a%2520glycine%2520reuptake%2520inhibitor%252C%2520on%2520negative%2520symptoms%2520of%2520schizophrenia%253A%2520A%2520randomized%252C%2520double-blind%252C%2520proof-of-concept%2520study%26jtitle%3DJAMA%2520Psychiatry%26date%3D2014%26volume%3D71%26spage%3D637%26epage%3D646%26doi%3D10.1001%2Fjamapsychiatry.2014.163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit36c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chue, P.</span></span> <span> </span><span class="NLM_article-title">Glycine reuptake inhibition as a new therapeutic approach in schizophrenia: Focus on the glycine transporter 1 (GlyT1)</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1311</span>– <span class="NLM_lpage">1320</span>, <span class="refDoi"> DOI: 10.2174/138161213804805766</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.2174%2F138161213804805766" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1311-1320&author=P.+Chue&title=Glycine+reuptake+inhibition+as+a+new+therapeutic+approach+in+schizophrenia%3A+Focus+on+the+glycine+transporter+1+%28GlyT1%29&doi=10.2174%2F138161213804805766"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36c&amp;dbid=16384&amp;doi=10.2174%2F138161213804805766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161213804805766%26sid%3Dliteratum%253Aachs%26aulast%3DChue%26aufirst%3DP.%26atitle%3DGlycine%2520reuptake%2520inhibition%2520as%2520a%2520new%2520therapeutic%2520approach%2520in%2520schizophrenia%253A%2520Focus%2520on%2520the%2520glycine%2520transporter%25201%2520%2528GlyT1%2529%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2013%26volume%3D19%26spage%3D1311%26epage%3D1320%26doi%3D10.2174%2F138161213804805766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit36d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenberg, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubrey, K. R.</span></span> <span> </span><span class="NLM_article-title">Glycine transport inhibitors as potential antipsychotic drugs</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">518</span>, <span class="refDoi"> DOI: 10.1517/14728222.5.4.507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1517%2F14728222.5.4.507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=12540263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntVSmtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2001&pages=507-518&author=R.+J.+Vandenbergauthor=K.+R.+Aubrey&title=Glycine+transport+inhibitors+as+potential+antipsychotic+drugs&doi=10.1517%2F14728222.5.4.507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36dR"><div class="casContent"><span class="casTitleNuber">36d</span><div class="casTitle"><span class="NLM_cas:atitle">Glycine transport inhibitors as potential antipsychotic drugs</span></div><div class="casAuthors">Vandenberg, Robert J.; Aubrey, Karin R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">507-518</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Current antipsychotic drugs are only partially effective in treating schizophrenia and there is a clear need to develop better therapies.  An alternative approach to develop new antipsychotics has come from the NMDA receptor hypofunction model for schizophrenia.  It was hypothesised that stimulation of NMDA receptors with Gly site agonists may be therapeutic, and a no. of clin. trials of Gly together with std. antipsychotic drugs were recently been conducted.  Modest improvements in neg. symptoms were reported in some studies but a potentially more effective treatment is to use inhibitors of the GLYT1 subtype of Gly transporters.  Expression of GLYT1 within the brain correlates with NMDA receptor expression patterns and it was suggested that GLYT1 may regulate synaptic Gly concns.  With the development of selective and potent non-transported inhibitors of GLYT1 it should be possible to elevate synaptic Gly concns. more effectively and thereby to increase NMDA receptor activity.  Recent in vitro studies demonstrate that the Gly transport inhibitor, N[3-(4-fluorophenyl)-3-(4'-phenylphenoxy)] propylsarcosine, enhances NMDA receptor activity and the use of this class of compds. in clin. studies is eagerly awaited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5BG1o5_GPOLVg90H21EOLACvtfcHk0lgwwDWKEqk43g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntVSmtr0%253D&md5=b51c6d7ffa3f2704a016979aae468fe2</span></div><a href="/servlet/linkout?suffix=cit36d&amp;dbid=16384&amp;doi=10.1517%2F14728222.5.4.507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.5.4.507%26sid%3Dliteratum%253Aachs%26aulast%3DVandenberg%26aufirst%3DR.%2BJ.%26aulast%3DAubrey%26aufirst%3DK.%2BR.%26atitle%3DGlycine%2520transport%2520inhibitors%2520as%2520potential%2520antipsychotic%2520drugs%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2001%26volume%3D5%26spage%3D507%26epage%3D518%26doi%3D10.1517%2F14728222.5.4.507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit36e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Javitt, D. C.</span></span> <span> </span><span class="NLM_article-title">Glycine transport inhibitors for the treatment of schizophrenia: symptom and disease modification</span>. <i>Curr. Opin. Drug. Discovery Dev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">468</span>– <span class="NLM_lpage">478</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=468-478&author=D.+C.+Javitt&title=Glycine+transport+inhibitors+for+the+treatment+of+schizophrenia%3A+symptom+and+disease+modification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJavitt%26aufirst%3DD.%2BC.%26atitle%3DGlycine%2520transport%2520inhibitors%2520for%2520the%2520treatment%2520of%2520schizophrenia%253A%2520symptom%2520and%2520disease%2520modification%26jtitle%3DCurr.%2520Opin.%2520Drug.%2520Discovery%2520Dev.%26date%3D2009%26volume%3D12%26spage%3D468%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit36f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">D’Souza, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elander, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbuto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udo de Haes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjogren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peeters, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranganathan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schipper, J.</span></span> <span> </span><span class="NLM_article-title">Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: preliminary evidence</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1036</span>– <span class="NLM_lpage">1046</span>, <span class="refDoi"> DOI: 10.1038/npp.2011.295</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1038%2Fnpp.2011.295" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=1036-1046&author=D.+C.+D%E2%80%99Souzaauthor=N.+Singhauthor=J.+Elanderauthor=M.+Carbutoauthor=B.+Pittmanauthor=J.+Udo+de+Haesauthor=M.+Sjogrenauthor=P.+Peetersauthor=M.+Ranganathanauthor=J.+Schipper&title=Glycine+transporter+inhibitor+attenuates+the+psychotomimetic+effects+of+ketamine+in+healthy+males%3A+preliminary+evidence&doi=10.1038%2Fnpp.2011.295"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36f&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2011.295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2011.295%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DD.%2BC.%26aulast%3DSingh%26aufirst%3DN.%26aulast%3DElander%26aufirst%3DJ.%26aulast%3DCarbuto%26aufirst%3DM.%26aulast%3DPittman%26aufirst%3DB.%26aulast%3DUdo%2Bde%2BHaes%26aufirst%3DJ.%26aulast%3DSjogren%26aufirst%3DM.%26aulast%3DPeeters%26aufirst%3DP.%26aulast%3DRanganathan%26aufirst%3DM.%26aulast%3DSchipper%26aufirst%3DJ.%26atitle%3DGlycine%2520transporter%2520inhibitor%2520attenuates%2520the%2520psychotomimetic%2520effects%2520of%2520ketamine%2520in%2520healthy%2520males%253A%2520preliminary%2520evidence%26jtitle%3DNeuropsychopharmacology%26date%3D2012%26volume%3D37%26spage%3D1036%26epage%3D1046%26doi%3D10.1038%2Fnpp.2011.295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit36g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Moschetti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liesenfeld, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbrock, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kammerer, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wunderlich, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wind, S.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability and pharmacokinetics of oral BI 425809, a glycine transporter 1 inhibitor, in healthy male volunteers: a partially randomised, single-blind, placebo-controlled, first-in-human study</span>. <i>Eur. J. Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1007/s13318-017-0440-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1007%2Fs13318-017-0440-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=29076028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGgsrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2018&pages=239-249&author=V.+Moschettiauthor=M.+Deschauthor=S.+Goetzauthor=K.+H.+Liesenfeldauthor=H.+Rosenbrockauthor=K.+P.+Kammererauthor=G.+Wunderlichauthor=S.+Wind&title=Safety%2C+tolerability+and+pharmacokinetics+of+oral+BI+425809%2C+a+glycine+transporter+1+inhibitor%2C+in+healthy+male+volunteers%3A+a+partially+randomised%2C+single-blind%2C+placebo-controlled%2C+first-in-human+study&doi=10.1007%2Fs13318-017-0440-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36gR"><div class="casContent"><span class="casTitleNuber">36g</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, Tolerability and Pharmacokinetics of Oral BI 425809, a Glycine Transporter 1 Inhibitor, in Healthy Male Volunteers: A Partially Randomised, Single-Blind, Placebo-Controlled, First-in-Human Study</span></div><div class="casAuthors">Moschetti, Viktoria; Desch, Michael; Goetz, Sophia; Liesenfeld, Karl-Heinz; Rosenbrock, Holger; Kammerer, Klaus-Peter; Wunderlich, Glen; Wind, Sven</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">239-249</span>CODEN:
                <span class="NLM_cas:coden">EJDPD2</span>;
        ISSN:<span class="NLM_cas:issn">0378-7966</span>.
    
            (<span class="NLM_cas:orgname">Springer France</span>)
        </div><div class="casAbstract">Background and objectives: Schizophrenia and Alzheimer's disease are characterised by glutamatergic pathway abnormalities related to N-methyl-D-aspartate (NMDA) receptor hypofunction and cognitive impairment.  Glycine is an NMDA receptor co-agonist; inhibition of glycine transporter 1 (GlyT1) should improve NMDA receptor hypofunction.  This study evaluated safety and pharmacokinetic properties of BI 425809-a potent and selective GlyT1 inhibitor.  Methods: In the single-rising dose (SRD) component of this study, subjects were randomised to a single dose of BI 425809 [doses (mg): 0.5, 1, 2, 5, 10, 25, 50, 100 and 150], or placebo.  The bioavailability/food effect (BA/FE) component investigated BI 425809 pharmacokinetics following single dosing (25-mg tablet) after overnight fasting or with a high-calorie meal or as soln. (25 mg) after overnight fasting.  Results: Overall, 33/83 (39.8%) subjects had ≥ 1 treatment-related adverse event (AE); there were no deaths or serious AEs.  Reported SRD part AEs trended towards dose dependency, occurring at the higher doses (mostly central nervous system related).  BI 425809 plasma concn.-time profiles were similarly shaped across all doses and plasma exposure increased proportional to dose.  In the BA/FE component, geometric mean ratios for the area under the concn.-time curve from time zero to the last measurable concn. and the max. plasma concn. for tablet fasted vs. soln. fasted were 80.5 and 50.0%, resp., and for tablet fed vs. fasted were 125.9 and 142.1%, resp.  Conclusion: BI 425809 was generally well-tolerated at doses expected to be clin. relevant.  The AE profile suggested possible GlyT1-inhibiting effects.  Clin. trial identifier: NCT02068690.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa22AbewOlcrVg90H21EOLACvtfcHk0ljbVRb-VgtGhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGgsrzK&md5=f8a0d2ab87f367aee026b54cfccab3c8</span></div><a href="/servlet/linkout?suffix=cit36g&amp;dbid=16384&amp;doi=10.1007%2Fs13318-017-0440-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13318-017-0440-z%26sid%3Dliteratum%253Aachs%26aulast%3DMoschetti%26aufirst%3DV.%26aulast%3DDesch%26aufirst%3DM.%26aulast%3DGoetz%26aufirst%3DS.%26aulast%3DLiesenfeld%26aufirst%3DK.%2BH.%26aulast%3DRosenbrock%26aufirst%3DH.%26aulast%3DKammerer%26aufirst%3DK.%2BP.%26aulast%3DWunderlich%26aufirst%3DG.%26aulast%3DWind%26aufirst%3DS.%26atitle%3DSafety%252C%2520tolerability%2520and%2520pharmacokinetics%2520of%2520oral%2520BI%2520425809%252C%2520a%2520glycine%2520transporter%25201%2520inhibitor%252C%2520in%2520healthy%2520male%2520volunteers%253A%2520a%2520partially%2520randomised%252C%2520single-blind%252C%2520placebo-controlled%252C%2520first-in-human%2520study%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D2018%26volume%3D43%26spage%3D239%26epage%3D249%26doi%3D10.1007%2Fs13318-017-0440-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span>A Study of Bitopertin (RO4917838) in Combination with Selective
Serotonin Reuptake Inhibitors in Patients with Obsessive Compulsive
Disorder. <a href="https://www.clinicaltrials.gov/ct2/show/NCT01674361" class="extLink">https://www.clinicaltrials.gov/ct2/show/NCT01674361</a> (accessed May 6, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study+of+Bitopertin+%28RO4917838%29+in+Combination+with+Selective%0ASerotonin+Reuptake+Inhibitors+in+Patients+with+Obsessive+Compulsive%0ADisorder.+https%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT01674361+%28accessed+May+6%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, I.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, G. E.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glycine transporter-1 as a novel mechanism for the treatment of depression</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">734</span>– <span class="NLM_lpage">741</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2013.02.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.biopsych.2013.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=23562005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1Cns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2013&pages=734-741&author=C.-C.+Huangauthor=I.-H.+Weiauthor=C.-L.+Huangauthor=K.-T.+Chenauthor=M.-H.+Tsaiauthor=P.+Tsaiauthor=R.+Tunauthor=K.-H.+Huangauthor=Y.-C.+Changauthor=H.-Y.+Laneauthor=G.+E.+Tsai&title=Inhibition+of+glycine+transporter-1+as+a+novel+mechanism+for+the+treatment+of+depression&doi=10.1016%2Fj.biopsych.2013.02.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38aR"><div class="casContent"><span class="casTitleNuber">38a</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Glycine Transporter-I as a Novel Mechanism for the Treatment of Depression</span></div><div class="casAuthors">Huang, Chih-Chia; Wei, I-Hua; Huang, Chieh-Liang; Chen, Kuang-Ti; Tsai, Mang-Hung; Tsai, Priscilla; Tun, Rene; Huang, Kuo-Hao; Chang, Yue-Cune; Lane, Hsien-Yuan; Tsai, Guochuan Emil</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">734-741</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Antidepressants, aiming at monoaminergic neurotransmission, exhibit delayed onset of action, limited efficacy, and poor compliance.  Glutamatergic neurotransmission is involved in depression.  However, it is unclear whether enhancement of the N-methyl-D-aspartate (NMDA) subtype glutamate receptor can be a treatment for depression.We studied sarcosine, a glycine transporter-I inhibitor that potentiates NMDA function, in animal models and in depressed patients.  We investigated its effects in forced swim test, tail suspension test, elevated plus maze test, novelty-suppressed feeding test, and chronic unpredictable stress test in rats and conducted a 6-wk randomized, double-blinded, citalopram-controlled trial in 40 patients with major depressive disorder.  Clin. efficacy and side effects were assessed biweekly, with the main outcomes of Hamilton Depression Rating Scale, Global Assessment of Function, and remission rate.  The time course of response and dropout rates was also compared.Sarcosine decreased immobility in the forced swim test and tail suspension test, reduced the latency to feed in the novelty-suppressed feeding test, and reversed behavioral deficits caused by chronic unpredictable stress test, which are characteristics for an antidepressant.  In the clin. study, sarcosine substantially improved scores of Hamilton Depression Rating Scale, Clin. Global Impression, and Global Assessment of Function more than citalopram treatment.  Sarcosine-treated patients were much more likely and quicker to remit and less likely to drop out.  Sarcosine was well tolerated without significant side effects.Our preliminary findings suggest that enhancing NMDA function can improve depression-like behaviors in rodent models and in human depression.  Establishment of glycine transporter-I inhibition as a novel treatment for depression waits for confirmation by further proof-of-principle studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr8Y9z0DqhkbVg90H21EOLACvtfcHk0ljbVRb-VgtGhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1Cns70%253D&md5=ea387d152da9f33b7baba5b7c07b0320</span></div><a href="/servlet/linkout?suffix=cit38a&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2013.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2013.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.-C.%26aulast%3DWei%26aufirst%3DI.-H.%26aulast%3DHuang%26aufirst%3DC.-L.%26aulast%3DChen%26aufirst%3DK.-T.%26aulast%3DTsai%26aufirst%3DM.-H.%26aulast%3DTsai%26aufirst%3DP.%26aulast%3DTun%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DK.-H.%26aulast%3DChang%26aufirst%3DY.-C.%26aulast%3DLane%26aufirst%3DH.-Y.%26aulast%3DTsai%26aufirst%3DG.%2BE.%26atitle%3DInhibition%2520of%2520glycine%2520transporter-1%2520as%2520a%2520novel%2520mechanism%2520for%2520the%2520treatment%2520of%2520depression%26jtitle%3DBiol.%2520Psychiatry%26date%3D2013%26volume%3D74%26spage%3D734%26epage%3D741%26doi%3D10.1016%2Fj.biopsych.2013.02.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit38b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, S. J.</span></span> <span> </span><span class="NLM_article-title">Glycine transporter-1 inhibitors: a new class of antidepressant?</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">710</span>– <span class="NLM_lpage">711</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2013.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.biopsych.2013.08.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=24144323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Grtr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2013&pages=710-711&author=S.+J.+Mathew&title=Glycine+transporter-1+inhibitors%3A+a+new+class+of+antidepressant%3F&doi=10.1016%2Fj.biopsych.2013.08.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38bR"><div class="casContent"><span class="casTitleNuber">38b</span><div class="casTitle"><span class="NLM_cas:atitle">Glycine Transporter-I Inhibitors: A New Class of Antidepressant?</span></div><div class="casAuthors">Mathew, Sanjay J.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">710-711</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">This article describes about the new class of antidepressant of glycine transporter-I inhibitor.  Drug discovery pathway focuses on compds. that directly or indirectly affect the glycine-B (Gly-B) allosteric modulatory site of the NMDAR are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZiGpKHZCUObVg90H21EOLACvtfcHk0li5iq0E7xe0VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Grtr3P&md5=b2abd7dfa139e09055fd03ada51bff53</span></div><a href="/servlet/linkout?suffix=cit38b&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2013.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2013.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DMathew%26aufirst%3DS.%2BJ.%26atitle%3DGlycine%2520transporter-1%2520inhibitors%253A%2520a%2520new%2520class%2520of%2520antidepressant%253F%26jtitle%3DBiol.%2520Psychiatry%26date%3D2013%26volume%3D74%26spage%3D710%26epage%3D711%26doi%3D10.1016%2Fj.biopsych.2013.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit38c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, I.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, G. E.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glycine tranporter-1 as a novel mechanism for the treatment of depression</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">734</span>– <span class="NLM_lpage">741</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2013.02.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.biopsych.2013.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=23562005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1Cns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2013&pages=734-741&author=C.-C.+Huangauthor=I.-H.+Weiauthor=C.-L.+Huangauthor=K.-T.+Chenauthor=M.-H.+Tsaiauthor=P.+Tsaiauthor=R.+Tunauthor=K.-H.+Huangauthor=Y.-C.+Changauthor=H.-Y.+Laneauthor=G.+E.+Tsai&title=Inhibition+of+glycine+tranporter-1+as+a+novel+mechanism+for+the+treatment+of+depression&doi=10.1016%2Fj.biopsych.2013.02.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38cR"><div class="casContent"><span class="casTitleNuber">38c</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Glycine Transporter-I as a Novel Mechanism for the Treatment of Depression</span></div><div class="casAuthors">Huang, Chih-Chia; Wei, I-Hua; Huang, Chieh-Liang; Chen, Kuang-Ti; Tsai, Mang-Hung; Tsai, Priscilla; Tun, Rene; Huang, Kuo-Hao; Chang, Yue-Cune; Lane, Hsien-Yuan; Tsai, Guochuan Emil</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">734-741</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Antidepressants, aiming at monoaminergic neurotransmission, exhibit delayed onset of action, limited efficacy, and poor compliance.  Glutamatergic neurotransmission is involved in depression.  However, it is unclear whether enhancement of the N-methyl-D-aspartate (NMDA) subtype glutamate receptor can be a treatment for depression.We studied sarcosine, a glycine transporter-I inhibitor that potentiates NMDA function, in animal models and in depressed patients.  We investigated its effects in forced swim test, tail suspension test, elevated plus maze test, novelty-suppressed feeding test, and chronic unpredictable stress test in rats and conducted a 6-wk randomized, double-blinded, citalopram-controlled trial in 40 patients with major depressive disorder.  Clin. efficacy and side effects were assessed biweekly, with the main outcomes of Hamilton Depression Rating Scale, Global Assessment of Function, and remission rate.  The time course of response and dropout rates was also compared.Sarcosine decreased immobility in the forced swim test and tail suspension test, reduced the latency to feed in the novelty-suppressed feeding test, and reversed behavioral deficits caused by chronic unpredictable stress test, which are characteristics for an antidepressant.  In the clin. study, sarcosine substantially improved scores of Hamilton Depression Rating Scale, Clin. Global Impression, and Global Assessment of Function more than citalopram treatment.  Sarcosine-treated patients were much more likely and quicker to remit and less likely to drop out.  Sarcosine was well tolerated without significant side effects.Our preliminary findings suggest that enhancing NMDA function can improve depression-like behaviors in rodent models and in human depression.  Establishment of glycine transporter-I inhibition as a novel treatment for depression waits for confirmation by further proof-of-principle studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr8Y9z0DqhkbVg90H21EOLACvtfcHk0li5iq0E7xe0VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1Cns70%253D&md5=ea387d152da9f33b7baba5b7c07b0320</span></div><a href="/servlet/linkout?suffix=cit38c&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2013.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2013.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.-C.%26aulast%3DWei%26aufirst%3DI.-H.%26aulast%3DHuang%26aufirst%3DC.-L.%26aulast%3DChen%26aufirst%3DK.-T.%26aulast%3DTsai%26aufirst%3DM.-H.%26aulast%3DTsai%26aufirst%3DP.%26aulast%3DTun%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DK.-H.%26aulast%3DChang%26aufirst%3DY.-C.%26aulast%3DLane%26aufirst%3DH.-Y.%26aulast%3DTsai%26aufirst%3DG.%2BE.%26atitle%3DInhibition%2520of%2520glycine%2520tranporter-1%2520as%2520a%2520novel%2520mechanism%2520for%2520the%2520treatment%2520of%2520depression%26jtitle%3DBiol.%2520Psychiatry%26date%3D2013%26volume%3D74%26spage%3D734%26epage%3D741%26doi%3D10.1016%2Fj.biopsych.2013.02.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Bejczy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nations, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szegedi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoemaker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruwe, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soderpalm, B.</span></span> <span> </span><span class="NLM_article-title">Efficacy and safety of the glycine transporter-1 inhibitor Org 25935 for the prevention of relapse in alcohol-dependent patients: a randomized, double-blind, placebo-controlled trial</span>. <i>Alcohol.: Clin. Exp. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">2427</span>– <span class="NLM_lpage">2435</span>, <span class="refDoi"> DOI: 10.1111/acer.12501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1111%2Facer.12501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=25257291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CiurrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2014&pages=2427-2435&author=A.+de+Bejczyauthor=K.+R.+Nationsauthor=A.+Szegediauthor=J.+Schoemakerauthor=F.+Ruweauthor=B.+Soderpalm&title=Efficacy+and+safety+of+the+glycine+transporter-1+inhibitor+Org+25935+for+the+prevention+of+relapse+in+alcohol-dependent+patients%3A+a+randomized%2C+double-blind%2C+placebo-controlled+trial&doi=10.1111%2Facer.12501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and Safety of the Glycine Transporter-1 Inhibitor Org 25935 for the Prevention of Relapse in Alcohol-Dependent Patients: A Randomized, Double-Blind, Placebo-Controlled Trial</span></div><div class="casAuthors">de Bejczy, Andrea; Nations, Kari R.; Szegedi, Armin; Schoemaker, Joep; Ruwe, Frank; Soederpalm, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Alcoholism: Clinical & Experimental Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2427-2435</span>CODEN:
                <span class="NLM_cas:coden">ACRSDM</span>;
        ISSN:<span class="NLM_cas:issn">0145-6008</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background : Org 25935 is a glycine transporter inhibitor that increases extracellular glycine levels and attenuates alc.-induced dopaminergic activity in the nucleus accumbens.  In animal models, Org 25935 has dose-dependent effects on ethanol intake, preference, and relapse-like behavior without tolerance.  The current study aimed to translate these animal findings to humans by examg. whether Org 25935 prevents relapse in detoxified alc.-dependent patients.  Methods : This was a multicenter, randomized, double-blind, placebo-controlled clin. trial.  Adult patients diagnosed with alc. dependence were randomly assigned to receive Org 25935 12 mg twice a day or placebo for 84 days.  The primary end point was percentage heavy drinking days (defined as ≥5 std. drinks per day for men and ≥4 for women).  Secondary end points included other measures of relapse-related drinking behavior (e.g., drinks per day, time to relapse), as well as measures of global functioning, alc.-related thoughts and cravings, and motivation.  Results : A total of 140 subjects were included in the intent-to-treat anal.  The trial was stopped approx. midway after a futility anal. showing that the likelihood of detecting a signal at study term was <40%.  There was no significant difference between Org 25935 and placebo on percentage heavy drinking days or any other measure of relapse-related drinking behavior.  Org 25935 showed no safety issues and was fairly well tolerated, with fatigue, dizziness, and transient visual events as the most commonly occurring side effects.  Conclusions : Org 25935 demonstrated no benefit over placebo in preventing alc. relapse.  Study limitations and implications are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3enmidY5gfbVg90H21EOLACvtfcHk0li5iq0E7xe0VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CiurrI&md5=1a55fa45256187420339b07f25c1dacc</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Facer.12501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Facer.12501%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BBejczy%26aufirst%3DA.%26aulast%3DNations%26aufirst%3DK.%2BR.%26aulast%3DSzegedi%26aufirst%3DA.%26aulast%3DSchoemaker%26aufirst%3DJ.%26aulast%3DRuwe%26aufirst%3DF.%26aulast%3DSoderpalm%26aufirst%3DB.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520the%2520glycine%2520transporter-1%2520inhibitor%2520Org%252025935%2520for%2520the%2520prevention%2520of%2520relapse%2520in%2520alcohol-dependent%2520patients%253A%2520a%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520trial%26jtitle%3DAlcohol.%253A%2520Clin.%2520Exp.%2520Res.%26date%3D2014%26volume%3D38%26spage%3D2427%26epage%3D2435%26doi%3D10.1111%2Facer.12501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, H. Y.</span></span> <span> </span><span class="NLM_article-title">Activation of N-methyl-D-aspartate receptor glycine site temporally ameliorates neuropsychiatric symptoms of Parkinson’s disease with dementia</span>. <i>Psychiatry Clin. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">692</span>– <span class="NLM_lpage">700</span>, <span class="refDoi"> DOI: 10.1111/pcn.12175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1111%2Fpcn.12175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=24612097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWlur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2014&pages=692-700&author=C.+H.+Tsaiauthor=H.+C.+Huangauthor=B.+L.+Liuauthor=C.+I.+Liauthor=M.+K.+Luauthor=X.+Chenauthor=M.+C.+Tsaiauthor=Y.+W.+Yangauthor=H.+Y.+Lane&title=Activation+of+N-methyl-D-aspartate+receptor+glycine+site+temporally+ameliorates+neuropsychiatric+symptoms+of+Parkinson%E2%80%99s+disease+with+dementia&doi=10.1111%2Fpcn.12175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of N-methyl-D-aspartate receptor glycine site temporally ameliorates neuropsychiatric symptoms of Parkinson's disease with dementia</span></div><div class="casAuthors">Tsai, Chon-Haw; Huang, Hui-Chun; Liu, Bey-Ling; Li, Chia-Ing; Lu, Ming-Kuei; Chen, Xianxiu; Tsai, Mu-Chieh; Yang, Yu-Wan; Lane, Hsien-Yuan</div><div class="citationInfo"><span class="NLM_cas:title">Psychiatry and Clinical Neurosciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">692-700</span>CODEN:
                <span class="NLM_cas:coden">PCNEFP</span>;
        ISSN:<span class="NLM_cas:issn">1323-1316</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aim : We have previously found that sarcosine, a glycine transporter I inhibitor, can improve the psychiatric symptoms of schizophrenia.  In this study, we aimed to investigate whether the agent can also ameliorate neuropsychiatric symptoms of Parkinson's disease (PD) patients with dementia.  Methods : An 8-wk, double-blind, placebo-controlled trial was conducted in patients who had PD with dementia (PD-D).  Neuropsychiatric manifestations were measured before and at week 2 (V1), week 4 (V2) and week 8 (V3) after treatment.  Linear regression with the generalized estg. equations was applied for data anal.  Results : Fifteen patients were randomized into a sarcosine group; the other 15 into a placebo group.  The generalized estg. equations model revealed significant differences in Hamilton Depression Rating Scale score (P = 0.049) at V1 and Neuropsychiatry Inventory (P = 0.039) at V2 between the treatment and placebo groups.  By excluding the advanced patients from anal., there were significant differences in Unified Parkinson's Disease Rating Scale V2 (P = 0.004) and V3 (P = 0.040), Hamilton Depression Rating Scale V1 (P = 0.014) and V2 (P = 0.047), Neuropsychiatry Inventory V1 (P = 0.002) and V2 (P < 0.001) and Behavior Pathol. in Alzheimer's Disease Rating Scale V2 (P = 0.025) in favor of sarcosine.  Conclusion : Sarcosine temporally improved depression and neuropsychiatric symptoms in PD-D patients without exacerbating the motor or cognitive features; the beneficial effects were more prominent in patients with mild-moderate severity.  Enhancement of N-methyl-D-aspartate receptor-glycine cascade may lead to a novel path for the management of PD-D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGrjNauNv3FbVg90H21EOLACvtfcHk0ljunRz6nWbiVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWlur%252FP&md5=1de9c6238de84800c8e3603c5bc93995</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1111%2Fpcn.12175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpcn.12175%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DC.%2BH.%26aulast%3DHuang%26aufirst%3DH.%2BC.%26aulast%3DLiu%26aufirst%3DB.%2BL.%26aulast%3DLi%26aufirst%3DC.%2BI.%26aulast%3DLu%26aufirst%3DM.%2BK.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DTsai%26aufirst%3DM.%2BC.%26aulast%3DYang%26aufirst%3DY.%2BW.%26aulast%3DLane%26aufirst%3DH.%2BY.%26atitle%3DActivation%2520of%2520N-methyl-D-aspartate%2520receptor%2520glycine%2520site%2520temporally%2520ameliorates%2520neuropsychiatric%2520symptoms%2520of%2520Parkinson%25E2%2580%2599s%2520disease%2520with%2520dementia%26jtitle%3DPsychiatry%2520Clin.%2520Neurosci.%26date%3D2014%26volume%3D68%26spage%3D692%26epage%3D700%26doi%3D10.1111%2Fpcn.12175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ouellet, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, V.</span></span> <span> </span><span class="NLM_article-title">First-time-in-human study with GSK1018921, a selective GlyT1 inhibitor: relationship between exposure and dizziness</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">597</span>– <span class="NLM_lpage">604</span>, <span class="refDoi"> DOI: 10.1038/clpt.2011.154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1038%2Fclpt.2011.154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=21866096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1WqtbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2011&pages=597-604&author=D.+Ouelletauthor=S.+Sutherlandauthor=T.+Wangauthor=P.+Griffiniauthor=V.+Murthy&title=First-time-in-human+study+with+GSK1018921%2C+a+selective+GlyT1+inhibitor%3A+relationship+between+exposure+and+dizziness&doi=10.1038%2Fclpt.2011.154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">First-Time-in-Human Study With GSK1018921, a Selective GlyT1 Inhibitor: Relationship Between Exposure and Dizziness</span></div><div class="casAuthors">Ouellet, D.; Sutherland, S.; Wang, T.; Griffini, P.; Murthy, V.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">597-604</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The pharmacokinetics (PK), safety, and tolerability of GSK1018921, a glycine transporter 1 (GlyT-1) inhibitor, were assessed in this first-time-in-human (FTIH) study.  Single oral doses ranging from 0.5 to 280 mg and placebo were administered to 25 healthy subjects in a five-period, two-cohort, crossover study.  GSK1018921 showed dose-proportional PK with a terminal half-life of ∼17 h.  The subjects reported dizziness with a dose-dependent frequency of 22-88% at doses of 70-280 mg.  The time course of the dizziness paralleled the PK of the drug, with peak response at 2 h after the dose, consistent with time to max. plasma concn. (Tmax).  The dizziness was resolved by 10-12 h in all subjects.  A Markov-chain logistic regression model was implemented in NONMEM to det. the probability of developing dizziness as a function of the plasma concn. of the compd.  Frequency, onset (<1 h), and offset (4 h) were well described by the model.  Exposure resulting in 80% receptor occupancy is predicted to be well tolerated.  Clin. Pharmacol. & Therapeutics (2011) 90 4, 597-604. doi:10.1038/clpt.2011.154.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBRw2PAoQ5U7Vg90H21EOLACvtfcHk0ljunRz6nWbiVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1WqtbnJ&md5=0d2e46ce8908265c32b02c3bb7bb5a19</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2011.154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2011.154%26sid%3Dliteratum%253Aachs%26aulast%3DOuellet%26aufirst%3DD.%26aulast%3DSutherland%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DGriffini%26aufirst%3DP.%26aulast%3DMurthy%26aufirst%3DV.%26atitle%3DFirst-time-in-human%2520study%2520with%2520GSK1018921%252C%2520a%2520selective%2520GlyT1%2520inhibitor%253A%2520relationship%2520between%2520exposure%2520and%2520dizziness%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2011%26volume%3D90%26spage%3D597%26epage%3D604%26doi%3D10.1038%2Fclpt.2011.154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borroni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hainzl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolidon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narquizian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettekoven, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norcross, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stalder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">5134</span>– <span class="NLM_lpage">5139</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.07.086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.bmcl.2008.07.086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=18752953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFelsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5134-5139&author=E.+Pinardauthor=D.+Alberatiauthor=E.+Borroniauthor=H.+Fischerauthor=D.+Hainzlauthor=S.+Jolidonauthor=J.+L.+Moreauauthor=R.+Narquizianauthor=M.+Nettekovenauthor=R.+D.+Norcrossauthor=H.+Stalderauthor=A.+W.+Thomas&title=Discovery+of+benzoylpiperazines+as+a+novel+class+of+potent+and+selective+GlyT1+inhibitors&doi=10.1016%2Fj.bmcl.2008.07.086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors</span></div><div class="casAuthors">Pinard, Emmanuel; Alberati, Daniela; Borroni, Edilio; Fischer, Holger; Hainzl, Dominik; Jolidon, Synese; Moreau, Jean-Luc; Narquizian, Robert; Nettekoven, Matthias; Norcross, Roger D.; Stalder, Henri; Thomas, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5134-5139</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Screening of the Roche compd. library led to the identification of the benzoylpiperazine I as a structurally novel GlyT1 inhibitor.  The SAR which was developed in this series resulted in the discovery of highly potent compds. displaying excellent selectivity against the GlyT2 isoform, drug-like properties, and in vivo efficacy after oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE1zn7kLXXuLVg90H21EOLACvtfcHk0ljunRz6nWbiVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFelsrnI&md5=766bbdbb096cb09dc27df4c539d98686</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.086%26sid%3Dliteratum%253Aachs%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DAlberati%26aufirst%3DD.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DHainzl%26aufirst%3DD.%26aulast%3DJolidon%26aufirst%3DS.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DNarquizian%26aufirst%3DR.%26aulast%3DNettekoven%26aufirst%3DM.%26aulast%3DNorcross%26aufirst%3DR.%2BD.%26aulast%3DStalder%26aufirst%3DH.%26aulast%3DThomas%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520benzoylpiperazines%2520as%2520a%2520novel%2520class%2520of%2520potent%2520and%2520selective%2520GlyT1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5134%26epage%3D5139%26doi%3D10.1016%2Fj.bmcl.2008.07.086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P. C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skillman, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, A.</span></span> <span> </span><span class="NLM_article-title">Comparison of shape-matching and docking as virtual screening tools</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1021/jm0603365</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0603365" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlansb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=74-82&author=P.+C.+D.+Hawkinsauthor=A.+G.+Skillmanauthor=A.+Nicholls&title=Comparison+of+shape-matching+and+docking+as+virtual+screening+tools&doi=10.1021%2Fjm0603365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of Shape-Matching and Docking as Virtual Screening Tools</span></div><div class="casAuthors">Hawkins, Paul C. D.; Skillman, A. Geoffrey; Nicholls, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-82</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ligand docking is a widely used approach in virtual screening.  In recent years a large no. of publications have appeared in which docking tools are compared and evaluated for their effectiveness in virtual screening against a wide variety of protein targets.  These studies have shown that the effectiveness of docking in virtual screening is highly variable due to a large no. of possible confounding factors.  Another class of method that has shown promise in virtual screening is the shape-based, ligand-centric approach.  Several direct comparisons of docking with the shape-based tool ROCS have been conducted using data sets from some of these recent docking publications.  The results show that a shape-based, ligand-centric approach is more consistent than, and often superior to, the protein-centric approach taken by docking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe0IKOly7zibVg90H21EOLACvtfcHk0ljunRz6nWbiVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlansb%252FF&md5=6f97f5c0cc092b4e225f7c2656c1bcf6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm0603365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603365%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DP.%2BC.%2BD.%26aulast%3DSkillman%26aufirst%3DA.%2BG.%26aulast%3DNicholls%26aufirst%3DA.%26atitle%3DComparison%2520of%2520shape-matching%2520and%2520docking%2520as%2520virtual%2520screening%2520tools%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D74%26epage%3D82%26doi%3D10.1021%2Fjm0603365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biftu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha-Roy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuethe, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scapin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krueger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiermann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hicks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salituro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doss, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sewall, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornberry, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A. E.</span></span> <span> </span><span class="NLM_article-title">Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3205</span>– <span class="NLM_lpage">3212</span>, <span class="refDoi"> DOI: 10.1021/jm401992e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401992e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslaltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3205-3212&author=T.+Biftuauthor=R.+Sinha-Royauthor=P.+Chenauthor=X.+Qianauthor=D.+Fengauthor=J.+T.+Kuetheauthor=G.+Scapinauthor=Y.+D.+Gaoauthor=Y.+Yanauthor=D.+Kruegerauthor=A.+Bakauthor=G.+Eiermannauthor=J.+Heauthor=J.+Coxauthor=J.+Hicksauthor=K.+Lyonsauthor=H.+Heauthor=G.+Salituroauthor=S.+Tongauthor=S.+Patelauthor=G.+Dossauthor=A.+Petrovauthor=J.+Wuauthor=S.+S.+Xuauthor=C.+Sewallauthor=X.+Zhangauthor=B.+Zhangauthor=N.+A.+Thornberryauthor=A.+E.+Weber&title=Omarigliptin+%28MK-3102%29%3A+a+novel+long-acting+DPP-4+inhibitor+for+once-weekly+treatment+of+type+2+diabetes&doi=10.1021%2Fjm401992e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Omarigliptin (MK-3102): A Novel Long-Acting DPP-4 Inhibitor for Once-Weekly Treatment of Type 2 Diabetes</span></div><div class="casAuthors">Biftu, Tesfaye; Sinha-Roy, Ranabir; Chen, Ping; Qian, Xiaoxia; Feng, Dennis; Kuethe, Jeffrey T.; Scapin, Giovanna; Gao, Ying Duo; Yan, Youwei; Krueger, Davida; Bak, Annette; Eiermann, George; He, Jiafang; Cox, Jason; Hicks, Jacqueline; Lyons, Kathy; He, Huaibing; Salituro, Gino; Tong, Sharon; Patel, Sangita; Doss, George; Petrov, Aleksandr; Wu, Joseph; Xu, Shiyao Sherrie; Sewall, Charles; Zhang, Xiaoping; Zhang, Bei; Thornberry, Nancy A.; Weber, Ann E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3205-3212</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In our effort to discover DPP-4 inhibitors with added benefits over currently com. available DPP-4 inhibitors, MK-3102 (omarigliptin), was identified as a potent and selective dipeptidyl peptidase 4 (DPP-4) inhibitor with an excellent pharmacokinetic profile amenable for once-weekly human dosing and selected as a clin. development candidate.  This manuscript summarizes the mechanism of action, scientific rationale, medicinal chem., pharmacokinetic properties, and human efficacy data for omarigliptin, which is currently in phase 3 clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGeQnvAA8cBbVg90H21EOLACvtfcHk0lgvb3N5vnyB9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslaltb4%253D&md5=14b15f61cd5cd6c981d93459ad372e62</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm401992e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401992e%26sid%3Dliteratum%253Aachs%26aulast%3DBiftu%26aufirst%3DT.%26aulast%3DSinha-Roy%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DKuethe%26aufirst%3DJ.%2BT.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DGao%26aufirst%3DY.%2BD.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DKrueger%26aufirst%3DD.%26aulast%3DBak%26aufirst%3DA.%26aulast%3DEiermann%26aufirst%3DG.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DCox%26aufirst%3DJ.%26aulast%3DHicks%26aufirst%3DJ.%26aulast%3DLyons%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DSalituro%26aufirst%3DG.%26aulast%3DTong%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DDoss%26aufirst%3DG.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DS.%2BS.%26aulast%3DSewall%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3DOmarigliptin%2520%2528MK-3102%2529%253A%2520a%2520novel%2520long-acting%2520DPP-4%2520inhibitor%2520for%2520once-weekly%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3205%26epage%3D3212%26doi%3D10.1021%2Fjm401992e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antilla, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klapars, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, S. A.</span></span> <span> </span><span class="NLM_article-title">The copper-catalyzed-arylation of indoles</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">11684</span>– <span class="NLM_lpage">11688</span>, <span class="refDoi"> DOI: 10.1021/ja027433h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja027433h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2002&pages=11684-11688&author=J.+C.+Antillaauthor=A.+Klaparsauthor=S.+A.+Buchwald&title=The+copper-catalyzed-arylation+of+indoles&doi=10.1021%2Fja027433h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fja027433h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja027433h%26sid%3Dliteratum%253Aachs%26aulast%3DAntilla%26aufirst%3DJ.%2BC.%26aulast%3DKlapars%26aufirst%3DA.%26aulast%3DBuchwald%26aufirst%3DS.%2BA.%26atitle%3DThe%2520copper-catalyzed-arylation%2520of%2520indoles%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2002%26volume%3D124%26spage%3D11684%26epage%3D11688%26doi%3D10.1021%2Fja027433h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bassinger, J.</span>; <span class="NLM_string-name">Bookser, B.</span>; <span class="NLM_string-name">Chen, M.</span>; <span class="NLM_string-name">Chung, D. M.</span>; <span class="NLM_string-name">Gupta, V.</span>; <span class="NLM_string-name">Hudson, A.</span>; <span class="NLM_string-name">Kaplan, A.</span>; <span class="NLM_string-name">Na, J.</span>; <span class="NLM_string-name">Renick, J.</span>; <span class="NLM_string-name">Santora, V.</span></span> <span> </span><span class="NLM_article-title">Substituted 2,4,5,6-Tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-Tetrahydro-2H-pyrazolo[4,3-c]pyridine Compounds as GlyT1 Inhibitors</span>. <span class="NLM_patent">US9708334B2</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+Bassinger&author=B.+Bookser&author=M.+Chen&author=D.+M.+Chung&author=V.+Gupta&author=A.+Hudson&author=A.+Kaplan&author=J.+Na&author=J.+Renick&author=V.+Santora&title=Substituted+2%2C4%2C5%2C6-Tetrahydropyrrolo%5B3%2C4-c%5Dpyrazole+and+4%2C5%2C6%2C7-Tetrahydro-2H-pyrazolo%5B4%2C3-c%5Dpyridine+Compounds+as+GlyT1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBassinger%26aufirst%3DJ.%26atitle%3DSubstituted%25202%252C4%252C5%252C6-Tetrahydropyrrolo%255B3%252C4-c%255Dpyrazole%2520and%25204%252C5%252C6%252C7-Tetrahydro-2H-pyrazolo%255B4%252C3-c%255Dpyridine%2520Compounds%2520as%2520GlyT1%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. T.</span></span> <span> </span><span class="NLM_article-title">High throughput artificial membrane permeability assay for bloodbrain barrier</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1016/S0223-5234(03)00012-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughput+artificial+membrane+permeability+assay+for+bloodbrain+barrier&doi=10.1016%2FS0223-5234%2803%2900012-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520bloodbrain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1016%2FS0223-5234%2803%2900012-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mireles, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janiszewski, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Morais, S. M.</span></span> <span> </span><span class="NLM_article-title">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">268</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1124/dmd.107.017434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1124%2Fdmd.107.017434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=17962372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=268-275&author=B.+Fengauthor=J.+B.+Millsauthor=R.+E.+Davidsonauthor=R.+J.+Mirelesauthor=J.+S.+Janiszewskiauthor=M.+D.+Troutmanauthor=S.+M.+de+Morais&title=In+vitro+P-glycoprotein+assays+to+predict+the+in+vivo+interactions+of+P-glycoprotein+with+drugs+in+the+central+nervous+system&doi=10.1124%2Fdmd.107.017434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span></div><div class="casAuthors">Feng, Bo; Mills, Jessica B.; Davidson, Ralph E.; Mireles, Rouchelle J.; Janiszewski, John S.; Troutman, Matthew D.; de Morais, Sonia M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-one structurally diverse marketed central nervous system (CNS)-active drugs, one active metabolite, and seven non-CNS-active compds. were tested in three P-glycoprotein (P-gp) in vitro assays: transwell assays using MDCK, human MDR1-MDCK, and mouse Mdr1a-MDCK cells, ATPase, and calcein AM inhibition.  Addnl., the permeability for these compds. was measured in two in vitro models: parallel artificial membrane permeation assay and apical-to-basolateral apparent permeability in MDCK.  The exposure of the same set of compds. in brain and plasma was measured in P-gp knockout (KO) and wild-type (WT) mice after s.c. administration.  One drug and its metabolite, risperidone and 9-hydroxyrisperidone, of the 32 CNS compds., and 6 of the 7 non-CNS drugs were detd. to have pos. efflux using ratio of ratios in MDR1-MDCK vs. MDCK transwell assays.  Data from transwell studies correlated well with the brain-to-plasma area under the curve ratios between P-gp KO and WT mice for the 32 CNS compds.  In addn., 3300 Pfizer compds. were tested in MDR1-MDCK and Mdr1a-MDCK transwell assays, with a good correlation (R2 = 0.92) between the efflux ratios in human MDR1-MDCK and mouse Mdr1a-MDCK cells.  Permeability data showed that the majority of the 32 CNS compds. have moderate to high passive permeability.  This work has demonstrated that in vitro transporter assays help in understanding the role of P-gp-mediated efflux activity in detg. the disposition of CNS drugs in vivo, and the transwell assay is a valuable in vitro assay to evaluate human P-gp interaction with compds. for assessing brain penetration of new chem. entities to treat CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQyRSOySyGLVg90H21EOLACvtfcHk0ljMmFncsv033A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D&md5=bbf8b6969bd6d6b3d741b6ef9e7853f3</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.017434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.017434%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DJ.%2BB.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DMireles%26aufirst%3DR.%2BJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26atitle%3DIn%2520vitro%2520P-glycoprotein%2520assays%2520to%2520predict%2520the%2520in%2520vivo%2520interactions%2520of%2520P-glycoprotein%2520with%2520drugs%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D268%26epage%3D275%26doi%3D10.1124%2Fdmd.107.017434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berna, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackermann, B. L.</span></span> <span> </span><span class="NLM_article-title">Quantification of serine enantiomers in rat brain microdialysate using Marfey’s reagent and LC/MS/MS</span>. <i>J. Chromatogr. B: Anal. Technol. Biomed. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>846</i></span>,  <span class="NLM_fpage">359</span>– <span class="NLM_lpage">363</span>, <span class="refDoi"> DOI: 10.1016/j.jchromb.2006.08.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.jchromb.2006.08.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=16962391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKgtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=846&publication_year=2007&pages=359-363&author=M.+J.+Bernaauthor=B.+L.+Ackermann&title=Quantification+of+serine+enantiomers+in+rat+brain+microdialysate+using+Marfey%E2%80%99s+reagent+and+LC%2FMS%2FMS&doi=10.1016%2Fj.jchromb.2006.08.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Quantification of serine enantiomers in rat brain microdialysate using Marfey's reagent and LC/MS/MS</span></div><div class="casAuthors">Berna, Michael J.; Ackermann, Bradley L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">846</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">359-363</span>CODEN:
                <span class="NLM_cas:coden">JCBAAI</span>;
        ISSN:<span class="NLM_cas:issn">1570-0232</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The ability to selectively measure serine enantiomer concns. in rat brain microdialyzate is essential during drug discovery to study the interaction of D-serine with the N-methyl-D-aspartate (NMDA) subtype of the glutamate receptor.  NMDA receptor-stimulating agents, such as D-serine, have been shown to reduce the neg. symptoms and cognitive dysfunction in individuals with schizophrenia when added to conventional or atypical antipsychotic drug regimens.  In the work presented here, an LC/MS/MS assay was developed and validated to simultaneously measure D-serine and L-serine concns. in rat brain microdialyzate.  Reverse phase chromatog. resoln. of the enantiomers was obtained through derivatization with 1-fluoro-2,4-dinitrophenyl-5-L-alanine amide (Marfey's reagent).  The assay was validated to det. concns. over the range of 10-7500 ng/mL using electrospray ionization and multiple reaction monitoring (MRM).  Both intra- and inter-day precision and accuracy were less than 16.5% (RE) and 7% (CV) for both analytes, resp., and assay throughput was increased significantly relative to existing methodologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxbWJSAa3zYbVg90H21EOLACvtfcHk0ljMmFncsv033A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKgtrY%253D&md5=feae1a6746181a156d9d85f6971fd5f2</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.jchromb.2006.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jchromb.2006.08.029%26sid%3Dliteratum%253Aachs%26aulast%3DBerna%26aufirst%3DM.%2BJ.%26aulast%3DAckermann%26aufirst%3DB.%2BL.%26atitle%3DQuantification%2520of%2520serine%2520enantiomers%2520in%2520rat%2520brain%2520microdialysate%2520using%2520Marfey%25E2%2580%2599s%2520reagent%2520and%2520LC%252FMS%252FMS%26jtitle%3DJ.%2520Chromatogr.%2520B%253A%2520Anal.%2520Technol.%2520Biomed.%2520Life%2520Sci.%26date%3D2007%26volume%3D846%26spage%3D359%26epage%3D363%26doi%3D10.1016%2Fj.jchromb.2006.08.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borhani, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span> <span> </span><span class="NLM_article-title">Molecular determinants of drug-receptor binding kinetics</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">667</span>– <span class="NLM_lpage">673</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2013.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.drudis.2013.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=23454741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksVyrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=667-673&author=A.+C.+Panauthor=D.+W.+Borhaniauthor=R.+O.+Drorauthor=D.+E.+Shaw&title=Molecular+determinants+of+drug-receptor+binding+kinetics&doi=10.1016%2Fj.drudis.2013.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular determinants of drug-receptor binding kinetics</span></div><div class="casAuthors">Pan, Albert C.; Borhani, David W.; Dror, Ron O.; Shaw, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">13-14</span>),
    <span class="NLM_cas:pages">667-673</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  It is increasingly appreciated that the rates at which drugs assoc. with and dissoc. from receptors - the binding kinetics - directly impact drug efficacy and safety.  The mol. determinants of drug-receptor binding kinetics remain poorly understood, however, esp. when compared with the well-known factors that affect binding affinity.  The rational modulation of kinetics during lead optimization thus remains challenging.  We review some of the key factors thought to control drug-receptor binding kinetics at the mol. level - mol. size, conformational fluctuations, electrostatic interactions and hydrophobic effects - and discuss several possible approaches for the rational design of drugs with desired binding kinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAvEt3tx06Z7Vg90H21EOLACvtfcHk0ljMmFncsv033A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksVyrtr0%253D&md5=df094bb86b1e280b9ddf5a90031b3f32</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2013.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2013.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DA.%2BC.%26aulast%3DBorhani%26aufirst%3DD.%2BW.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26atitle%3DMolecular%2520determinants%2520of%2520drug-receptor%2520binding%2520kinetics%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2013%26volume%3D18%26spage%3D667%26epage%3D673%26doi%3D10.1016%2Fj.drudis.2013.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ennaceur, A.</span></span> <span> </span><span class="NLM_article-title">One-trial object recognition in rats and mice: methodological and theoretical issues</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>215</i></span>,  <span class="NLM_fpage">244</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2009.12.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.bbr.2009.12.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=20060020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A280%3ADC%252BC3cfgs1Wjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2010&pages=244-254&author=A.+Ennaceur&title=One-trial+object+recognition+in+rats+and+mice%3A+methodological+and+theoretical+issues&doi=10.1016%2Fj.bbr.2009.12.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">One-trial object recognition in rats and mice: methodological and theoretical issues</span></div><div class="casAuthors">Ennaceur A</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural brain research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">244-54</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The one-trial object recognition task involves memory of a familiar object in parallel with the detection and encoding of a novel object.  It provides the basis for the study of a wide range of cognitive and neuropsychological functions and processes in rats and mice.  However, unlike in humans, primate and pigeon studies, object recognition in rats and mice has been mostly limited to memory while little is known about object perception, affordances and acquisition of a representation of an object.  In the present paper, we addressed some of these issues.  We also described novelty preference models and hypotheses that account for one-trial object recognition and question the validity of the novelty preference concept.  In addition, we discussed whether one-trial object recognition involves working memory and how it involves memory of an episode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9BsdfR84alMkU0YCbOU3EfW6udTcc2eYfHkPxsmR7abntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfgs1Wjsw%253D%253D&md5=d512ab89760b133c25180b9eec1b1a2a</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2009.12.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2009.12.036%26sid%3Dliteratum%253Aachs%26aulast%3DEnnaceur%26aufirst%3DA.%26atitle%3DOne-trial%2520object%2520recognition%2520in%2520rats%2520and%2520mice%253A%2520methodological%2520and%2520theoretical%2520issues%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2010%26volume%3D215%26spage%3D244%26epage%3D254%26doi%3D10.1016%2Fj.bbr.2009.12.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallorga, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemaire, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettibone, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sur, C.</span></span> <span> </span><span class="NLM_article-title">Development of a scintillation proximity assay for analysis of Na<sup>+</sup>/Cl<sup>–</sup> -dependent neurotransmitter transporter activity</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>321</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.1016/S0003-2697(03)00431-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2FS0003-2697%2803%2900431-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2003&pages=31-37&author=J.+B.+Williamsauthor=P.+J.+Mallorgaauthor=W.+Lemaireauthor=D.+L.+Williamsauthor=S.+Naauthor=S.+Patelauthor=J.+P.+Connauthor=D.+J.+Pettiboneauthor=C.+Austinauthor=C.+Sur&title=Development+of+a+scintillation+proximity+assay+for+analysis+of+Na%2B%2FCl%E2%80%93+-dependent+neurotransmitter+transporter+activity&doi=10.1016%2FS0003-2697%2803%2900431-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0003-2697%2803%2900431-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0003-2697%252803%252900431-7%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DJ.%2BB.%26aulast%3DMallorga%26aufirst%3DP.%2BJ.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26aulast%3DNa%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DConn%26aufirst%3DJ.%2BP.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DAustin%26aufirst%3DC.%26aulast%3DSur%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520a%2520scintillation%2520proximity%2520assay%2520for%2520analysis%2520of%2520Na%252B%252FCl%25E2%2580%2593%2520-dependent%2520neurotransmitter%2520transporter%2520activity%26jtitle%3DAnal.%2520Biochem.%26date%3D2003%26volume%3D321%26spage%3D31%26epage%3D37%26doi%3D10.1016%2FS0003-2697%2803%2900431-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c','cit1d'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31a','cit31b'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36a','cit36b','cit36c','cit36d','cit36e','cit36f','cit36g'],'ref37':['cit37'],'ref38':['cit38a','cit38b','cit38c'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 8 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jia-Nan Zhu, Wen-Kang Wang, Ze-Hui Jin, Qian-Kun Wang, <span class="NLM_string-name hlFld-ContribAuthor">Sheng-Yin Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrrolo[3,4-c]pyrazole Synthesis via Copper(Ι) Chloride-Catalyzed Oxidative Coupling of Hydrazones to Maleimides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (13)
                                     , 5046-5050. <a href="https://doi.org/10.1021/acs.orglett.9b01641" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b01641</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b01641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b01641%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPyrrolo%25255B3%25252C4-c%25255Dpyrazole%252BSynthesis%252Bvia%252BCopper%252528%2525CE%252599%252529%252BChloride-Catalyzed%252BOxidative%252BCoupling%252Bof%252BHydrazones%252Bto%252BMaleimides%26aulast%3DZhu%26aufirst%3DJia-Nan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D09052019%26date%3D19062019%26volume%3D21%26issue%3D13%26spage%3D5046%26epage%3D5050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xudong Cao, Yifang Zhang, Yin Chen, Yinli Qiu, Minquan Yu, Xiangqing Xu, Xin Liu, Bi-Feng Liu, Liangren Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Guisen Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Fused Tricyclic Heterocycle Piperazine (Piperidine) Derivatives As Potential Multireceptor Atypical Antipsychotics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (22)
                                     , 10017-10039. <a href="https://doi.org/10.1021/acs.jmedchem.8b01096" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01096%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BFused%252BTricyclic%252BHeterocycle%252BPiperazine%252B%252528Piperidine%252529%252BDerivatives%252BAs%252BPotential%252BMultireceptor%252BAtypical%252BAntipsychotics%26aulast%3DCao%26aufirst%3DXudong%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D12072018%26date%3D09112018%26date%3D01112018%26volume%3D61%26issue%3D22%26spage%3D10017%26epage%3D10039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angela S.  Carlson</span>, <span class="hlFld-ContribAuthor ">Alexandru M.  Petre</span>, <span class="hlFld-ContribAuthor ">Joseph J.  Topczewski</span>. </span><span class="cited-content_cbyCitation_article-title">A cascade reaction of cinnamyl azides with vinyl sulfones directly generates dihydro-pyrrolo-pyrazole heterocycles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2021,</strong> <em>67 </em>, 152860. <a href="https://doi.org/10.1016/j.tetlet.2021.152860" title="DOI URL">https://doi.org/10.1016/j.tetlet.2021.152860</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2021.152860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2021.152860%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Bcascade%252Breaction%252Bof%252Bcinnamyl%252Bazides%252Bwith%252Bvinyl%252Bsulfones%252Bdirectly%252Bgenerates%252Bdihydro-pyrrolo-pyrazole%252Bheterocycles%26aulast%3DCarlson%26aufirst%3DAngela%2BS.%26date%3D2021%26volume%3D67%26spage%3D152860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dean  Paes</span>, <span class="hlFld-ContribAuthor ">Keqiang  Xie</span>, <span class="hlFld-ContribAuthor ">Damian G.  Wheeler</span>, <span class="hlFld-ContribAuthor ">Douglas  Zook</span>, <span class="hlFld-ContribAuthor ">Jos  Prickaerts</span>, <span class="hlFld-ContribAuthor ">Marco  Peters</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of PDE2 and PDE4 synergistically improves memory consolidation processes. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2021,</strong> <em>184 </em>, 108414. <a href="https://doi.org/10.1016/j.neuropharm.2020.108414" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2020.108414</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2020.108414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2020.108414%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DInhibition%252Bof%252BPDE2%252Band%252BPDE4%252Bsynergistically%252Bimproves%252Bmemory%252Bconsolidation%252Bprocesses%26aulast%3DPaes%26aufirst%3DDean%26date%3D2021%26volume%3D184%26spage%3D108414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susan  McQuown</span>, <span class="hlFld-ContribAuthor ">Dean  Paes</span>, <span class="hlFld-ContribAuthor ">Karsten  Baumgärtel</span>, <span class="hlFld-ContribAuthor ">Jos  Prickaerts</span>, <span class="hlFld-ContribAuthor ">Marco  Peters</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological inhibition of phosphodiesterase 7 enhances consolidation processes of spatial memory. </span><span class="cited-content_cbyCitation_journal-name">Neurobiology of Learning and Memory</span><span> <strong>2021,</strong> <em>177 </em>, 107357. <a href="https://doi.org/10.1016/j.nlm.2020.107357" title="DOI URL">https://doi.org/10.1016/j.nlm.2020.107357</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nlm.2020.107357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nlm.2020.107357%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurobiology%2520of%2520Learning%2520and%2520Memory%26atitle%3DPharmacological%252Binhibition%252Bof%252Bphosphodiesterase%252B7%252Benhances%252Bconsolidation%252Bprocesses%252Bof%252Bspatial%252Bmemory%26aulast%3DMcQuown%26aufirst%3DSusan%26date%3D2021%26volume%3D177%26spage%3D107357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Ramesh  Sistla</span>. </span><span class="cited-content_cbyCitation_article-title">A survey of applications of tetrahydropyrrolo-3,4-azoles and tetrahydropyrrolo-2,3-azoles in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 31-100. <a href="https://doi.org/10.1016/bs.aihch.2020.10.004" title="DOI URL">https://doi.org/10.1016/bs.aihch.2020.10.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2020.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2020.10.004%26sid%3Dliteratum%253Aachs%26atitle%3DA%252Bsurvey%252Bof%252Bapplications%252Bof%252Btetrahydropyrrolo-3%25252C4-azoles%252Band%252Btetrahydropyrrolo-2%25252C3-azoles%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2021%26spage%3D31%26epage%3D100%26pub%3DElsevier%26atitle%3DApplications%252Bof%252BHeterocycles%252Bin%252Bthe%252BDesign%252Bof%252BDrugs%252Band%252BAgricultural%252BProducts%26date%3D2021%26volume%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew R.  Hudson</span>, <span class="hlFld-ContribAuthor ">Vincent J.  Santora</span>, <span class="hlFld-ContribAuthor ">Robert E.  Petroski</span>, <span class="hlFld-ContribAuthor ">Theresa A.  Almos</span>, <span class="hlFld-ContribAuthor ">Gary  Anderson</span>, <span class="hlFld-ContribAuthor ">Richard  Barido</span>, <span class="hlFld-ContribAuthor ">Jillian  Basinger</span>, <span class="hlFld-ContribAuthor ">Chris L.  Bellows</span>, <span class="hlFld-ContribAuthor ">Brett C.  Bookser</span>, <span class="hlFld-ContribAuthor ">Nicola J.  Broadbent</span>, <span class="hlFld-ContribAuthor ">Clifford  Cabebe</span>, <span class="hlFld-ContribAuthor ">Chih-Kun  Chai</span>, <span class="hlFld-ContribAuthor ">Mi  Chen</span>, <span class="hlFld-ContribAuthor ">Stephine  Chow</span>, <span class="hlFld-ContribAuthor ">De Michael  Chung</span>, <span class="hlFld-ContribAuthor ">Lindsay  Heger</span>, <span class="hlFld-ContribAuthor ">Anne M.  Danks</span>, <span class="hlFld-ContribAuthor ">Graeme C.  Freestone</span>, <span class="hlFld-ContribAuthor ">Dany  Gitnick</span>, <span class="hlFld-ContribAuthor ">Varsha  Gupta</span>, <span class="hlFld-ContribAuthor ">Christine  Hoffmaster</span>, <span class="hlFld-ContribAuthor ">Alan P.  Kaplan</span>, <span class="hlFld-ContribAuthor ">Michael R.  Kennedy</span>, <span class="hlFld-ContribAuthor ">Dong  Lee</span>, <span class="hlFld-ContribAuthor ">James  Limberis</span>, <span class="hlFld-ContribAuthor ">Kiev  Ly</span>, <span class="hlFld-ContribAuthor ">Chi Ching  Mak</span>, <span class="hlFld-ContribAuthor ">Brittany  Masatsugu</span>, <span class="hlFld-ContribAuthor ">Andrew C.  Morse</span>, <span class="hlFld-ContribAuthor ">Jim  Na</span>, <span class="hlFld-ContribAuthor ">David  Neul</span>, <span class="hlFld-ContribAuthor ">John  Nikpur</span>, <span class="hlFld-ContribAuthor ">Joel  Renick</span>, <span class="hlFld-ContribAuthor ">Kristen  Sebring</span>, <span class="hlFld-ContribAuthor ">Samantha  Sevidal</span>, <span class="hlFld-ContribAuthor ">Ali  Tabatabaei</span>, <span class="hlFld-ContribAuthor ">Jenny  Wen</span>, <span class="hlFld-ContribAuthor ">Shouzhen  Xia</span>, <span class="hlFld-ContribAuthor ">Yingzhuo  Yan</span>, <span class="hlFld-ContribAuthor ">Zachary W.  Yoder</span>, <span class="hlFld-ContribAuthor ">Douglas  Zook</span>, <span class="hlFld-ContribAuthor ">Marco  Peters</span>, <span class="hlFld-ContribAuthor ">J. Guy  Breitenbucher</span>. </span><span class="cited-content_cbyCitation_article-title">Azetidine-based selective glycine transporter-1 (GlyT1) inhibitors with memory enhancing properties. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (14)
                                     , 127214. <a href="https://doi.org/10.1016/j.bmcl.2020.127214" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127214%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAzetidine-based%252Bselective%252Bglycine%252Btransporter-1%252B%252528GlyT1%252529%252Binhibitors%252Bwith%252Bmemory%252Benhancing%252Bproperties%26aulast%3DHudson%26aufirst%3DAndrew%2BR.%26date%3D2020%26volume%3D30%26issue%3D14%26spage%3D127214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas M.  Ackermann</span>, <span class="hlFld-ContribAuthor ">Karuna  Bhokare</span>, <span class="hlFld-ContribAuthor ">Georg  Höfner</span>, <span class="hlFld-ContribAuthor ">Klaus T.  Wanner</span>. </span><span class="cited-content_cbyCitation_article-title">MS binding assays for GlyT1 based on Org24598 as nonlabelled reporter ligand. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2019,</strong> <em>161 </em>, 107561. <a href="https://doi.org/10.1016/j.neuropharm.2019.03.004" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2019.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2019.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2019.03.004%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DMS%252Bbinding%252Bassays%252Bfor%252BGlyT1%252Bbased%252Bon%252BOrg24598%252Bas%252Bnonlabelled%252Breporter%252Bligand%26aulast%3DAckermann%26aufirst%3DThomas%2BM.%26date%3D2019%26volume%3D161%26spage%3D107561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/medium/jm-2018-00372r_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00372&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/medium/jm-2018-00372r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative GlyT1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00372&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/medium/jm-2018-00372r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. ROCS comparison of Roche compound <b>7</b> (blue) and aryl-pyrrolopyrazole <b>21</b> (gray).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00372&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/medium/jm-2018-00372r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Routes to Intermediates <b>10</b>–<b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00372&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>8a</b> or <b>9a</b>, <i><sup>i</sup></i>PrOH, NaH, 70 °C; (b) <b>8a</b> or <b>9a</b>, R<sub>2</sub>OH, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 110 °C; (c) <b>8a</b> or <b>9a</b>, 4,4-difluoropiperidine, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 120 °C; (d) <b>8b</b> or <b>9b</b>, 3-F-phenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub> or Pd(dppf)Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, 80 °C.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/medium/jm-2018-00372r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes to Intermediates <b>20a</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00372&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) ArI or ArBr, K<sub>3</sub>PO<sub>4</sub>, CuI, (1<i>S</i>,2<i>S</i>)-(+)-1,2-diaminocyclohexane, THF or dioxane, 120 °C; (b) alkyl halide, NaH, DMF; (c) HCl, dioxane.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/medium/jm-2018-00372r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Routes to Compounds <b>21</b>–<b>50</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00372&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) <b>10</b>–<b>17</b>, SOCl<sub>2</sub>; (ii) <b>20a</b>–<b>f</b>, Et<sub>3</sub>N, DCM; (b) HATU, Et<sub>3</sub>N, DMF.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/medium/jm-2018-00372r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Rat plasma concentrations of <b>46</b> following either a single 1 mg/kg po or 1 mg/kg iv administration in 10:50:40 NMP/PEG400/H<sub>2</sub>O.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00372&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/medium/jm-2018-00372r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of <b>46</b> in a rat model of recognition memory. (A) Study design, <i>n</i> = 18–24 male, Long–Evans rats/treatment group. (B) Effect on 24 h memory retention. Rats treated with 0.1, 1, and 3 mg/kg <b>46</b> exhibited significantly higher memory scores than rats treated with vehicle and trained for 3 min. Asterisk = <i>p</i> < 0.05 vs 3 min training + vehicle. (C) Exploration of the novel and familiar object during 24 h memory testing. (D) Compound <b>46</b> did not affect object exploration during training. (E) Compound <b>46</b> did not affect locomotion during training. The mean ± SEM values are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00372/20180719/images/large/jm-2018-00372r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00372&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i88">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50762" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50762" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 52 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomeza, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armsen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholze, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eulenburg, V.</span></span> <span> </span><span class="NLM_article-title">Glycine transporters: essential regulators of synaptic transmission</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1042/BST0340055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1042%2FBST0340055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=16417482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtlOquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=55-58&author=H.+Betzauthor=J.+Gomezaauthor=W.+Armsenauthor=P.+Scholzeauthor=V.+Eulenburg&title=Glycine+transporters%3A+essential+regulators+of+synaptic+transmission&doi=10.1042%2FBST0340055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Glycine transporters: essential regulators of synaptic transmission</span></div><div class="casAuthors">Betz, H.; Gomeza, J.; Armsen, W.; Scholze, P.; Eulenburg, V.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-58</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Glycine is a major inhibitory neurotransmitter in the mammalian CNS (central nervous system).  Glycinergic neurotransmission is terminated by the uptake of glycine into glycinergic nerve terminals and neighboring glial cells.  This uptake process is mediated by specific Na+/Cl--dependent GlyTs (glycine transporters), GlyT1 and GlyT2.  GlyT1, in addn., is thought to regulate the concn. of glycine at excitatory synapses contg. NMDARs (N-methyl-D-aspartate receptors), which require glycine as a co-agonist.  We have analyzed the physiol. roles and regulation of GlyT1 and GlyT2 by generating transporter-deficient mice and searching for interacting proteins.  Our genetic results indicate that at glycinergic synapses, the glial transporter GlyT1 catalyzes the removal of glycine from the synaptic cleft, whereas GlyT2 is required for the re-uptake of glycine into nerve terminals, thereby allowing for neurotransmitter reloading of synaptic vesicles.  Both GlyT1 and GlyT2 are essential for CNS function, as revealed by the lethal phenotypes of the resp. knockout mice.  Mice expressing only a single GlyT1 allele are phenotypically normal but may have enhanced NMDAR function.  GlyT2 is highly enriched at glycinergic nerve terminals, and Ca2+-triggered exocytosis and internalization are thought to regulate GlyT2 nos. in the pre-synaptic plasma membrane.  We have identified different interacting proteins that may play a role in GlyT2 trafficking and/or pre-synaptic localization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt4U0hOmczH7Vg90H21EOLACvtfcHk0ljjpZrA11_FCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtlOquw%253D%253D&md5=9d9f8d182fd88bef8fed7b79d13fcf70</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1042%2FBST0340055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0340055%26sid%3Dliteratum%253Aachs%26aulast%3DBetz%26aufirst%3DH.%26aulast%3DGomeza%26aufirst%3DJ.%26aulast%3DArmsen%26aufirst%3DW.%26aulast%3DScholze%26aufirst%3DP.%26aulast%3DEulenburg%26aufirst%3DV.%26atitle%3DGlycine%2520transporters%253A%2520essential%2520regulators%2520of%2520synaptic%2520transmission%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2006%26volume%3D34%26spage%3D55%26epage%3D58%26doi%3D10.1042%2FBST0340055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zafra, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giménez, C.</span></span> <span> </span><span class="NLM_article-title">Glycine transporters and synaptic function</span>. <i>IUBMB Life</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">810</span>– <span class="NLM_lpage">817</span>, <span class="refDoi"> DOI: 10.1002/iub.128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1002%2Fiub.128" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=810-817&author=F.+Zafraauthor=C.+Gim%C3%A9nez&title=Glycine+transporters+and+synaptic+function&doi=10.1002%2Fiub.128"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1002%2Fiub.128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fiub.128%26sid%3Dliteratum%253Aachs%26aulast%3DZafra%26aufirst%3DF.%26aulast%3DGim%25C3%25A9nez%26aufirst%3DC.%26atitle%3DGlycine%2520transporters%2520and%2520synaptic%2520function%26jtitle%3DIUBMB%2520Life%26date%3D2008%26volume%3D60%26spage%3D810%26epage%3D817%26doi%3D10.1002%2Fiub.128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Eulenburg, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armsen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomeza, J.</span></span> <span> </span><span class="NLM_article-title">Glycine transporters: essential regulators of neurotransmission</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">325</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2005.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.tibs.2005.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=15950877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFCks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2005&pages=325-333&author=V.+Eulenburgauthor=W.+Armsenauthor=H.+Betzauthor=J.+Gomeza&title=Glycine+transporters%3A+essential+regulators+of+neurotransmission&doi=10.1016%2Fj.tibs.2005.04.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Glycine transporters: essential regulators of neurotransmission</span></div><div class="casAuthors">Eulenburg, Volker; Armsen, Wencke; Betz, Heinrich; Gomeza, Jesus</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">325-333</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Glycine has important neurotransmitter functions at inhibitory and excitatory synapses in the vertebrate central nervous system.  The effective synaptic concns. of glycine are regulated by glycine transporters (GlyTs), which mediate its reuptake into nerve terminals and adjacent glial cells.  GlyTs are members of the Na+/Cl--dependent transporter family, whose activities and subcellular distributions are regulated by phosphorylation and interactions with other proteins.  The anal. of GlyT knockout mice has revealed distinct functions of individual GlyT subtypes in synaptic transmission and provided animal models for two hereditary human diseases, glycine encephalopathy and hyperekplexia.  Selective GlyT inhibitors could be of therapeutic value in cognitive disorders, schizophrenia and pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqofHR4bEe5crVg90H21EOLACvtfcHk0ljjpZrA11_FCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFCks7g%253D&md5=301b273b32ec8f6858285b101d1403a6</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2005.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2005.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DEulenburg%26aufirst%3DV.%26aulast%3DArmsen%26aufirst%3DW.%26aulast%3DBetz%26aufirst%3DH.%26aulast%3DGomeza%26aufirst%3DJ.%26atitle%3DGlycine%2520transporters%253A%2520essential%2520regulators%2520of%2520neurotransmission%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2005%26volume%3D30%26spage%3D325%26epage%3D333%26doi%3D10.1016%2Fj.tibs.2005.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Benarroch, E. E.</span></span> <span> </span><span class="NLM_article-title">Glycine and its synaptic interactions: functional and clinical implications</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">683</span>, <span class="refDoi"> DOI: 10.1212/WNL.0b013e31822a2791</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1212%2FWNL.0b013e31822a2791" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2011&pages=677-683&author=E.+E.+Benarroch&title=Glycine+and+its+synaptic+interactions%3A+functional+and+clinical+implications&doi=10.1212%2FWNL.0b013e31822a2791"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1212%2FWNL.0b013e31822a2791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.0b013e31822a2791%26sid%3Dliteratum%253Aachs%26aulast%3DBenarroch%26aufirst%3DE.%2BE.%26atitle%3DGlycine%2520and%2520its%2520synaptic%2520interactions%253A%2520functional%2520and%2520clinical%2520implications%26jtitle%3DNeurology%26date%3D2011%26volume%3D77%26spage%3D677%26epage%3D683%26doi%3D10.1212%2FWNL.0b013e31822a2791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pow, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrickson, A.</span></span> <span> </span><span class="NLM_article-title">Distribution of the glycine transporter in mammalian and non-mammalian retinae</span>. <i>Vis. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1017/S0952523899162047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1017%2FS0952523899162047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10367958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A280%3ADyaK1M3psVChtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1999&pages=231-239&author=D.+V.+Powauthor=A.+Hendrickson&title=Distribution+of+the+glycine+transporter+in+mammalian+and+non-mammalian+retinae&doi=10.1017%2FS0952523899162047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of the glycine transporter glyt-1 in mammalian and nonmammalian retinae</span></div><div class="casAuthors">Pow D V; Hendrickson A E</div><div class="citationInfo"><span class="NLM_cas:title">Visual neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">231-9</span>
        ISSN:<span class="NLM_cas:issn">0952-5238</span>.
    </div><div class="casAbstract">We have examined the distribution of the glycine transporter glyt-1 in retinae of macaques, cats, rabbits, rats, and chickens.  In all species, all glycine-containing amacrine cells expressed immunoreactivity for glyt-1, though the intensity of immunoreactivity for glyt-1 did not appear to directly correlate with the intensity of immunoreactivity for glycine in individual cells.  A small subpopulation of glycine-immunoreactive displaced amacrine cells or ganglion cells also expressed glyt-1 in retinae from macaques, cats, chickens, and rats but not in retinae from rabbits.  In addition, in all species examined, some displaced amacrine cells also contained glycine but did not express glyt-1.  In monkeys, cats, and rats, populations of cells which we interpret as being glycine-containing interplexiform cells expressed glyt-1: these cells lacked a content of glutamate, suggesting they are not bipolar cells.  The glycine-containing bipolar cells did not express glyt-1, suggesting that these cells probably acquired their content of glycine by other means such as via gap junctional connections with glycine-containing amacrine cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQMTWo3e6n07-WhZTslLrfffW6udTcc2eYlOqVRrxN3tbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3psVChtg%253D%253D&md5=3ab08fedf5f32b1a76fd69c49747d5f2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1017%2FS0952523899162047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0952523899162047%26sid%3Dliteratum%253Aachs%26aulast%3DPow%26aufirst%3DD.%2BV.%26aulast%3DHendrickson%26aufirst%3DA.%26atitle%3DDistribution%2520of%2520the%2520glycine%2520transporter%2520in%2520mammalian%2520and%2520non-mammalian%2520retinae%26jtitle%3DVis.%2520Neurosci.%26date%3D1999%26volume%3D16%26spage%3D231%26epage%3D239%26doi%3D10.1017%2FS0952523899162047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlösser, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barthel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandenburger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eulenburg, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werdehausen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermanns, H.</span></span> <span> </span><span class="NLM_article-title">Glycine transporter GlyT1, but not GlyT2, is expressed in rat dorsal root ganglion--Possible implications for neuropathic pain</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>600</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">219</span>, <span class="refDoi"> DOI: 10.1016/j.neulet.2015.06.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.neulet.2015.06.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=600&publication_year=2015&pages=213-219&author=L.+Schl%C3%B6sserauthor=F.+Barthelauthor=T.+Brandenburgerauthor=E.+Neumannauthor=I.+Bauerauthor=V.+Eulenburgauthor=R.+Werdehausenauthor=H.+Hermanns&title=Glycine+transporter+GlyT1%2C+but+not+GlyT2%2C+is+expressed+in+rat+dorsal+root+ganglion%2D%2DPossible+implications+for+neuropathic+pain&doi=10.1016%2Fj.neulet.2015.06.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2015.06.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2015.06.026%26sid%3Dliteratum%253Aachs%26aulast%3DSchl%25C3%25B6sser%26aufirst%3DL.%26aulast%3DBarthel%26aufirst%3DF.%26aulast%3DBrandenburger%26aufirst%3DT.%26aulast%3DNeumann%26aufirst%3DE.%26aulast%3DBauer%26aufirst%3DI.%26aulast%3DEulenburg%26aufirst%3DV.%26aulast%3DWerdehausen%26aufirst%3DR.%26aulast%3DHermanns%26aufirst%3DH.%26atitle%3DGlycine%2520transporter%2520GlyT1%252C%2520but%2520not%2520GlyT2%252C%2520is%2520expressed%2520in%2520rat%2520dorsal%2520root%2520ganglion--Possible%2520implications%2520for%2520neuropathic%2520pain%26jtitle%3DNeurosci.%2520Lett.%26date%3D2015%26volume%3D600%26spage%3D213%26epage%3D219%26doi%3D10.1016%2Fj.neulet.2015.06.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Santos, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schranzhofer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheftel, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponka, P.</span></span> <span> </span><span class="NLM_article-title">Extracellular glycine is necessary for optimal hemoglobinization of erythroid cells</span>. <i>Haematologica</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">1314</span>– <span class="NLM_lpage">1323</span>, <span class="refDoi"> DOI: 10.3324/haematol.2016.155671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.3324%2Fhaematol.2016.155671" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2017&pages=1314-1323&author=D.+Garcia-Santosauthor=M.+Schranzhoferauthor=R.+Bergeronauthor=A.+D.+Sheftelauthor=P.+Ponka&title=Extracellular+glycine+is+necessary+for+optimal+hemoglobinization+of+erythroid+cells&doi=10.3324%2Fhaematol.2016.155671"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2016.155671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2016.155671%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Santos%26aufirst%3DD.%26aulast%3DSchranzhofer%26aufirst%3DM.%26aulast%3DBergeron%26aufirst%3DR.%26aulast%3DSheftel%26aufirst%3DA.%2BD.%26aulast%3DPonka%26aufirst%3DP.%26atitle%3DExtracellular%2520glycine%2520is%2520necessary%2520for%2520optimal%2520hemoglobinization%2520of%2520erythroid%2520cells%26jtitle%3DHaematologica%26date%3D2017%26volume%3D102%26spage%3D1314%26epage%3D1323%26doi%3D10.3324%2Fhaematol.2016.155671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. G. M.</span></span> <span> </span><span class="NLM_article-title">NMDA receptors and memory encoding</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2013.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.neuropharm.2013.04.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2013&pages=32-40&author=R.+G.+M.+Morris&title=NMDA+receptors+and+memory+encoding&doi=10.1016%2Fj.neuropharm.2013.04.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2013.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2013.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DR.%2BG.%2BM.%26atitle%3DNMDA%2520receptors%2520and%2520memory%2520encoding%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D74%26spage%3D32%26epage%3D40%26doi%3D10.1016%2Fj.neuropharm.2013.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huerta, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonegawa, S.</span></span> <span> </span><span class="NLM_article-title">Formation of temporal memory requires NMDA receptors within CA1 pyramidal neurons</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">473</span>– <span class="NLM_lpage">480</span>, <span class="refDoi"> DOI: 10.1016/S0896-6273(00)80909-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2FS0896-6273%2800%2980909-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2000&pages=473-480&author=P.+T.+Huertaauthor=L.+D.+Sunauthor=M.+A.+Wilsonauthor=S.+Tonegawa&title=Formation+of+temporal+memory+requires+NMDA+receptors+within+CA1+pyramidal+neurons&doi=10.1016%2FS0896-6273%2800%2980909-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2980909-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252980909-5%26sid%3Dliteratum%253Aachs%26aulast%3DHuerta%26aufirst%3DP.%2BT.%26aulast%3DSun%26aufirst%3DL.%2BD.%26aulast%3DWilson%26aufirst%3DM.%2BA.%26aulast%3DTonegawa%26aufirst%3DS.%26atitle%3DFormation%2520of%2520temporal%2520memory%2520requires%2520NMDA%2520receptors%2520within%2520CA1%2520pyramidal%2520neurons%26jtitle%3DNeuron%26date%3D2000%26volume%3D25%26spage%3D473%26epage%3D480%26doi%3D10.1016%2FS0896-6273%2800%2980909-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, A. J.</span></span> <span> </span><span class="NLM_article-title">The molecular and cellular biology of enhanced cognition</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1038/nrn2572</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1038%2Fnrn2572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=19153576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntFGksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=126-140&author=Y.+S.+Leeauthor=A.+J.+Silva&title=The+molecular+and+cellular+biology+of+enhanced+cognition&doi=10.1038%2Fnrn2572"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular and cellular biology of enhanced cognition</span></div><div class="casAuthors">Lee, Yong-Seok; Silva, Alcino J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">126-140</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Most mol. and cellular studies of cognitive function have focused on either normal or pathol. states, but recent research with transgenic mice has started to address the mechanisms of enhanced cognition.  These results point to key synaptic and nuclear signaling events that can be manipulated to facilitate the induction or increase the stability of synaptic plasticity, and therefore enhance the acquisition or retention of information.  Here, the authors review these surprising findings and explore their implications to both mechanisms of learning and memory and to ongoing efforts to develop treatments for cognitive disorders.  The extent and consistency of the findings reviewed suggest that the key conclusions, namely that long-term potentiation-like mechanisms play a role in learning and memory and that there are a core of rate-limiting mechanisms that can enhance learning and memory, may well stand the test of time.  These findings represent the beginning of a fundamental new approach in the study of enhanced cognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTAKBocZGitbVg90H21EOLACvtfcHk0liBPy-D0j7b_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntFGksw%253D%253D&md5=ff98bdd158f73453db577b7e8ba45b14</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrn2572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2572%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DSilva%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520molecular%2520and%2520cellular%2520biology%2520of%2520enhanced%2520cognition%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2009%26volume%3D10%26spage%3D126%26epage%3D140%26doi%3D10.1038%2Fnrn2572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collingridge, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volianskis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">France, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidball, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaghan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortolotto, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molnár, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodge, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jane, D. E.</span></span> <span> </span><span class="NLM_article-title">The NMDA receptor as a target for cognitive enhancement</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2012.06.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.neuropharm.2012.06.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=22796429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFahsL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=13-26&author=G.+L.+Collingridgeauthor=A.+Volianskisauthor=N.+Bannisterauthor=G.+Franceauthor=L.+Hannaauthor=M.+Mercierauthor=P.+Tidballauthor=G.+Fangauthor=M.+W.+Irvineauthor=B.+M.+Costaauthor=D.+T.+Monaghanauthor=Z.+A.+Bortolottoauthor=E.+Moln%C3%A1rauthor=D.+Lodgeauthor=D.+E.+Jane&title=The+NMDA+receptor+as+a+target+for+cognitive+enhancement&doi=10.1016%2Fj.neuropharm.2012.06.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The NMDA receptor as a target for cognitive enhancement</span></div><div class="casAuthors">Collingridge, Graham L.; Volianskis, Arturas; Bannister, Neil; France, Grace; Hanna, Lydia; Mercier, Marion; Tidball, Patrick; Fang, Guangyu; Irvine, Mark W.; Costa, Blaise M.; Monaghan, Daniel T.; Bortolotto, Zuner A.; Molnar, Elek; Lodge, David; Jane, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-26</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  NMDA receptors (NMDARs) play an important role in neural plasticity including long-term potentiation and long-term depression, which are likely to explain their importance for learning and memory.  Cognitive decline is a major problem facing an aging human population, so much so that its reversal has become an important goal for scientific research and pharmaceutical development.  Enhancement of NMDAR function is a core strategy toward this goal.  In this review we indicate some of the major ways of potentiating NMDAR function by both direct and indirect modulation.  There is good evidence that both pos. and neg. modulation can enhance function suggesting that a subtle approach correcting imbalances in particular clin. situations will be required.  Excessive activation and the resultant deleterious effects will need to be carefully avoided.  Finally we describe some novel pos. allosteric modulators of NMDARs, with some subunit selectivity, and show initial evidence of their ability to affect NMDAR mediated events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwosQmB8cQb7Vg90H21EOLACvtfcHk0lgxmr8rkg7Mag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFahsL3P&md5=4d63552250a5bb940a8d0a7a2d51fd75</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2012.06.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2012.06.051%26sid%3Dliteratum%253Aachs%26aulast%3DCollingridge%26aufirst%3DG.%2BL.%26aulast%3DVolianskis%26aufirst%3DA.%26aulast%3DBannister%26aufirst%3DN.%26aulast%3DFrance%26aufirst%3DG.%26aulast%3DHanna%26aufirst%3DL.%26aulast%3DMercier%26aufirst%3DM.%26aulast%3DTidball%26aufirst%3DP.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DIrvine%26aufirst%3DM.%2BW.%26aulast%3DCosta%26aufirst%3DB.%2BM.%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26aulast%3DBortolotto%26aufirst%3DZ.%2BA.%26aulast%3DMoln%25C3%25A1r%26aufirst%3DE.%26aulast%3DLodge%26aufirst%3DD.%26aulast%3DJane%26aufirst%3DD.%2BE.%26atitle%3DThe%2520NMDA%2520receptor%2520as%2520a%2520target%2520for%2520cognitive%2520enhancement%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D13%26epage%3D26%26doi%3D10.1016%2Fj.neuropharm.2012.06.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. G.</span></span> <span> </span><span class="NLM_article-title">The NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.12-01-00021.1992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1523%2FJNEUROSCI.12-01-00021.1992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1345945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADyaK38Xit1yks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1992&pages=21-34&author=S.+Davisauthor=S.+P.+Butcherauthor=R.+G.+Morris&title=The+NMDA+receptor+antagonist+D-2-amino-5-phosphonopentanoate+%28D-AP5%29+impairs+spatial+learning+and+LTP+in+vivo+at+intracerebral+concentrations+comparable+to+those+that+block+LTP+in+vitro&doi=10.1523%2FJNEUROSCI.12-01-00021.1992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro</span></div><div class="casAuthors">Davis, S.; Butcher, S. P.; Morris, R. G. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-34</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    </div><div class="casAbstract">This series of expts. investigated whether the NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) could induce impairments of spatial learning across a dose range comparable to its impairment of hippocampal long-term potentiation (LTP) in vivo.  Estns. of the extracellular concn. of D-AP5 in hippocampus using microdialysis were also made to compare whether these impairments occur at concns. similar to those required to impair LTP in the in vitro hippocampal slice.  Rats were chronically infused with D-AP5 into the lateral ventricle at a range of concns. (0-50 mM) via osmotic minipumps.  They were first trained to find and escape onto a hidden platform in an open-field water maze task.  After the behavioral learning, they were anesthetized with urethane and an attempt was made to evoke and monitor hippocampal LTP.  Extracellular samples of D-AP5 in hippocampus were then taken using microdialysis, and finally, the animals were killed and tissue samples dissected.  The microdialysis and tissue samples were analyzed for D-AP5 content using HPLC with fluorescence detection.  The results established, first, that D-AP5 impairs spatial learning in a linear dose-dependent manner, highly correlated with its corresponding impairment of hippocampal LTP in vivo.  No concn. of D-AP5 was obsd. to block LTP without affecting learning.  Second, the microdialysis ests. indicated that, subject to certain assumptions, D-AP5 causes these impairments at extracellular concns. comparable to those that impair LTP in vitro.  Third, comparison of the whole tissue and microdialysis samples revealed a concn. ratio of approx. 30:1, indicating that 97% of the intracerebral D-AP5 is inaccessible to the dialysis probes.  Infusion of 20 mM EGTA was found to cause a sevenfold increase in D-AP5 in the dialysis perfusates, suggesting that at least part of the inaccessible D-AP5 is trapped by calcium-dependent mechanism.  Two further behavioral control studies indicated that the D-AP5-induced impairment of spatial learning is unlikely to be secondary to a drug-induced motor disturbance, and that the performance of the D-AP5 group whose concn. was just sufficient to block hippocampal LTP completely was statistically indistinguishable from that of a group of rats with bilateral hippocampal lesions induced by ibotenic acid.  Taken together, these findings offer support for the hypothesis that activation of NMDA receptors is necessary for certain kinds of learning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpltcERCuXxWbVg90H21EOLACvtfcHk0lgxmr8rkg7Mag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xit1yks7g%253D&md5=c57812e0952ff507321bd3ab759d97ca</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.12-01-00021.1992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.12-01-00021.1992%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DS.%26aulast%3DButcher%26aufirst%3DS.%2BP.%26aulast%3DMorris%26aufirst%3DR.%2BG.%26atitle%3DThe%2520NMDA%2520receptor%2520antagonist%2520D-2-amino-5-phosphonopentanoate%2520%2528D-AP5%2529%2520impairs%2520spatial%2520learning%2520and%2520LTP%2520in%2520vivo%2520at%2520intracerebral%2520concentrations%2520comparable%2520to%2520those%2520that%2520block%2520LTP%2520in%2520vitro%26jtitle%3DJ.%2520Neurosci.%26date%3D1992%26volume%3D12%26spage%3D21%26epage%3D34%26doi%3D10.1523%2FJNEUROSCI.12-01-00021.1992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steele, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. G. M.</span></span> <span> </span><span class="NLM_article-title">Delay-dependent impairment of a matching-to-place task with chronic and intrahippocampal infusion of the NMDA-antagonist D-AP5</span>. <i>Hippocampus</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1002%2F%28SICI%291098-1063%281999%299%3A2%3C118%3A%3AAID-HIPO4%3E3.0.CO%3B2-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=118-136&author=R.+J.+Steeleauthor=R.+G.+M.+Morris&title=Delay-dependent+impairment+of+a+matching-to-place+task+with+chronic+and+intrahippocampal+infusion+of+the+NMDA-antagonist+D-AP5&doi=10.1002%2F%28SICI%291098-1063%281999%299%3A2%3C118%3A%3AAID-HIPO4%3E3.0.CO%3B2-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1063%281999%299%3A2%3C118%3A%3AAID-HIPO4%3E3.0.CO%3B2-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1063%25281999%25299%253A2%253C118%253A%253AAID-HIPO4%253E3.0.CO%253B2-8%26sid%3Dliteratum%253Aachs%26aulast%3DSteele%26aufirst%3DR.%2BJ.%26aulast%3DMorris%26aufirst%3DR.%2BG.%2BM.%26atitle%3DDelay-dependent%2520impairment%2520of%2520a%2520matching-to-place%2520task%2520with%2520chronic%2520and%2520intrahippocampal%2520infusion%2520of%2520the%2520NMDA-antagonist%2520D-AP5%26jtitle%3DHippocampus%26date%3D1999%26volume%3D9%26spage%3D118%26epage%3D136%26doi%3D10.1002%2F%28SICI%291098-1063%281999%299%3A2%3C118%3A%3AAID-HIPO4%3E3.0.CO%3B2-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baudry, M.</span></span> <span> </span><span class="NLM_article-title">Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>319</i></span>,  <span class="NLM_fpage">774</span>– <span class="NLM_lpage">776</span>, <span class="refDoi"> DOI: 10.1038/319774a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1038%2F319774a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=2869411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADyaL28XhsVaktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=1986&pages=774-776&author=R.+G.+M.+Morrisauthor=E.+Andersonauthor=G.+S.+Lynchauthor=M.+Baudry&title=Selective+impairment+of+learning+and+blockade+of+long-term+potentiation+by+an+N-methyl-D-aspartate+receptor+antagonist%2C+AP5&doi=10.1038%2F319774a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5</span></div><div class="casAuthors">Morris, R. G. M.; Anderson, E.; Lynch, G. S.; Baudry, M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">6056</span>),
    <span class="NLM_cas:pages">774-6</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">In rats, chronic intraventricular administration of D,L-aminophosphonovaleric acid (D,L-AP5)  [76326-31-3], an N-methyl-D-aspartate  [6384-92-5] receptor antagonist, caused a selective impairment of spacial learning, which is highly sensitive to hippocampal damage, without affecting visual discrimination learning, which is not sensitive to hippocampal damage; the L-isomer of AP5 did not produce behavioral effects.  Treatment with D,L-AP5 also suppressed the induction of hippocampal long-term potentiation following brief high-frequency stimulation.  Thus, N-methyl-D-aspartate receptors are involved in spatial learning, and hippocampal long-term potentiation is involved in some, but not all, forms of learning.  The results are discussed in relation to the potential anticonvulsant activities of N-methyl-D-aspartate receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4kRpAEXklM7Vg90H21EOLACvtfcHk0ljUNcQfnkMEZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XhsVaktLc%253D&md5=cb6be2239121e185b19278fe77791125</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2F319774a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F319774a0%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DR.%2BG.%2BM.%26aulast%3DAnderson%26aufirst%3DE.%26aulast%3DLynch%26aufirst%3DG.%2BS.%26aulast%3DBaudry%26aufirst%3DM.%26atitle%3DSelective%2520impairment%2520of%2520learning%2520and%2520blockade%2520of%2520long-term%2520potentiation%2520by%2520an%2520N-methyl-D-aspartate%2520receptor%2520antagonist%252C%2520AP5%26jtitle%3DNature%26date%3D1986%26volume%3D319%26spage%3D774%26epage%3D776%26doi%3D10.1038%2F319774a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsien, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huerta, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonegawa, S.</span></span> <span> </span><span class="NLM_article-title">The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">1327</span>– <span class="NLM_lpage">1338</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)81827-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2FS0092-8674%2800%2981827-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=8980238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADyaK2sXitlSjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1996&pages=1327-1338&author=J.+Z.+Tsienauthor=P.+T.+Huertaauthor=S.+Tonegawa&title=The+essential+role+of+hippocampal+CA1+NMDA+receptor-dependent+synaptic+plasticity+in+spatial+memory&doi=10.1016%2FS0092-8674%2800%2981827-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory</span></div><div class="casAuthors">Tsien, Joe Z.; Huerta, Patricio T.; Tonegawa, Susumu</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1327-1338</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The authors have produced a mouse strain in which the deletion of the NMDAR1 gene is restricted to the CA1 pyramidal cells of the hippocampus by using a new and general method that allows CA1-restricted gene knockout.  The mutant mice grow into adulthood without obvious abnormalities.  Adult mice lack NMDA receptor-mediated synaptic currents and long-term potentiation in the CA1 synapses and exhibit impaired spatial memory but unimpaired nonspatial learning.  The authors' results strongly suggest that activity-dependent modifications of CA1 synapses, mediated by NMDA receptors, play an essential role in the acquisition of spatial memories.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBYS66CjljfbVg90H21EOLACvtfcHk0ljUNcQfnkMEZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitlSjuw%253D%253D&md5=c3b83ba8ebe367b3383c32d5fec652f0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981827-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981827-9%26sid%3Dliteratum%253Aachs%26aulast%3DTsien%26aufirst%3DJ.%2BZ.%26aulast%3DHuerta%26aufirst%3DP.%2BT.%26aulast%3DTonegawa%26aufirst%3DS.%26atitle%3DThe%2520essential%2520role%2520of%2520hippocampal%2520CA1%2520NMDA%2520receptor-dependent%2520synaptic%2520plasticity%2520in%2520spatial%2520memory%26jtitle%3DCell%26date%3D1996%26volume%3D87%26spage%3D1327%26epage%3D1338%26doi%3D10.1016%2FS0092-8674%2800%2981827-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dube, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerchner, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsien, J. Z.</span></span> <span> </span><span class="NLM_article-title">Genetic enhancement of learning and memory in mice</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>401</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1038/43432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1038%2F43432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10485705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADyaK1MXlvVGms70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=1999&pages=63-69&author=Y.+P.+Tangauthor=E.+Shimizuauthor=G.+R.+Dubeauthor=C.+Ramponauthor=G.+A.+Kerchnerauthor=M.+Zhuoauthor=G.+Liuauthor=J.+Z.+Tsien&title=Genetic+enhancement+of+learning+and+memory+in+mice&doi=10.1038%2F43432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic enhancement of learning and memory in mice</span></div><div class="casAuthors">Tang, Ya-Ping; Shimizu, Eiji; Dube, Gilles, R.; Rampon, Claire; Kerchner, Geoffrey; Zhuo, Min; Liu, Guosong; Tsien, Joe Z.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">6748</span>),
    <span class="NLM_cas:pages">63-69</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Hebb's rule (1949) states that learning and memory are based on modifications of synaptic strength among neurons that are simultaneously active.  This implies that enhanced synaptic coincidence detection would lead to better learning and memory.  If the NMDA (N-methyl-D-aspartate) receptor, a synaptic coincidence detection would lead to better learning and memory.  If the NMDA (N-methyl-D-aspartate) receptor, a synaptic coincidence detector, acts as a graded switch for memory formation, enhanced signal detection by NMDA receptors should enhance learning and memory.  Here we show that overexpression of NMDA receptor 2B (NR2B) in the forebrains of transgenic mice leads to enhanced activation of NMDA receptors, facilitating synaptic potentiation in response to stimulation at 10-100 Hz.  These mice exhibit superior ability in learning and memory in various behavioral tasks, showing that NR2B is crit. in gating the age-dependent threshold for plasticity and memory formation.  NMDA-receptor-dependent modifications of synaptic efficacy, therefore, represent a unifying mechanism for associative learning and memory.  Our results suggest that genetic enhancement of mental and cognitive attributes such as intelligence and memory in mammals is feasible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpztBLI9qsOIbVg90H21EOLACvtfcHk0ljUNcQfnkMEZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvVGms70%253D&md5=b2ef8b0610c3c070063f869f82a838e6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2F43432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F43432%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DY.%2BP.%26aulast%3DShimizu%26aufirst%3DE.%26aulast%3DDube%26aufirst%3DG.%2BR.%26aulast%3DRampon%26aufirst%3DC.%26aulast%3DKerchner%26aufirst%3DG.%2BA.%26aulast%3DZhuo%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DTsien%26aufirst%3DJ.%2BZ.%26atitle%3DGenetic%2520enhancement%2520of%2520learning%2520and%2520memory%2520in%2520mice%26jtitle%3DNature%26date%3D1999%26volume%3D401%26spage%3D63%26epage%3D69%26doi%3D10.1038%2F43432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kistler, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawasli, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiederhold, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibb, J. A.</span></span> <span> </span><span class="NLM_article-title">Memory enhancement by targeting Cdk5 regulation of NR2B</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">1070</span>– <span class="NLM_lpage">1083</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2014.01.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.neuron.2014.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=24607229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjslKksr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2014&pages=1070-1083&author=F.+Plattnerauthor=A.+Hern%C3%A1ndezauthor=T.+M.+Kistlerauthor=K.+Pozoauthor=P.+Zhongauthor=E.+Y.+Yuenauthor=C.+Tanauthor=A.+H.+Hawasliauthor=S.+F.+Cookeauthor=A.+Nishiauthor=A.+Guoauthor=T.+Wiederholdauthor=Z.+Yanauthor=J.+A.+Bibb&title=Memory+enhancement+by+targeting+Cdk5+regulation+of+NR2B&doi=10.1016%2Fj.neuron.2014.01.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Memory Enhancement by Targeting Cdk5 Regulation of NR2B</span></div><div class="casAuthors">Plattner, Florian; Hernandez, Adan; Kistler, Tara M.; Pozo, Karine; Zhong, Ping; Yuen, Eunice Y.; Tan, Chunfeng; Hawasli, Ammar H.; Cooke, Sam F.; Nishi, Akinori; Guo, Ailan; Wiederhold, Thorsten; Yan, Zhen; Bibb, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1070-1083</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Many psychiatric and neurol. disorders are characterized by learning and memory deficits, for which cognitive enhancement is considered a valid treatment strategy.  The N-methyl-D-aspartate receptor (NMDAR) is a prime target for the development of cognitive enhancers because of its fundamental role in learning and memory.  In particular, the NMDAR subunit NR2B improves synaptic plasticity and memory when overexpressed in neurons.  However, NR2B regulation is not well understood and no therapies potentiating NMDAR function have been developed.  Here, we show that serine 1116 of NR2B is phosphorylated by cyclin-dependent kinase 5 (Cdk5).  Cdk5-dependent NR2B phosphorylation is regulated by neuronal activity and controls the receptor's cell surface expression.  Disrupting NR2B-Cdk5 interaction via a small interfering peptide (siP) increases NR2B surface levels, facilitates synaptic transmission, and improves memory formation in vivo.  Our results reveal a regulatory mechanism crit. to NR2B function that can be targeted for the development of cognitive enhancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEMKrScxILe7Vg90H21EOLACvtfcHk0ljLJvkktQ01fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjslKksr8%253D&md5=a309690cecd4c9a91da508dcea7c3bd0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2014.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2014.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DPlattner%26aufirst%3DF.%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DKistler%26aufirst%3DT.%2BM.%26aulast%3DPozo%26aufirst%3DK.%26aulast%3DZhong%26aufirst%3DP.%26aulast%3DYuen%26aufirst%3DE.%2BY.%26aulast%3DTan%26aufirst%3DC.%26aulast%3DHawasli%26aufirst%3DA.%2BH.%26aulast%3DCooke%26aufirst%3DS.%2BF.%26aulast%3DNishi%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DA.%26aulast%3DWiederhold%26aufirst%3DT.%26aulast%3DYan%26aufirst%3DZ.%26aulast%3DBibb%26aufirst%3DJ.%2BA.%26atitle%3DMemory%2520enhancement%2520by%2520targeting%2520Cdk5%2520regulation%2520of%2520NR2B%26jtitle%3DNeuron%26date%3D2014%26volume%3D81%26spage%3D1070%26epage%3D1083%26doi%3D10.1016%2Fj.neuron.2014.01.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zlomuzica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Souza Silva, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huston, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dere, E.</span></span> <span> </span><span class="NLM_article-title">NMDA receptor modulation by D-cycloserine promotes episodic-like memory in mice</span>. <i>Psychopharmacology (Berl.)</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>193</i></span>,  <span class="NLM_fpage">503</span>– <span class="NLM_lpage">509</span>, <span class="refDoi"> DOI: 10.1007/s00213-007-0816-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1007%2Fs00213-007-0816-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=17497136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotVWmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2007&pages=503-509&author=A.+Zlomuzicaauthor=M.+A.+De+Souza+Silvaauthor=J.+P.+Hustonauthor=E.+Dere&title=NMDA+receptor+modulation+by+D-cycloserine+promotes+episodic-like+memory+in+mice&doi=10.1007%2Fs00213-007-0816-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor modulation by D-cycloserine promotes episodic-like memory in mice</span></div><div class="casAuthors">Zlomuzica, Armin; Souza Silva, Maria A.; Huston, Joseph P.; Dere, Ekrem</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">503-509</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Rationale: NMDA-R (N-methyl-D-aspartate receptors) have been implicated in synaptic plasticity underlying one-trial learning of event-place assocns.  In rodents, episodic-like memory (ELM) of personally experienced events can be inferred from behavior that reflects the remembrance of the content (what kind of object was presented), place (where was this object placed), and temporal context (when was the object presented).  We have previously shown that D-cycloserine (DCS), an NMDA-R agonist, ameliorates stress-induced deficits in ELM.  Objectives: In this study, we used an exptl. protocol designed to detect promnestic drug effects and investigated whether DCS, which is known to enhance learning and memory, can induce ELM under conditions where mice normally do not show ELM.  Results: Mice that have been treated i.p. with DCS (20 mg/kg) both remembered the temporal order in which two different objects had been encountered during two consecutive sample trials, as well as their spatial position during the sample trials.  Most importantly, the test trial performance of these mice is compatible with ELM in terms of an integrated memory for unique experiences comprising "what", "where", and "when" information.  In contrast, mice that have received either a saline injection or lower doses of DCS (0.2 and 2.0 mg/kg) did not show such an integrated ELM.  Conclusions: To our knowledge, this is the first report showing that DCS can promote ELM in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqiw2pqDmS97Vg90H21EOLACvtfcHk0ljLJvkktQ01fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotVWmurk%253D&md5=a31c38d39adce451eec996cb9f5a123d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2Fs00213-007-0816-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-007-0816-x%26sid%3Dliteratum%253Aachs%26aulast%3DZlomuzica%26aufirst%3DA.%26aulast%3DDe%2BSouza%2BSilva%26aufirst%3DM.%2BA.%26aulast%3DHuston%26aufirst%3DJ.%2BP.%26aulast%3DDere%26aufirst%3DE.%26atitle%3DNMDA%2520receptor%2520modulation%2520by%2520D-cycloserine%2520promotes%2520episodic-like%2520memory%2520in%2520mice%26jtitle%3DPsychopharmacology%2520%2528Berl.%2529%26date%3D2007%26volume%3D193%26spage%3D503%26epage%3D509%26doi%3D10.1007%2Fs00213-007-0816-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peters, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz-Lopez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. G.</span></span> <span> </span><span class="NLM_article-title">Spatial memory and hippocampal enhancement</span>. <i>Curr. Opin. Behav. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1016/j.cobeha.2015.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.cobeha.2015.03.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=81-91&author=M.+Petersauthor=M.+Munoz-Lopezauthor=R.+G.+Morris&title=Spatial+memory+and+hippocampal+enhancement&doi=10.1016%2Fj.cobeha.2015.03.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.cobeha.2015.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cobeha.2015.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DM.%26aulast%3DMunoz-Lopez%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DR.%2BG.%26atitle%3DSpatial%2520memory%2520and%2520hippocampal%2520enhancement%26jtitle%3DCurr.%2520Opin.%2520Behav.%2520Sci.%26date%3D2015%26volume%3D4%26spage%3D81%26epage%3D91%26doi%3D10.1016%2Fj.cobeha.2015.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolkenberg, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinney, G. G.</span></span> <span> </span><span class="NLM_article-title">Progress in the preparation and testing of glycine transporter type-1 (GlyT1) inhibitors</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1883</span>– <span class="NLM_lpage">1896</span>, <span class="refDoi"> DOI: 10.2174/156802606778249784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.2174%2F156802606778249784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=17017963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVClurnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1883-1896&author=C.+W.+Lindsleyauthor=S.+E.+Wolkenbergauthor=G.+G.+Kinney&title=Progress+in+the+preparation+and+testing+of+glycine+transporter+type-1+%28GlyT1%29+inhibitors&doi=10.2174%2F156802606778249784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the preparation and testing of glycine transporter type-1 (GlyT1) inhibitors</span></div><div class="casAuthors">Lindsley, Craig W.; Wolkenberg, Scott E.; Kinney, Gene G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1883-1896</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Clin. utilized antipsychotic agents share as a common mechanism the ability to antagonize dopamine D2 receptors and it is widely assumed that this activity contributes to their efficacy against the pos. symptoms of schizophrenia.  The efficacy of currently marketed antipsychotic agents on the neg. and cognitive symptoms of this disease, however, is not optimal.  One alternate hypothesis to the "dopamine hypothesis" of schizophrenia derives from the observation that antagonists of NMDA receptor activity better mimic the symptomatol. of schizophrenia in its entirety than do dopamine agonists.  Findings from this line of research have led to the NMDA receptor hypofunction (or glutamate dysfunction) hypothesis of schizophrenia, which complements existing research implicating dopamine dysfunction in the disease.  According to the NMDA receptor hypofunction hypothesis, any treatment that enhances NMDA receptor activity may prove useful for the treatment of the complex symptoms that define schizophrenia.  This idea is now supported by numerous clin. studies that have reported an efficacious response following treatment with activators of the NMDA receptor co-agonist glycineB site.  One area of study, aimed at potentiating the NMDA receptor via activation of the glycineB site is small mol. blockade of the glycine reuptake transporter type 1 (GlyT1).  Broadly, these efforts have focused on derivs. of the substrate inhibitor, sarcosine, and non-sarcosine based GlyT1 inhibitors.  Accordingly, the following review discusses the development of both sarcosine and non-sarcosine based GlyT1 inhibitors and their current status as putative treatments for schizophrenia and other disorders assocd. with NMDA receptor hypoactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5Qzf3xnbWSbVg90H21EOLACvtfcHk0ljtOBiQkt_glQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVClurnN&md5=a3d701faff26e057b2b36fd2a160ebb2</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F156802606778249784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606778249784%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DWolkenberg%26aufirst%3DS.%2BE.%26aulast%3DKinney%26aufirst%3DG.%2BG.%26atitle%3DProgress%2520in%2520the%2520preparation%2520and%2520testing%2520of%2520glycine%2520transporter%2520type-1%2520%2528GlyT1%2529%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1883%26epage%3D1896%26doi%3D10.2174%2F156802606778249784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bridges, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span> <span> </span><span class="NLM_article-title">Design of potent GlyT1 inhibitors: in vitro and in vivo profiles</span>. <i>Curr. Opin. Mol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">591</span>– <span class="NLM_lpage">601</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=19051137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvFKlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=591-601&author=T.+M.+Bridgesauthor=R.+Williamsauthor=C.+W.+Lindsley&title=Design+of+potent+GlyT1+inhibitors%3A+in+vitro+and+in+vivo+profiles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Design of potent GlyT1 inhibitors: in vitro and in vivo profiles</span></div><div class="casAuthors">Bridges, Thomas M.; Williams, Richard; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Molecular Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">591-601</span>CODEN:
                <span class="NLM_cas:coden">CUOTFO</span>;
        ISSN:<span class="NLM_cas:issn">1464-8431</span>.
    
            (<span class="NLM_cas:orgname">Thomson Reuters</span>)
        </div><div class="casAbstract">A review.  Inhibitors of Gly transporter type-1 (GlyT1) for the treatment of schizophrenia have been pursued on the basis of the NMDA receptor (R) hypofunction hypothesis, which stems largely from the observation that NMDAR antagonists induce symptoms that more closely mimic those characteristic of schizophrenia than do other classes of psychotic agents.  GlyT1 is responsible for uptake of synoptic Gly, an NMDAR co-agonist amino acid, in neuronal populations throughout the forebrain.  GlyT1 inhibition thereby potentiates NMDAR activity by increasing synoptic Gly levels.  Correspondingly, a large body of data suggests that GlyT1 inhibitors likely confer more comprehensive symptom alleviation than current antipsychotics.  To date, a no. of small-mol. GlyT1 inhibitors have been reported by the pharmaceutical industry.  Developments in the discovery and characterization of GlyT1 inhibitors are discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj_Xg_UVKWkrVg90H21EOLACvtfcHk0ljtOBiQkt_glQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvFKlsw%253D%253D&md5=d2bcb77b26535a440edfdabe13f18433</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDesign%2520of%2520potent%2520GlyT1%2520inhibitors%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520profiles%26jtitle%3DCurr.%2520Opin.%2520Mol.%2520Ther.%26date%3D2008%26volume%3D10%26spage%3D591%26epage%3D601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wolkenberg, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sur, C.</span></span> <span> </span><span class="NLM_article-title">Recent progress in the discovery of non-sarcosine based GlyT1 inhibitors</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.2174/156802610790410974</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.2174%2F156802610790410974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=20166956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFajsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=170-186&author=S.+E.+Wolkenbergauthor=C.+Sur&title=Recent+progress+in+the+discovery+of+non-sarcosine+based+GlyT1+inhibitors&doi=10.2174%2F156802610790410974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the discovery of non-sarcosine based GlyT1 inhibitors</span></div><div class="casAuthors">Wolkenberg, Scott E.; Sur, Cyrille</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">170-186</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The simple amino acid glycine is implicated in both inhibitory and excitatory neurotransmission in mammalian central nervous system, and it modulates excitatory neurotransmission through its role as a necessary co-agonist for glutamatergic N-methyl-D-aspartate (NMDA) receptors.  Given the involvement of NMDA receptor-mediated neurotransmission in complex cerebral processes such as cognition, pharmacol. manipulation of extracellular synaptic glycine biol. is an active area of pharmaceutical research to develop novel treatments for neuropsychiatric disorders.  A key component of cerebral glycine metab. is the glycine transporter type 1 (GlyT1) and elevation of extracellular synaptic glycine concn. by blockade of GlyT1 has been hypothesized to potentiate NMDA receptor function in vivo and to represent a rational approach for the treatment of schizophrenia and cognitive disorders.  The present article will review the wealth of scientific evidence supporting that hypothesis and the medicinal chem. effort by many pharmaceutical companies and academic institutions to develop potent and selective GlyT1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmkOKDTB4jd7Vg90H21EOLACvtfcHk0lgIgXTl7TJUbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFajsrs%253D&md5=5a06f909d25a62ca71ea8a915a46cda4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F156802610790410974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610790410974%26sid%3Dliteratum%253Aachs%26aulast%3DWolkenberg%26aufirst%3DS.%2BE.%26aulast%3DSur%26aufirst%3DC.%26atitle%3DRecent%2520progress%2520in%2520the%2520discovery%2520of%2520non-sarcosine%2520based%2520GlyT1%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D170%26epage%3D186%26doi%3D10.2174%2F156802610790410974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Porter, R.</span>; <span class="NLM_string-name">Dawson, L.</span></span> In  <i>Small Molecule Therapeutics for Schizophrenia</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celanire, S.</span>, <span class="NLM_string-name">Poli, S.</span></span>, Eds.; <span class="NLM_publisher-name">Springer International Publishing</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2015</span>; Vol.  <span class="NLM_volume">13</span>, pp  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">99</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=51-99&author=R.+Porter&author=L.+Dawsonauthor=S.+Celanire&author=S.+Poli&title=Small+Molecule+Therapeutics+for+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DR.%26btitle%3DSmall%2520Molecule%2520Therapeutics%2520for%2520Schizophrenia%26aulast%3DCelanire%26aufirst%3DS.%26pub%3DSpringer%2520International%2520Publishing%26date%3D2015%26volume%3D13%26spage%3D51%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albert, J. S.</span>; <span class="NLM_string-name">Wood, M. W.</span></span> In  <i>Targets and Emerging Therapies for Schizophrenia</i>; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2012</span>; pp  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">254</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1002%2F9781118309421.ch8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=233-254&author=J.+S.+Albert&author=M.+W.+Wood&title=Targets+and+Emerging+Therapies+for+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2F9781118309421.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118309421.ch8%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26btitle%3DTargets%2520and%2520Emerging%2520Therapies%2520for%2520Schizophrenia%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2012%26spage%3D233%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vivo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalski, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lechner, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ognyanov, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tham, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klitenick, M. A.</span></span> <span> </span><span class="NLM_article-title">ALX 5407: a potent, selective inhibitor of the hGlyT1 glycine transporter</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1414</span>– <span class="NLM_lpage">1420</span>, <span class="refDoi"> DOI: 10.1124/mol.60.6.1414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1124%2Fmol.60.6.1414" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=1414-1420&author=B.+N.+Atkinsonauthor=S.+C.+Bellauthor=M.+De+Vivoauthor=L.+R.+Kowalskiauthor=S.+M.+Lechnerauthor=V.+I.+Ognyanovauthor=C.+S.+Thamauthor=C.+Tsaiauthor=J.+Jiaauthor=D.+Ashtonauthor=M.+A.+Klitenick&title=ALX+5407%3A+a+potent%2C+selective+inhibitor+of+the+hGlyT1+glycine+transporter&doi=10.1124%2Fmol.60.6.1414"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fmol.60.6.1414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.60.6.1414%26sid%3Dliteratum%253Aachs%26aulast%3DAtkinson%26aufirst%3DB.%2BN.%26aulast%3DBell%26aufirst%3DS.%2BC.%26aulast%3DDe%2BVivo%26aufirst%3DM.%26aulast%3DKowalski%26aufirst%3DL.%2BR.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DOgnyanov%26aufirst%3DV.%2BI.%26aulast%3DTham%26aufirst%3DC.%2BS.%26aulast%3DTsai%26aufirst%3DC.%26aulast%3DJia%26aufirst%3DJ.%26aulast%3DAshton%26aufirst%3DD.%26aulast%3DKlitenick%26aufirst%3DM.%2BA.%26atitle%3DALX%25205407%253A%2520a%2520potent%252C%2520selective%2520inhibitor%2520of%2520the%2520hGlyT1%2520glycine%2520transporter%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D1414%26epage%3D1420%26doi%3D10.1124%2Fmol.60.6.1414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Man, T.</span>; <span class="NLM_string-name">Milot, G.</span>; <span class="NLM_string-name">Porter, W. J.</span>; <span class="NLM_string-name">Reel, J. K.</span>; <span class="NLM_string-name">Rudyk, H. C. E.</span>; <span class="NLM_string-name">Valli, M. J.</span>; <span class="NLM_string-name">Walter, M. W.</span></span> <span> </span><span class="NLM_article-title">Preparation of N-(2-aryloxyethyl)glycine Derivatives and Their Use as Glycine Transport Inhibitors</span>. <span class="NLM_patent">WO2005100301</span>, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=T.+Man&author=G.+Milot&author=W.+J.+Porter&author=J.+K.+Reel&author=H.+C.+E.+Rudyk&author=M.+J.+Valli&author=M.+W.+Walter&title=Preparation+of+N-%282-aryloxyethyl%29glycine+Derivatives+and+Their+Use+as+Glycine+Transport+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMan%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520N-%25282-aryloxyethyl%2529glycine%2520Derivatives%2520and%2520Their%2520Use%2520as%2520Glycine%2520Transport%2520Inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kopec, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flood, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasior, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuvich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvino, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durkin, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ator, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, M. J.</span></span> <span> </span><span class="NLM_article-title">Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 mice</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">1407</span>– <span class="NLM_lpage">1417</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2010.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.bcp.2010.07.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2010&pages=1407-1417&author=K.+Kopecauthor=D.+G.+Floodauthor=M.+Gasiorauthor=B.+A.+McKennaauthor=E.+Zuvichauthor=J.+Schreiberauthor=J.+M.+Salvinoauthor=J.+T.+Durkinauthor=M.+A.+Atorauthor=M.+J.+Marino&title=Glycine+transporter+%28GlyT1%29+inhibitors+with+reduced+residence+time+increase+prepulse+inhibition+without+inducing+hyperlocomotion+in+DBA%2F2+mice&doi=10.1016%2Fj.bcp.2010.07.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2010.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2010.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DKopec%26aufirst%3DK.%26aulast%3DFlood%26aufirst%3DD.%2BG.%26aulast%3DGasior%26aufirst%3DM.%26aulast%3DMcKenna%26aufirst%3DB.%2BA.%26aulast%3DZuvich%26aufirst%3DE.%26aulast%3DSchreiber%26aufirst%3DJ.%26aulast%3DSalvino%26aufirst%3DJ.%2BM.%26aulast%3DDurkin%26aufirst%3DJ.%2BT.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DMarino%26aufirst%3DM.%2BJ.%26atitle%3DGlycine%2520transporter%2520%2528GlyT1%2529%2520inhibitors%2520with%2520reduced%2520residence%2520time%2520increase%2520prepulse%2520inhibition%2520without%2520inducing%2520hyperlocomotion%2520in%2520DBA%252F2%2520mice%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D80%26spage%3D1407%26epage%3D1417%26doi%3D10.1016%2Fj.bcp.2010.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perry, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcone, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fell, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Love, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Man, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomikos, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phebus, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cauvin, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandusky, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, K. A.</span></span> <span> </span><span class="NLM_article-title">Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areas</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">743</span>– <span class="NLM_lpage">754</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2008.06.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.neuropharm.2008.06.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=743-754&author=K.+W.+Perryauthor=J.+F.+Falconeauthor=M.+J.+Fellauthor=J.+W.+Ryderauthor=H.+Yuauthor=P.+L.+Loveauthor=J.+Katnerauthor=K.+D.+Gordonauthor=M.+R.+Wadeauthor=T.+Manauthor=G.+G.+Nomikosauthor=L.+A.+Phebusauthor=A.+J.+Cauvinauthor=K.+W.+Johnsonauthor=C.+K.+Jonesauthor=B.+J.+Hoffmannauthor=G.+E.+Sanduskyauthor=M.+W.+Walterauthor=W.+J.+Porterauthor=L.+Yangauthor=K.+M.+Merchantauthor=H.+E.+Shannonauthor=K.+A.+Svensson&title=Neurochemical+and+behavioral+profiling+of+the+selective+GlyT1+inhibitors+ALX5407+and+LY2365109+indicate+a+preferential+action+in+caudal+vs.+cortical+brain+areas&doi=10.1016%2Fj.neuropharm.2008.06.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2008.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2008.06.016%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DK.%2BW.%26aulast%3DFalcone%26aufirst%3DJ.%2BF.%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DRyder%26aufirst%3DJ.%2BW.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DLove%26aufirst%3DP.%2BL.%26aulast%3DKatner%26aufirst%3DJ.%26aulast%3DGordon%26aufirst%3DK.%2BD.%26aulast%3DWade%26aufirst%3DM.%2BR.%26aulast%3DMan%26aufirst%3DT.%26aulast%3DNomikos%26aufirst%3DG.%2BG.%26aulast%3DPhebus%26aufirst%3DL.%2BA.%26aulast%3DCauvin%26aufirst%3DA.%2BJ.%26aulast%3DJohnson%26aufirst%3DK.%2BW.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DHoffmann%26aufirst%3DB.%2BJ.%26aulast%3DSandusky%26aufirst%3DG.%2BE.%26aulast%3DWalter%26aufirst%3DM.%2BW.%26aulast%3DPorter%26aufirst%3DW.%2BJ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DMerchant%26aufirst%3DK.%2BM.%26aulast%3DShannon%26aufirst%3DH.%2BE.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26atitle%3DNeurochemical%2520and%2520behavioral%2520profiling%2520of%2520the%2520selective%2520GlyT1%2520inhibitors%2520ALX5407%2520and%2520LY2365109%2520indicate%2520a%2520preferential%2520action%2520in%2520caudal%2520vs.%2520cortical%2520brain%2520areas%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D743%26epage%3D754%26doi%3D10.1016%2Fj.neuropharm.2008.06.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gomeza, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hülsmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohno, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eulenburg, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szöke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, H.</span></span> <span> </span><span class="NLM_article-title">Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic Inhibition</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">785</span>– <span class="NLM_lpage">796</span>, <span class="refDoi"> DOI: 10.1016/S0896-6273(03)00672-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2FS0896-6273%2803%2900672-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2003&pages=785-796&author=J.+Gomezaauthor=S.+H%C3%BClsmannauthor=K.+Ohnoauthor=V.+Eulenburgauthor=K.+Sz%C3%B6keauthor=D.+Richterauthor=H.+Betz&title=Inactivation+of+the+glycine+transporter+1+gene+discloses+vital+role+of+glial+glycine+uptake+in+glycinergic+Inhibition&doi=10.1016%2FS0896-6273%2803%2900672-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2803%2900672-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252803%252900672-X%26sid%3Dliteratum%253Aachs%26aulast%3DGomeza%26aufirst%3DJ.%26aulast%3DH%25C3%25BClsmann%26aufirst%3DS.%26aulast%3DOhno%26aufirst%3DK.%26aulast%3DEulenburg%26aufirst%3DV.%26aulast%3DSz%25C3%25B6ke%26aufirst%3DK.%26aulast%3DRichter%26aufirst%3DD.%26aulast%3DBetz%26aufirst%3DH.%26atitle%3DInactivation%2520of%2520the%2520glycine%2520transporter%25201%2520gene%2520discloses%2520vital%2520role%2520of%2520glial%2520glycine%2520uptake%2520in%2520glycinergic%2520Inhibition%26jtitle%3DNeuron%26date%3D2003%26volume%3D40%26spage%3D785%26epage%3D796%26doi%3D10.1016%2FS0896-6273%2803%2900672-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szoke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graß, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirrlinger, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirrlinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulsmann, S.</span></span> <span> </span><span class="NLM_article-title">Glycine transporter 1 expression in the ventral respiratory group is restricted to protoplasmic astrocytes</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1119</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2006.08.089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.brainres.2006.08.089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=17010320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKmtLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1119&publication_year=2006&pages=182-189&author=K.+Szokeauthor=K.+Hartelauthor=D.+Gra%C3%9Fauthor=P.+G.+Hirrlingerauthor=J.+Hirrlingerauthor=S.+Hulsmann&title=Glycine+transporter+1+expression+in+the+ventral+respiratory+group+is+restricted+to+protoplasmic+astrocytes&doi=10.1016%2Fj.brainres.2006.08.089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Glycine transporter 1 expression in the ventral respiratory group is restricted to protoplasmic astrocytes</span></div><div class="casAuthors">Szoke, Katalin; Haertel, Kai; Grass, Dennis; Hirrlinger, Petra G.; Hirrlinger, Johannes; Huelsmann, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1119</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">182-189</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The lack of the glycine transporter 1 (GlyT1) leads to early postnatal death due to failure of respiratory network activity.  Here we demonstrate a segregated expression of GlyT1 on different astroglial cell populations of the ventral respiratory group.  In TgN(hGFAP-EGFP) mice a combined immunohistochem. and electrophysiol. approach was used to define the cellular expression of GlyT1 in the respiratory network.  EGFP-labeled cells with outwardly rectifying current-voltage relationship did not express glycine transporter 1, while GlyT1 was abundantly expressed in mature protoplasmic astrocytes, which are electrophysiol. characterized by a large potassium conductance, a more neg. membrane potential and the expression of glutamate transporters.  Taken together, the vital capacity for the clearance of extracellular glycine is restricted to a subpopulation of astroglial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcvXQs5p573rVg90H21EOLACvtfcHk0lizh9Dr8OE3Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKmtLbJ&md5=4d8531529ac41fec22e779ae54b75f0b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2006.08.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2006.08.089%26sid%3Dliteratum%253Aachs%26aulast%3DSzoke%26aufirst%3DK.%26aulast%3DHartel%26aufirst%3DK.%26aulast%3DGra%25C3%259F%26aufirst%3DD.%26aulast%3DHirrlinger%26aufirst%3DP.%2BG.%26aulast%3DHirrlinger%26aufirst%3DJ.%26aulast%3DHulsmann%26aufirst%3DS.%26atitle%3DGlycine%2520transporter%25201%2520expression%2520in%2520the%2520ventral%2520respiratory%2520group%2520is%2520restricted%2520to%2520protoplasmic%2520astrocytes%26jtitle%3DBrain%2520Res.%26date%3D2006%26volume%3D1119%26spage%3D182%26epage%3D189%26doi%3D10.1016%2Fj.brainres.2006.08.089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, J. A.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tingley, F. D.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHardy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deninno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tunucci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valentine, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronk, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, E.</span></span> <span> </span><span class="NLM_article-title">The discovery of a structurally novel class of inhibitors of the type 1 glycine transporter</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2974</span>– <span class="NLM_lpage">2976</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.04.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.bmcl.2009.04.035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2974-2976&author=J.+A.+Loweauthor=X.+Houauthor=C.+Schmidtauthor=F.+D.+Tingleyauthor=S.+McHardyauthor=M.+Kalmanauthor=S.+Deninnoauthor=M.+Sannerauthor=K.+Wardauthor=L.+Lebelauthor=D.+Tunucciauthor=J.+Valentineauthor=B.+S.+Bronkauthor=E.+Schaeffer&title=The+discovery+of+a+structurally+novel+class+of+inhibitors+of+the+type+1+glycine+transporter&doi=10.1016%2Fj.bmcl.2009.04.035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.04.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.04.035%26sid%3Dliteratum%253Aachs%26aulast%3DLowe%26aufirst%3DJ.%2BA.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DSchmidt%26aufirst%3DC.%26aulast%3DTingley%26aufirst%3DF.%2BD.%26aulast%3DMcHardy%26aufirst%3DS.%26aulast%3DKalman%26aufirst%3DM.%26aulast%3DDeninno%26aufirst%3DS.%26aulast%3DSanner%26aufirst%3DM.%26aulast%3DWard%26aufirst%3DK.%26aulast%3DLebel%26aufirst%3DL.%26aulast%3DTunucci%26aufirst%3DD.%26aulast%3DValentine%26aufirst%3DJ.%26aulast%3DBronk%26aufirst%3DB.%2BS.%26aulast%3DSchaeffer%26aufirst%3DE.%26atitle%3DThe%2520discovery%2520of%2520a%2520structurally%2520novel%2520class%2520of%2520inhibitors%2520of%2520the%2520type%25201%2520glycine%2520transporter%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2974%26epage%3D2976%26doi%3D10.1016%2Fj.bmcl.2009.04.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blackaby, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, A. S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodacre, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLeod, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almond, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guscott, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamill, T. G.</span></span> <span> </span><span class="NLM_article-title">Identification of an orally bioavailable, potent, and selective inhibitor of GlyT1</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">350</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1021/ml1001085</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml1001085" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=350-354&author=W.+P.+Blackabyauthor=R.+T.+Lewisauthor=J.+L.+Thomsonauthor=A.+S.+R.+Jenningsauthor=S.+C.+Goodacreauthor=L.+J.+Streetauthor=A.+M.+MacLeodauthor=A.+Pikeauthor=S.+Woodauthor=S.+Thomasauthor=T.+A.+Brownauthor=A.+Smithauthor=G.+Pillaiauthor=S.+Almondauthor=M.+R.+Guscottauthor=H.+D.+Burnsauthor=W.+Engauthor=C.+Ryanauthor=J.+Cookauthor=T.+G.+Hamill&title=Identification+of+an+orally+bioavailable%2C+potent%2C+and+selective+inhibitor+of+GlyT1&doi=10.1021%2Fml1001085"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fml1001085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1001085%26sid%3Dliteratum%253Aachs%26aulast%3DBlackaby%26aufirst%3DW.%2BP.%26aulast%3DLewis%26aufirst%3DR.%2BT.%26aulast%3DThomson%26aufirst%3DJ.%2BL.%26aulast%3DJennings%26aufirst%3DA.%2BS.%2BR.%26aulast%3DGoodacre%26aufirst%3DS.%2BC.%26aulast%3DStreet%26aufirst%3DL.%2BJ.%26aulast%3DMacLeod%26aufirst%3DA.%2BM.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DT.%2BA.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DPillai%26aufirst%3DG.%26aulast%3DAlmond%26aufirst%3DS.%26aulast%3DGuscott%26aufirst%3DM.%2BR.%26aulast%3DBurns%26aufirst%3DH.%2BD.%26aulast%3DEng%26aufirst%3DW.%26aulast%3DRyan%26aufirst%3DC.%26aulast%3DCook%26aufirst%3DJ.%26aulast%3DHamill%26aufirst%3DT.%2BG.%26atitle%3DIdentification%2520of%2520an%2520orally%2520bioavailable%252C%2520potent%252C%2520and%2520selective%2520inhibitor%2520of%2520GlyT1%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D350%26epage%3D354%26doi%3D10.1021%2Fml1001085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugane, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamaguchi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeno, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimizuka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, S.-i.</span></span> <span> </span><span class="NLM_article-title">Atropisomeric 4-Phenyl-4H-1,2,4-triazoles as selective glycine transporter 1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5744</span>– <span class="NLM_lpage">5756</span>, <span class="refDoi"> DOI: 10.1021/jm400383w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400383w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKqtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5744-5756&author=T.+Suganeauthor=T.+Tobeauthor=W.+Hamaguchiauthor=I.+Shimadaauthor=K.+Maenoauthor=J.+Miyataauthor=T.+Suzukiauthor=T.+Kimizukaauthor=S.+Sakamotoauthor=S.-i.+Tsukamoto&title=Atropisomeric+4-Phenyl-4H-1%2C2%2C4-triazoles+as+selective+glycine+transporter+1+inhibitors&doi=10.1021%2Fjm400383w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Atropisomeric 4-Phenyl-4H-1,2,4-triazoles as Selective Glycine Transporter 1 Inhibitors</span></div><div class="casAuthors">Sugane, Takashi; Tobe, Takahiko; Hamaguchi, Wataru; Shimada, Itsuro; Maeno, Kyoichi; Miyata, Junji; Suzuki, Takeshi; Kimizuka, Tetsuya; Sakamoto, Shuichi; Tsukamoto, Shin-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5744-5756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of trisubstituted 4H-1,2,4-triazoles was synthesized and evaluated aiming to increase their activity and selectivity as glycine transporter 1 (GlyT1) inhibitors.  Structure-activity relationship exploration resulted in the identification of 3-[3-ethyl-5-(6-phenylpyridin-3-yl)-4H-1,2,4-triazol-4-yl]-2-methylbenzonitrile (I) with markedly higher selectivity for GlyT1.  Physiochem. studies revealed that the compd. I exists as a stable pair of atropisomers under physiol. conditions.  These atropisomers were successfully sepd. to obtain active enantiomer (R)-I, which displayed favorable pharmacokinetic properties, as well as pos. results in the mice Y-maze test.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM-2SGK3g_mrVg90H21EOLACvtfcHk0liwLMqMxKgArg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKqtLvN&md5=c3218bd9ccae1f172f6d995e089a1a74</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm400383w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400383w%26sid%3Dliteratum%253Aachs%26aulast%3DSugane%26aufirst%3DT.%26aulast%3DTobe%26aufirst%3DT.%26aulast%3DHamaguchi%26aufirst%3DW.%26aulast%3DShimada%26aufirst%3DI.%26aulast%3DMaeno%26aufirst%3DK.%26aulast%3DMiyata%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKimizuka%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DTsukamoto%26aufirst%3DS.-i.%26atitle%3DAtropisomeric%25204-Phenyl-4H-1%252C2%252C4-triazoles%2520as%2520selective%2520glycine%2520transporter%25201%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5744%26epage%3D5756%26doi%3D10.1021%2Fjm400383w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Alberati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lengyel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mory, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borroni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoflach, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlotterbeck, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hainzl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettstein, J. G.</span></span> <span> </span><span class="NLM_article-title">Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1152</span>– <span class="NLM_lpage">1161</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2011.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.neuropharm.2011.11.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=1152-1161&author=D.+Alberatiauthor=J.+L.+Moreauauthor=J.+Lengyelauthor=N.+Hauserauthor=R.+Moryauthor=E.+Borroniauthor=E.+Pinardauthor=F.+Knoflachauthor=G.+Schlotterbeckauthor=D.+Hainzlauthor=J.+G.+Wettstein&title=Glycine+reuptake+inhibitor+RG1678%3A+a+pharmacologic+characterization+of+an+investigational+agent+for+the+treatment+of+schizophrenia&doi=10.1016%2Fj.neuropharm.2011.11.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2011.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2011.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DAlberati%26aufirst%3DD.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DLengyel%26aufirst%3DJ.%26aulast%3DHauser%26aufirst%3DN.%26aulast%3DMory%26aufirst%3DR.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DKnoflach%26aufirst%3DF.%26aulast%3DSchlotterbeck%26aufirst%3DG.%26aulast%3DHainzl%26aufirst%3DD.%26aulast%3DWettstein%26aufirst%3DJ.%2BG.%26atitle%3DGlycine%2520reuptake%2520inhibitor%2520RG1678%253A%2520a%2520pharmacologic%2520characterization%2520of%2520an%2520investigational%2520agent%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DNeuropharmacology%26date%3D2012%26volume%3D62%26spage%3D1152%26epage%3D1161%26doi%3D10.1016%2Fj.neuropharm.2011.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit31b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alanine, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borroni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourdeaux, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brom, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hainzl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halm, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolidon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lengyel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marty, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mory, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narquizian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettekoven, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norcross, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puellmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stalder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermuth, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettstein, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerli, D.</span></span> <span> </span><span class="NLM_article-title">Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4603</span>– <span class="NLM_lpage">4614</span>, <span class="refDoi"> DOI: 10.1021/jm100210p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100210p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4603-4614&author=E.+Pinardauthor=A.+Alanineauthor=D.+Alberatiauthor=M.+Benderauthor=E.+Borroniauthor=P.+Bourdeauxauthor=V.+Bromauthor=S.+Burnerauthor=H.+Fischerauthor=D.+Hainzlauthor=R.+Halmauthor=N.+Hauserauthor=S.+Jolidonauthor=J.+Lengyelauthor=H.+P.+Martyauthor=T.+Meyerauthor=J.+L.+Moreauauthor=R.+Moryauthor=R.+Narquizianauthor=M.+Nettekovenauthor=R.+D.+Norcrossauthor=B.+Puellmannauthor=P.+Schmidauthor=S.+Schmittauthor=H.+Stalderauthor=R.+Wermuthauthor=J.+G.+Wettsteinauthor=D.+Zimmerli&title=Selective+GlyT1+inhibitors%3A+discovery+of+%5B4-%283-fluoro-5-trifluoromethylpyridin-2-yl%29piperazin-1-yl%5D%5B5-methanesulfonyl-2-%28%28S%29-2%2C2%2C2-trifluoro-1-methylethoxy%29phenyl%5Dmethanone+%28RG1678%29%2C+a+promising+novel+medicine+to+treat+schizophrenia&doi=10.1021%2Fjm100210p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=10.1021%2Fjm100210p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100210p%26sid%3Dliteratum%253Aachs%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DAlanine%26aufirst%3DA.%26aulast%3DAlberati%26aufirst%3DD.%26aulast%3DBender%26aufirst%3DM.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DBourdeaux%26aufirst%3DP.%26aulast%3DBrom%26aufirst%3DV.%26aulast%3DBurner%26aufirst%3DS.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DHainzl%26aufirst%3DD.%26aulast%3DHalm%26aufirst%3DR.%26aulast%3DHauser%26aufirst%3DN.%26aulast%3DJolidon%26aufirst%3DS.%26aulast%3DLengyel%26aufirst%3DJ.%26aulast%3DMarty%26aufirst%3DH.%2BP.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DMory%26aufirst%3DR.%26aulast%3DNarquizian%26aufirst%3DR.%26aulast%3DNettekoven%26aufirst%3DM.%26aulast%3DNorcross%26aufirst%3DR.%2BD.%26aulast%3DPuellmann%26aufirst%3DB.%26aulast%3DSchmid%26aufirst%3DP.%26aulast%3DSchmitt%26aufirst%3DS.%26aulast%3DStalder%26aufirst%3DH.%26aulast%3DWermuth%26aufirst%3DR.%26aulast%3DWettstein%26aufirst%3DJ.%2BG.%26aulast%3DZimmerli%26aufirst%3DD.%26atitle%3DSelective%2520GlyT1%2520inhibitors%253A%2520discovery%2520of%2520%255B4-%25283-fluoro-5-trifluoromethylpyridin-2-yl%2529piperazin-1-yl%255D%255B5-methanesulfonyl-2-%2528%2528S%2529-2%252C2%252C2-trifluoro-1-methylethoxy%2529phenyl%255Dmethanone%2520%2528RG1678%2529%252C%2520a%2520promising%2520novel%2520medicine%2520to%2520treat%2520schizophrenia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4603%26epage%3D4614%26doi%3D10.1021%2Fjm100210p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varnes, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forst, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmquist, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frietze, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dembofsky, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andisik, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinkley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steelman, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkins, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonak, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potts, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brugel, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alhambra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veale, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, J. S.</span></span> <span> </span><span class="NLM_article-title">Bicyclo((aryl)methyl)benzamides as inhibitors of GlyT1</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1043</span>– <span class="NLM_lpage">1049</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.02.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.bmcl.2018.02.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=1043-1049&author=J.+G.+Varnesauthor=H.+Xiongauthor=J.+M.+Forstauthor=C.+R.+Holmquistauthor=G.+E.+Ernstauthor=W.+Frietzeauthor=B.+Dembofskyauthor=D.+W.+Andisikauthor=W.+E.+Palmerauthor=L.+Hinkleyauthor=G.+B.+Steelmanauthor=D.+E.+Wilkinsauthor=G.+Tianauthor=G.+Jonakauthor=W.+M.+Pottsauthor=X.+Wangauthor=T.+A.+Brugelauthor=C.+Alhambraauthor=M.+W.+Woodauthor=C.+A.+Vealeauthor=J.+S.+Albert&title=Bicyclo%28%28aryl%29methyl%29benzamides+as+inhibitors+of+GlyT1&doi=10.1016%2Fj.bmcl.2018.02.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.02.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.02.029%26sid%3Dliteratum%253Aachs%26aulast%3DVarnes%26aufirst%3DJ.%2BG.%26aulast%3DXiong%26aufirst%3DH.%26aulast%3DForst%26aufirst%3DJ.%2BM.%26aulast%3DHolmquist%26aufirst%3DC.%2BR.%26aulast%3DErnst%26aufirst%3DG.%2BE.%26aulast%3DFrietze%26aufirst%3DW.%26aulast%3DDembofsky%26aufirst%3DB.%26aulast%3DAndisik%26aufirst%3DD.%2BW.%26aulast%3DPalmer%26aufirst%3DW.%2BE.%26aulast%3DHinkley%26aufirst%3DL.%26aulast%3DSteelman%26aufirst%3DG.%2BB.%26aulast%3DWilkins%26aufirst%3DD.%2BE.%26aulast%3DTian%26aufirst%3DG.%26aulast%3DJonak%26aufirst%3DG.%26aulast%3DPotts%26aufirst%3DW.%2BM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DBrugel%26aufirst%3DT.%2BA.%26aulast%3DAlhambra%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DM.%2BW.%26aulast%3DVeale%26aufirst%3DC.%2BA.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26atitle%3DBicyclo%2528%2528aryl%2529methyl%2529benzamides%2520as%2520inhibitors%2520of%2520GlyT1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D1043%26epage%3D1049%26doi%3D10.1016%2Fj.bmcl.2018.02.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cioffi, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzzo, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadalapure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parthasarathy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loong, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeng, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carulli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karunakaran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matta, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panduga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckle, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakwa, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sargent, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luche, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khmelnitsky, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismail, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leong, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sachdev, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mhyre, A. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of N-((1-(4-(Sulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide inhibitors of glycine transporter-1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8473</span>– <span class="NLM_lpage">8494</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00914</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00914" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWntr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8473-8494&author=C.+L.+Cioffiauthor=S.+Liuauthor=M.+A.+Wolfauthor=P.+R.+Guzzoauthor=K.+Sadalapureauthor=V.+Parthasarathyauthor=D.+T.+Loongauthor=J.+H.+Maengauthor=E.+Carulliauthor=X.+Fangauthor=K.+Karunakaranauthor=L.+Mattaauthor=S.+H.+Chooauthor=S.+Pandugaauthor=R.+N.+Buckleauthor=R.+N.+Davisauthor=S.+A.+Sakwaauthor=P.+Guptaauthor=B.+J.+Sargentauthor=N.+A.+Mooreauthor=M.+M.+Lucheauthor=G.+J.+Carrauthor=Y.+L.+Khmelnitskyauthor=J.+Ismailauthor=M.+Chungauthor=M.+Baiauthor=W.+Y.+Leongauthor=N.+Sachdevauthor=S.+Swaminathanauthor=A.+J.+Mhyre&title=Synthesis+and+biological+evaluation+of+N-%28%281-%284-%28Sulfonyl%29piperazin-1-yl%29cycloalkyl%29methyl%29benzamide+inhibitors+of+glycine+transporter-1&doi=10.1021%2Facs.jmedchem.6b00914"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of N-((1-(4-(Sulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide Inhibitors of Glycine Transporter-1</span></div><div class="casAuthors">Cioffi, Christopher L.; Liu, Shuang; Wolf, Mark A.; Guzzo, Peter R.; Sadalapure, Kashinath; Parthasarathy, Visweswaran; Loong, David T. J.; Maeng, Jun-Ho; Carulli, Edmund; Fang, Xiao; Karunakaran, Kalesh; Matta, Lakshman; Choo, Sok Hui; Panduga, Shailijia; Buckle, Ronald N.; Davis, Randall N.; Sakwa, Samuel A.; Gupta, Priya; Sargent, Bruce J.; Moore, Nicholas A.; Luche, Michele M.; Carr, Grant J.; Khmelnitsky, Yuri L.; Ismail, Jiffry; Chung, Mark; Bai, Mei; Leong, Wei Yee; Sachdev, Nidhi; Swaminathan, Srividya; Mhyre, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8473-8494</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors previously disclosed the discovery of rationally designed N-((1-(4-(propylsulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide inhibitors of glycine transporter-1 (GlyT-1), represented by analogs 10 and 11.  The authors describe herein further structure-activity relationship exploration of this series via an optimization strategy that primarily focused on the sulfonamide and benzamide appendages of the scaffold.  These efforts led to the identification of advanced leads possessing a desirable balance of excellent in vitro GlyT-1 potency and selectivity, favorable ADME and in vitro pharmacol. profiles, and suitable pharmacokinetic and safety characteristics.  Representative analog I exhibited robust in vivo activity in the cerebral spinal fluid glycine biomarker model in both rodents and nonhuman primates.  Furthermore, rodent microdialysis expts. also demonstrated that oral administration of I significantly elevated extracellular glycine levels within the medial prefrontal cortex (mPFC).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJGpndM6DMLLVg90H21EOLACvtfcHk0lgsPzhphxXuEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWntr%252FO&md5=798d272412524f3c8af25cdccc595c63</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00914%26sid%3Dliteratum%253Aachs%26aulast%3DCioffi%26aufirst%3DC.%2BL.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DWolf%26aufirst%3DM.%2BA.%26aulast%3DGuzzo%26aufirst%3DP.%2BR.%26aulast%3DSadalapure%26aufirst%3DK.%26aulast%3DParthasarathy%26aufirst%3DV.%26aulast%3DLoong%26aufirst%3DD.%2BT.%26aulast%3DMaeng%26aufirst%3DJ.%2BH.%26aulast%3DCarulli%26aufirst%3DE.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DKarunakaran%26aufirst%3DK.%26aulast%3DMatta%26aufirst%3DL.%26aulast%3DChoo%26aufirst%3DS.%2BH.%26aulast%3DPanduga%26aufirst%3DS.%26aulast%3DBuckle%26aufirst%3DR.%2BN.%26aulast%3DDavis%26aufirst%3DR.%2BN.%26aulast%3DSakwa%26aufirst%3DS.%2BA.%26aulast%3DGupta%26aufirst%3DP.%26aulast%3DSargent%26aufirst%3DB.%2BJ.%26aulast%3DMoore%26aufirst%3DN.%2BA.%26aulast%3DLuche%26aufirst%3DM.%2BM.%26aulast%3DCarr%26aufirst%3DG.%2BJ.%26aulast%3DKhmelnitsky%26aufirst%3DY.%2BL.%26aulast%3DIsmail%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DM.%26aulast%3DBai%26aufirst%3DM.%26aulast%3DLeong%26aufirst%3DW.%2BY.%26aulast%3DSachdev%26aufirst%3DN.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DMhyre%26aufirst%3DA.%2BJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520N-%2528%25281-%25284-%2528Sulfonyl%2529piperazin-1-yl%2529cycloalkyl%2529methyl%2529benzamide%2520inhibitors%2520of%2520glycine%2520transporter-1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8473%26epage%3D8494%26doi%3D10.1021%2Facs.jmedchem.6b00914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yee, B. K.</span></span> <span> </span><span class="NLM_article-title">Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">866</span>– <span class="NLM_lpage">885</span>, <span class="refDoi"> DOI: 10.1038/nrd3893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1038%2Fnrd3893" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=866-885&author=R.+J.+Harveyauthor=B.+K.+Yee&title=Glycine+transporters+as+novel+therapeutic+targets+in+schizophrenia%2C+alcohol+dependence+and+pain&doi=10.1038%2Fnrd3893"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnrd3893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3893%26sid%3Dliteratum%253Aachs%26aulast%3DHarvey%26aufirst%3DR.%2BJ.%26aulast%3DYee%26aufirst%3DB.%2BK.%26atitle%3DGlycine%2520transporters%2520as%2520novel%2520therapeutic%2520targets%2520in%2520schizophrenia%252C%2520alcohol%2520dependence%2520and%2520pain%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D866%26epage%3D885%26doi%3D10.1038%2Fnrd3893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarimizu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aota, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doihara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, N.</span></span> <span> </span><span class="NLM_article-title">A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer’s disease</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>685</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2012.04.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.ejphar.2012.04.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=22542656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFCisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=685&publication_year=2012&pages=59-69&author=K.+Haradaauthor=K.+Nakatoauthor=J.+Yarimizuauthor=M.+Yamazakiauthor=M.+Moritaauthor=S.+Takahashiauthor=M.+Aotaauthor=K.+Saitaauthor=H.+Doiharaauthor=Y.+Satoauthor=T.+Yamajiauthor=K.+Niauthor=N.+Matsuoka&title=A+novel+glycine+transporter-1+%28GlyT1%29+inhibitor%2C+ASP2535+%284-%5B3-isopropyl-5-%286-phenyl-3-pyridyl%29-4H-1%2C2%2C4-triazol-4-yl%5D-2%2C1%2C3-benzoxadiazole%29%2C+improves+cognition+in+animal+models+of+cognitive+impairment+in+schizophrenia+and+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejphar.2012.04.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease</span></div><div class="casAuthors">Harada, Katsuya; Nakato, Kazuhiro; Yarimizu, Junko; Yamazaki, Mayako; Morita, Masahiko; Takahashi, Shinji; Aota, Masaki; Saita, Kyoko; Doihara, Hitoshi; Sato, Yuichiro; Yamaji, Takayuki; Ni, Keni; Matsuoka, Nobuya</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">685</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">59-69</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hypofunction of brain N-methyl-d-aspartate (NMDA) receptors has been implicated in psychiatric disorders such as schizophrenia and Alzheimer's disease.  Inhibition of glycine transporter-1 (GlyT1) is expected to increase glycine, a co-agonist of the NMDA receptor and, consequently, to facilitate NMDA receptor function.  We have identified ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole) as a novel GlyT1 inhibitor, and here describe our in vitro and in vivo characterization of this compd.  ASP2535 potently inhibited rat GlyT1 (IC50 = 92 nM) with 50-fold selectivity over rat glycine transporter-2 (GlyT2).  It showed minimal affinity for many other receptors except for μ-opioid receptors (IC50 = 1.83 μM).  Oral administration of ASP2535 dose-dependently inhibited ex vivo [3H]-glycine uptake in mouse cortical homogenate, suggesting good brain permeability.  This profile was confirmed by pharmacokinetic anal.  We then evaluated the effect of ASP2535 on animal models of cognitive impairment in schizophrenia and Alzheimer's disease.  Working memory deficit in MK-801-treated mice and visual learning deficit in neonatally phencyclidine (PCP)-treated mice were both attenuated by ASP2535 (0.3-3 mg/kg, p.o. and 0.3-1 mg/kg, p.o., resp.).  ASP2535 (1-3 mg/kg, p.o.) also improved the PCP-induced deficit in prepulse inhibition in rats.  Moreover, the working memory deficit in scopolamine-treated mice and the spatial learning deficit in aged rats were both attenuated by ASP2535 (0.1-3 mg/kg, p.o. and 0.1 mg/kg, p.o., resp.).  These studies provide compelling evidence that ASP2535 is a novel and centrally-active GlyT1 inhibitor that can improve cognitive impairment in animal models of schizophrenia and Alzheimer's disease, suggesting that ASP2535 may satisfy currently unmet medical needs for the treatment of these diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKCfrEvZzV97Vg90H21EOLACvtfcHk0li6PVYv3m2vKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFCisr0%253D&md5=d98206f687016709ea9d6b2ddc29ab33</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2012.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2012.04.013%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DK.%26aulast%3DNakato%26aufirst%3DK.%26aulast%3DYarimizu%26aufirst%3DJ.%26aulast%3DYamazaki%26aufirst%3DM.%26aulast%3DMorita%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DAota%26aufirst%3DM.%26aulast%3DSaita%26aufirst%3DK.%26aulast%3DDoihara%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DYamaji%26aufirst%3DT.%26aulast%3DNi%26aufirst%3DK.%26aulast%3DMatsuoka%26aufirst%3DN.%26atitle%3DA%2520novel%2520glycine%2520transporter-1%2520%2528GlyT1%2529%2520inhibitor%252C%2520ASP2535%2520%25284-%255B3-isopropyl-5-%25286-phenyl-3-pyridyl%2529-4H-1%252C2%252C4-triazol-4-yl%255D-2%252C1%252C3-benzoxadiazole%2529%252C%2520improves%2520cognition%2520in%2520animal%2520models%2520of%2520cognitive%2520impairment%2520in%2520schizophrenia%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D685%26spage%3D59%26epage%3D69%26doi%3D10.1016%2Fj.ejphar.2012.04.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Singer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubroqua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yee, B. K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glycine transporter 1: The yellow brick road to new schizophrenia therapy?</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3771</span>– <span class="NLM_lpage">3787</span>, <span class="refDoi"> DOI: 10.2174/1381612821666150724100952</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.2174%2F1381612821666150724100952" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=3771-3787&author=P.+Singerauthor=S.+Dubroquaauthor=B.+K.+Yee&title=Inhibition+of+glycine+transporter+1%3A+The+yellow+brick+road+to+new+schizophrenia+therapy%3F&doi=10.2174%2F1381612821666150724100952"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.2174%2F1381612821666150724100952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612821666150724100952%26sid%3Dliteratum%253Aachs%26aulast%3DSinger%26aufirst%3DP.%26aulast%3DDubroqua%26aufirst%3DS.%26aulast%3DYee%26aufirst%3DB.%2BK.%26atitle%3DInhibition%2520of%2520glycine%2520transporter%25201%253A%2520The%2520yellow%2520brick%2520road%2520to%2520new%2520schizophrenia%2520therapy%253F%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2015%26volume%3D21%26spage%3D3771%26epage%3D3787%26doi%3D10.2174%2F1381612821666150724100952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit36b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Umbricht, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Facklam, M.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: A randomized, double-blind, proof-of-concept study</span>. <i>JAMA Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">646</span>, <span class="refDoi"> DOI: 10.1001/jamapsychiatry.2014.163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1001%2Fjamapsychiatry.2014.163" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=637-646&author=D.+Umbrichtauthor=D.+Alberatiauthor=M.+Martin-Facklam&title=Effect+of+bitopertin%2C+a+glycine+reuptake+inhibitor%2C+on+negative+symptoms+of+schizophrenia%3A+A+randomized%2C+double-blind%2C+proof-of-concept+study&doi=10.1001%2Fjamapsychiatry.2014.163"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=10.1001%2Fjamapsychiatry.2014.163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamapsychiatry.2014.163%26sid%3Dliteratum%253Aachs%26aulast%3DUmbricht%26aufirst%3DD.%26aulast%3DAlberati%26aufirst%3DD.%26aulast%3DMartin-Facklam%26aufirst%3DM.%26atitle%3DEffect%2520of%2520bitopertin%252C%2520a%2520glycine%2520reuptake%2520inhibitor%252C%2520on%2520negative%2520symptoms%2520of%2520schizophrenia%253A%2520A%2520randomized%252C%2520double-blind%252C%2520proof-of-concept%2520study%26jtitle%3DJAMA%2520Psychiatry%26date%3D2014%26volume%3D71%26spage%3D637%26epage%3D646%26doi%3D10.1001%2Fjamapsychiatry.2014.163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit36c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chue, P.</span></span> <span> </span><span class="NLM_article-title">Glycine reuptake inhibition as a new therapeutic approach in schizophrenia: Focus on the glycine transporter 1 (GlyT1)</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1311</span>– <span class="NLM_lpage">1320</span>, <span class="refDoi"> DOI: 10.2174/138161213804805766</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.2174%2F138161213804805766" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1311-1320&author=P.+Chue&title=Glycine+reuptake+inhibition+as+a+new+therapeutic+approach+in+schizophrenia%3A+Focus+on+the+glycine+transporter+1+%28GlyT1%29&doi=10.2174%2F138161213804805766"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36c&amp;dbid=16384&amp;doi=10.2174%2F138161213804805766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161213804805766%26sid%3Dliteratum%253Aachs%26aulast%3DChue%26aufirst%3DP.%26atitle%3DGlycine%2520reuptake%2520inhibition%2520as%2520a%2520new%2520therapeutic%2520approach%2520in%2520schizophrenia%253A%2520Focus%2520on%2520the%2520glycine%2520transporter%25201%2520%2528GlyT1%2529%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2013%26volume%3D19%26spage%3D1311%26epage%3D1320%26doi%3D10.2174%2F138161213804805766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit36d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenberg, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubrey, K. R.</span></span> <span> </span><span class="NLM_article-title">Glycine transport inhibitors as potential antipsychotic drugs</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">518</span>, <span class="refDoi"> DOI: 10.1517/14728222.5.4.507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1517%2F14728222.5.4.507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=12540263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntVSmtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2001&pages=507-518&author=R.+J.+Vandenbergauthor=K.+R.+Aubrey&title=Glycine+transport+inhibitors+as+potential+antipsychotic+drugs&doi=10.1517%2F14728222.5.4.507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36dR"><div class="casContent"><span class="casTitleNuber">36d</span><div class="casTitle"><span class="NLM_cas:atitle">Glycine transport inhibitors as potential antipsychotic drugs</span></div><div class="casAuthors">Vandenberg, Robert J.; Aubrey, Karin R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">507-518</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Current antipsychotic drugs are only partially effective in treating schizophrenia and there is a clear need to develop better therapies.  An alternative approach to develop new antipsychotics has come from the NMDA receptor hypofunction model for schizophrenia.  It was hypothesised that stimulation of NMDA receptors with Gly site agonists may be therapeutic, and a no. of clin. trials of Gly together with std. antipsychotic drugs were recently been conducted.  Modest improvements in neg. symptoms were reported in some studies but a potentially more effective treatment is to use inhibitors of the GLYT1 subtype of Gly transporters.  Expression of GLYT1 within the brain correlates with NMDA receptor expression patterns and it was suggested that GLYT1 may regulate synaptic Gly concns.  With the development of selective and potent non-transported inhibitors of GLYT1 it should be possible to elevate synaptic Gly concns. more effectively and thereby to increase NMDA receptor activity.  Recent in vitro studies demonstrate that the Gly transport inhibitor, N[3-(4-fluorophenyl)-3-(4'-phenylphenoxy)] propylsarcosine, enhances NMDA receptor activity and the use of this class of compds. in clin. studies is eagerly awaited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5BG1o5_GPOLVg90H21EOLACvtfcHk0li6PVYv3m2vKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntVSmtr0%253D&md5=b51c6d7ffa3f2704a016979aae468fe2</span></div><a href="/servlet/linkout?suffix=cit36d&amp;dbid=16384&amp;doi=10.1517%2F14728222.5.4.507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.5.4.507%26sid%3Dliteratum%253Aachs%26aulast%3DVandenberg%26aufirst%3DR.%2BJ.%26aulast%3DAubrey%26aufirst%3DK.%2BR.%26atitle%3DGlycine%2520transport%2520inhibitors%2520as%2520potential%2520antipsychotic%2520drugs%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2001%26volume%3D5%26spage%3D507%26epage%3D518%26doi%3D10.1517%2F14728222.5.4.507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit36e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Javitt, D. C.</span></span> <span> </span><span class="NLM_article-title">Glycine transport inhibitors for the treatment of schizophrenia: symptom and disease modification</span>. <i>Curr. Opin. Drug. Discovery Dev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">468</span>– <span class="NLM_lpage">478</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=468-478&author=D.+C.+Javitt&title=Glycine+transport+inhibitors+for+the+treatment+of+schizophrenia%3A+symptom+and+disease+modification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJavitt%26aufirst%3DD.%2BC.%26atitle%3DGlycine%2520transport%2520inhibitors%2520for%2520the%2520treatment%2520of%2520schizophrenia%253A%2520symptom%2520and%2520disease%2520modification%26jtitle%3DCurr.%2520Opin.%2520Drug.%2520Discovery%2520Dev.%26date%3D2009%26volume%3D12%26spage%3D468%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit36f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">D’Souza, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elander, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbuto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udo de Haes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjogren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peeters, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranganathan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schipper, J.</span></span> <span> </span><span class="NLM_article-title">Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: preliminary evidence</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1036</span>– <span class="NLM_lpage">1046</span>, <span class="refDoi"> DOI: 10.1038/npp.2011.295</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1038%2Fnpp.2011.295" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=1036-1046&author=D.+C.+D%E2%80%99Souzaauthor=N.+Singhauthor=J.+Elanderauthor=M.+Carbutoauthor=B.+Pittmanauthor=J.+Udo+de+Haesauthor=M.+Sjogrenauthor=P.+Peetersauthor=M.+Ranganathanauthor=J.+Schipper&title=Glycine+transporter+inhibitor+attenuates+the+psychotomimetic+effects+of+ketamine+in+healthy+males%3A+preliminary+evidence&doi=10.1038%2Fnpp.2011.295"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36f&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2011.295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2011.295%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DD.%2BC.%26aulast%3DSingh%26aufirst%3DN.%26aulast%3DElander%26aufirst%3DJ.%26aulast%3DCarbuto%26aufirst%3DM.%26aulast%3DPittman%26aufirst%3DB.%26aulast%3DUdo%2Bde%2BHaes%26aufirst%3DJ.%26aulast%3DSjogren%26aufirst%3DM.%26aulast%3DPeeters%26aufirst%3DP.%26aulast%3DRanganathan%26aufirst%3DM.%26aulast%3DSchipper%26aufirst%3DJ.%26atitle%3DGlycine%2520transporter%2520inhibitor%2520attenuates%2520the%2520psychotomimetic%2520effects%2520of%2520ketamine%2520in%2520healthy%2520males%253A%2520preliminary%2520evidence%26jtitle%3DNeuropsychopharmacology%26date%3D2012%26volume%3D37%26spage%3D1036%26epage%3D1046%26doi%3D10.1038%2Fnpp.2011.295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit36g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Moschetti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liesenfeld, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbrock, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kammerer, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wunderlich, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wind, S.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability and pharmacokinetics of oral BI 425809, a glycine transporter 1 inhibitor, in healthy male volunteers: a partially randomised, single-blind, placebo-controlled, first-in-human study</span>. <i>Eur. J. Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1007/s13318-017-0440-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1007%2Fs13318-017-0440-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=29076028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGgsrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2018&pages=239-249&author=V.+Moschettiauthor=M.+Deschauthor=S.+Goetzauthor=K.+H.+Liesenfeldauthor=H.+Rosenbrockauthor=K.+P.+Kammererauthor=G.+Wunderlichauthor=S.+Wind&title=Safety%2C+tolerability+and+pharmacokinetics+of+oral+BI+425809%2C+a+glycine+transporter+1+inhibitor%2C+in+healthy+male+volunteers%3A+a+partially+randomised%2C+single-blind%2C+placebo-controlled%2C+first-in-human+study&doi=10.1007%2Fs13318-017-0440-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36gR"><div class="casContent"><span class="casTitleNuber">36g</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, Tolerability and Pharmacokinetics of Oral BI 425809, a Glycine Transporter 1 Inhibitor, in Healthy Male Volunteers: A Partially Randomised, Single-Blind, Placebo-Controlled, First-in-Human Study</span></div><div class="casAuthors">Moschetti, Viktoria; Desch, Michael; Goetz, Sophia; Liesenfeld, Karl-Heinz; Rosenbrock, Holger; Kammerer, Klaus-Peter; Wunderlich, Glen; Wind, Sven</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">239-249</span>CODEN:
                <span class="NLM_cas:coden">EJDPD2</span>;
        ISSN:<span class="NLM_cas:issn">0378-7966</span>.
    
            (<span class="NLM_cas:orgname">Springer France</span>)
        </div><div class="casAbstract">Background and objectives: Schizophrenia and Alzheimer's disease are characterised by glutamatergic pathway abnormalities related to N-methyl-D-aspartate (NMDA) receptor hypofunction and cognitive impairment.  Glycine is an NMDA receptor co-agonist; inhibition of glycine transporter 1 (GlyT1) should improve NMDA receptor hypofunction.  This study evaluated safety and pharmacokinetic properties of BI 425809-a potent and selective GlyT1 inhibitor.  Methods: In the single-rising dose (SRD) component of this study, subjects were randomised to a single dose of BI 425809 [doses (mg): 0.5, 1, 2, 5, 10, 25, 50, 100 and 150], or placebo.  The bioavailability/food effect (BA/FE) component investigated BI 425809 pharmacokinetics following single dosing (25-mg tablet) after overnight fasting or with a high-calorie meal or as soln. (25 mg) after overnight fasting.  Results: Overall, 33/83 (39.8%) subjects had ≥ 1 treatment-related adverse event (AE); there were no deaths or serious AEs.  Reported SRD part AEs trended towards dose dependency, occurring at the higher doses (mostly central nervous system related).  BI 425809 plasma concn.-time profiles were similarly shaped across all doses and plasma exposure increased proportional to dose.  In the BA/FE component, geometric mean ratios for the area under the concn.-time curve from time zero to the last measurable concn. and the max. plasma concn. for tablet fasted vs. soln. fasted were 80.5 and 50.0%, resp., and for tablet fed vs. fasted were 125.9 and 142.1%, resp.  Conclusion: BI 425809 was generally well-tolerated at doses expected to be clin. relevant.  The AE profile suggested possible GlyT1-inhibiting effects.  Clin. trial identifier: NCT02068690.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa22AbewOlcrVg90H21EOLACvtfcHk0lg-ufVBFhs5dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGgsrzK&md5=f8a0d2ab87f367aee026b54cfccab3c8</span></div><a href="/servlet/linkout?suffix=cit36g&amp;dbid=16384&amp;doi=10.1007%2Fs13318-017-0440-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13318-017-0440-z%26sid%3Dliteratum%253Aachs%26aulast%3DMoschetti%26aufirst%3DV.%26aulast%3DDesch%26aufirst%3DM.%26aulast%3DGoetz%26aufirst%3DS.%26aulast%3DLiesenfeld%26aufirst%3DK.%2BH.%26aulast%3DRosenbrock%26aufirst%3DH.%26aulast%3DKammerer%26aufirst%3DK.%2BP.%26aulast%3DWunderlich%26aufirst%3DG.%26aulast%3DWind%26aufirst%3DS.%26atitle%3DSafety%252C%2520tolerability%2520and%2520pharmacokinetics%2520of%2520oral%2520BI%2520425809%252C%2520a%2520glycine%2520transporter%25201%2520inhibitor%252C%2520in%2520healthy%2520male%2520volunteers%253A%2520a%2520partially%2520randomised%252C%2520single-blind%252C%2520placebo-controlled%252C%2520first-in-human%2520study%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D2018%26volume%3D43%26spage%3D239%26epage%3D249%26doi%3D10.1007%2Fs13318-017-0440-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span>A Study of Bitopertin (RO4917838) in Combination with Selective
Serotonin Reuptake Inhibitors in Patients with Obsessive Compulsive
Disorder. <a href="https://www.clinicaltrials.gov/ct2/show/NCT01674361" class="extLink">https://www.clinicaltrials.gov/ct2/show/NCT01674361</a> (accessed May 6, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study+of+Bitopertin+%28RO4917838%29+in+Combination+with+Selective%0ASerotonin+Reuptake+Inhibitors+in+Patients+with+Obsessive+Compulsive%0ADisorder.+https%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT01674361+%28accessed+May+6%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, I.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, G. E.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glycine transporter-1 as a novel mechanism for the treatment of depression</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">734</span>– <span class="NLM_lpage">741</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2013.02.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.biopsych.2013.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=23562005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1Cns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2013&pages=734-741&author=C.-C.+Huangauthor=I.-H.+Weiauthor=C.-L.+Huangauthor=K.-T.+Chenauthor=M.-H.+Tsaiauthor=P.+Tsaiauthor=R.+Tunauthor=K.-H.+Huangauthor=Y.-C.+Changauthor=H.-Y.+Laneauthor=G.+E.+Tsai&title=Inhibition+of+glycine+transporter-1+as+a+novel+mechanism+for+the+treatment+of+depression&doi=10.1016%2Fj.biopsych.2013.02.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38aR"><div class="casContent"><span class="casTitleNuber">38a</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Glycine Transporter-I as a Novel Mechanism for the Treatment of Depression</span></div><div class="casAuthors">Huang, Chih-Chia; Wei, I-Hua; Huang, Chieh-Liang; Chen, Kuang-Ti; Tsai, Mang-Hung; Tsai, Priscilla; Tun, Rene; Huang, Kuo-Hao; Chang, Yue-Cune; Lane, Hsien-Yuan; Tsai, Guochuan Emil</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">734-741</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Antidepressants, aiming at monoaminergic neurotransmission, exhibit delayed onset of action, limited efficacy, and poor compliance.  Glutamatergic neurotransmission is involved in depression.  However, it is unclear whether enhancement of the N-methyl-D-aspartate (NMDA) subtype glutamate receptor can be a treatment for depression.We studied sarcosine, a glycine transporter-I inhibitor that potentiates NMDA function, in animal models and in depressed patients.  We investigated its effects in forced swim test, tail suspension test, elevated plus maze test, novelty-suppressed feeding test, and chronic unpredictable stress test in rats and conducted a 6-wk randomized, double-blinded, citalopram-controlled trial in 40 patients with major depressive disorder.  Clin. efficacy and side effects were assessed biweekly, with the main outcomes of Hamilton Depression Rating Scale, Global Assessment of Function, and remission rate.  The time course of response and dropout rates was also compared.Sarcosine decreased immobility in the forced swim test and tail suspension test, reduced the latency to feed in the novelty-suppressed feeding test, and reversed behavioral deficits caused by chronic unpredictable stress test, which are characteristics for an antidepressant.  In the clin. study, sarcosine substantially improved scores of Hamilton Depression Rating Scale, Clin. Global Impression, and Global Assessment of Function more than citalopram treatment.  Sarcosine-treated patients were much more likely and quicker to remit and less likely to drop out.  Sarcosine was well tolerated without significant side effects.Our preliminary findings suggest that enhancing NMDA function can improve depression-like behaviors in rodent models and in human depression.  Establishment of glycine transporter-I inhibition as a novel treatment for depression waits for confirmation by further proof-of-principle studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr8Y9z0DqhkbVg90H21EOLACvtfcHk0lg-ufVBFhs5dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1Cns70%253D&md5=ea387d152da9f33b7baba5b7c07b0320</span></div><a href="/servlet/linkout?suffix=cit38a&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2013.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2013.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.-C.%26aulast%3DWei%26aufirst%3DI.-H.%26aulast%3DHuang%26aufirst%3DC.-L.%26aulast%3DChen%26aufirst%3DK.-T.%26aulast%3DTsai%26aufirst%3DM.-H.%26aulast%3DTsai%26aufirst%3DP.%26aulast%3DTun%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DK.-H.%26aulast%3DChang%26aufirst%3DY.-C.%26aulast%3DLane%26aufirst%3DH.-Y.%26aulast%3DTsai%26aufirst%3DG.%2BE.%26atitle%3DInhibition%2520of%2520glycine%2520transporter-1%2520as%2520a%2520novel%2520mechanism%2520for%2520the%2520treatment%2520of%2520depression%26jtitle%3DBiol.%2520Psychiatry%26date%3D2013%26volume%3D74%26spage%3D734%26epage%3D741%26doi%3D10.1016%2Fj.biopsych.2013.02.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit38b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, S. J.</span></span> <span> </span><span class="NLM_article-title">Glycine transporter-1 inhibitors: a new class of antidepressant?</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">710</span>– <span class="NLM_lpage">711</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2013.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.biopsych.2013.08.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=24144323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Grtr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2013&pages=710-711&author=S.+J.+Mathew&title=Glycine+transporter-1+inhibitors%3A+a+new+class+of+antidepressant%3F&doi=10.1016%2Fj.biopsych.2013.08.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38bR"><div class="casContent"><span class="casTitleNuber">38b</span><div class="casTitle"><span class="NLM_cas:atitle">Glycine Transporter-I Inhibitors: A New Class of Antidepressant?</span></div><div class="casAuthors">Mathew, Sanjay J.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">710-711</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">This article describes about the new class of antidepressant of glycine transporter-I inhibitor.  Drug discovery pathway focuses on compds. that directly or indirectly affect the glycine-B (Gly-B) allosteric modulatory site of the NMDAR are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZiGpKHZCUObVg90H21EOLACvtfcHk0lgFNDJALa5A0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Grtr3P&md5=b2abd7dfa139e09055fd03ada51bff53</span></div><a href="/servlet/linkout?suffix=cit38b&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2013.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2013.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DMathew%26aufirst%3DS.%2BJ.%26atitle%3DGlycine%2520transporter-1%2520inhibitors%253A%2520a%2520new%2520class%2520of%2520antidepressant%253F%26jtitle%3DBiol.%2520Psychiatry%26date%3D2013%26volume%3D74%26spage%3D710%26epage%3D711%26doi%3D10.1016%2Fj.biopsych.2013.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit38c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, I.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, G. E.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glycine tranporter-1 as a novel mechanism for the treatment of depression</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">734</span>– <span class="NLM_lpage">741</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2013.02.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.biopsych.2013.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=23562005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1Cns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2013&pages=734-741&author=C.-C.+Huangauthor=I.-H.+Weiauthor=C.-L.+Huangauthor=K.-T.+Chenauthor=M.-H.+Tsaiauthor=P.+Tsaiauthor=R.+Tunauthor=K.-H.+Huangauthor=Y.-C.+Changauthor=H.-Y.+Laneauthor=G.+E.+Tsai&title=Inhibition+of+glycine+tranporter-1+as+a+novel+mechanism+for+the+treatment+of+depression&doi=10.1016%2Fj.biopsych.2013.02.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38cR"><div class="casContent"><span class="casTitleNuber">38c</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Glycine Transporter-I as a Novel Mechanism for the Treatment of Depression</span></div><div class="casAuthors">Huang, Chih-Chia; Wei, I-Hua; Huang, Chieh-Liang; Chen, Kuang-Ti; Tsai, Mang-Hung; Tsai, Priscilla; Tun, Rene; Huang, Kuo-Hao; Chang, Yue-Cune; Lane, Hsien-Yuan; Tsai, Guochuan Emil</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">734-741</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Antidepressants, aiming at monoaminergic neurotransmission, exhibit delayed onset of action, limited efficacy, and poor compliance.  Glutamatergic neurotransmission is involved in depression.  However, it is unclear whether enhancement of the N-methyl-D-aspartate (NMDA) subtype glutamate receptor can be a treatment for depression.We studied sarcosine, a glycine transporter-I inhibitor that potentiates NMDA function, in animal models and in depressed patients.  We investigated its effects in forced swim test, tail suspension test, elevated plus maze test, novelty-suppressed feeding test, and chronic unpredictable stress test in rats and conducted a 6-wk randomized, double-blinded, citalopram-controlled trial in 40 patients with major depressive disorder.  Clin. efficacy and side effects were assessed biweekly, with the main outcomes of Hamilton Depression Rating Scale, Global Assessment of Function, and remission rate.  The time course of response and dropout rates was also compared.Sarcosine decreased immobility in the forced swim test and tail suspension test, reduced the latency to feed in the novelty-suppressed feeding test, and reversed behavioral deficits caused by chronic unpredictable stress test, which are characteristics for an antidepressant.  In the clin. study, sarcosine substantially improved scores of Hamilton Depression Rating Scale, Clin. Global Impression, and Global Assessment of Function more than citalopram treatment.  Sarcosine-treated patients were much more likely and quicker to remit and less likely to drop out.  Sarcosine was well tolerated without significant side effects.Our preliminary findings suggest that enhancing NMDA function can improve depression-like behaviors in rodent models and in human depression.  Establishment of glycine transporter-I inhibition as a novel treatment for depression waits for confirmation by further proof-of-principle studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr8Y9z0DqhkbVg90H21EOLACvtfcHk0lgFNDJALa5A0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1Cns70%253D&md5=ea387d152da9f33b7baba5b7c07b0320</span></div><a href="/servlet/linkout?suffix=cit38c&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2013.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2013.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.-C.%26aulast%3DWei%26aufirst%3DI.-H.%26aulast%3DHuang%26aufirst%3DC.-L.%26aulast%3DChen%26aufirst%3DK.-T.%26aulast%3DTsai%26aufirst%3DM.-H.%26aulast%3DTsai%26aufirst%3DP.%26aulast%3DTun%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DK.-H.%26aulast%3DChang%26aufirst%3DY.-C.%26aulast%3DLane%26aufirst%3DH.-Y.%26aulast%3DTsai%26aufirst%3DG.%2BE.%26atitle%3DInhibition%2520of%2520glycine%2520tranporter-1%2520as%2520a%2520novel%2520mechanism%2520for%2520the%2520treatment%2520of%2520depression%26jtitle%3DBiol.%2520Psychiatry%26date%3D2013%26volume%3D74%26spage%3D734%26epage%3D741%26doi%3D10.1016%2Fj.biopsych.2013.02.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Bejczy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nations, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szegedi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoemaker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruwe, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soderpalm, B.</span></span> <span> </span><span class="NLM_article-title">Efficacy and safety of the glycine transporter-1 inhibitor Org 25935 for the prevention of relapse in alcohol-dependent patients: a randomized, double-blind, placebo-controlled trial</span>. <i>Alcohol.: Clin. Exp. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">2427</span>– <span class="NLM_lpage">2435</span>, <span class="refDoi"> DOI: 10.1111/acer.12501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1111%2Facer.12501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=25257291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CiurrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2014&pages=2427-2435&author=A.+de+Bejczyauthor=K.+R.+Nationsauthor=A.+Szegediauthor=J.+Schoemakerauthor=F.+Ruweauthor=B.+Soderpalm&title=Efficacy+and+safety+of+the+glycine+transporter-1+inhibitor+Org+25935+for+the+prevention+of+relapse+in+alcohol-dependent+patients%3A+a+randomized%2C+double-blind%2C+placebo-controlled+trial&doi=10.1111%2Facer.12501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and Safety of the Glycine Transporter-1 Inhibitor Org 25935 for the Prevention of Relapse in Alcohol-Dependent Patients: A Randomized, Double-Blind, Placebo-Controlled Trial</span></div><div class="casAuthors">de Bejczy, Andrea; Nations, Kari R.; Szegedi, Armin; Schoemaker, Joep; Ruwe, Frank; Soederpalm, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Alcoholism: Clinical & Experimental Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2427-2435</span>CODEN:
                <span class="NLM_cas:coden">ACRSDM</span>;
        ISSN:<span class="NLM_cas:issn">0145-6008</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background : Org 25935 is a glycine transporter inhibitor that increases extracellular glycine levels and attenuates alc.-induced dopaminergic activity in the nucleus accumbens.  In animal models, Org 25935 has dose-dependent effects on ethanol intake, preference, and relapse-like behavior without tolerance.  The current study aimed to translate these animal findings to humans by examg. whether Org 25935 prevents relapse in detoxified alc.-dependent patients.  Methods : This was a multicenter, randomized, double-blind, placebo-controlled clin. trial.  Adult patients diagnosed with alc. dependence were randomly assigned to receive Org 25935 12 mg twice a day or placebo for 84 days.  The primary end point was percentage heavy drinking days (defined as ≥5 std. drinks per day for men and ≥4 for women).  Secondary end points included other measures of relapse-related drinking behavior (e.g., drinks per day, time to relapse), as well as measures of global functioning, alc.-related thoughts and cravings, and motivation.  Results : A total of 140 subjects were included in the intent-to-treat anal.  The trial was stopped approx. midway after a futility anal. showing that the likelihood of detecting a signal at study term was <40%.  There was no significant difference between Org 25935 and placebo on percentage heavy drinking days or any other measure of relapse-related drinking behavior.  Org 25935 showed no safety issues and was fairly well tolerated, with fatigue, dizziness, and transient visual events as the most commonly occurring side effects.  Conclusions : Org 25935 demonstrated no benefit over placebo in preventing alc. relapse.  Study limitations and implications are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3enmidY5gfbVg90H21EOLACvtfcHk0lgFNDJALa5A0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CiurrI&md5=1a55fa45256187420339b07f25c1dacc</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Facer.12501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Facer.12501%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BBejczy%26aufirst%3DA.%26aulast%3DNations%26aufirst%3DK.%2BR.%26aulast%3DSzegedi%26aufirst%3DA.%26aulast%3DSchoemaker%26aufirst%3DJ.%26aulast%3DRuwe%26aufirst%3DF.%26aulast%3DSoderpalm%26aufirst%3DB.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520the%2520glycine%2520transporter-1%2520inhibitor%2520Org%252025935%2520for%2520the%2520prevention%2520of%2520relapse%2520in%2520alcohol-dependent%2520patients%253A%2520a%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520trial%26jtitle%3DAlcohol.%253A%2520Clin.%2520Exp.%2520Res.%26date%3D2014%26volume%3D38%26spage%3D2427%26epage%3D2435%26doi%3D10.1111%2Facer.12501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, H. Y.</span></span> <span> </span><span class="NLM_article-title">Activation of N-methyl-D-aspartate receptor glycine site temporally ameliorates neuropsychiatric symptoms of Parkinson’s disease with dementia</span>. <i>Psychiatry Clin. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">692</span>– <span class="NLM_lpage">700</span>, <span class="refDoi"> DOI: 10.1111/pcn.12175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1111%2Fpcn.12175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=24612097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWlur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2014&pages=692-700&author=C.+H.+Tsaiauthor=H.+C.+Huangauthor=B.+L.+Liuauthor=C.+I.+Liauthor=M.+K.+Luauthor=X.+Chenauthor=M.+C.+Tsaiauthor=Y.+W.+Yangauthor=H.+Y.+Lane&title=Activation+of+N-methyl-D-aspartate+receptor+glycine+site+temporally+ameliorates+neuropsychiatric+symptoms+of+Parkinson%E2%80%99s+disease+with+dementia&doi=10.1111%2Fpcn.12175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of N-methyl-D-aspartate receptor glycine site temporally ameliorates neuropsychiatric symptoms of Parkinson's disease with dementia</span></div><div class="casAuthors">Tsai, Chon-Haw; Huang, Hui-Chun; Liu, Bey-Ling; Li, Chia-Ing; Lu, Ming-Kuei; Chen, Xianxiu; Tsai, Mu-Chieh; Yang, Yu-Wan; Lane, Hsien-Yuan</div><div class="citationInfo"><span class="NLM_cas:title">Psychiatry and Clinical Neurosciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">692-700</span>CODEN:
                <span class="NLM_cas:coden">PCNEFP</span>;
        ISSN:<span class="NLM_cas:issn">1323-1316</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aim : We have previously found that sarcosine, a glycine transporter I inhibitor, can improve the psychiatric symptoms of schizophrenia.  In this study, we aimed to investigate whether the agent can also ameliorate neuropsychiatric symptoms of Parkinson's disease (PD) patients with dementia.  Methods : An 8-wk, double-blind, placebo-controlled trial was conducted in patients who had PD with dementia (PD-D).  Neuropsychiatric manifestations were measured before and at week 2 (V1), week 4 (V2) and week 8 (V3) after treatment.  Linear regression with the generalized estg. equations was applied for data anal.  Results : Fifteen patients were randomized into a sarcosine group; the other 15 into a placebo group.  The generalized estg. equations model revealed significant differences in Hamilton Depression Rating Scale score (P = 0.049) at V1 and Neuropsychiatry Inventory (P = 0.039) at V2 between the treatment and placebo groups.  By excluding the advanced patients from anal., there were significant differences in Unified Parkinson's Disease Rating Scale V2 (P = 0.004) and V3 (P = 0.040), Hamilton Depression Rating Scale V1 (P = 0.014) and V2 (P = 0.047), Neuropsychiatry Inventory V1 (P = 0.002) and V2 (P < 0.001) and Behavior Pathol. in Alzheimer's Disease Rating Scale V2 (P = 0.025) in favor of sarcosine.  Conclusion : Sarcosine temporally improved depression and neuropsychiatric symptoms in PD-D patients without exacerbating the motor or cognitive features; the beneficial effects were more prominent in patients with mild-moderate severity.  Enhancement of N-methyl-D-aspartate receptor-glycine cascade may lead to a novel path for the management of PD-D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGrjNauNv3FbVg90H21EOLACvtfcHk0liwrt9Jv17MQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWlur%252FP&md5=1de9c6238de84800c8e3603c5bc93995</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1111%2Fpcn.12175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpcn.12175%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DC.%2BH.%26aulast%3DHuang%26aufirst%3DH.%2BC.%26aulast%3DLiu%26aufirst%3DB.%2BL.%26aulast%3DLi%26aufirst%3DC.%2BI.%26aulast%3DLu%26aufirst%3DM.%2BK.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DTsai%26aufirst%3DM.%2BC.%26aulast%3DYang%26aufirst%3DY.%2BW.%26aulast%3DLane%26aufirst%3DH.%2BY.%26atitle%3DActivation%2520of%2520N-methyl-D-aspartate%2520receptor%2520glycine%2520site%2520temporally%2520ameliorates%2520neuropsychiatric%2520symptoms%2520of%2520Parkinson%25E2%2580%2599s%2520disease%2520with%2520dementia%26jtitle%3DPsychiatry%2520Clin.%2520Neurosci.%26date%3D2014%26volume%3D68%26spage%3D692%26epage%3D700%26doi%3D10.1111%2Fpcn.12175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ouellet, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, V.</span></span> <span> </span><span class="NLM_article-title">First-time-in-human study with GSK1018921, a selective GlyT1 inhibitor: relationship between exposure and dizziness</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">597</span>– <span class="NLM_lpage">604</span>, <span class="refDoi"> DOI: 10.1038/clpt.2011.154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1038%2Fclpt.2011.154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=21866096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1WqtbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2011&pages=597-604&author=D.+Ouelletauthor=S.+Sutherlandauthor=T.+Wangauthor=P.+Griffiniauthor=V.+Murthy&title=First-time-in-human+study+with+GSK1018921%2C+a+selective+GlyT1+inhibitor%3A+relationship+between+exposure+and+dizziness&doi=10.1038%2Fclpt.2011.154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">First-Time-in-Human Study With GSK1018921, a Selective GlyT1 Inhibitor: Relationship Between Exposure and Dizziness</span></div><div class="casAuthors">Ouellet, D.; Sutherland, S.; Wang, T.; Griffini, P.; Murthy, V.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">597-604</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The pharmacokinetics (PK), safety, and tolerability of GSK1018921, a glycine transporter 1 (GlyT-1) inhibitor, were assessed in this first-time-in-human (FTIH) study.  Single oral doses ranging from 0.5 to 280 mg and placebo were administered to 25 healthy subjects in a five-period, two-cohort, crossover study.  GSK1018921 showed dose-proportional PK with a terminal half-life of ∼17 h.  The subjects reported dizziness with a dose-dependent frequency of 22-88% at doses of 70-280 mg.  The time course of the dizziness paralleled the PK of the drug, with peak response at 2 h after the dose, consistent with time to max. plasma concn. (Tmax).  The dizziness was resolved by 10-12 h in all subjects.  A Markov-chain logistic regression model was implemented in NONMEM to det. the probability of developing dizziness as a function of the plasma concn. of the compd.  Frequency, onset (<1 h), and offset (4 h) were well described by the model.  Exposure resulting in 80% receptor occupancy is predicted to be well tolerated.  Clin. Pharmacol. & Therapeutics (2011) 90 4, 597-604. doi:10.1038/clpt.2011.154.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBRw2PAoQ5U7Vg90H21EOLACvtfcHk0liwrt9Jv17MQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1WqtbnJ&md5=0d2e46ce8908265c32b02c3bb7bb5a19</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2011.154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2011.154%26sid%3Dliteratum%253Aachs%26aulast%3DOuellet%26aufirst%3DD.%26aulast%3DSutherland%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DGriffini%26aufirst%3DP.%26aulast%3DMurthy%26aufirst%3DV.%26atitle%3DFirst-time-in-human%2520study%2520with%2520GSK1018921%252C%2520a%2520selective%2520GlyT1%2520inhibitor%253A%2520relationship%2520between%2520exposure%2520and%2520dizziness%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2011%26volume%3D90%26spage%3D597%26epage%3D604%26doi%3D10.1038%2Fclpt.2011.154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borroni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hainzl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolidon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narquizian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettekoven, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norcross, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stalder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">5134</span>– <span class="NLM_lpage">5139</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.07.086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.bmcl.2008.07.086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=18752953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFelsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5134-5139&author=E.+Pinardauthor=D.+Alberatiauthor=E.+Borroniauthor=H.+Fischerauthor=D.+Hainzlauthor=S.+Jolidonauthor=J.+L.+Moreauauthor=R.+Narquizianauthor=M.+Nettekovenauthor=R.+D.+Norcrossauthor=H.+Stalderauthor=A.+W.+Thomas&title=Discovery+of+benzoylpiperazines+as+a+novel+class+of+potent+and+selective+GlyT1+inhibitors&doi=10.1016%2Fj.bmcl.2008.07.086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors</span></div><div class="casAuthors">Pinard, Emmanuel; Alberati, Daniela; Borroni, Edilio; Fischer, Holger; Hainzl, Dominik; Jolidon, Synese; Moreau, Jean-Luc; Narquizian, Robert; Nettekoven, Matthias; Norcross, Roger D.; Stalder, Henri; Thomas, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5134-5139</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Screening of the Roche compd. library led to the identification of the benzoylpiperazine I as a structurally novel GlyT1 inhibitor.  The SAR which was developed in this series resulted in the discovery of highly potent compds. displaying excellent selectivity against the GlyT2 isoform, drug-like properties, and in vivo efficacy after oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE1zn7kLXXuLVg90H21EOLACvtfcHk0liwrt9Jv17MQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFelsrnI&md5=766bbdbb096cb09dc27df4c539d98686</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.086%26sid%3Dliteratum%253Aachs%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DAlberati%26aufirst%3DD.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DHainzl%26aufirst%3DD.%26aulast%3DJolidon%26aufirst%3DS.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DNarquizian%26aufirst%3DR.%26aulast%3DNettekoven%26aufirst%3DM.%26aulast%3DNorcross%26aufirst%3DR.%2BD.%26aulast%3DStalder%26aufirst%3DH.%26aulast%3DThomas%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520benzoylpiperazines%2520as%2520a%2520novel%2520class%2520of%2520potent%2520and%2520selective%2520GlyT1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5134%26epage%3D5139%26doi%3D10.1016%2Fj.bmcl.2008.07.086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P. C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skillman, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, A.</span></span> <span> </span><span class="NLM_article-title">Comparison of shape-matching and docking as virtual screening tools</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1021/jm0603365</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0603365" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlansb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=74-82&author=P.+C.+D.+Hawkinsauthor=A.+G.+Skillmanauthor=A.+Nicholls&title=Comparison+of+shape-matching+and+docking+as+virtual+screening+tools&doi=10.1021%2Fjm0603365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of Shape-Matching and Docking as Virtual Screening Tools</span></div><div class="casAuthors">Hawkins, Paul C. D.; Skillman, A. Geoffrey; Nicholls, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-82</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ligand docking is a widely used approach in virtual screening.  In recent years a large no. of publications have appeared in which docking tools are compared and evaluated for their effectiveness in virtual screening against a wide variety of protein targets.  These studies have shown that the effectiveness of docking in virtual screening is highly variable due to a large no. of possible confounding factors.  Another class of method that has shown promise in virtual screening is the shape-based, ligand-centric approach.  Several direct comparisons of docking with the shape-based tool ROCS have been conducted using data sets from some of these recent docking publications.  The results show that a shape-based, ligand-centric approach is more consistent than, and often superior to, the protein-centric approach taken by docking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe0IKOly7zibVg90H21EOLACvtfcHk0liod6Knfh4cKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlansb%252FF&md5=6f97f5c0cc092b4e225f7c2656c1bcf6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm0603365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603365%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DP.%2BC.%2BD.%26aulast%3DSkillman%26aufirst%3DA.%2BG.%26aulast%3DNicholls%26aufirst%3DA.%26atitle%3DComparison%2520of%2520shape-matching%2520and%2520docking%2520as%2520virtual%2520screening%2520tools%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D74%26epage%3D82%26doi%3D10.1021%2Fjm0603365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biftu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha-Roy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuethe, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scapin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krueger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiermann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hicks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salituro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doss, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sewall, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornberry, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A. E.</span></span> <span> </span><span class="NLM_article-title">Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3205</span>– <span class="NLM_lpage">3212</span>, <span class="refDoi"> DOI: 10.1021/jm401992e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401992e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslaltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3205-3212&author=T.+Biftuauthor=R.+Sinha-Royauthor=P.+Chenauthor=X.+Qianauthor=D.+Fengauthor=J.+T.+Kuetheauthor=G.+Scapinauthor=Y.+D.+Gaoauthor=Y.+Yanauthor=D.+Kruegerauthor=A.+Bakauthor=G.+Eiermannauthor=J.+Heauthor=J.+Coxauthor=J.+Hicksauthor=K.+Lyonsauthor=H.+Heauthor=G.+Salituroauthor=S.+Tongauthor=S.+Patelauthor=G.+Dossauthor=A.+Petrovauthor=J.+Wuauthor=S.+S.+Xuauthor=C.+Sewallauthor=X.+Zhangauthor=B.+Zhangauthor=N.+A.+Thornberryauthor=A.+E.+Weber&title=Omarigliptin+%28MK-3102%29%3A+a+novel+long-acting+DPP-4+inhibitor+for+once-weekly+treatment+of+type+2+diabetes&doi=10.1021%2Fjm401992e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Omarigliptin (MK-3102): A Novel Long-Acting DPP-4 Inhibitor for Once-Weekly Treatment of Type 2 Diabetes</span></div><div class="casAuthors">Biftu, Tesfaye; Sinha-Roy, Ranabir; Chen, Ping; Qian, Xiaoxia; Feng, Dennis; Kuethe, Jeffrey T.; Scapin, Giovanna; Gao, Ying Duo; Yan, Youwei; Krueger, Davida; Bak, Annette; Eiermann, George; He, Jiafang; Cox, Jason; Hicks, Jacqueline; Lyons, Kathy; He, Huaibing; Salituro, Gino; Tong, Sharon; Patel, Sangita; Doss, George; Petrov, Aleksandr; Wu, Joseph; Xu, Shiyao Sherrie; Sewall, Charles; Zhang, Xiaoping; Zhang, Bei; Thornberry, Nancy A.; Weber, Ann E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3205-3212</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In our effort to discover DPP-4 inhibitors with added benefits over currently com. available DPP-4 inhibitors, MK-3102 (omarigliptin), was identified as a potent and selective dipeptidyl peptidase 4 (DPP-4) inhibitor with an excellent pharmacokinetic profile amenable for once-weekly human dosing and selected as a clin. development candidate.  This manuscript summarizes the mechanism of action, scientific rationale, medicinal chem., pharmacokinetic properties, and human efficacy data for omarigliptin, which is currently in phase 3 clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGeQnvAA8cBbVg90H21EOLACvtfcHk0liod6Knfh4cKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslaltb4%253D&md5=14b15f61cd5cd6c981d93459ad372e62</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm401992e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401992e%26sid%3Dliteratum%253Aachs%26aulast%3DBiftu%26aufirst%3DT.%26aulast%3DSinha-Roy%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DKuethe%26aufirst%3DJ.%2BT.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DGao%26aufirst%3DY.%2BD.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DKrueger%26aufirst%3DD.%26aulast%3DBak%26aufirst%3DA.%26aulast%3DEiermann%26aufirst%3DG.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DCox%26aufirst%3DJ.%26aulast%3DHicks%26aufirst%3DJ.%26aulast%3DLyons%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DSalituro%26aufirst%3DG.%26aulast%3DTong%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DDoss%26aufirst%3DG.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DS.%2BS.%26aulast%3DSewall%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3DOmarigliptin%2520%2528MK-3102%2529%253A%2520a%2520novel%2520long-acting%2520DPP-4%2520inhibitor%2520for%2520once-weekly%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3205%26epage%3D3212%26doi%3D10.1021%2Fjm401992e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antilla, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klapars, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, S. A.</span></span> <span> </span><span class="NLM_article-title">The copper-catalyzed-arylation of indoles</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">11684</span>– <span class="NLM_lpage">11688</span>, <span class="refDoi"> DOI: 10.1021/ja027433h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja027433h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2002&pages=11684-11688&author=J.+C.+Antillaauthor=A.+Klaparsauthor=S.+A.+Buchwald&title=The+copper-catalyzed-arylation+of+indoles&doi=10.1021%2Fja027433h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fja027433h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja027433h%26sid%3Dliteratum%253Aachs%26aulast%3DAntilla%26aufirst%3DJ.%2BC.%26aulast%3DKlapars%26aufirst%3DA.%26aulast%3DBuchwald%26aufirst%3DS.%2BA.%26atitle%3DThe%2520copper-catalyzed-arylation%2520of%2520indoles%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2002%26volume%3D124%26spage%3D11684%26epage%3D11688%26doi%3D10.1021%2Fja027433h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bassinger, J.</span>; <span class="NLM_string-name">Bookser, B.</span>; <span class="NLM_string-name">Chen, M.</span>; <span class="NLM_string-name">Chung, D. M.</span>; <span class="NLM_string-name">Gupta, V.</span>; <span class="NLM_string-name">Hudson, A.</span>; <span class="NLM_string-name">Kaplan, A.</span>; <span class="NLM_string-name">Na, J.</span>; <span class="NLM_string-name">Renick, J.</span>; <span class="NLM_string-name">Santora, V.</span></span> <span> </span><span class="NLM_article-title">Substituted 2,4,5,6-Tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-Tetrahydro-2H-pyrazolo[4,3-c]pyridine Compounds as GlyT1 Inhibitors</span>. <span class="NLM_patent">US9708334B2</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+Bassinger&author=B.+Bookser&author=M.+Chen&author=D.+M.+Chung&author=V.+Gupta&author=A.+Hudson&author=A.+Kaplan&author=J.+Na&author=J.+Renick&author=V.+Santora&title=Substituted+2%2C4%2C5%2C6-Tetrahydropyrrolo%5B3%2C4-c%5Dpyrazole+and+4%2C5%2C6%2C7-Tetrahydro-2H-pyrazolo%5B4%2C3-c%5Dpyridine+Compounds+as+GlyT1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBassinger%26aufirst%3DJ.%26atitle%3DSubstituted%25202%252C4%252C5%252C6-Tetrahydropyrrolo%255B3%252C4-c%255Dpyrazole%2520and%25204%252C5%252C6%252C7-Tetrahydro-2H-pyrazolo%255B4%252C3-c%255Dpyridine%2520Compounds%2520as%2520GlyT1%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. T.</span></span> <span> </span><span class="NLM_article-title">High throughput artificial membrane permeability assay for bloodbrain barrier</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1016/S0223-5234(03)00012-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughput+artificial+membrane+permeability+assay+for+bloodbrain+barrier&doi=10.1016%2FS0223-5234%2803%2900012-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520bloodbrain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1016%2FS0223-5234%2803%2900012-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mireles, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janiszewski, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Morais, S. M.</span></span> <span> </span><span class="NLM_article-title">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">268</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1124/dmd.107.017434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1124%2Fdmd.107.017434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=17962372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=268-275&author=B.+Fengauthor=J.+B.+Millsauthor=R.+E.+Davidsonauthor=R.+J.+Mirelesauthor=J.+S.+Janiszewskiauthor=M.+D.+Troutmanauthor=S.+M.+de+Morais&title=In+vitro+P-glycoprotein+assays+to+predict+the+in+vivo+interactions+of+P-glycoprotein+with+drugs+in+the+central+nervous+system&doi=10.1124%2Fdmd.107.017434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span></div><div class="casAuthors">Feng, Bo; Mills, Jessica B.; Davidson, Ralph E.; Mireles, Rouchelle J.; Janiszewski, John S.; Troutman, Matthew D.; de Morais, Sonia M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-one structurally diverse marketed central nervous system (CNS)-active drugs, one active metabolite, and seven non-CNS-active compds. were tested in three P-glycoprotein (P-gp) in vitro assays: transwell assays using MDCK, human MDR1-MDCK, and mouse Mdr1a-MDCK cells, ATPase, and calcein AM inhibition.  Addnl., the permeability for these compds. was measured in two in vitro models: parallel artificial membrane permeation assay and apical-to-basolateral apparent permeability in MDCK.  The exposure of the same set of compds. in brain and plasma was measured in P-gp knockout (KO) and wild-type (WT) mice after s.c. administration.  One drug and its metabolite, risperidone and 9-hydroxyrisperidone, of the 32 CNS compds., and 6 of the 7 non-CNS drugs were detd. to have pos. efflux using ratio of ratios in MDR1-MDCK vs. MDCK transwell assays.  Data from transwell studies correlated well with the brain-to-plasma area under the curve ratios between P-gp KO and WT mice for the 32 CNS compds.  In addn., 3300 Pfizer compds. were tested in MDR1-MDCK and Mdr1a-MDCK transwell assays, with a good correlation (R2 = 0.92) between the efflux ratios in human MDR1-MDCK and mouse Mdr1a-MDCK cells.  Permeability data showed that the majority of the 32 CNS compds. have moderate to high passive permeability.  This work has demonstrated that in vitro transporter assays help in understanding the role of P-gp-mediated efflux activity in detg. the disposition of CNS drugs in vivo, and the transwell assay is a valuable in vitro assay to evaluate human P-gp interaction with compds. for assessing brain penetration of new chem. entities to treat CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQyRSOySyGLVg90H21EOLACvtfcHk0li6cPhDoCLXVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D&md5=bbf8b6969bd6d6b3d741b6ef9e7853f3</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.017434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.017434%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DJ.%2BB.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DMireles%26aufirst%3DR.%2BJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26atitle%3DIn%2520vitro%2520P-glycoprotein%2520assays%2520to%2520predict%2520the%2520in%2520vivo%2520interactions%2520of%2520P-glycoprotein%2520with%2520drugs%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D268%26epage%3D275%26doi%3D10.1124%2Fdmd.107.017434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berna, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackermann, B. L.</span></span> <span> </span><span class="NLM_article-title">Quantification of serine enantiomers in rat brain microdialysate using Marfey’s reagent and LC/MS/MS</span>. <i>J. Chromatogr. B: Anal. Technol. Biomed. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>846</i></span>,  <span class="NLM_fpage">359</span>– <span class="NLM_lpage">363</span>, <span class="refDoi"> DOI: 10.1016/j.jchromb.2006.08.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.jchromb.2006.08.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=16962391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKgtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=846&publication_year=2007&pages=359-363&author=M.+J.+Bernaauthor=B.+L.+Ackermann&title=Quantification+of+serine+enantiomers+in+rat+brain+microdialysate+using+Marfey%E2%80%99s+reagent+and+LC%2FMS%2FMS&doi=10.1016%2Fj.jchromb.2006.08.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Quantification of serine enantiomers in rat brain microdialysate using Marfey's reagent and LC/MS/MS</span></div><div class="casAuthors">Berna, Michael J.; Ackermann, Bradley L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">846</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">359-363</span>CODEN:
                <span class="NLM_cas:coden">JCBAAI</span>;
        ISSN:<span class="NLM_cas:issn">1570-0232</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The ability to selectively measure serine enantiomer concns. in rat brain microdialyzate is essential during drug discovery to study the interaction of D-serine with the N-methyl-D-aspartate (NMDA) subtype of the glutamate receptor.  NMDA receptor-stimulating agents, such as D-serine, have been shown to reduce the neg. symptoms and cognitive dysfunction in individuals with schizophrenia when added to conventional or atypical antipsychotic drug regimens.  In the work presented here, an LC/MS/MS assay was developed and validated to simultaneously measure D-serine and L-serine concns. in rat brain microdialyzate.  Reverse phase chromatog. resoln. of the enantiomers was obtained through derivatization with 1-fluoro-2,4-dinitrophenyl-5-L-alanine amide (Marfey's reagent).  The assay was validated to det. concns. over the range of 10-7500 ng/mL using electrospray ionization and multiple reaction monitoring (MRM).  Both intra- and inter-day precision and accuracy were less than 16.5% (RE) and 7% (CV) for both analytes, resp., and assay throughput was increased significantly relative to existing methodologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxbWJSAa3zYbVg90H21EOLACvtfcHk0li6cPhDoCLXVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKgtrY%253D&md5=feae1a6746181a156d9d85f6971fd5f2</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.jchromb.2006.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jchromb.2006.08.029%26sid%3Dliteratum%253Aachs%26aulast%3DBerna%26aufirst%3DM.%2BJ.%26aulast%3DAckermann%26aufirst%3DB.%2BL.%26atitle%3DQuantification%2520of%2520serine%2520enantiomers%2520in%2520rat%2520brain%2520microdialysate%2520using%2520Marfey%25E2%2580%2599s%2520reagent%2520and%2520LC%252FMS%252FMS%26jtitle%3DJ.%2520Chromatogr.%2520B%253A%2520Anal.%2520Technol.%2520Biomed.%2520Life%2520Sci.%26date%3D2007%26volume%3D846%26spage%3D359%26epage%3D363%26doi%3D10.1016%2Fj.jchromb.2006.08.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borhani, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span> <span> </span><span class="NLM_article-title">Molecular determinants of drug-receptor binding kinetics</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">667</span>– <span class="NLM_lpage">673</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2013.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.drudis.2013.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=23454741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksVyrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=667-673&author=A.+C.+Panauthor=D.+W.+Borhaniauthor=R.+O.+Drorauthor=D.+E.+Shaw&title=Molecular+determinants+of+drug-receptor+binding+kinetics&doi=10.1016%2Fj.drudis.2013.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular determinants of drug-receptor binding kinetics</span></div><div class="casAuthors">Pan, Albert C.; Borhani, David W.; Dror, Ron O.; Shaw, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">13-14</span>),
    <span class="NLM_cas:pages">667-673</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  It is increasingly appreciated that the rates at which drugs assoc. with and dissoc. from receptors - the binding kinetics - directly impact drug efficacy and safety.  The mol. determinants of drug-receptor binding kinetics remain poorly understood, however, esp. when compared with the well-known factors that affect binding affinity.  The rational modulation of kinetics during lead optimization thus remains challenging.  We review some of the key factors thought to control drug-receptor binding kinetics at the mol. level - mol. size, conformational fluctuations, electrostatic interactions and hydrophobic effects - and discuss several possible approaches for the rational design of drugs with desired binding kinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAvEt3tx06Z7Vg90H21EOLACvtfcHk0li6cPhDoCLXVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksVyrtr0%253D&md5=df094bb86b1e280b9ddf5a90031b3f32</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2013.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2013.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DA.%2BC.%26aulast%3DBorhani%26aufirst%3DD.%2BW.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26atitle%3DMolecular%2520determinants%2520of%2520drug-receptor%2520binding%2520kinetics%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2013%26volume%3D18%26spage%3D667%26epage%3D673%26doi%3D10.1016%2Fj.drudis.2013.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ennaceur, A.</span></span> <span> </span><span class="NLM_article-title">One-trial object recognition in rats and mice: methodological and theoretical issues</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>215</i></span>,  <span class="NLM_fpage">244</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2009.12.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2Fj.bbr.2009.12.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=20060020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=1%3ACAS%3A280%3ADC%252BC3cfgs1Wjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2010&pages=244-254&author=A.+Ennaceur&title=One-trial+object+recognition+in+rats+and+mice%3A+methodological+and+theoretical+issues&doi=10.1016%2Fj.bbr.2009.12.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">One-trial object recognition in rats and mice: methodological and theoretical issues</span></div><div class="casAuthors">Ennaceur A</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural brain research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">244-54</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The one-trial object recognition task involves memory of a familiar object in parallel with the detection and encoding of a novel object.  It provides the basis for the study of a wide range of cognitive and neuropsychological functions and processes in rats and mice.  However, unlike in humans, primate and pigeon studies, object recognition in rats and mice has been mostly limited to memory while little is known about object perception, affordances and acquisition of a representation of an object.  In the present paper, we addressed some of these issues.  We also described novelty preference models and hypotheses that account for one-trial object recognition and question the validity of the novelty preference concept.  In addition, we discussed whether one-trial object recognition involves working memory and how it involves memory of an episode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9BsdfR84alMkU0YCbOU3EfW6udTcc2eawCrPJ1UmhA7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfgs1Wjsw%253D%253D&md5=d512ab89760b133c25180b9eec1b1a2a</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2009.12.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2009.12.036%26sid%3Dliteratum%253Aachs%26aulast%3DEnnaceur%26aufirst%3DA.%26atitle%3DOne-trial%2520object%2520recognition%2520in%2520rats%2520and%2520mice%253A%2520methodological%2520and%2520theoretical%2520issues%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2010%26volume%3D215%26spage%3D244%26epage%3D254%26doi%3D10.1016%2Fj.bbr.2009.12.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallorga, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemaire, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettibone, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sur, C.</span></span> <span> </span><span class="NLM_article-title">Development of a scintillation proximity assay for analysis of Na<sup>+</sup>/Cl<sup>–</sup> -dependent neurotransmitter transporter activity</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>321</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.1016/S0003-2697(03)00431-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;key=10.1016%2FS0003-2697%2803%2900431-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2003&pages=31-37&author=J.+B.+Williamsauthor=P.+J.+Mallorgaauthor=W.+Lemaireauthor=D.+L.+Williamsauthor=S.+Naauthor=S.+Patelauthor=J.+P.+Connauthor=D.+J.+Pettiboneauthor=C.+Austinauthor=C.+Sur&title=Development+of+a+scintillation+proximity+assay+for+analysis+of+Na%2B%2FCl%E2%80%93+-dependent+neurotransmitter+transporter+activity&doi=10.1016%2FS0003-2697%2803%2900431-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0003-2697%2803%2900431-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0003-2697%252803%252900431-7%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DJ.%2BB.%26aulast%3DMallorga%26aufirst%3DP.%2BJ.%26aulast%3DLemaire%26aufirst%3DW.%26aulast%3DWilliams%26aufirst%3DD.%2BL.%26aulast%3DNa%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DConn%26aufirst%3DJ.%2BP.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DAustin%26aufirst%3DC.%26aulast%3DSur%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520a%2520scintillation%2520proximity%2520assay%2520for%2520analysis%2520of%2520Na%252B%252FCl%25E2%2580%2593%2520-dependent%2520neurotransmitter%2520transporter%2520activity%26jtitle%3DAnal.%2520Biochem.%26date%3D2003%26volume%3D321%26spage%3D31%26epage%3D37%26doi%3D10.1016%2FS0003-2697%2803%2900431-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i86"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00372">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_77005"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00372">10.1021/acs.jmedchem.8b00372</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Off-target selectivity panel for compound <b>46</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00372/suppl_file/jm8b00372_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (SMILES data) and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00372/suppl_file/jm8b00372_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00372/suppl_file/jm8b00372_si_001.pdf">jm8b00372_si_001.pdf (240.98 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00372/suppl_file/jm8b00372_si_002.csv">jm8b00372_si_002.csv (4.09 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00372&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-14%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00372%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00372" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799ac443f02d956","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
